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A range of fluorophosphite, diphosphite and pyridylphosphine ligands have been prepared and 
their application in alkene hydroformylation or alkyne methoxycarbonylation catalysis explored. 
In addition, 9-phospha[3.3.1]bicyclononane (Phobane, PhobPH) derived ligands have been 
applied in Rh-catalysed asymmetric hydrogenation. The coordination chemistry of all the ligands 
has been investigated to probe their catalytic performance.  
A series of cyclic fluorophosphites L2.1-2.4, containing 5- to 8-membered phosphacycles, derived 
from 1,2-catechol, 1,8-naphthalenediol, 2,2’-biphenol or bis(2-hydroxyphenyl)methane, have 
been synthesised and the effect of ring size on coordination has been probed. The 5- and 6-
membered fluorophosphites L2.6-2.8, containing alkyl substituents on the catechol or naphthalene 
rings, have also been synthesised. The IR spectra of the cis-[Mo(CO)4L2] complexes (L = L2.1-2.8) 
show the -acceptor properties of the fluorophosphites increase with decreasing ring size, and in 
terms of /-bonding sit between PF3 and P{(OAr)3}. The effect of aryl substitution on the 
electronic properties of the ligand appear to be minimal. The IR data for cis-[Mo(CO)4(L2.5)2] (L2.5 
is the methoxy phosphite derived from 1,8-naphthalenediol) reflect the significant difference in 
electronics between ligands containing a P-F and P-OMe fragment. Reaction of the ligands L2.2-2.8 
with [PtCl2(cod)] give the cis-[PtCl2L2] complexes. The reaction of [Pt(nbe)3] with 4 equiv. of L2.1-2.5 
yields the [PtL4] complexes. Whereas, using 2 equiv. of the ligand, equilibrium mixtures of 
[PtLx(nbe)y] species form. There is a trend in the CO substitution reactions of [Rh2Cl2(CO)4] with 
L2.1-2.8: as the ring size and aryl substitution of the fluorophosphite increase, the properties move 
away from that of PF3 towards phosphite L2.5.  
Ligands L2.1-2.8 have been tested in the Rh-catalysed hydroformylation of 1-hexene. The 5-
membered fluorophosphites display no hydroformylation activity due to their high susceptibility 
to hydrolysis. Whereas, the other ligands display good catalyst performance; the 6-membered 
fluorophosphites, L2.2 and L2.8, give the most active and n-selective catalysts. Upon increasing the 
concentration of the 6- and 7-membered fluorophosphites, the n-selectivity significantly increases, 
albeit with a diminution in activity. The selectivity and activity are also sensitive to the catalytic 
conditions used; the n-selectivity is higher under “concentrated-catalyst” conditions.  
A novel route to cyclic chlorophosphites and aryl dichlorophosphites has been developed which 
involves a silicon-phosphorus exchange reaction. The novel 6-membered diphosphite L4.2 derived 
from 1,8-naphthalenediol has been prepared. The (CO) value for cis-[Mo(CO)4(L4.2)] shows L4.2 
is a significantly stronger -acceptor than its monophosphite analogue, L2.5. Reaction of L4.2 with 
[PtMe2(cod)] gives the cis-[PtMe2(L4.2)] complex. Diphosphites L4.1-4.3, containing 5- to 7-
membered phosphacycles, have been tested in the Rh-catalysed hydroformylation of 1-hexene. 
The 6-membered L4.2 shows promising catalyst performance, but high concentrations of ligand 
inhibit catalysis.  
6-Chloro-2-(diphenylphosphino)pyridine, L5.2, has been synthesised and tested in the Pd-catalysed 
methoxycarbonylation of phenylacetylene, and produces a more active catalyst than Ph2P(2-Py) 
(L5.1). The Pt(II) and Pd(II) coordination of L5.2 show the ligand can adopt both к1-P and к2-P,N 
coordination modes, a feature that is key to the catalytic mechanism proposed. The dialkyl 2-
pyridyl phosphines, R2P(2-Py) (L5.3-5.5), have been prepared and tested in the Pd-catalysed 
methoxycarbonylation of phenylacetylene. When R = tBu, the ligand L5.3a gives a highly active 
and branched-selective catalyst, comparable to that with L5.1. This reaction has been scaled up 
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successfully in collaboration with Lucite and in addition displays similar branched-selectivity to 
L5.1 in the catalytic methoxycarbonylation of propyne. In contrast, the Cy2P and s-PhobP (9-
phospha[3.3.1]bicyclononane) derived ligands L5.4-5.5 display poor catalytic performance in the 
methoxycarbonylation of phenylacetylene. The tBu2P derived ligand L5.3a displays the strongest 
preference for P,N-chelation to Pt, Pd and Rh. In addition, L5.3a readily protonates at the pyridyl-
N. Both of these properties are likely critical to the excellent catalyst performance of L5.3a. 
The cis-[Rh(cod*)L2][OTf] complexes, where L = PhobPR (R = nBu or iBu) L5.1-5.5, have been 
prepared. The chiral diene (bicyclo[3.3.1]nona-2,6-diene, cod*) is used in a successful resolution 
of the chiral anti-conformations ( and ) of the complexes (up to 96%). The enantiopure cis-
[Rh((S,S)-cod*)(L6.1)2][OTf] complex has been tested in the Rh-catalysed asymmetric 
hydrogenation of MAA (methyl-2-acetamidoacrylate). No enantioselectivity is observed at -20 °C 
due to the lack of optical stability. Unfortunately, at lower temperatures (-40 °C), no conversion 
is detected. NMR studies of the catalysis show the hydrogenation of the catalyst precursor cis-
[Rh(cod*)(L6.1)2]+ is extremely slow. The crystal structure of cis-[Rh(cod*)(L6.1)2]+ suggests this is 
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The following chapter includes a brief introduction to the properties of phosphorus 
ligands and an overview of the coordination chemistry and catalytic applications of 
fluorophos ligands, including PF3, fluorophosphines and fluorophosphites as ligands. 
This will put into context the research work described in succeeding Chapters 2 and 3. 
Chapters 4 – 6 are self-contained, since the areas of research discussed have been more 
recently reviewed. 
1.1 Properties of phosphorus(III) ligands  
Phosphorus ligands have found extensive application in late-transition metal 
homogeneous catalysis.1,2 One of the crucial features of phosphorus ligands is their high 
level of tunability; changing the substituents at the phosphorus centre alter the -donor 
and -acceptor properties as well as the steric properties of the ligand.1 Factors that affect 
metal-phosphorus bonding and the reactivity of P-ligand complexes have been quantified, 
which facilitates the design and optimisation of new and existing catalysts.1   
1.1.1 Electronic ligand parameters 
Phosphorus-metal bonding is synergic with both -donor and -acceptor components. 
The lone pair of the P-ligand can -donate into a vacant d-orbital on the metal with the 
correct symmetry (Figure 1.1a).1,2 While an empty orbital on the P-ligand with -symmetry 
can accept electron density from a filled d-orbital on the metal atom (Figure 1.1b).1,3 There 
has been much debate about which empty P-ligand orbitals are involved in the -bonding, 
but the prevailing view is that it involves the antibonding *-orbitals.1,2 Experimental 
evidence presented by Orpen and Connelly suggested that this -accepting orbital is a 
hybrid of the P-* and P-3d orbitals (Figure 1.2).3,4         
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Figure 1.2 Hybridisation of P-* orbitals, involved in the -component of M-P bonding.   
The -donor and -accepting properties of a P(III)-ligand can be controlled by the 
electronics of the substituents bonded to the phosphorus: the -donor ability of the ligand 
increases when using electron-donating R-substituents (e.g. alkylphosphines). Whereas, 
electron-withdrawing R-substituents increase the -accepting capacity of the ligand (e.g. 
fluorophosphines). The electronic properties of a ligand can be assessed by measuring the 
stretching frequency of coordinated carbonyl ligands ((CO), A1) in transition metal 
complexes.5,6 Tolman defined the electronic parameter, , which is based on the (CO) 
of nickel complexes of the type [Ni(CO)3L], with L = tBu3P as a reference.
5,7 The 
electronic parameter () for other phosphorus ligands is defined as the difference between 
the (CO) (A1) of [Ni(CO)3L] and [Ni(CO)3(tBu3P)] (in cm
-1).1,5 Alternatively, the (CO) 
(A1) of cis-[Mo(CO)4L2] complexes can be used since it is linearly related to Tolman’s 
electronic parameter.8 The (CO) stretch of trans-[RhCl(CO)L2] complexes has also been 
previously used.6,9 
1.1.2 Steric ligand parameters  
The steric properties of a phosphorus ligand can also greatly affect their donor properties. 
Tolman’s cone angle (θ) is the most commonly used concept of measuring the steric bulk 
of monophosphine ligands (Figure 1.3a); it is defined as the angle at the metal centre 
formed by the cone which encompasses all the atoms in the ligand, where the phosphorus 
centre is located 2.28 Å away from the metal (a typical Ni-P bond distance).1,7  
* 3d P- 
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White et al. developed another approach to measure the steric bulk around the metal: the 
solid angles concept (Figure 1.3b).1,10 The van der Waals radii of the ligand atoms are 
projected onto the van der Waals surface of the metal, constructed from either the crystal 






Figure 1.3 Steric parameters of a phosphorus ligand: (a) Tolman’s definition of a cone 
angle and (b) White’s definition of the solid angle.        
1.2 Coordination chemistry of PF3 
The first PF3 transition metal complex dates back to 1890 and the synthesis of cis-
[PtF2(PF3)2] by Moissan.
11 However, it was not until the 1950s, following the synthesis of 
cis-[PtCl2(PF3)2] and [Pt2Cl4(PF3)2], that metal-PF3 chemistry advanced mainly due to the 
extensive work of Kruck and Nixon.12–15 The coordination chemistry of PF3 has been 
reviewed up to the early 1990s.11–13,16,17  
In the last 3 decades, the field of homoleptic metal complexes of PF3 has received scant 
attention. This may be attributed to PF3 being a poisonous and expensive gas which is 
difficult to obtain in large amounts and high purity.18,19 
Herein, the transition metal chemistry of PF3 since the 1990s will be summarised. 
1.2.1 Metal-PF3 bonding  
Trifluorophosphine has an iconic status in coordination chemistry as a ligand that has -
acceptor properties that rival or exceed those of CO,12 as demonstrated by their respective 
Tolman electronic parameters: 2111 cm-1 for PF3 and 2128 cm
-1 for CO.20,21 Further 
evidence for this is that the complexes [M(CO)4] (M = Pd, Pt) only have fleeting existence 
in Ar matrices at <10 K, whereas the PF3 analogues [M(PF3)4] are relatively stable.
22–25 In 
addition, the [Ni(PF3)4] complex is known to be more stable than the analogous 
[Ni(CO)4].
26 The strong back-bonding of PF3 is related to the presence of three highly 
electronegative fluorine atoms. 
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1.2.2 More recent developments in the coordination chemistry of PF3 
Many of the current applications of PF3 are found in materials science in photovoltaic 
devices and chemical vapour deposition (CVD) applications, specifically the use of 
[Ni(PF3)4] and [Pt(PF3)4] complexes.
27–30   
Although it has been frequently used in CVD, the chemistry of [Pt(PF3)4] remained little 
developed.19 However, Seppelt et al. have carried out a systematic study of the chemistry 
of [Pt(PF3)4], where a large number of other Pt-PF3 complexes were prepared and 
characterised by X-ray crystallography.19 They further investigated the thermal 
decomposition of [Pt(PF3)4] to [Pt4(PF3)8], which was first reported in 1997.
31  
The extensive research into the Pt coordination chemistry of PF3 has been reviewed by 
Nixon and Heuer.11,16 In 2013, Seppelt et al. synthesised the volatile complex cis-
[PtMe2(PF3)2] (Scheme 1.1) alongside the analogous CO and dfmpe (dfmpe = 
(CF3)2PC2H4P(CF3)2) complexes.
32 Demethylation reactions using anhydrous HF were 
carried out in an attempt to obtain the partially stabilised “half-naked” L2Pt
2+ complexes. 
However, this was not achieved with the PF3 and CO analogues.
32 Reactions with 
[PtMe2(dfmpe)] were more successful due to its higher stability; the crystal structure of 
[Pt(dfmpe)][Sb2F11] was obtained.
32 Nevertheless, HF was always bound to Pt in the 
presence of HF and xenon.32 Recently, trans-[PtF(PF3)(Cy3P)2][PF6] was synthesised by P-
F bond activation of PF5 using the Pt(0) complex, [(Cy3P)2Pt] (where Cy = cyclohexyl); 





Scheme 1.1 Synthesis of cis-[PtMe2(PF3)2].
32  
Since the 1990s there have been many reports of metal complexes containing both PF3 
and CO. In 1993, Huang et al. described the synthesis of the cis-[W(CO)4(Ph3P)L] 
complexes, where L = PF3 or other fluorophosphines, and studied their reactivity with 
Me3NO in MeCN.
34 For each complex, the fluorophosphine was eliminated instead of 
the CO ligand and the resulting complexes, cis-[W(CO)4(Ph3P)(MeCN)], were identified.
34 
This reactivity suggests that the CO ligands are less susceptible to nucleophilic attack by 
the amine oxide than the fluorophosphines.34 They also reported the synthesis of the 
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novel complex [W(PF3)4(dppe)] from the photolysis of [W(CO)4(dppe)] in the presence 
of a large excess of PF3.
34 More recently, similar [M(CO)5(PX3)] complexes (where M = 
Cr, Mo, W; X = H, Me, F, Cl) have been studied in order to assess the nature of the metal-
ligand bonding.35 It was shown that -bonding contributes to approximately 50% of the 
total orbital interaction of the M-P bond in the PF3 and PCl3 analogues.
35 Complete 
analysis of the complicated NMR spectra of such complexes has also been carried out, 
for example for [Mo(CO)3(PF3)3].
36 The substitution of  binuclear complexes, [M2(CO)10] 
(M = Mn, Tc, Re), with PF3 has also been investigated.
37,38 Incomplete substitution of the 
CO ligands with PF3 was observed in all cases. When M = Mn, only four CO ligands were 
displaced by PF3.
37 Whereas, for the Tc complex up to eight of the CO ligands were 
displaced, and up to ten for the Re analogue.38  
Metal complexes containing bridging PF3 groups are very rare relative to those containing 
terminal PF3 groups and bridging CO groups, despite reports of complexes containing a 
µ3-PF3 bridging ligand in the 1990s (e.g. 1.1).
39,40 King et al. have recently presented several 
density functional theory studies on the reasons for the lack of binuclear transition metal 
complexes containing bridging PF3 groups.
18,41–44 They have suggested that this is due to 
the energetically unfavourable hypervalent coordination of a bridging PF3.
44 To facilitate 
this penta-coordinate P-centre, a high energy d-orbital or a three-centre four-electron 
system must be involved in the bonding.44 In contrast, bridging CO ligands involve only 






While there are abundant examples of transition metal complexes of PF3, compounds 
containing homoleptic metal-PF3 cations are rare.
45 In 1992, [Au(PF3)Cl] was first 
reported46 and has recently been characterised by X-ray crystallography.47 The [Au(PF3)Cl] 
complex was shown to be more stable than its CO analogue.46 In addition, Kruck et al. 
reported the preparation of [Au(PF3)(CF3)], but due to its thermal instability the complex 
was only characterised by mass spectrometry.48 The complex, [Au(PF3)2][Sb2F11], was the 
first example of a linear thermally stable metal (PF3)2 complex; it was prepared by CO 
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displacement of [Au(CO)2][Sb2F11] by PF3.
45 The cation, [Au(PF3)2]
+, was also obtained in 
either HSO3F or SO2 solution, from the reduction of [Au(SO3F)3] with PF3.
45   
In 2004, Jagirdar et al. reported the novel dicationic dihydrogen complexes, trans-[M(η2-
H2)(PF3)(diphosphane)2]
2+ (where M = Fe or Ru, diphosphane = dppe or dppm).49 Only 
one other example of a dihydrogen complex with PF3 is known.
50 The complex, trans-
[Ru(η2-H2)(PF3)(dppe)2]
2+, displayed remarkable stability with respect to the loss of the 
bound H2.
49  
In 1995, Howard et al. described the synthesis of the Al(0) species [Al(PF3)2] and compared 
its magnetic properties to those of [Al(CO)2].
51 The magnetic parameters of [Al(PF3)2] 
were similar to that of [Al(CO)2], suggesting that both complexes have similar structures 
with C2V symmetry and the same electronic ground state (
2B1).
51  
1.3 Coordination chemistry of fluorophosphines  
To the best of our knowledge, there are no reviews on the coordination chemistry of 
phosphorus-fluorine ligands. Therefore, a review of transition metal complexes of 
monofluorophosphine (R2PF), difluorophosphine (RPF2), fluorophosphite {(RO)2PF} 
and difluorophosphinite (ROPF2) ligands will be presented herein. There are a few 
examples of metal complexes of bidentate difluorophosphines32,52–54 and 
difluorophosphinites,55–59 but these will not be discussed. Complexes of amino-
fluorophosphine complexes are also known, but will not be discussed.60   
1.3.1 Disproportionation of fluorophosphines 
Unlike trifluorophosphine, the stereoelectronics of fluorophosphines, RxPFy (x + y = 3), 
can be modified via substituent effects. Fluorophosphines can be readily prepared from 
their corresponding chlorophosphine, RxPCly. In 1958, Brendel et al. reported the first 
synthesis of a fluorophosphine.61 In general, fluorophosphines are strong -acceptors due 
to the high electronegativity of the fluorine atoms (depending on the R substituent), but 
have rarely been explored as ligands for transition metals.21 There are few reported 
applications of fluorophosphines in catalysis, perhaps due to their instability with respect 
to redox disproportionation in spite of their strong P-F bond (545 kJ mol-1, cf. C-H = 418 
kJ mol-1) (Scheme 1.2).62–64 This disproportionation reaction is well established and has 
been extensively studied by Schmutzler and others.65–67 The following observations were 
made: (1) fluorophosphines such as Ph2PF, Me2PF and nBu2PF are highly susceptible to 
disproportionation; (2) fluorophosphines containing bulky substituents, such as tBu2PF, 
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or electron-withdrawing substituents, such as (C6F5)2PF or (CF3)2PF, are thermally 
stabilised to disproportionation.61,68–70  
 
 
Scheme 1.2 Disproportionation of fluorophosphines, R2PF.  
1.3.2 Ni coordination chemistry 
Analogous to PF3, some fluorophosphine ligands efficiently stabilise zerovalent metal 
complexes. In the late 1960s, Nixon et al. reported the synthesis of zerovalent NiL4 
complexes of several mono- and difluorophosphines, such as (CF3)2PF, (CF3)PF2 and 
(CCl3)PF2.
71,72 The complexes were synthesised by the reaction of Ni (formed from the 
decarboxylation of nickel oxalate) with the phosphine at 60 – 80 °C.71 [Ni{(CF3)PF2}4] 
had been previously synthesised by Street et al. from [Ni(CO)4];
73 NiL4 complexes were 
typically prepared via this route but would often produce mixed carbonyl phosphine 
complexes.74 In 1961, Schmutzler reported the synthesis of the difluorophosphine 
complexes [NiL4], where L = PhPF2 and MePF2; these complexes have also been reported 
by other research groups.75–79 
Nixon et al. have reported detailed analyses of the 1H, 19F and 31P NMR spectra of [NiL4] 
complexes, where L is a range of mono- and difluorophosphines such as (CF3)2PF, 
(CF3)PF2 and (CCl3)PF2; the corresponding coupling constants were calculated from the 
spectra.72,74,80,81  
Schmutzler et al. have studied the 31P and 19F NMR spectra of NiL4 complexes of 
numerous mono- and difluorophosphines and fluorophosphites (see Section 1.4.1); they 
observed that almost invariably, the 1JP,F value of the ligands decreased upon 
coordination.82 Cassoux et al. also studied the [NiL4] complexes, where L = Ph2PF and 
PhPF2.
83  
In 1971, Schmutzler reported the synthesis of the first stable dialkylfluorophosphine, 
tBu2PF.
84 To assess the electronic properties of tBu2PF and tBuPF2 the corresponding 
[Ni(CO)3L] complexes were prepared and analysed by IR and NMR spectroscopy.
82,84 The 
stretching frequencies, (CO) (A1), were compared to the corresponding PF3 and tBu3P 
complexes, and it was shown that the -acceptor character increases in the order PF3 > 
tBuPF2 > tBu2PF > tBu3P.
84 This trend is also reflected in the change of NMR 
parameters.84  
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The 2-thienyldifluorophosphine ligand, 1.2, was synthesised by Schmutzler et al. from the 
corresponding dichlorophosphine; the ligand was not entirely stable to redox 
disproportionation.85 Nevertheless, the zerovalent [Ni(1.2)4] complex was prepared from 
the reaction of [Ni(CO)4] with 1.2, this was also then oxidised to give the Ni(II) complex, 
[NiI2(1.2)2].
85   
 
 
The Ni(II) complex, [NiBr2(tBu2PF)2], was first synthesised in 1973 from anhydrous nickel 
dibromide (Scheme 1.3) and its crystal structure confirmed the trans-square planar 
geometry around the Ni centre.86 The molecular structure also provided evidence for a 
theoretical study reported by Crasnier et al., where it was shown that the CPC angle was 
higher for the tBu2PF complex than in tBu3P.
87 The synthesis of [NiBr2(tBu2PF)2] was 
repeated in 1978 and its properties summarised.88 The [NiX2(tBu2PF)2] complexes, where 
X = Cl or I, have been synthesised and the resulting NMR, IR and UV spectra confirmed 
their trans-square planar geometries.86,89 For the chloro analogue, a cis-trans equilibrium 
existed in solution.89  
 
 
Scheme 1.3 Synthesis of trans-[NiBr2(tBu2PF)2].
86 
1.3.3 Pt and Pd coordination chemistry  
Stabilisation of low oxidation state transition metals by fluorophosphines has been further 
demonstrated through the synthesis of the zerovalent [PtL4] complexes, where L = PF3, 
(CF3)PF2, PhPF2 and (CF3)2PF.
71,90,91 Nixon et al. prepared such complexes from the 
reaction of [PtCl2] and an excess of fluorophosphine (Scheme 1.4); this reaction 
demonstrates the strong reducing nature of fluorophosphines as well as their coordinating 
ability.71 In contrast to the PPh3 analogue, the fluorophosphine Pt(0) complexes displayed 
remarkable stability to alkyl halides, hydrogen chloride, ethylene and carbon disulphide.90 
This difference in reactivity was attributed to fluorophosphines being significantly weaker 
-donors and stronger -acceptors than PPh3, which leads to reduced electron density at 
the metal centre, minimising its propensity to dissociate to more reactive intermediates.90  
 






Scheme 1.4 Synthesis of zerovalent PtL4 complexes.   
The [PtL4] complexes in Scheme 1.4 were stable to ligand dissociation, unlike many 
[Pt(PR3)4] complexes. A series of [Pt(triphos)P’] complexes were synthesised by Meek
92 
and later by Nixon93 where triphos = MeC(CH2PPh3)3 and P’ = a range of phosphines 
including the fluorophosphines (CF3)2PF, (PhO)PF2 and (Cl2CH)PF2. Meek and Nixon 
both carried out detailed analysis of the corresponding 31P NMR spectra.92,93  
More recently, in 2004 Perutz et al. showed that the reaction of the Pt(0) [Pt(PR3)2] (R = 
iPr, Cy) with pentafluoropyridine in THF gave the fluorophosphine complexes, 
[Pt(R2PF)(PR3)(4-C5NF4)(R)], where R = iPr or Cy (Scheme 1.5a).
94 The complexes were 
characterised by multinuclear (1H, 31P, 19F and 195Pt) NMR spectroscopy.94 The Cy 
analogue was characterised by X-ray crystallography, which showed a square planar 
geometry about the Pt centre.94 This reaction is an elegant example of both C-F and P-C 
activation.94 On the other hand, when the reaction was carried out in hexane (where R = 
Cy), C-H activation occurred to form cis-[Pt(H)(PCy3)2(4-C5NF4)], which isomerised to 
the trans isomer upon photolysis (Scheme 1.5b); it was suggested that the source of the 
hydride in the complex was one of the C-H bonds of PCy3.
94 In contrast, upon reaction 
with the palladium analogues, [Pd(PR3)2] (R = Cy, iPr), C-F oxidation occurred to form 
the complexes, trans-[Pd(F)(PR3)2(4-C5NF4)].









Scheme 1.5 Reaction of pentafluoropyridyine at Pt(0) in different solvents.  
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Platinum(II) complexes of fluorophosphines were primarily investigated in the late 1980s 
and early 1990s by Schmutzler et al. In 1988, they synthesised several ArPF2 (such as 1.3 
– 1.5); the substituents in the 2- and 6-position were shown to sterically protect the PF2 
centre from disproportionation.95 The cis-[PtCl2L2] complexes, where L = 1.3 – 1.5, were 
synthesised and their NMR and mass spectra reported.95 Schmutzler et al. also described 
the synthesis of a range of novel cyclopentadienyl-difluorophosphines (e.g. 1.6) and the 
corresponding cis-[PtCl2L2] complexes.
96 The analogous cis-[PtCl2L2] complexes, where L 
= tBuPF2, AdPF2 and trtPF2 and Ad = adamantyl, trt = triphenylmethyl, have also been 






Schmutzler et al. synthesised the difluorophosphine derivative of anthracene (1.7) and its 
cis-[PtCl2L2] complex.
99,100 The unusual aryldifluorophosphine 1.8 was also reported and 
an intramolecular interaction between the NMe2 group and the phosphorus atom of PF2 
was suggested.101 They synthesised the corresponding cis-[PtCl2(1.8)2] complex, which was 
characterised by X-ray crystallography.101 The crystal structure showed a pronounced 
distortion from tetrahedral to trigonal bipyramidal geometry around the P atom; it was 
suggested that this was as a result of the attractive interaction between the nitrogen and 
phosphorus atoms of 1.8.101  
Schmutzler et al. synthesised the cis-[PtCl2L2] complexes, where L is the 
arylfluorophosphines, 1.9 and 1.10.102,103 The complexes were characterised by X-ray 
crystallography, which showed bond lengths in the expected range based on previously 
synthesised difluorophosphine Pt(II) complexes.102–104 The crystal structures confirmed 
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Cavell et al. reported the synthesis of the difluoro-diazophosphole 1.11 from the reaction 
of its corresponding dichlorophosphine and NaF.105 Detailed analysis of the ligand’s 
NMR spectra was carried out.105 The coordination chemistry of 1.11 was investigated 
through the synthesis of cis-[PtCl2(1.11)2].
106 In addition, it was shown that the reaction of 
2 equiv. of 1.11 to [PtClMe(cod)] gave the expected cis-[PtMeCl(1.11)2] product.
106 
However, using an excess of ligand 1.11 gave the zerovalent complex [Pt(1.11)4], where 
the Pt(II) centre has been reduced to Pt(0).106 The product was structurally characterised 
and showed the ligands coordinated via the exocyclic phosphine.106   
More recently, the aryl fluorophosphine 1.12 was reacted with the chloro-dimer, trans-
[Pt2Cl2(µ-Cl)2(PEt3)2] in a 2:1 ratio to give the mononuclear trans-[PtCl2(PEt3)(1.12)] 







Scheme 1.6 Synthesis of trans-[PtCl2(PEt3)L], where L = 1.12.
107  
In contrast to platinum, there are few reports of palladium complexes of 
fluorophosphines. Wild et al. achieved the first resolution of a free fluorophosphine, rac-
Ph(iPr)PF, through fractional crystallisation of the diastereomeric Pd binuclear complexes 
(Scheme 1.7), where the (R,RP) diastereomer was less soluble than the (R,SP) isomer.
108,109 
Optically pure (S)-Ph(iPr)PF was liberated from the (R,RP) diastereomer and obtained in 
a good yield of 64%.108,109  











Scheme 1.7 Resolution of Ph(iPr)PF using Pd complexation.108,109  
In 1992, the synthesis of the first fluorophosphine Pd(II) complex was described; the 
reaction of 2 equiv. of ligand with [PdCl2(cod)] gave the cis-[PdCl2L2] complexes, where L 
= tBuPF2 or AdPF2..
97 The analogous reaction using L = trtPF2 (trt = triphenylmethyl)   
to give cis-[PdCl2L2] was reported in 1995.
98  
The coordination chemistry of the difluoro-diazophosphole 1.11 was extended to 
palladium by Cavell et al.106 The reaction of ligand 1.11 with [PdCl2(cod)] gave a mixture 
of the zerovalent complex, [Pd(1.11)4] and the Pd(II) complex, [PdCl2(1.11)2]; [Pd(1.11)4] 
was also synthesised from [Pd2(dba)3] (dba = dibenzylideneacetone) to confirm this 
assignment.106          
1.3.4 Mo(0) coordination chemistry  
Stelzer et al. have synthesised a range of cis-[Mo(CO)4L2] complexes, where L = R(3-n)PXn 
and X = Cl, F or H; their CO stretching frequencies and force constants were measured 
to assess the -donor and -acceptor properties of the phosphine ligands.110 The -
acceptor character of fluorophosphines, tBu2PF and tBuPF2, has also been explored by 
Stelzer et al. through the synthesis of the corresponding Mo(CO)5L, cis-[Mo(CO)4L2] 
(Scheme 1.8) and cis-[Mo(CO)3L3] complexes.
84,88 The IR data from each of these studies 
showed that the -acceptor capacity of the phosphines increase in the order PF3 > tBuPF2 
> tBu2PF > tBu3P.
84 Complete analysis of the NMR spectra was also carried out to obtain 
the spin coupling constants and was consistent with the observed trend in electronics.84     






Scheme 1.8 Synthesis of cis-[Mo(CO)4L2] complexes, where L = tBu2PF and tBuPF2.
84  
The 31P and 19F NMR spectra of cis-[Mo(CO)4L2] and fac-[Mo(CO)3L3] complexes using 
numerous fluorophosphines (e.g. (CF3)PF2, (CF3)2PF, (ClCH2)PF2 and PhPF2) have been 
analysed by Nixon and Schmutzler.75,81,82,111 The coupling constants were accurately 
calculated and it was shown that the 2JP,P values increase with increasing electron-
withdrawing power of the R substituent, i.e. PF3 > (ClCH2)PF2.
111 As with the NiL4 
complexes, a decrease in the 1JP,F values upon coordination and a negative coordination 
shift was also observed.82 Schmutzler et al. evaluated the changes in the 31P and 19F 
chemical shifts as a measure of the nature of the metal-ligand bond; one of the 
conclusions drawn from this was that for all complexes studied, there is an appreciable 
amount of -bonding between the metal and the phosphorus atom.82   
Nixon also presented the IR data, Raman data and calculated CO stretching force 
constants of such complexes, in conjunction with the analogous fac-[Mo(CO)3L3] 
complexes.112 It was shown that the fluorophosphines have comparable -accepting 
properties to CO. The trifluoromethyl fluorophosphines, (CF3)PF2 and (CF3)2PF, were 
shown to be stronger -acceptors than PF3.
112 This was rationalised by the competitive -
donor bonding between F and P and -acceptor bonding between the metal and P.112 The 
CF3 group does not compete as much for the vacant -orbitals of the P-atom, and so 
favours metal-phosphorus -bonding.112 Calculation of CO stretching force constants for 
a range of fluoro- and difluorophosphine Mo complexes has since been presented using 
rigorous algebraic procedures; the procedure was based on the Cotton and Kraihanzel 
force field.113 It was shown that using interaction force constant relations did not improve 
the calculations.113      
Several molybdenum-carbonyl complexes of other difluorophosphines have been 
reported.77 The coordination chemistry of the difluoro-diazophosphole 1.11 (Section 
1.3.3) has been extended to molybdenum by Cavell et al.; the cis-[Mo(CO)4(1.11)2] and fac-
[Mo(CO)3(1.11)3] complexes were synthesised from [Mo(CO4)(nbd)] and 
[Mo(CO)3(MeCN)3] respectively.
105 The cis-[Mo(CO)4L2] and fac-[Mo(CO)3L3] complexes 
of the 2-thienyldifluorophosphine ligand 1.2 (Section 1.3.2) have also been previously 
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synthesised.85 The cis-[Mo(CO)4L2] complex of the difluorophosphine, trtPF2 (trt = 
triphenylmethyl), has also been reported; upon heating the cis complex isomerisation to 
the thermodynamically more stable trans complex occurred.98    
1.3.5 Other Group 6 coordination chemistry  
In contrast to molybdenum, there are few reports of other group 6 metal complexes of 
fluorophosphines.  The synthesis of the [M(CO)5L] complexes, where L = (CF3)2PF and 
M = Cr and W, has been described.114 The high -acidity of the fluorophosphine was 
demonstrated by the complexes’ IR and NMR spectroscopic data.114 The [M(CO)5L], cis-
[M(CO)4L2] and fac-[M(CO)3L3] complexes of the bulky fluorophosphines, tBu2PF and 
tBuPF2 (where M = Cr and W), have been synthesised.
84 The complexes were evaluated 
and showed similar trends in ligand properties to their corresponding molybdenum 
complexes discussed in Section 1.3.4.84  
Cavell et al. synthesised the [Cr(CO)5L] complex of the difluoro-diazophosphole 1.11 
(Section 1.3.3) to evaluate its donor properties.105 From the IR data for [Cr(CO)5(1.11)], 
the stretching frequency of the Ni(CO)3L complex was estimated and the electronic 
parameter, χ, calculated; the calculated value of 1.11 was similar to that of PF3 (51 cm
-1 vs. 
55 cm-1 respectively).105     
 
 
To the best of our knowledge, the only example of a group VII metal complex of a 
fluorophosphine is [MnH(CO)4{(CF3)2PF}], synthesised in 1971 by Dobbie.
115  
1.3.6 Group 8 coordination chemistry  
In 1969, the first Fe complex of a fluorophosphine was reported by Haas et al.116 The 
[Fe(CO)4L] complexes, where L = (CF3)2PF and (CF3)PF2, were synthesised from the 
substitution reaction of [Fe(CO)5].
116 It was observed that an equatorial position was 
preferred by the fluorophosphines, in contrast to the fluorophosphites (MeO)3-xPFx where 
a strong preference for an axial position was displayed.116 [Fe(CO)4L] complexes of the 
aryl-fluorophosphines, 1.13 and 1.14, have since been reported by Schmutzler et al., and it 
was shown that 1.14 was stable to redox disproportionation.103   








In 2019, Wolf et al. reported the synthesis of [Cp*Fe{(C5Ph3H2)PF}] (1.15), which 
contains a fluorophosphinine.117 Although there has recently been extensive research into 
phosphinines, metals complexes of halophosphinines have remained rare.117 The crystal 
structure of complex 1.15 showed the P-F bond is covalent, in contrast to the Br and I 





The binuclear species, [Fe2Cl5(PhPF2)5], was synthesised by Stezler et al. from the redox 
reaction of PhPF2 and FeCl3, and full spectroscopic data was reported.
118 X-ray 
crystallography identified the species as the mixed valence complex, [Fe(II)Cl(PhPF2)5]-
[Fe(III)Cl4]; a distorted octahedral geometry was identified at the Fe(II) centre.
118 They 
also showed that the product from the reduction of the complex was dependent on the 
reducing agent used.78 Using Zn/Hg afforded the Fe(0) complex, [Fe(PhPF2)5], whereas 
using Fe powder as the reducing agent gave the Fe(II) complex, cis-[FeCl2(PhPF2)4].
78   
There are only a few of examples of ruthenium complexes of fluorophosphines. Recently, 
Peruzzini et al. accessed desired fluorophosphines from the fluorination of phosphorus 
oxyacids, mediated by [RuClCp(PPh3)2] (Scheme 1.9).
119 The commercial salt XtalFluor-
E ([Et2NSF2][BF4]) was used as the fluorinating agent, which due to its high stability and 
non-toxicity offered advantages over traditional routes.119 The crystal structure of a Ru(II) 
arene complex of the novel hybrid fluorophosphine ligand, Ph2PFBF3, has been reported; 
the ligand was coordinated to the metal via the P centre of the Ph2P moiety and the F 
atom of the BF4.
120 The only other example of a Ru complex of a difluorophosphine was 
reported by Cavell et al.121 In conjunction with the coordination of the difluoro-
diazophosphole 1.11 discussed above, the synthesis of [CpRuCl(1.11)(PPh3)] was 
described; analysis of the complicated 31P and 19F NMR spectra was reported and showed 
agreement with calculated spectra.121  




Scheme 1.9 Synthesis of Ru-fluorophosphine complexes, where R = H, F, Ph.119  
To the best of our knowledge, Schromburg et al. have reported the only examples of 
osmium coordination of a fluorophosphine; the syntheses of osmium clusters of tBu2PF 
were described and the complexes characterised by X-ray crystallography.122  
1.3.7 Group 9 coordination chemistry  
There are few examples of cobalt complexes of fluorophosphines. In 1973, 
[CoX2(tBu2PF)2] complexes, where X = Cl, Br or I, were synthesised.
89 Spectroscopic data 
for the complexes were collected and showed a tetrahedral geometry about the Co 
centre.89 The reaction of the fluorophosphines, (CF3)3-xPFx, with [Co(CO)3(NO)] gave 
[Co(CO)2(NO)L], where L = (CF3)3-xPFx.
123 Displacement reactions between a range of 
free phosphines (L’) and the coordinated ligand (L) in [Co(CO)2(NO)L] were carried out; 
relative to other halophosphines the fluorophosphines had the strongest tendency to 
displace the coordinated ligand.123 Stelzer et al. have prepared the Co(I) complexes 
[CoXL4] (where X = Br or I and L = tBu2PF or PhPF2), from the Co(II) precursors 
[COX2L3].
78 The [CoX2(PhPF2)3] complex was reduced using Zn/Hg and gave the 
unexpected complex, Hg[Co(PhPF2)4]2.
78     
Traditionally the reaction of phosphine ligands with [Rh2Cl2(CO)4] give the trans-
[RhCl(CO)L2] complexes. Schmutzler et al. showed that the reaction of 2 equiv. of the 
aryl-fluorophosphine 1.13 (Section 1.3.6) with [Rh2Cl2(CO)4] gave [Rh2Cl2(CO)2(1.13)2]; 
the addition of a further 2 equiv. of 1.13 led to the expected trans-[RhCl(CO)(1.13)2] 
complex (Scheme 1.10).103 By contrast, PF3 displaces either the CO or -alkene from a 
variety of Rh(I) precursors to give the binuclear species [Rh2Cl2(PF3)4].
121 Nixon et al. 
synthesised [Rh2Cl2(PF3)4] from the reaction of [Rh2Cl2(C2H4)4] with PF3 under mild 
conditions; analogous behaviour was observed when using the difluorophosphine 
(CF3)PF2.
124,125 Nixon also showed that upon the addition of (CF3)PF2 to [Rh2Cl2(PF3)4], 
PF3 was displaced by (CF3)PF2.
124 The mixed phosphine Rh complex, 
[RhCl(PPh3)2{(CF3)PF2}], was also synthesised by Nixon et al.
124      






Scheme 1.10 Synthesis of trans-[RhCl(CO)(1.13)2].
103 
Decomposition of the difluoro-diazophosphole 1.11 (Section 1.3.5) was observed upon 
reaction with the Rh(I) binuclear precursors [Rh2Cl2(CO)4] and [Rh2Cl2(cod)2].
121 It was 
suggested that the Rh-Cl bonds were not cleaved due to the poor -donor capacity of 
1.11, but as discussed above PF3 can react readily with these precursors.
121 Furthermore, 
ligand 1.11 reacts readily with the binuclear [Cp*2Rh2Cl4] precursor to give 
[Cp*RhCl2(1.11)2].
121 Similar to PF3, ligand 1.11 displaced both CO ligands from 
[CpRh(CO)2] to give [CpRh(1.11)2]; typically phosphines only displace one of the CO 
ligands.121  
1.3.8 Group 11 coordination chemistry 
To the best of our knowledge, Kruck et al. have been the only research group to report 
group 11 complexes of fluorophosphines. In 1996, they reported the synthesis of the 
difluorophosphine Au(I) complexes, [Au(CF3)(RPF2)] and [AuCl(RPF2)], where R = tBu, 
Ph or Cp.48   
1.4 Coordination chemistry of fluorophosphites  
Compared to fluorophosphines and difluorophosphines, there are fewer reports of metal 
complexes of fluorophosphites or difluorophosphinites; this section summarises those 
complexes which have been reported to date.   
1.4.1 Ni coordination chemistry  
As with fluorophosphines, there have been several reports of zerovalent [NiL4] complexes 
of fluorophosphites. In 1963, Schmutzler et al. described the synthesis of [NiL4] 
complexes from the reaction of [Ni(CO)4] with ligands such as the 5-membered cyclic 
fluorophosphite 1.16 (Scheme 1.11) and the difluorophosphinites, nPrOPF2 and 
PhOPF2.
59,126 In 1967, Schmutzler interpreted the 31P and 19F NMR spectra obtained for 
such complexes.82 One of the conclusions made for these NiL4 complexes was that the 
M-P bond has a significant amount of -bonding.82  Detailed analysis of the 31P and 19F 
NMR spectra of [Ni(1.16)4] was also carried out by Lynden-Bell; group theory methods 
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were used to construct the [AX]4 nuclear spin Hamiltonian for the tetrahedral system.
127  
The synthesis of [NiL4], where L = MeOPF2, was described by Kruck et al. from the 
methanolysis of [Ni(ClPF2)4]; the high reactivity of the P-Cl bond ensures rapid reaction 




Scheme 1.11 Synthesis of [Ni(1.16)4].
59,126  
Cassoux et al. have also studied the magneto-optical effects of [NiL4] complexes.
83,129 In 
1969, they reported the synthesis and characterisation of a range of fluorophosphite 
[Ni{(RO)2PF}4] and difluorophosphinite [Ni(ROPF2)4] complexes, where R = Et, Pr, Bu 
or Pn.130 Detailed analysis of the 31P and 19F NMR spectra has also been described and 
the coordination chemical shifts calculated.131 A decrease in the 1JP,F values was observed 
upon coordination.131 The effect of the substituent was also discussed and the 
fluorophosphite complexes were compared to the chlorophosphite analogues.131 
Goodfellow et al. reported the heteronuclear INDOR spectra of the [NiL4] complexes, 
where L = 1.16 or (PhO)2PF, and calculated the magnitudes and relative signs of the 
coupling constants.132 There are only two reports of nickel-carbonyl complexes of 
fluorophosphites, which include a mixture of bidentate and monodentate ligands.59,126 
There are no reports of Ni(II) complexes of fluorophosphite ligands.  
1.4.2 Pt and Pd coordination chemistry 
There are a few reports of zerovalent platinum complexes of fluorophosphites. In 
conjunction with the [NiL4] complexes discussed above, Goodfellow et al. also presented 
the heteronuclear INDOR spectra of the [PtL4] complexes, where L = 1.16 or (PhO)2PF; 
the complexes have a [AX]4 (Td) spin system.
132 The complexes were synthesised from the 
reaction of [Pt(cod)2] and a 10% excess of ligand (Scheme 1.12).
132 The magnitudes of the 
coupling constants were calculated and it was shown that the 2JP,P values for the Pt(0) 
complexes were significantly larger than the analogous Ni(0) complexes (ca. 100 vs. 20 
Hz).132 Matos et al. reported the synthesis of the Pt(0) complex [Pt(PPh3)2L], where L is 
the 6-membered fluorophosphite 1.17, from the reaction of [Pt(PPh3)2(C2H4)] with 1.17.
133 
Relative to the chlorophosphite analogue, the 1JP,Pt value was significantly higher (6603 vs. 
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4856 Hz), as expected from the presence of the more electronegative fluorine atom which 









The only reported example of a fluorophosphite complex of the type [PtCl2L2] is the cis-
[PtCl2(PhOPF2)2] complex.
134 There have been a few reports of mixed phosphine Pt(II) 
complexes. In 1976, Schmutzler et al. prepared the cis-[PtCl2(PEt3)(ROPF2)] complexes, 
where R = nBu or Ph, from the reaction of ROPF2 and [PtCl2(PEt3)2]; this was the first 
example of a Pt(II) difluorophosphinite complex.135 The analogous Pd(II) complex was 
also reported.135  
In 2000, Matos et al. also reported the synthesis of the cis-[PtCl2(PEt3)L] complexes, where 
L are the 5-membered cyclic fluorophosphites 1.16 and 1.18.133 Unlike the Pt(0) complexes 
discussed above, the 1JP,Pt values decreased upon changing the ligand from a 
chlorophosphite to a fluorophosphite.133 This was attributed to the lower stability of the 
fluorophosphite complexes, since they can be regarded as a combination of a hard acid-
soft base; the Pt-P bond should be longer in the fluorophosphite complexes than in the 
chlorophosphite analogues and hence result in a lower 1JP,Pt.
133 The analogous Pd(II) 
complexes have also been prepared.133 
A range of difluorophosphinites ROPF2 have been synthesised from the silicon-
phosphorus exchange reaction of the silyl ethers ROSiMe3 and ClPF2 (where R = p-
substituted benzyl group, neopentyl, 1-adamantyl); high yields were achieved under mild 
conditions.136 The difluorophosphinites (L’) were reacted with [PtCl2L2] (L = PPh3 or 
PEt3) to give the [PtClL2(L’)][Cl] complexes, which in some cases continued to react in an 
Arbuzov-Michaelis type fashion and produce [PtClL2(PF2O)] and RCl.
136  
The binuclear species, [Pt2I4{(PhO)2PF}2], was synthesised by Goggin et al.
137 Detailed 
analysis of the 31P and 19F NMR spectra showed that the complex existed as both the trans 
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and cis isomers in a CDCl3 solution; the major component was identified as the trans-
isomer.137 The analogous Pd(II) dimer existed as two isomers in solution, but NMR could 
not be used to elucidate their structures due to the absence of a suitable spin-active Pd 
nucleus.137 
1.4.3 Mo(0) coordination chemistry  
There are a few examples of [Mo(CO)3L3] complexes with fluorophosphite ligands. In 
1963, Schmutzler et al. reported the first synthesis of [Mo(CO)3L3] complexes using the 
cyclic fluorophosphite 1.16 (Section 1.4.1) and difluorophosphinites, PrOPF2 and 
PhOPF2.
59,82,126 The complexes were characterised and analysis of their 31P and 19F NMR 
spectra was carried out.59,82,126 In 1971, Schmutzler et al. also presented a theoretical 
analysis of the 19F NMR spectrum of a general [AXn]3 spin system, which was then applied 
to the mer-[Mo(CO)3L3] complexes, where L = 1.16 or PhOPF2, to yield the various 
coupling constants.138 They showed that the magnitude of 2JP,P increased with the 
electronegativity of the group attached to the P atom.138 In 1997, the lab of Schmutzler 
reported the synthesis of the allyldifluorophosphinite 1.19 and explored its coordination 
chemistry.139 Included in this study was the synthesis of fac-[Mo(CO)3(1.19)3], which was 





In 1977, Schmutzler et al. reported the first example of a fluorophosphite cis-[Mo(CO)4L2] 
complex.140 The cyclic fluorophosphite, 1.20, was synthesised from the reduction of a 
fluorophosphazophosphorane by Ph2PSiMe3 (Scheme 1.13); the fluorophosphite 1.20 
displaced the coordinated alkene from [Mo(CO)4(nbd)] to give cis-[Mo(CO)4(1.20)2].
140 
The IR and NMR data for the complex were reported.140 The cis-[Mo(CO)4L2] complex 
of the difluorophosphinite 1.21 has also been prepared from [Mo(CO)4(nbd)] by Rankin 
et al., but due to its instability to air and moisture it was not isolated.56 The hexa-substituted 
[MoL6] complexes have been reported for the fluorophosphites, (nPrO)2PF and 
(MeO)2PF, and the difluorophosphinites, nPrOPF2 and MeOPF2.
141  






Scheme 1.13 Synthesis of cyclic fluorophosphite 1.20. 
1.4.4 Other Group 6 metal coordination chemistry  
There are a limited number of examples of other Group 6 metal complexes of 
fluorophosphites. Krivykh et al. have presented new chromium arene complexes 
containing either mono-, bi- or tridentate difluorophosphinites.142 They demonstrated 
that under UV irradiation, the difluorophosphinites can replace CO ligands from arene-
tricarbonylchromium complexes (Scheme 1.14).143,144 All three CO ligands can be 
displaced by the fluorophosphite to form a novel chelated chromium derivative.143,144 The 
complexes were characterised by NMR and IR spectroscopy143 and detailed analysis of 
the mass spectra of the complexes was also reported.145 Krivykh et al. also showed that 
such polydentate complexes can be prepared from electrochemical oxidation of the arene-
tricarbonylchromium complex; this route offers a novel method of CO substitution by 
other ligands in transition metal complexes.146,147  
 
Scheme 1.14 Synthesis of a mono-chelate chromium arene-difluorophosphinite 
complex.143 
Schmutzler et al. have synthesised fac- and mer-isomers of [Cr(CO)3(L)3] (where L = 1.19) 
from [Cr(CO)3(C7H8)].
139 They also prepared [W(CO)5L] (where L = 1.19) from 
[W(CO)5(THF)].
139 Both complexes were characterised by IR and NMR spectroscopy and 
mass spectrometry.139 It was shown that the allylic difluorophosphinite was coordinated 
via the phosphorus only; the allylic -system was not involved in the metal-ligand 
bonding.139 The Cr and W analogues of the hexa-substituted [MoL6] complexes described 
in Section 1.4.3 were also synthesised; the ease with which the complexes could be 
prepared was in the order Mo > W > Cr.141 There are no reported examples of Group 7 
metal complexes of fluorophosphites to the best of our knowledge.  
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1.4.5 Group 8 metal coordination chemistry  
Iron carbonyl complexes have attracted interest due to their fluxionality resulting from 
either the ligand adopting an axial or equatorial position.148 In 1969, the fluorophosphite 
complexes [Fe(CO)4{(MeO)3-xPFx}] were prepared from methanolysis of the 
trifluorophosphine analogue.116 Rapid isomerisation was observed upon replacement of 
the fluorine group by OMe since the fluorophosphite complexes displayed a preference 
for axial positions (in contrast to the fluorophosphines in Section 1.3.6).116 It was 
suggested that electronic effects determine which isomer is formed. Consequently, Ruff 
et al. prepared the [Fe(CO)4L] complexes, where L is both the bulky and highly 
electronegative difluorophosphinite, (CF3)2CNCOPF2.
148 The analogous fluorophosphite 
(RO)2PF and phosphite (RO)3P complexes were also synthesised (where R = 
(CF3)2CNC).
148 A mixture of both the axial and equatorial isomers were observed for the 
fluorophosphite complexes, in contrast to the phosphite analogue where only the 
equatorial isomer was present.148       
Schmutzler et al. synthesised the [Fe(CO)4L] complex, where L = 1.19 (Section 1.4.3), 
from [Fe(CO)5] and showed that the allylic difluorophosphinite occupied an axial 
position.139 Similar to its Group 6 coordination described above, the difluorophosphinite 
coordinated via only the phosphorus atom.139 The 7-membered cyclic fluorophosphite 
1.22 was prepared from the reaction of 2,2-biphenol and Cl2PF by Schmutzler et al.
149 
Attempts to synthesise the ligand from the corresponding chlorophosphite were 
unsuccessful since the reaction of PCl3 and 2,2-biphenol gave the undesired 7-membered 
cyclic diphosphite.149 The reaction of [Fe2(CO)9] and 1.22 gave the [Fe(CO)4(1.22)] 




Scheme 1.15 Synthesis of [Fe(CO)4(1.22)].
149  
Schmutzler et al. reported the synthesis of several ruthenium complexes of nPrOPF2, 
including [RuCl(CO)H(PPh3)2(nPrOPF2)] which was characterised by X-ray 
crystallography.150 In 2000, the fluorophosphite complexes, trans-[(dppe)2RuH(L’)], where 
L’ = (RO)2PF and R = Me, Et, iPr, were prepared from the reaction of the hydride 
complexes, trans-[(dppe)2RuH(L)] (where L = P(OR)3) and HBF4.Et2O.
151 The stability of 
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the resulting complex appeared to be dependent on the cone angle of the trans phosphine 
ligand; increasing the steric hindrance of the trans phosphine decreased the strength of the 
metal-phosphine bonding.151 
1.4.6 Group 9 metal coordination chemistry  
Group 9 metal complexes of fluorophosphites are rare. The only examples of cobalt 
complexes of fluorophosphites were reported by Clark et al. in 1968.152 Methanolysis of 
the [Co(NO)(CO)x(PF3)3-x] complexes was carried out to yield the fluorophosphite 
complexes [Co(NO)(CO)x(L)3-x], where L = MeOPF2 or (MeO)2PF.
152 As the degree of 
solvolysis was increased, the stretching frequencies of the CO and NO bands in the IR 
spectra of the complexes decreased.152 
The [Rh2Cl2(CO)2L2] complex, where L = nPrOPF2, was synthesised from the reaction of 
ligand with [Rh2Cl2(CO)2(C2H4)2]; unlike PF3 (see Section 1.3.7), the difluorophosphinite 
did not displace the CO ligands from the rhodium centre.153 In 1985, Nixon et al. reported 
the synthesis of the binuclear fluorophosphite species, [Rh2Cl2(1.16)4], from the reaction 
of the cyclic fluorophosphite 1.16 and [Rh2Cl2(C6H10)2] (Scheme 1.16).
154 The 31P and 19F 
NMR spectra of the complex were obtained and the coupling constants calculated.154 






Scheme 1.16 Synthesis of the binuclear complex, [Rh2Cl2(1.16)4].
154 
1.5 Catalytic applications of fluorophos complexes 
1.5.1 Fluorophosphites in hydroformylation catalysis  
The most notable example of the application of fluorophos ligands in homogeneous 
catalysis is the use of cyclic fluorophosphites, such as Ethanox 398TM (1.23), in Rh-
catalysed hydroformylation by Eastman.155,156 Fluorophosphites were initially approached 
with scepticism because it was assumed that the P-F bond of Ethanox 398TM would be 
highly reactive to hydrolysis or disproportionation, leading to the generation of free 
fluoride ions.156,157 This would be detrimental to the activity of the hydroformylation 
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catalyst since the damaging effects of halogens on hydroformylation had been well 
documented.158–160  
  
    
 
 
However, Klender et al. demonstrated the unexpected high stability of 1.23 and other 
fluorophosphites to hydrolysis.161,162 Even at elevated temperatures (up to 350 °C) or 
under reflux in aqueous isopropanol, no free fluoride ions were generated.161,162 The 
stability and hence the success of 1.23 was attributed to the 8-membered phosphacycle 
which entropically stabilises the ligand, and the bulky tBu substituents which sterically 
protect the P-centre. Other ways of hampering the degradation of fluorophosphite-
containing catalysts was using another Group 8 metal in addition to the catalyst or by 
adding an epoxide to the reaction mixture.163,164 A suitable concentration of either 
stabiliser was required to react with the strongly acidic by-products generated throughout 
catalysis; these acidic conditions are known to catalyse the degradation of the 
fluorophosphite ligand.164   
In 1998, Eastman first reported the use of fluorophosphites as ligands for 
hydroformylation catalysis, where a range of alkenes were tested such as propylene and 
octene.165 Before this, there had been no reports of Ethanox 398TM as a ligand for 
transition metals despite its numerous applications as an antioxidant and a flame 
retardant.166 Subsequently, Eastman have described the use of fluorophosphites in Rh-
catalysed hydroformylation of sterically hindered olefins,155 the preparation of 
glycoaldehyde from formaldehyde (Scheme 1.17)167 and low pressure hydroformylation 
of terminal and internal olefins.157 Catalysts from a range of fluorophosphites were shown 
by Eastman to display unusual “ligand acceleration effects” for the hydroformylation of 
simple alkenes, where increasing the concentration of ligand increased the 
hydroformylation activity.168,169    
 
 
Scheme 1.17 Catalytic hydroformylation of formaldehyde to produce glycolaldehyde.167  
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The production of propionaldehyde from the hydroformylation of ethylene is an 
important industrial reaction. Typically, ethylene from commercial sources contains 
variable amounts of acetylene impurities which can be detrimental to the catalyst 
depending on the phosphorus ligand used.170,171 Eastman have reported that 
hydroformylation catalysts using fluorophosphites can tolerate high levels of alkyne 
impurities in an alkene feed stream; remarkably no loss of hydroformylation catalytic 
activity was observed when using an ethylene feed stream containing 1,000 ppm of 
acetylene.170,171 
Since the phosphorus atom in Ethanox 398TM is part of a ring, cis and trans stereoisomers 
of the ligand are possible (Figure 1.4). In the cis isomer (cis-1.23), the lone pair on the P-
atom is in a pseudo-axial orientation whereas, in the trans isomer (trans-1.23) it is in a 
pseudo-equatorial orientation.172,173 A detailed coordination study of the isomers of 
Ethanox 398TM has shown the preferential coordination of trans-1.23 to metals such as Pt 
and Rh.174 Eastman have developed a method of separating the isomers of Ethanox 398TM 
and have also shown that trans-1.23 binds preferentially to Rh, even at low concentrations 
of trans-1.23.172,173 The effect of isomer ratio on hydroformylation catalysis was also 
explored; studies showed that increasing the amount of trans-1.23 increased the n-
selectivity and catalytic activity observed.172,173    





Figure 1.4 Geometric isomers of Ethanox 398TM (1.23).  
In 2013, the synthesis of stable amido-fluorophosphite ligands (e.g. 1.24) were reported by 
Eastman.175,176 The ligands were readily prepared from the reaction of the corresponding 
amido-chlorophosphites and ammonium fluoride.175,176 The Rh catalysts of these ligands 
gave high catalytic activity in the hydroformylation of various alkenes.175,176 A wide range 
of selectivities was accessed through varying the reaction conditions.175,176     
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1.5.2 Other catalytic applications  
In 2012, Pringle et al. prepared remarkably stable fluorophosphines based on a phopha-
adamantane cage (CgPF, 1.25) or a phosphabicycle (s-PhobPF, 1.26).177 The thermal 
stability of ligands 1.25 and 1.26 was partly attributed to their constrained C-P-C angles, 
which inhibited disproportionation.177 Rhodium catalysts of 1.25 and 1.26 displayed 
comparable activity to PPh3 in the catalytic hydroformylation of 1-heptene (Scheme 1.18) 
and increased n-selectivity was achieved using the Rh-catalyst derived from CgPF (1.25).177 
Catalysts derived from 1.25 and 1.26 were tested in the Ni-catalysed hydrocyanation of 3-
pentenenitrile to yield adiponitrile (ADN); the Ni-catalyst derived from 1.25 showed 
excellent catalytic activity, comparable to commercial catalysts.177–180 This was the first 




Scheme 1.18 Catalytic hydroformylation of 1-heptene using catalysts derived from ligands 





A range of 3,3’-substituted BINOL-based fluorophosphites (1.27a-d) were synthesised 
from their corresponding chlorophosphites and tested in the Rh-catalysed asymmetric 
hydrogenation of benchmark substrates (Scheme 1.19).181 High catalytic activities and 
enantioselectivities were achieved, particularly when using MAA (methyl-2-
acetamidoacrylate) as the substrate (ee = 95% (S) for Rh-1.27b).181 The enantioselectivity 
was dependent on the 3,3-substituent, increasing in the order H < Ph < p-tolyl, and when 
using the very bulky mesityl ligand a drop in ee was observed.181 











Scheme 1.19 Catalytic asymmetric hydrogenation of MAA using catalysts derived from 
ligands 1.27a-d.181  
The fluorophosphite, BIFOP-F (1.28), was employed as a ligand in an enantioselective 
intramolecular Pd-catalysed alkyl-aryl cross-coupling reaction by Goldfuss et al.182 
Moderate enantioselectivity (ee = 64%) and good yields were achieved relative to when 
using catalysts derived from BIFOP-Cl and BIFOP-Br; this was attributed to the high 
electronegativity of the fluorine atom.182 In 2019, Goldfuss et al. also tested ligand 1.28 in 
the enantioselective Cu-catalysed 1,4-addition of organozinc and Grignard reagents to 
enones.183 However, no conversion was observed due to decomposition of the ligand 













From the late 1960s research into the synthesis and metal coordination chemistry of 
fluorophos ligands has flourished. These developments have culminated in the Eastman 
hydroformylation process, which was established in the late 1990s. Subsequently, 
Eastman have applied fluorophosphites to a range of hydroformylation processes with 
great success. Presently, there are sporadic reports of fluorophos coordination chemistry, 
however, future developments might be anticipated leading on from this breakthrough 
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Synthesis and coordination chemistry of  
cyclic fluorophosphites  
 
2.1 Introduction 
Dioxaphosphacyclic ligands are ubiquitous in homogeneous catalysis.1 Such ligands are 
entropically stabilised relative to their acyclic analogues containing a P(OAr)2 moiety.
1 
Additionally, they are less susceptible to hydrolytic P-O cleavage (Scheme 2.1), which is a 





Scheme 2.1 Hydrolysis of (a) cyclic phosphorus ligands and (b) acyclic R’P(OAr)2 
analogues.     
In the 1980s and 1990s, cyclic aryl phosphites, such as 2.1, emerged as important ligands 
for hydroformylation2–7 and hydrocyanation.8–13 Inspired by these discoveries there have 
been numerous subsequent applications of cyclic aryl phosphites,14–18 phosphoramidites 
(R’ = N, e.g. 2.2)19,20 and phosphonites (R’ = C, e.g. 2.3)21–23 in a range of catalyses. With 
the exception of Ethanox 398TM (2.4),24 there are very few examples of cyclic 
fluorophosphites (R’ = F) as ligands for transition metals (see Section 1.5). Cyclic 
fluorophosphites can be readily prepared from cyclic chlorophosphites. In general, the 
cyclic ligands of most interest in the literature contain 7- or 8-membered phosphacycles 
derived from 2,2’-biphenols.  















Discovered over 40 years ago, the Tolman electronic parameter (TEP), the (CO) for 
[Ni(CO)3(PX3)], remains one of the most commonly used measures of the / -bonding 
of a phosphorus ligand to a transition metal.25,26 There is a near-continuum of TEP values 
between tBu3P and P(OPh)3, but a near-void between P(OPh)3 and PF3. Consequently, 
the coordination chemistry of the strong -acceptors, cyclic fluorophosphites, is of 
intrinsic interest since their bonding properties should populate this gap. Furthermore, 
unlike PF3, cyclic fluorophosphites are amenable to modification. As shown for Ethanox 
398TM (2.4), decoration of the aryl rings with substituents is possible. In addition, the 
fluorophosphite phosphacycle ring size can be varied. Both of these modifications 












Accordingly, we aimed to synthesise the cyclic fluorophosphites L2.1-2.4 containing 5- to 8-
membered phosphacycles and probe the effect of ring size on their coordination 
properties. To gauge the effect of the fluoro substituent, the coordination chemistry of 
the 6-membered comparator phosphite, L2.5, was also to be investigated. The limited 
coordination chemistry of the 5- and 7-membered fluorophosphites, L2.1 and L2.3, has 
been discussed in Section 1.4. The effect of substitution on the aryl rings of the 5- and 6-
membered ligands, L2.1 and L2.2, was also to be probed.    
 
The prediction that there is a correlation between the phosphacycle ring size and the 
electronics of the ligand can be attributed to the energies of the frontier orbitals.27–29 The 
Walsh diagram, shown in Figure 2.1, shows how the energies of the molecular orbitals of 
a PX3 molecule depend on its geometry.
27,28,30 As the symmetry is lowered from planar 
(D3h) towards trigonal pyramidal (C3v), the HOMO () and LUMO () orbitals become 
more bonding and so are lowered in energy (2a1 and 2e respectively).
30 Consequently, a 
more pyramidalised PX3 molecule should be a poorer -donor but a stronger -acceptor. 
As the phosphacycle ring size of the cyclic fluorophosphites L2.1-2.4 decreases (from 8- to 
5-membered), the P-centre becomes progressively more pyramidalised and hence the 
energies of the frontier orbitals will decrease. Therefore, it is predicted that the -donor 
capacity will decrease and the -acceptor capacity will increase.30 Pringle et al. have 
previously shown a clear correlation between the phosphacycle ring size (C-P-C angle) 
and donor properties of a series of cyclic mono- and diphosphines.29,31    















Figure 2.1 Walsh diagram of a PX3 molecule.
30  
One of the central aims of this part of the project was to determine the veracity of these 
predicted trends in the metal-binding properties of the cyclic fluorophosphites L2.1-2.4. This 
was to be attempted by preparing a range of coordination complexes of the cyclic 
fluorophosphites and exploring correlations between ring size and the spectroscopic (IR 
and NMR) properties or structural features (from X-ray crystallography) of the 
complexes.  
All of the work within this Chapter was performed by the author, with the exception of 
the initial synthesis of ligand L2.3 and complexes 2.7c and 2.8c, which was carried out by 
Eliza G. Hunt, a PhD student who worked under the supervision of the author.  
2.2 Synthesis of cyclic fluorophosphites 
2.2.1 Synthesis of chlorophosphite intermediates  
Cyclic fluorophosphites L2.1-2.4 and the comparator phosphite ligand L2.5 have been 
prepared from the corresponding cyclic chlorophosphites, 2.5a-d. The chlorophosphite 
precursors were prepared by the modified literature method (see Chapter 7 for 
experimental details) of the reaction of the dihydroxyarene with PCl3 in the presence of 
NEt3 (Scheme 2.2).
1,32–35 










Scheme 2.2 Modified literature syntheses of chlorophosphites 2.5a-d.  
Avoiding the formation of spirophosphorane P(V) by-products (such as x) was often 
challenging using the above method, particularly in the synthesis of the 5-membered 2.5a 
(see Chapter 4 for more details). In addition, only 60% conversion of the 
dichlorophosphorus intermediate, y, formed in the synthesis of the 8-membered 2.5d, 




A novel route to 2.5a-d from the silyl ethers 2.6a-d, which involved a silicon-phosphorus 
exchange reaction, has been developed (Scheme 2.3). The silyl ethers 2.6a-d were readily 
prepared from the dihydroxyarene and purified by distillation. All chlorophosphites were 
obtained in good yields and high purity. This route to chlorophosphites 2.5a-d required 
2 steps, but this disadvantage is balanced by the simplicity of the work-up since the 
ClSiMe3 by-product is volatile. Furthermore, this route overcomes the issues of the 
formation of spirophosphorane side-products (for 2.5a) and incomplete conversion (for 


















Scheme 2.3 Route to chlorophosphites 2.5a-d via the silyl ethers 2.6a-d. Compounds 
2.6a and 2.6c have been previously reported.36,37   
2.2.2 Synthesis of fluorophosphites and comparator phosphite  
Treatment of chlorophosphites 2.5a-d with 2 equiv. SbF3 (Scheme 2.4) gave the 
fluorophosphites L2.1-2.4 in moderate yields (55-73%). All ligands were fully characterised 
and data for fluorophosphites L2.1
38–40 and L2.3
41 compared to the literature. The 31P{1H} 
and 19F{1H} NMR spectra for L2.1-2.4 each showed a characteristic doublet with large 
1JP,F 
values (1241-1309 Hz). No correlations are apparent between the phosphacycle ring size 

















Table 2.1. NMR data for fluorophosphites L2.1-2.4.
a 
Ligand P / ppm F / ppm 
1JP,F / Hz 
L2.1 124.3 -37.2 1306 
L2.2 100.6 -52.7 1241 
L2.3 135.8 -52.4 1309 
L2.4 107.8 -62.2 1254 
a Measured in C6D6.  
Despite using a short silica column to purify ligands L2.2-2.4, the presence of SbCl3 
contaminent was identified based upon the following observations: (a) the reaction of 2 
equiv. of L2.2-2.4 with [Pt(nbe)3] gave significant amounts (5-25%) of cis-[PtCl2L2] 
complexes in addition to the expected Pt(0) species (see Section 2.5); (b) upon the addition 
of SbCl3 to this reaction mixture an increase in cis-[PtCl2L2] was observed; (c) the 
assignment of cis-[PtCl2L2] complexes was based on the products obtained from the 
reaction of 2 equiv. of L2.2-2.4 with [PtCl2(cod)] (see Section 2.3). The amount of the SbCl3 
impurity present was capricious and batch dependent. Passing the ligands through a short 
florisil column and stirring the ligands with florisil over 2 h usually removed all of the 
SbCl3. The presence of minor amounts of SbCl3 had no apparent effect on the ligands’ 
coordination chemistry but did affect the ligands’ performance in hydroformylation 
catalysis (see Chapter 3). 
Treatment of the chlorophosphite 2.5b with MeOH in the presence of NEt3 gave the 
phosphite ligand L2.5 (Scheme 2.5) in a good yield (82%). The 
31P NMR spectrum was a 
quartet (P
 = 113.9 ppm, 3JP,H = 12 Hz).




Scheme 2.5 Synthesis of L2.5.  
The 5-membered cyclic fluorophosphite L2.1 is highly moisture sensitive, but the P-F 
bonds in the other fluorophosphacycles L2.2-2.4 are considerably more resistant to 
hydrolysis than the P-Cl bond in the corresponding chlorophosphites 2.5a-d. In the 




presence of water (0.55 M in MeOH), the approximate times for samples to be 50% 
hydrolysed were: L2.1 < 2 min; L2.2 24 h; L2.3 40 h; L2.4 2 h. 
2.3 Synthesis of cis-[Mo(CO)4L2] complexes of fluorophosphites  
Complexes of the type cis-[Mo(CO)4L2] were targeted as a way to compare the 
stereoelectronic properties of L2.1-2.5 from their IR spectra and X-ray crystal structures. 
Ligands L2.1-2.5 react smoothly with [Mo(CO)4(nbd)] (nbd = norbornadiene) in CH2Cl2 to 
give the cis-[Mo(CO)4L2] complexes 2.7a-e, where L =  L2.1-2.5 (Scheme 2.6).  
 
Scheme 2.6 Synthesis of the cis-[Mo(CO)4L2] complexes 2.7a-e.   
Table 2.2 NMR data for complexes 2.7a-e.a  
Ligand Complex P / ppm 
1JP,F / Hzb   ppm 
L2.1 2.7a 170.2 1318  
L2.2 2.7b 144.3 1248 44 
L2.3 2.7c 174.0 1229 38 
L2.4 2.7d 148.2 1204 41 
L2.5 2.7e 151.1 - 37 
 a Measured in CD2Cl2. 
b Calculated from N = ∣1JP,F + 3JP,F∣.  
The 31P{1H} and 19F{1H} NMR spectra for complexes 2.7a-d showed a doublet of triplets 
which is a deceptively simple pattern for the AA’XX’ spin system; the separation of the 
doublet (corresponding to N = ∣1JP,F + 3JP,F∣) is of the order of 1200 Hz in each case. The 
NMR spectra were simulated using the calculated coupling constants given in Chapter 7. 
Figure 2.2 shows an example of the excellent agreement between the (a) observed and (b) 
simulated 31P{1H} NMR spectra (complex 2.7a). Values computed for 2JP,P are of the 
order of 50 Hz; consistent with a cis-geometry.43 The coordination chemical shift  for 
L2.1-2.4 in 2.7a-d is ca. +40 ppm which is similar to that for L2.5 in 2.7e. There do not appear 
to be consistent correlations between the NMR data for 2.7a-d and the ring size of the 
fluorophosphites L2.1-2.4 (Table 2.2). 




Figure 2.2 (a) Observed 31P{1H} NMR spectrum of complex 2.7a; (b) simulated 31P{1H} 
NMR spectrum of complex 2.7a using calculated coupling constants given in Chapter 7.  
The IR spectra for complexes 2.7a-e are consistent with a cis-geometry of ligands. The 
(CO) (A1) values for [Mo(CO)4L2] can be used as a proxy for the TEP since they are 
linearly related.44 From the values illustrated in Figure 2.3 and IR data given in Chapter 7, 
the fluorophosphites L2.1-2.4 sit between PF3 and P(OPh)3 in terms of their TEP, with the 
smallest phosphacycle L2.1 being closest to PF3. This is consistent with the reported 
correlation between the ligand ring size and energies of the frontier orbitals: the smaller 
the O–P–O angle, the lower lying the HOMO and LUMO energies (see Section 2.1).27–29 
The (CO) values for the complexes 2.7b and  2.7e featuring the six-membered 
phosphacycles L2.2 and L2.5 (2066 and 2051 cm
-1 respectively) reflect the significant 
difference between the ligands having P– F and P–OMe fragments. 
Figure 2.3 (CO) bands for 2.7a-e (see Chapter 7 for values).45,46  




L2.1 PF3 L2.2 L2.3 L2.4 P(OPh)3 L2.5 
(a) 
(b) 
 / ppm 




Crystals suitable for X-ray crystallography of each of complexes 2.7a-e were grown by 
slow diffusion of hexane into a saturated CH2Cl2 solution of the complex or by storing a 
saturated hexane solution of the complex at -20 ˚C; selected metrical data are given in 
Table 2.3. In each case, the crystal structures confirmed the cis-geometry of the complexes 
(Figure 2.4). The Mo-P bond lengths decrease in the order 2.7d > 2.7c > 2.7b > 2.7a, 
consistent with increasing Mo–P bond strength as the phosphacycle ring size decreases 
as a result of the -acceptor capacity increasing in the order L2.1 > L2.2 > L2.3 > L2.4. The 
Mo-P -bonding should perturb the bond lengths and angles around the P atom27–29 but 
these effects may be very subtle since no trends in P-O/P-F bond lengths or O-P-F angles 
are evident in the crystallographic data. The Mo-P bond length in complex 2.7b is 
considerably shorter than in 2.7e, consistent with the fluorophosphite L2.2 having a greater 
-acceptor capacity than its phosphite analogue, L2.5. The fluorophosphite ligands adopt 
a syn-conformation in complexes 2.7a and 2.7c and an anti-conformation in complexes 
2.7b and 2.7d (Figure 2.4), which may be indicative of syn- and anti-conformers being 
close in energy.  
The steric properties of the P-ligands in 2.7a-e were assessed using the solid angles 
approach47 for the ligands calculated from the crystal structures, with the G parameter 
(Gx) representing the area of the metal centre shielded by the ligand. Interpretation of the 
Gx values given in Table 2.3 is complicated by there being two values for L2.3 in 2.7c and 
for L2.4 in 2.7d. This arises because the coordinated ligands adopt different geometries, 
and hence there are two unique P environments in the crystallographic asymmetric unit. 
Nevertheless, the data suggest that in the Mo structures of 2.7a-e, L2.1/L2.2 have similar 
bulk, as do L2.3/L2.4 and that L2.1/L2.2 are smaller than L2.3/L2.4; the phosphite L2.5 is larger 












Table 2.3 Selected bond lengths (Å) from the molecular structures of complexes 2.7a-e. 
Ligand Complex Mo-P / Å P-F / Å Mo-C / Åa  Gx b (%) 
L2.1 2.7a 2.3794(4) 1.5735(10) 2.0330(17) 17.5 
L2.2 2.7b 2.3846(6) 1.5832(13) 2.042(2) 17.3 








L2.5 2.7e 2.4270(4) - 2.0165(18) 18.5 
  2.4163(4)  2.0258(17) 20.0 
a Mo-C bond length trans to P. b  The Gx areas were calculated using the following van der 











Figure 2.4 Crystal structures of cis-[Mo(CO)4L2] complexes: (a) L = L2.1 (2.7a); (b) L = 
L2.2 (2.7b); (c) L = L2.3 (2.7c); (d) L = L2.4 (2.7d); (e) L = L2.5 (2.7e). The hydrogen atoms 
are omitted for clarity. Thermal ellipsoids at 50% probability. See Table 2.3 for selected 








2.4 Platinum(II) coordination of cyclic fluorophosphites  
The reaction of 2 equiv. of ligands L2.2-2.5 with [PtCl2(cod)] (cod = 1,5-cyclooctadiene) in 
CH2Cl2 gave the cis-[PtCl2L2] complexes 2.8b-e, where L = L2.2-2.5 (Scheme 2.7). The 
31P{1H} and 19F{1H} NMR spectra for each fluorophosphite complex (2.8b-d) showed a 
characteristic AA’XX’ pattern. 
 
Scheme 2.7 Synthesis of the cis-[PtCl2L2] complexes 2.8b-e. 
Table 2.4 NMR data for complexes 2.8b-e.a  
Ligand Complex P / ppm 
1JP,Pt / Hz 1JP,F / Hzb 
PF3 cis-[PtCl2(PF3)2]
48 65.6 6479 1318 
L2.2 2.8b 63.6 6172 1248 
L2.3 2.8c 80.8 6056 1229 
L2.4 2.8d 58.2 6209 1204 
L2.5 2.8e 62.7 5869 - 
 a Measured in CD2Cl2. 
b Calculated from N = ∣1JP,F + 3JP,F∣.  
The 31P{1H} and 19F{1H} NMR spectra of complexes 2.8b-d were simulated using the 
calculated coupling constants given in Chapter 7. Figure 2.5 shows an example of the 
excellent agreement between the (a) observed and (b) simulated 31P{1H} NMR spectra 
(complex 2.8b). Values calculated for 2JP,P are of the order of 25 Hz consistent with a cis-
geometry.49 The large 1JP,Pt values are also indicative of a cis-geometry. There is no 
consistent correlation between the 1JP,Pt values for 2.8b-d and the ring size of L2.2-2.4. 
However, the 1JP,Pt values for fluorophosphites L2.2-2.4 in 2.8b-d sit between PF3 in cis-
[PtCl2(PF3)2]
48 and phosphite L2.5 in 2.8e (Table 2.4). This is consistent with the 
relationship between -acceptor capacity and Pt-P bond strength: the stronger the -
acceptor capacity of the ligand, the stronger the Pt-P bond leading to a higher 1JP,Pt value. 
The trend in 1JP,F values or ΔJP,F(complex-ligand) for PF3 and fluorophosphites L2.2-2.4 in cis-
[PtCl2(PF3)2] and 2.8b-d respectively do not reflect this. The coordination chemical shift 
 for L2.2-2.4 in 2.8b-d ranges from -37 to -55 ppm similar to that for L2.5 in 2.8e.  




Figure 2.5 (a) Observed 31P{1H} NMR spectrum of complex 2.8b; (b) simulated 31P{1H} 
NMR spectrum of complex 2.8b using calculated coupling constants given in Chapter 7. 
195Pt satellite signals have been omitted for clarity.    
Crystals suitable for X-ray crystallography of complexes 2.8c and 2.8e were grown by 
slow diffusion of hexane or pentane respectively into a saturated CH2Cl2 solution of the 
complex. In both cases, the crystal structures confirmed the cis-geometry of the complexes 
and showed the ligands are arranged in a square planar geometry about the Pt centre 
(Figures 2.6 – 2.7). The fluorophosphite ligands adopt an anti-conformation in complex 
2.8c. Whereas, the phosphite ligands adopt a syn-conformation in complex 2.8e. There is 
no consistent correlation between the Pt-P bond lengths and electronic properties of 





 / ppm 
(a) 
(b) 





Figure 2.6 Crystal structure of 2.8c. The hydrogen atoms are omitted for clarity. Thermal 
ellipsoids at 50% probability. Selected bond lengths (Å) and angles (°): P1-F1 1.540(2), 
P2-F2 1.545(2), Pt1-P1 2.1938(9), Pt1-P2 2.1889(9), P1-Pt1-P2 98.14(3), Cl1-Pt1-Cl2 
90.16(3), O1-P1-O2 105.17(13), O4-P2-O5 105.70(14). See Appendix for experimental 
details.   
 
Figure 2.7 Crystal structure of 2.8e. The hydrogen atoms are omitted for clarity. Thermal 
ellipsoids at 50% probability. Selected bond lengths (Å) and angles (°): P1-O3 1.5754(18), 
P2-O6 1.5562(18), Pt1-P1 2.1949(6), Pt1-P2 2.1993(6), P1-Pt1-P2 93.24(2), Cl1-Pt1-Cl2 
89.69(2), O1-P1-O2 104.53(9), O4-P2-O5 101.95(9). See Appendix for experimental 
details.      




Relative to ligands L2.2-2.4, the P-F bond of the 5-membered fluorophosphite L2.1 was 
kinetically labile upon reaction with [PtCl2(cod)]. However, the reaction of 2 equiv. of L2.1 
with [PtMe2(cod)] in d8-toluene gave cis-[PtMe2(L2.1)2] (2.9a) (Scheme 2.8). A characteristic 
AA’XX’ pattern was observed in the 31P{1H} and 19F{1H} NMR spectra; the calculated 




Scheme 2.8 Synthesis of cis-[PtMe2(L2.1)2] complex 2.9a.  
The 1JP,Pt value of 3070 Hz for complex 2.9a, indicative of a cis-geometry, is considerably 
smaller than that of the cis-[PtCl2L2] complexes (2.8b-e); this can be attributed to the high 
trans-influence of Me- ligands relative to Cl-.50 The 1JP,Pt value of 3070 Hz for complex 2.9a 
is smaller than that of the strongly electron withdrawing PF3 in cis-[PtMe2(PF3)2] (
1JP,Pt = 
3300 Hz).50,51 This is as expected since PF3 is a stronger -acceptor than L2.1, resulting in 
a stronger Pt-P bond and a higher 1JP,Pt value.  The coordination chemical shift  for L2.1 
in 2.9a and PF3 in cis-[PtMe2(PF3)2] is ca. +20 ppm.
51   
2.5 Platinum(0) coordination of cyclic fluorophosphites  
The reaction of 4 equiv. of ligands L2.1-2.5 with [Pt(nbe)3] (nbe = norbornene) in THF gave 
the 4-coordinate, 18-electron complexes, [PtL4] (2.10a-e), where L = L2.1-2.5 (Scheme 2.9). 
The 195Pt{1H} NMR spectra for each fluorophosphite complex showed a binomial quintet 
of quintets. Goodfellow et al. have previously synthesised complex 2.10a from [Pt(cod)2] 
and L2.1.
52 Complicated AA'3XX'3 patterns for the 
31P{1H} and 19F{1H} NMR spectra were 
obtained for each of the [PtL4] complexes 2.10a,c,d (see Figure 2.8 for the NMR spectra 
of 2.10c). The 1JP,Pt values increase in the order 2.10a > 2.10c > 2.10d > 2.10e (Table 2.5), 
consistent with increasing Pt-P bond strength as a result of the -acceptor capacity 
increasing in the order L2.1 > L2.3 > L2.4 > L2.5, as shown from the cis-[Mo(CO)4L2] 
complexes (Section 2.3).  
 
Scheme 2.9 Synthesis of the [PtL4] complexes 2.10a-e. 




Table 2.5 NMR data for complexes 2.10a,c-e.a  
Ligand Complex P / ppm 
1JP,Pt / Hz 
L2.1 2.10a 118.0 6102 
L2.3 2.10c 127.1 6000 
L2.4 2.10d 155.6 5981 
L2.5 2.10e 110.1 5745 
a Measured in d8-THF.  
 
(b) 
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Figure 2.8 NMR spectra of [Pt(L2.3)4] (2.10c) in d8-THF. (a) 
31P{1H}; (b) 19 F{1H}; (c) 
195Pt{1H}. 
The complex [Pt(L2.2)4] (2.10b) is insoluble in all common organic solvents and so we 
were unable to characterise it by NMR spectroscopy. However, crystals of 2.10b suitable 
for X-ray crystallography were obtained by the slow diffusion of layered chlorobenzene 
solutions of [Pt(nbe)3] and L2.2 into each other. The crystal structure (Figure 2.9) 
confirmed the coordination of four ligands to the Pt(0) in an approximately tetrahedral 
arrangement. There are multiple, intermolecular  and C-H.... interactions between 
the aryl rings of the ligands detected in the solid state producing an extended structure 
(Figure 2.9b); these intermolecular interactions may explain the lack of solubility of 2.10b. 
Crystals of the analogous phosphite complex, [Pt(L2.5)4] (2.10e), suitable for X-ray 
crystallography were obtained by slow diffusion of hexane into a saturated THF solution 
of the complex (Figure 2.10). In contrast to its fluorophosphite analogue, complex 2.10e 
is soluble in all common organic solvents, in accord its crystal structure shows no 
intermolecular  and C-H.... interactions. The Pt-P bond length in complex 2.10b is 
only slightly shorter (ca. 0.08Å) than in its phosphite analogue 2.10e, despite L2.2 having a 
significantly greater -acceptor capacity than L2.5.  
(c) 
 / ppm 





Figure 2.9 Crystal structure of [Pt(L2.2)4].C6H5Cl. Thermal ellipsoids at 50% probability. 
(a) Molecular structure of 2.10b (C6H5Cl solvate molecules and hydrogens are omitted for 
clarity). Selected bond lengths (Å) and angles (°): P1-F1 1.575(3), Pt1-P1 2.2303(12), P1-
Pt1-P1(-0.5+y, 1-x, -z) 107.61(3), O1-P1-O2 102.61(18). (b) Extended structure 
highlighting the intermolecular  interactions indicated by red dashed lines. The  
interaction distances are 3.964 Å with a shift of 2.07 Å. Weak C-H- interactions with C-
H-plane ~2.87 Å (or H-centroid distance of 3.03 Å), plane centroid-H-C angle 157˚ are 
also present but these are not highlighted. See Appendix for experimental details. 
(a) 
(b) 













Figure 2.10 Crystal structure of 2.10e. The hydrogen atoms are omitted for clarity. 
Thermal ellipsoids at 50% probability. Selected bond lengths (Å) and angles (°): P1-O3 
1.6089(13), Pt1-P1 2.2284(5), P1-Pt1-P2 104.822(17), O1-P1-O2 10.86(7). See Appendix 
for experimental details.       
The formation of the 18-electron [PtL4] complex is common to L = PF3, the 
fluorophosphites L2.1-2.4, phosphite L2.5 and P(OPh)3.
53 In contrast, upon the reaction of 
4 equiv. of Ethanox 398TM (2.4, Section 2.1) with [Pt(nbe)3] no [PtL4] complex was 
observed. The reaction mixture contained [Pt(2.4)3] (2.11f) (60%, identified by the quartet 
of quartets for its 195Pt{1H} NMR signal), [Pt(2.4)2(nbe)] (2.12f) (10%, identified by the 
triplet of triplets for its 195Pt{1H} NMR signal) and the two isomers of free ligand 2.4 in 
a 2:1 ratio (30%) (Scheme 2.10). The difference in reactivity between L2.4 and 2.4 with 
[Pt(nbe)3] can be attributed to the greater steric bulk of Ethanox 398
TM (2.4).   
Scheme 2.10 Reaction of 4 equiv. 2.4 with [Pt(nbe)3]. 
Differences emerged between the fluorophosphites L2.1-2.4 in the reaction of [Pt(nbe)3] 
with 2 equiv. of L2.1-2.4. The expectation was that [PtL2(nbe)] (L = L2.1-2.4) would be the 
products but instead, the equilibria shown in Scheme 2.11 involving Pt(0) species 2.10-




2.13 were observed. Structures 2.10-2.13 have been assigned on the basis of the 
characteristic splitting patterns present in the 31P{1H} NMR spectra and the multiplicity 
of the 195Pt{1H} NMR signals (see Chapter 7 for the data). Despite the stability of the 
three-coordinate [Pt(2.4)3] complex (2.11f) above, the [PtL3] species 2.11a-d were not 
detected but are presumably intermediates that are unstable with respect to 2.10a-d and 
2.12a-d. Addition of 2 equiv. of L2.1 to [Pt(nbe)3] gave a mixture of 2.10a (identified as 
above), 2.12a (identified by the AA'XX' pattern for its 31P{1H} NMR signal and the triplet 
of triplets for its 195Pt{1H} NMR signal), 2.13a (identified by the doublet for its 31P{1H} 
NMR signal and doublet of doublets for its 195Pt{1H} NMR signal). Addition of 2 equiv. 
of L2.2 to [Pt(nbe)3] gave an insoluble white precipitate assumed to be 2.10b (see above) 
and in the filtrate 2.12b and 2.13b were both identified by 31P{1H} and 195Pt{1H} NMR 
spectroscopy. Addition of 2 equiv. of L2.3 to [Pt(nbe)3] initially gave [PtL4] (2.10c) which, 
over the next 2 h, equilibrated to a mixture of 2.10c, 2.12c and 2.13c. Addition of 2 equiv. 
of L2.4 to [Pt(nbe)3] initially gave [PtL4] (2.10d) which then converted to predominantly 
2.12d (see Figure 2.11). Addition of 2 equiv. of 2.4 to [Pt(nbe)3] gave three isomers of 
[PtL2(nbe)] (2.12f) in approximately a 1:12:2 ratio. The proportions of the species obtained 







Scheme 2.11 Proportions of the species observed at equilibrium upon reaction of 2 equiv. 






L = L2.1      77% -         16% 7% 
L = L2.3      40% -         44%  16% 
L = L2.4       6% -         91% 3% 
L = 2.4         - -         100% - 




Figure 2.11 In situ 31P{1H} NMR spectra observed upon reaction of 2 equiv. L2.4 with 
[Pt(nbe)3] at (a) 5 min (2.10d observed only); (b) 30 min (2.10d and 2.12d observed); (c) 
1 h (2.12d observed only).     
Interpretation of the data is complicated by the accuracy of integrating the 31P{1H} or 
19F{1H} NMR signals, the presence of small amounts (<5%) of [Pt(nbe)3] which are 
impractical to detect in the 195Pt{1H} NMR spectra; moreover for the L2.2 system, 
precipitation of 2.10b makes the mixture inhomogeneous and therefore is not included. 
Despite these provisos, it appears that there is a trend in the amount of [PtL2(nbe)] formed 
with increasing size and decreasing -acceptor capacity of the phosphacycle and vice versa 
for the trend in the amount of [PtL4] formed. Furthermore, [PtL2(nbe)] is the sole product 
when using the bulkiest ligand, Ethanox 398TM 2.4. Similar trends were observed upon 
the reaction of 3 equiv. of L2.1-2.4 and 2.4 with [Pt(nbe)3].   
When 2 equiv. of L2.5 was added to [Pt(nbe)3], the product was initially 2.10e which 
equilibrated over 1 h to give 2.10e (35%), 2.12e (53%) and 2.13e (12%) identified from 
the quintet, triplet and doublet respectively in the 195Pt{1H} NMR spectrum. The Pt(0) 
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2.6 Rhodium(I) coordination of cyclic fluorophosphites 
Nixon et al. showed that [Rh2Cl2(L2.1)4] (2.14a) is the product of the addition of L2.1 to 
[Rh2Cl2(C6H10)2].
54 Complex 2.14a is also the sole product of the reaction of [Rh2Cl2(CO)4] 
with 4 equiv. of L2.1 (Scheme 2.12) as shown by the absence of CO bands in the IR 
spectrum and the 19F{1H} and 31P{1H} NMR spectra. This is an indication of the high -
acidity of L2.1 since displacing CO from [Rh2Cl2(CO)4] is a reaction observed with PF3
55 
and a few chelating fluoroaryl diphosphines.56–58 
 
Scheme 2.12 Proportions of the Rh(I) complexes 2.14-2.16 observed upon reaction of 4 
equiv. L2.1-2.5 with [Rh2Cl2(CO)4].  
When [Rh2Cl2(CO)4] was treated with 4 equiv. of L2.2, two P-containing products formed 
that have been identified from their 31P{1H} and 19F{1H} NMR spectra; the broad spectra 
obtained at ambient temperature were resolved at -40 ˚C indicating that the species were 
exchanging on the NMR timescale (Figure 2.12). The binuclear complex 2.14b formed by 
displacement of CO by L2.2 was assigned to the major component (ca. 80%) of the product 
mixture on the basis of the observation that the same species was formed exclusively 
upon addition of 4 equiv. of L2.2 to [Rh2Cl2(cod)2] (see Chapter 7). The minor component 
of the product from [Rh2Cl2(CO)4] was assigned to the salt [Rh(L2.2)5]Cl (2.15b) featuring 




the five-coordinate Rh cation on the basis of: (a) the complicated 31P{1H} and 19F{1H} 
spectra, as expected for a AA'4XX'4M spin system; (b) the reaction of 5 equiv. of L2.2 to 
[Rh(cod)2][BF4] (Scheme 2.14) gave a single product which had the same 
31P{1H} NMR 
spectrum as 2.15b and in the 19F{1H} NMR spectrum, two signals in the ratio 5:4 were 
observed, consistent with the structure [Rh(L2.2)5][BF4] (2.15b'). The IR spectrum of the 
product mixture showed bands for [Rh2Cl2(CO)4], as would be expected to balance the 
stoichiometry (Scheme 2.12) but no other Rh–CO bands. 
 
 
Figure 2.12 Low temperature 31P{1H} NMR spectra of complex 2.14b and 2.15b in 
CD2Cl2.  
According to 31P{1H} and 19F{1H} NMR spectroscopy, the mixtures of products formed 
from the addition of fluorophosphites L2.3 or L2.4 to [Rh2Cl2(CO)4] contained binuclear 
2.14c or 2.14d, and the salts 2.15c or 2.15d (Scheme 2.12). In addition, minor products 
(<15%) were observed which were tentatively assigned to the structures trans-
[RhCl(CO)L2] (2.16c or 2.16d) on the basis of the IR spectrum of the mixtures which 
showed (CO) bands at 2032 cm-1 (for 2.16c) and 2028 cm-1 (for 2.16d). It was found that 
the reaction of [Rh2Cl2(CO)4] with phosphite L2.5 gave 2.16e as the major product (70%) 











with a (CO) band at 2023 cm-1. There is a trend in the reactions of [Rh2Cl2(CO)4] with 
the fluorophosphites on increasing the ring size from L2.1 to L2.4: the chemistry with L2.1 
resembles PF3 and as the ring size expands the chemistry progressively moves towards 
resembling that of phosphite L2.5. 
In addition, differences emerged between ligands L2.2 and L2.3 upon the reaction of 10 
equiv. of ligand with [Rh2Cl2(CO)4] (Scheme 2.13). Ligand L2.3 gave a single product which 
had the same 31P{1H} and 19F{1H} NMR spectra as 2.15c above. In contrast, the 31P{1H} 
NMR spectrum for the reaction with L2.2 gave predominantly a doublet which was 
resolved at -40 ˚C (Figure 2.13) to give an equilibrium mixture of 2.14b, 2.15b and free 
ligand L2.2 (Scheme 2.13).   
 
Scheme 2.13 Reaction of 10 equiv. L2.2-2.3 with [Rh2Cl2(CO)4].  
 
 




Figure 2.13 Low temperature 31P{1H} NMR spectra of the reaction of 10 equiv. L2.2 with 
[Rh2Cl2(CO)4]: 2.14b (*), 2.15b (*) and L2.2 in CD2Cl2. 
The reaction of 5 equiv. of L2.2-2.3 and L2.5 with [Rh(cod)2][BF4] in CH2Cl2 gave the 
[RhL5][BF4] complexes (2.15b’-c’, 2.15e’), where L = L2.2-2.3, L2.5 (Scheme 2.14). Each 
complex gave the same 31P{1H} NMR spectrum as the analogous [RhL5][Cl] salts (2.15b-
c, 2.15e) (see above). Crystals of complex 2.15e’ were obtained by slow diffusion of 
pentane into a saturated CH2Cl2 solution of the complex. The crystal structure showed 
whole molecule disorder (relative occupancies 0.824: 0.176) (Figure 2.14), with multiple 
restraints and constraints required to maintain sensible geometric and thermal parameters. 
Accordingly, no reliable geometric parameters could be provided; despite this the crystal 



























Scheme 2.14 Synthesis of the [RhL5][BF4] complexes 2.15b’-c’ and 2.15e’.  
 
Figure 2.14 Crystal structure of 2.15e’ (a) shows the molecular disorder (b) molecular 
disorder has been omitted for clarity. The hydrogen atoms are omitted for clarity. Thermal 
ellipsoids at 50% probability. The disorder is so extensive that no reliable metrical data 
could be extracted from the X-ray structure.  
2.7 Substituted aryl fluorophosphites 
2.7.1 Synthesis of substituted aryl fluorophosphites 
Novel aryl substituted cyclic fluorophosphites L2.6-2.8 have been prepared from the 
corresponding cyclic chlorophosphites, 2.5e-g. The chlorophosphite 2.5e has been 
previously reported but was often contaminated with spirophosphorane P(V) by-
products.59 Chlorophosphite 2.5f has been previously reported from the reaction of diol 
with excess PCl3.
60 Chlorophosphites 2.5e-f were prepared herein from the silyl ethers 
2.6e-f (Scheme 2.15); this route was required to minimise the formation of 
spirophosphorane P(V) by-products. Despite forcing conditions and long reaction times 




the formation of 2.5f only went to 85% completion and the isolated product was 









Scheme 2.15 Route to chlorophosphites 2.5e-f via the silyl ethers 2.6e-f. Compound 2.6e 




The novel chlorophosphite 2.5g was prepared from the reaction of 2,7-dimethyl-1,8-
naphthalenediol62 with PCl3 in the presence of NEt3 (Scheme 2.16, see Chapter 7 for 
experimental details). The product was contaminated with ca. 7% of an impurity which 





Scheme 2.16 Synthesis of chlorophosphite 2.5g.  
Treatment of chlorophosphites 2.5e-g with SbF3 gave the fluorophosphites L2.6-2.8 
(Scheme 2.17) in good yields (ca. 75%). Fluorophosphite L2.8 was contaminated with 7% 
of an impurity, which was tentatively assigned to the mono-methylsubstituted 
fluorophosphite. All ligands were fully characterised and the 31P{1H} and 19F{1H} NMR 
spectra each showed a characteristic doublet with large 1JP,F values of 1235-1292 Hz (see 




Chapter 7 for data). The unsymmetrical fluorophoshite L2.7 is unsymmetrical and thus 
assumed to exist as a racemic mixture. In the presence of water (0.55 M in MeOH) the 
tBu substituted ligand L2.7 was much less susceptible to hydrolysis than its unsubstituted 








Scheme 2.17 Synthesis of L2.6-2.8.  
Crystals of L2.8 suitable for X-ray crystallography were obtained by slow evaporation of a 
saturated toluene solution of the ligand (Figure 2.15). The crystal structure showed that 
the naphthalene ring lies in the same plane as the two methyl substituents. The P atom is 
pyramidalised (Σ(angles at P) = 297°) which is consistent with sp3 hybridisation, whereas 









Figure 2.15 Crystal structure of L2.8. The hydrogen atoms are omitted for clarity. Thermal 
ellipsoids at 50% probability. Selected bond lengths (Å) and angles (°): P1-F1 1.6062(12), 
P1-O1 1.6101(13), P1-O2 1.6096(13), O1-P1-O2 102.10(7), O1-P1-F1 97.64(6), O2-P1-
F1 98.24(7). See Appendix for experimental details.   




2.7.2 Synthesis of cis-[Mo(CO)4L2] complexes of aryl substituted 
fluorophosphites 
Complexes of the type cis-[Mo(CO)4L2] were targeted as a way to compare the electronic 
properties of fluorophosphites L2.6-2.8 to their unsubstituted analogues L2.1-2.2. The reaction 
of 2 equiv. of ligands L2.6-2.8 with [Mo(CO)4(nbd)] (nbd = norbornadiene) in CH2Cl2 gave 





Scheme 2.18 Synthesis of cis-[Mo(CO)4L2] complexes 2.7f-h. 
Table 2.6 NMR data for complexes 2.7f-h.a  
Ligand Complex P / ppm 
1JP,F / Hzb   ppm 
L2.6 2.7f 168.0 1267 45 
L2.7 2.7g 165.9 1263 47 
L2.8 2.7h 144.1 1200 43 
 a Measured in CD2Cl2. 
b Calculated from N = ∣1JP,F + 3JP,F∣.  
Similar to complexes 2.7a-d, the 31P{1H} and 19F{1H} NMR spectra for complexes 2.7g-
h showed a doublet of triplets, a deceptively simple pattern for the AA’XX’ spin system. 
Rac and meso diastereomeric complexes of 2.7f were observed in the 31P{1H} NMR 
spectrum; shown by two overlapping doublet of triplets which appeared as a doublet of 
quartets. There is excellent agreement between the observed and simulated NMR spectra 
of complexes 2.7f-h, using the calculated coupling constants given in Chapter 7. Values 
of ca. 50 Hz for 2JP,P are similar to that of cis-[Mo(CO)4(PF3)2] and are indicative of a cis-
geometry.63 Substitution on either the phenyl or naphthalene ring of L2.1 or L2.2 appears 
to have little effect on the NMR data for complexes 2.7f-h (relative to complexes 2.7a-
b). 
The IR spectra for complexes 2.7f-h are consistent with a cis-geometry of ligands. The 
(CO) values shown in Figure 2.16 for complexes 2.7f-h and 2.7a, featuring the five-
membered phosphacycles L2.6-2.7 and L2.1, reflect the small effect substitution with 




electron-donating tBu substituents has on the electronic properties of L2.1. Similarly, 
minimal effect of substitution was observed in complexes 2.7h and 2.7b, featuring 6-
membered phosphacycles L2.8 and L2.2 respectively. Despite this, when taking 
electronegativity of substituents and phosphacycle ring size into consideration, the trend 
in (CO) correlates as expected, with -acceptor capacity increasing in the order L2.1 > 
L2.6 ≈ L2.7 > L2.2 > L2.8.
64  
Figure 2.16 (CO) bands for 2.7f-h vs. 2.7a-b (see Chapter 7 for values). 
Crystals of 2.7h suitable for X-ray crystallography were obtained by slow diffusion of 
hexane into a saturated CH2Cl2 solution of the complex (Figure 2.17). The crystal structure 
confirmed the cis-geometry of the complex and shows that the fluorophosphite ligands 
adopt a syn-conformation. The Mo-P -bonding should perturb the bond lengths and 
angles around the P centre relative to the free ligand (L2.8);
27–29 no trend was observed in 
the P-F bond length, but a small increase in the F-P-O (by ca. 1.6°) and O-P-O (by ca. 
1.3°) angles was observed in complex 2.7h (Table 2.7). The Mo-P bond length in complex 
2.7h is slightly longer than in 2.7b (by ca. 0.008 Å), consistent with the substituted 
fluorophosphite L2.8 being a poorer -acceptor than its unsubstituted analogue L2.2.
27,28  
Table 2.7 Selected bond lengthsa (Å) and anglesa (°) from the molecular structures of L2.8 
and complexes 2.7b,h.    
Ligand Complex Mo-P / Å P-F / Å F-P-O / ° O-P-O / ° 
L2.8 - - 1.6062(12) 97.94(7) 102.10(7)  
L2.2 2.7b 2.3846(6) 1.5832(13) 99.50(8) 103.52(8) 
L2.8 2.7h 2.3924(5) 1.5845(12) 99.51(7) 103.35(7) 
aAverage values have been calculated for simplicity. 
 
 
(CO) / cm-1 
L2.1 L2.6 
2062  2066  2072  2074  2070  2068  2064  
L2.7 L2.8 L2.2 





Figure 2.17 Crystal structure of 2.7h. The hydrogen atoms are omitted for clarity. 
Thermal ellipsoids at 50% probability. See Table 2.7 for selected bond lengths (Å) and 
angles (°). See Appendix for experimental details.   
2.7.3 Platinum(II) coordination of substituted aryl fluorophosphites 
The reaction of 2 equiv. of ligands L2.6-2.8 with [PtCl2(cod)] (cod = 1,5-cyclooctadiene) in 
CH2Cl2 gave the cis-[PtCl2L2] complexes 2.8f-h, where L = L2.6-2.8 (Scheme 2.19). 
Characteristic AA’XX’ patterns for the 31P{1H} and 19F{1H} NMR spectra were obtained 
for each complex 2.8f-h. The large 1JP,Pt values are consistent with a cis-geometry (Table 
2.8). Similar to the cis-[Mo(CO)4(L2.6)2] complex (2.7f), rac and meso diastereomeric 
complexes of cis-[PtCl2(L2.6)2] (2.8f) were observed in the 





Scheme 2.19 Synthesis of the cis-[PtCl2L2] complexes 2.8f-h. 
Table 2.8 NMR data for complexes 2.8f-h.a  
Ligand Complex P / ppm 
1JP,Pt / Hz 1JP,F / Hzb 
L2.6 2.8f 89.9, 89.0 6032, 6038 - 
L2.7 2.8g 90.0 5947 - 
L2.8 2.8h 63.8 6159 1242 
 a Measured in CD2Cl2. 
b Calculated from N = ∣1JP,F + 3JP,F∣.  




The 31P{1H} and 19F{1H} NMR spectra of complex 2.8h was simulated using the 
calculated coupling constants given in Chapter 7. There is excellent agreement between 
the observed and simulated spectra. The coupling constants for complexes 2.8f-g could 
not be calculated due to poor signal resolution. The 1JP,F and 
1JP,Pt values of complex 2.8h 
are similar to that of the unsubstituted analogue, L2.2 in 2.8b (see Section 2.4).  
2.7.4 Rhodium(I) coordination of aryl substituted fluorophosphites   
When [Rh2Cl2(CO)4] was treated with 4 equiv. of ligands L2.6-2.8 (Scheme 2.20), two P-
containing species formed and have been identified as [Rh2Cl2L4] complexes (2.14f-h) and 
[RhL5][Cl] salts (2.15f-h) on the basis of their characteristic NMR spectra and the evidence 
discussed in Section 2.6 for the unsubtituted analogues. The IR spectra of the reaction 









Scheme 2.20 Proportions of the Rh(I) complexes 2.14-2.15 observed upon reaction of 4 
equiv. L2.6-2.8 with [Rh2Cl2(CO)4].  
The broad 31P{1H} NMR spectrum obtained at ambient temperature for the reaction with 
L2.6 was partially resolved at -80 °C, but due to the presence of rac and meso complexes for 
both 2.14f and 2.15f, the complicated 31P{1H} NMR signals were unsuitable for accurate 
integration. Unlike the reaction with the unsubstituted 5-membered fluorophosphite L2.1, 
where the binuclear complex 2.14a was the sole product (see Section 2.6), upon reaction 
with the tBu-substituted L2.6 and L2.7 the salts 2.15f-g were also observed (Scheme 2.20). 
Substitution on the phenyl ring moves the chemistry away from that of PF3. A similar 
trend was observed for the fluorophosphites featuring the six-membered phosphacycles, 
L2.2 and L2.8; upon reaction with the substituted analogue L2.8, an increase in the amount 




of the salt [RhL5][Cl] (2.15h) to 60% was observed (cf. 20% when using L2.2). In both 
cases, the trend is likely a consequence of the balance of electronic factors (stronger -
acceptor ligands stabilise [Rh2Cl2L4]) outweighing steric factors (pentacoordinate 


























2.8 Conclusions  
A series of fluorophosphites L2.1-2.4, with varying phosphacycle ring size, has been 
successfully synthesised. The IR spectra and crystal structures of the cis-[Mo(CO)4L2] 
complexes (2.7a-d), where L = L2.1-2.4, confirmed the expectation that the 
fluorophosphites would populate the space between P(OAr)3 and PF3, in terms of their 
/ -bonding to transition metals. Pronounced effects of phosphacycle ring size on the 
stereoelectronic properties of the ligands were observed, and can be summarised in terms 
of the following trends for L2.1-2.4: (1) the smaller the phosphacycle, the closer the 
fluorophosphite properties are to PF3, so L2.1 is the most PF3-like of the series; (2) the 
steric bulk of the ligands is in the order: L2.1/L2.2 < L2.3/L2.4. The IR spectra of the cis-
[Mo(CO)4L2] complexes featuring the six-membered fluorophosphite L2.2 and phosphite 
L2.5 demonstrate the significant effect the P-F fragment has on increasing the -accepting 
capacity of the ligand, relative to the P-OMe fragment.  
Using these generalisations, the Pt(II), Pt(0) and Rh(I) coordination chemistry of ligands 
L2.1-2.4 could be understood. The 
1JP,Pt values of the cis-[PtCl2L2] complexes, where L = L2.2-
2.4, sit between the analogous PF3 and phosphite L2.5 complexes. The 18-electron [PtL4] 
complexes are common to the whole series from PF3, through L2.1-2.4, to phosphite L2.5. 
A trend emerged in the proportions of [PtL2(nbe)] and [PtL4] species observed upon the 
addition of 2 equiv. of ligand to [Pt(nbe)3]. Using the 5-membered L2.1, [PtL4] was the 
major species (77%), whereas with the 8-membered L2.4 [PtL2(nbe)] predominated (91%). 
This trend is likely a consequence of the balance of steric factors ([PtL4] is more crowded 
than [PtL2(nbe)]) and electronic characteristics (fluorophosphites stabilise Pt(0) better 
than nbe).  
The reaction of [Rh2Cl2(CO)4] with P(OAr)3 to give trans-[RhCl(CO){P(OAr)3}2] is 
general. However, the fluorophosphites L2.1-2.4 displace CO from [Rh2Cl2(CO)4] to give 
the binuclear [Rh2Cl2L4] species; this is an excellent demonstration of their PF3-like 
properties. Furthermore, the observed trend in the extent to which the ligand displaces 
CO reflects the closeness in its properties to PF3: [Rh2Cl2L4] is the sole product when 
using the 5-membered L2.1 but constitutes only 65% of the product when using the 8-
membered L2.4.  
Novel aryl-substituted analogues of fluorophosphites L2.1 and L2.2 have been synthesised 
(L2.6-2.8). Most likely due to the high steric bulk of the 3,6-tBu substitution in L2.7, the 
synthesis of the chlorophosphite precursor did not reach completion and so pure L2.7 was 




not obtained. The synthesis of this ligand should be optimised in the future. The IR 
spectra of the cis-[Mo(CO)4L2] complexes (2.7f-h), where L = L2.6-2.8, showed that 
substitution on the aryl ring had a small effect on the electronic properties of the 
fluorophosphites. Despite this, the trend was as expected whereby substitution on the aryl 
ring with electron-donating groups (such as tBu or Me) decreases the -accepting 
properties of the ligand.  
The aryl substituted fluorophosphites L2.6-2.8 displayed similar Rh(I) coordination 
behaviour to L2.1-2.2; the substitution of CO in [Rh2Cl2(CO)4] by fluorophosphites L2.6-2.8 
readily occurs. However, increased amounts of [RhL5][Cl] species were observed when 
using the substituted fluorophosphites, demonstrating how the coordination properties 
of the substituted ligands move away from that of PF3. The Pt(0) coordination chemistry 
of the substituted fluorophosphites should be explored to further investigate these 
differences in behaviour. Decoration of the aryl rings with other substituents should also 
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Fluorophosphites for alkene 
hydroformylation  
 
3.1 Introduction  
3.1.1 Rh-catalysed hydroformylation  
Hydroformylation is the addition of “syngas” (H2/CO) to an alkene in the presence of a 
catalyst to form a mixture of linear (n) and branched (iso) isomeric aldehydes (Scheme 3.1). 
Since its fortuitous discovery by Otto Roelen in 1938,1,2 hydroformylation has developed 
into one of the most valuable industrial processes.3 Aldehydes are important intermediates 
in the synthesis of fine and bulk chemicals. Initially, exclusively cobalt catalysts were 
applied to hydroformylation until the discovery of the first ligand modified rhodium 
catalyst, [RhH(CO)(PPh3)3], by Wilkinson in 1968.
4,5 Rh-catalysts are generally more 
expensive than Co-catalysts, but due to their extremely high catalytic activities at low 





Scheme 3.1 Catalytic hydroformylation of an alkene.  
The use of phosphorus ligands in Rh-catalysed hydroformylation is extensive and has 
been thoroughly reviewed in many textbook chapters6–11 and journals.12–15 Figure 3.1 
shows examples of key monophos ligands which have been applied in the Rh-catalysed 
hydroformylation of alkenes: water-soluble tris(3-sulfophenyl)phosphine trisodium salt 
(TPPTS, 3.1),16 bulky phosphites (e.g. 3.2)17–20 and cyclic phosphites (e.g. 3.3),19,21,22 




23–25 phosphinines (e.g. 3.5)26,27 and the cyclic 
fluorophosphite Ethanox 398TM (3.6).28,29 The use of the fluorophosphite 3.6 for Rh-












Figure 3.1 Key examples of monophos ligands used in Rh-catalysed hydroformylation 
since the discovery of [RhH(CO)(PPh3)3]. 
3.1.2 Recent developments in Rh-catalysed hydroformylation  
Rh-catalysed hydroformylation was most recently reviewed in 2012.12 Here the highlights 
of Rh-catalysed hydroformylation research since 2012 will be presented.  
3.1.2.1 Monophos ligands  
Recently, in 2019 a facile synthesis of the azaphosphatriptycene ligand 3.7 was reported; 
the difficulty of the syntheses of such ligands has limited their use in catalysis previously.32 
The IR spectrum of the corresponding [Rh(acac)(CO)(3.7)] complex showed the strong 
-acceptor/weak -donor character of the ligand.32 The catalyst derived from 3.7 
displayed high activity in the Rh-catalysed hydroformylation of cyclohexene.32 Borner et 
al. have recently reported the use of bulky tBu phosphinites (e.g. 3.8a) and phosphonites 
(e.g. 3.8b) in the Rh-catalysed hydroformylation of 1-ocetene.33,34 










3.1.2.2 Diphos ligands  
In 2012, a new class of bidentate phosphoramidite ligands based on a spiroketal backbone 
(e.g. 3.9a) was reported for the Rh-catalysed hydroformylation of a range of alkenes.35 
Using the catalyst derived from ligand 3.9a, an excellent linear to branched ratio (n:iso) of 
174 was achieved for the hydroformylation of 1-hexene.35 Analogous spiroketal-based 
diphosphite ligands (such as 3.9b) were also reported for the hydroformylation of 
terminal and internal alkenes; an n:iso ratio of up to 93 was obtained.36 The pyrrolyl and 
7-membered phosphacycle substituents have also been employed in the novel 
diphosphoramidite and diphosphite tridentate ligands, 3.10a and 3.10b respectively, by 
Zheng et al.37 They were tested in the hydroformylation of a range of cyclic olefins.37 When 
using cyclohexene as the substrate a high aldehyde yield (92.0%) was obtained using the 
catalyst derived from ligand 3.10b; a similar yield was achieved using the catalyst derived 
from 3.10a but a higher L/Rh ratio of 20 was required (vs. 5).37  
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3.1.2.3 Tri- and tetraphos ligands      
Since 2006, Zhang et al. have focussed their research efforts into tetraphos ligands for Rh-
catalysed hydroformylation. More recently, in 2016 they developed a range of novel 
tetraphosphite ligands (3.11) and applied them to Rh-catalysed hydroformylation of 1-
octene.38 Linear selectivities of up to 98.9% were obtained with 3.11, when R = Me.38 In 
2014, Zheng et al. applied the bi- and tetradentate pyrrolyl phosphanes, 3.12a and 3.13a, 
in the Rh-catalysed hydroformylation of 1-octene, but only moderate regioselectivities 
were observed.39 Later in 2019, Zheng et al. employed the air-stable phenyl analogues 
3.12b and 3.13b in the Rh-catalysed hydroformylation of 1-octene and 1-hexene; high 
yields of aldehyde were obtained even at 40 °C.40 Additionally, the catalyst derived from 
3.13b could be recycled seven times with retention of catalytic activity and selectivity.40 
 
In 2019, Borner et al. employed tetradentate tripodal phosphinophosphite ligands (e.g. 
3.14) in the hydroformylation of 1-octene; preliminary studies gave high yields of aldehyde 
(up to 92%) but no additional information was disclosed in the patent.41  
Triphosphorus ligands have rarely been explored as ligands for hydroformylation despite 
many examples of both bi- and tetradentate phosphorus ligands. The first triphosphorus 
ligand for regioselective linear hydroformylation was reported in 2013.42 The novel 
triphosphoramidite 3.15 was employed in the hydroformylation of a range of terminal and 
















3.1.2.4 Branched selective hydroformylation  
To date, there are only a few examples of catalysts that show a preference for branched 
aldehyde formation in hydroformylation. Branched aldehyde products are increasingly 
desired due to their use in the fragrance, flavour and life-sciences industries.43 To achieve 
branched selective hydroformylation at temperatures used in industry is challenging; 
originally the best selectivities could only be obtained at low temperatures (e.g. 19 °C).44 
Reek et al. employed the rhodium encapsulation complex 3.16 in the hydroformylation of 
propene and a good iso selectivity of ca. 50% was achieved at 70 °C.44,45  
Since 2012, Clark et al. have demonstrated excellent branched selectivity in the 
hydroformylation of a range of substrates using a catalyst derived from the phosphite-
phospholane bidentate ligand, BOBPHOS (3.17).46 This pioneering work was the first 
example of an enantioselective hydroformylation to give the branched aldehyde product; 
an ee of up to 93% was achieved.46 In addition, Clarke et al. have applied this system in the 
hydroformylation of allylglycine derivatives which give chiral intermediates of industrial 
importance for new antibiotics.47 The origin of the branched selectivity produced from 
the Rh/BOBPHOS system has since been investigated in detail.48,49 In 2019, 
unprecedentedly high branched-selectivity (82.0%) in the hydroformylation of propene 
was obtained using the Rh/BOBPHOS system; unusual solvents, such as 
octafluorotoluene, were crucial to the selectivity observed and high enough temperatures 
were used to achieve fast conversion.50–52 Other ligands recently employed in branched 
selective hydroformylation include nitrogen-centred triphosphines (3.18) and phosphine-
phosphoramidites (e.g. 3.19); branched selectivities of up to 56% using the catalyst derived 
from 3.19 were observed in the hydroformylation of propene.43,53 














3.1.2.5 Other active areas of research  
Supramolecular strategies have been used extensively to control both the activity and 
selectivity of hydroformylation reactions,54–57 and have recently been reviewed by Reek et 
al.58 Other current active areas of research in hydroformylation include asymmetric 
hydroformylation (recently reviewed by Landis et al.),59 biphasic hydroformylation and the 
use of water-soluble ligands60–62 and ionic liquid phase hydroformylation (recently 
reviewed by Haumann et al.).63 Tandem hydroformylation reactions are also increasingly 
being explored, for example isomerisation-hydroformylation reactions, which are 
important for the production of linear aldehydes from internal alkenes.64,65  
3.1.3 Mechanism of Rh-catalysed hydroformylation  
The mechanism of hydroformylation has been well studied.6,9,13,66–68 The generally 
accepted mechanism for Rh-catalysed hydroformylation is the dissociative mechanism 
shown in Scheme 3.2 (pathway I),6 which was proposed by Wilkinson in the 1960s for 
the [RhH(CO)(PPh3)3] catalyst.
4 The mechanism is based on Heck’s original mechanism 
for Co-catalysed hydroformylation.69 It proceeds via initial CO or ligand dissociation to 
form the cis and trans unsaturated species a and b (Scheme 3.2). Coordination of the alkene 
(c and d) is then followed by regioselectivity determining hydride migration to give alkyl 
complexes e and f. -hydride elimination of the alkyl complexes can occur at this point 
leading to the formation of isomerisation products. Coordination of CO (g and h) is then 
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followed by alkyl migration to the CO ligand to form the acyl complexes i and j. The final 
irreversible hydrogenolysis step yields the aldehyde product and regenerates complexes a 
and b.   
 
Scheme 3.2 Simplified mechanism for the Rh-catalysed hydroformylation of an alkene, 
where L = PPh3. Only the pathway to the linear aldehyde is shown.  
Generally, strong -acceptor ligands (e.g. phosphites) facilitate CO dissociation from the 
RhH(CO)2L2 complexes and alkene association to form complexes c and d, resulting in a 
highly active catalyst.6 The Rh-L species present in hydroformylation depends on the 
pressure of CO and the concentration and nature of the ligand. In pathway I (Scheme 
3.2) the bulky trans-Rh(CO)L2 fragment promotes n-regioselectivity, since the n-alkyl 
intermediate is favoured over the iso isomer.6 Decreasing the ligand concentration or 
increasing the CO concentration is known to decrease the n-selectivity due to the potential 
formation of highly active but less selective Rh(CO)2L species (or even Rh(CO)3 species).     
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3.1.4 Recently proposed “RhL3” mechanism  
Recently, Pringle et al. have proposed the “RhL3” mechanism (pathway II, Scheme 3.3) 
for Rh-catalysed hydroformylation using a Rh-tris(pyrrolyl)phosphine (PPyr3, 3.4) 
catalyst.70 They observed that upon increasing the PPyr3 concentration from a L/Rh ratio 
of 4.5 to 40 dramatically increased the n-selectivity from a n:iso ratio of 2 to 48.70 Whereas, 
when using the catalyst derived from PPh3 only a small increase from 3 to 6 was 
observed.70 It was suggested that the excellent n-regioselectivity observed when using high 
concentrations of PPyr3 was due to the presence of highly selective RhL3 species. Such 
RhL3 intermediates have previously only been suggested in hydroformylation catalysis as 
out-of-cycle resting states, as seen in pathway I (Scheme 3.2). The RhL3 intermediates in 
pathway II, B and C, have a high steric bulk which promote the formation of n-alkyl Rh 















Scheme 3.3 Simplified “RhL3” mechanism for the Rh-catalysed hydroformylation of 
ethene, where L = PPyr3.  
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To explore the viability of the Rh(CO)L2 mechanism (pathway I) relative to the RhL3 
mechanism (pathway II), DFT calculations were carried out for both mechanistic 
pathways using catalysts derived from PPh3 and PPyr3.
70 It was argued that pathway II 
was accessible for the Rh-PPyr3 catalyst, but less likely to occur for the Rh-PPh3 catalyst.
70 
The potential involvement of the highly selective RhL3 species when using high 
concentrations of PPyr3 explains the remarkable increase in n-selectivity described above.  
3.1.5 Aims of the project  
Following the success of Ethanox 398TM (3.6, Section 3.1.1) in hydroformylation, the aim 
of this project was to test the fluorophosphites L2.1-2.4 and L2.6-2.8 (Chapter 2) in the Rh-
catalysed hydroformylation of 1-hexene. As shown in Chapter 2, the fluorophosphites are 
strong -acceptors and so it was anticipated that they would give active hydroformylation 
catalysts. It was of interest to gauge the effect of phosphacycle ring size on 
hydroformylation by comparing the 5- to 8-membered fluorophosphites L2.1-2.4. In 
addition, the effect of substitution on the aryl rings of the 5- and 6-membered ligands was 
to be investigated by testing ligands L2.6-2.8. Following the excellent n-selectivity previously 
obtained when using high concentrations of PPyr3 (Section 3.1.4), it was of interest to 







3.2 Catalytic hydroformylation of 1-hexene under “concentrated-catalyst” 
conditions 
The fluorophosphites L2.1-2.4 and L2.6-2.8 described in Chapter 2 were tested in the Rh-
catalysed hydroformylation of 1-hexene. The catalysis performed at the University of 
Bristol was carried out at a Rh concentration of 3.9 mmol L-1 (conditions A) and the 
results are presented below (see Chapter 7 for experimental details). The selectivity is 
given as a % rather than as a n:iso ratio.     
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3.2.1 Effect of fluorophosphite ring size 
To probe the effect of fluorophosphite ring size on hydroformylation, the 5- to 8-
membered fluorophosphites L2.1-2.4 were tested in the hydroformylation of 1-hexene 
(Scheme 3.4). For consistency the catalysis was stopped at ca. 30% conversion by 
quenching the reaction mixture with an excess of tributylphosphite. The selectivity, 
conversion and turnover frequency to aldehyde products (TOFaldehyde) were determined by 
1H NMR spectroscopy (see Chapter 7 for details) and the results are shown in Table 3.1. 
A L/Rh ratio of 5 was employed for these initial catalytic runs.  
 
Scheme 3.4 Catalytic hydroformylation of 1-hexene using ligands L2.1-2.5.  
Table 3.1 Catalytic hydroformylation of 1-hexene using L/Rh = 5 under conditions A.a 
a Method: 4.83 mmol 1-hexene, 0.012 mmol [Rh(acac)(CO)2], 0.060 mmol ligand (L/Rh 
= 5), 2.5 cm3 toluene, 20 bar of H2/CO (1/1), 90 °C. 
b Conversion = conversion to 
aldehydes, i.e. 100% - (1-hexene and isomerisation). c TOF at the given conversion. d 
Isomerisation to 2- and 3-hexene. Conversion and selectivity were determined by 1H 
NMR spectroscopy. *Result is an average of at least two runs. 
    
Entry 
 








1* L2.1 0 0 - 0 
2* L2.2 91.3 36 669 18 
3* L2.3 90.2 37 112 5 
4 L2.4 90.1 24 32 1 
5 L2.5 88.2 20 36 3 
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The catalyst derived from the 5-membered fluorophosphite L2.1 showed no 
hydroformylation activity (Entry 1, Table 3.1); this experiment was repeated. The 31P{1H} 
NMR spectrum of the reaction mixture after catalysis showed degradation of L2.1 had 
occurred. The signals observed were singlets (P ≈ 8.1, -1.9, -13.7 ppm) and so the P–F 
bond was no longer intact, suggesting hydrolysis of the ligand had occurred. The 5-
membered L2.1 is extremely sensitive to water (see Chapter 2), which may have been 
present adventitiously or due to some aldol condensation of a small amount of aldehyde 
formed. The generation of free fluoride ions from the hydrolysis of fluorophosphite L2.1 
would be detrimental to catalyst activity, according to Puckette et al.71,72   
The catalysts derived from the larger ring fluorophosphites, L2.2-2.4, were stable to 
hydrolysis under catalytic conditions and displayed good hydroformylation activity. The 
6-membered ligand L2.2 gave the most active and n-selective catalyst (Entry 2, Table 3.1). 
The TOF was significantly higher for the catalyst derived from L2.2 than that of the 7-
membered L2.3: 669 vs. 112 h
-1 (Entry 2 vs. 3). However, ligand L2.2 also gave a highly 
active isomerisation catalyst, relative to ligands L2.3-2.4. The catalysts derived from L2.3 and 
L2.4, containing 7- and 8-membered rings, gave similar n-selectivities (Entries 3 and 4, ca. 
90%).  
Both catalysts derived from L2.3 and L2.4 were considerably less active than the 6-
membered fluorophosphite L2.2. The catalyst derived from the 8-membered L2.4 gave a 
particularly low TOF of 32 h-1 (Entry 4, Table 3.1). Problems were encountered during 
the purification of the 8-membered ligand L2.4: considerable amounts (ca. 25%) of SbCl3 
were detected in the ligand (see Chapter 2) but attempts to purify the ligand through silica 
or florisil often led to the telomerisation of L2.4, making complete removal of SbCl3 
problematic. The low activity of the catalyst derived from L2.4 may be attributed to the 
hydrolysis of SbCl3 under catalytic conditions; the generation of free chloride ions is 
known to be detrimental to the activity of a hydroformylation catalyst.21,71,73 The 
capriciousness of the results obtained when using the other fluorophosphites may also be 
due to the presence of SbCl3; purification of the ligands through florisil before use was 
essential to maintaining the catalytic activity.      
To explore the effect of the fluoro-substituent on hydroformylation catalysis, the 
analogous 6-membered phosphite L2.5 (Scheme 3.4) was also tested in the 
hydroformylation of 1-hexene (Entry 5, Table 3.1). The TOF when using the 6-membered 
phosphite ligand L2.5 was significantly lower than the analogous 6-membered 
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fluorophosphite L2.2 (36 vs. 669 h
-1). The catalyst derived from the phosphite L2.5 was also 
less selective towards the n-aldehyde cf. L2.2 (88.2 vs. 91.3%, Entry 5 vs. 2). The difference 
in activity may be attributed to their different donor properties (as seen in Chapter 2); the 
fluorophosphite L2.2 is a significantly stronger -acceptor than the phosphite L2.5. 
Increasing the -accepting properties of the ligand increases the rate of reaction, since 
CO dissociation and alkene association is facilitated.9 Stronger -acceptors also have a 
higher preference for equatorial sites on the Rh centre, which promotes the formation of 
the n-aldehyde.9  
3.2.2 Effect of ligand concentration  
It is well-known that ligand concentration can greatly affect the catalyst selectivity and 
activity of Rh-catalysed hydroformylation.71,74 The effect of concentration of ligands L2.2 
and L2.3 on catalysis was investigated. A range of L/Rh ratios (5-15) were tested in the 
same volume of solvent and the results are shown in Table 3.2. As above, all reactions 
were quenched at ca. 30% conversion for consistency.  
Table 3.2 Effect of ligand concentration on the catalytic hydroformylation of 1-hexene 
using L2.2-2.3.
a 
a Method: 4.83 mmol 1-hexene, 0.012 mmol [Rh(acac)(CO)2], ligand (L/Rh = 5, 10 or 15), 
2.5 cm3 toluene, 20 bar of H2/CO (1/1), 90 °C. 
b Conversion = conversion to aldehydes, 
i.e. 100% - (1-hexene and isomerisation). c TOF at the given conversion. d Isomerisation 
to 2- and 3-hexene. Conversion and selectivity were determined by 1H NMR 
spectroscopy. *Results are an average of at least two runs.  
For the catalysts derived from both the 6- and 7-membered ligands L2.2 and L2.3, increasing 
the ligand concentration considerably decreased the catalytic activity. For example, the 










/ h-1 c 
Isom. 
/ %d 
1* L2.2 5 91.3 36 669 18 
2* L2.2 10 96.6 28 48 15 
3 L2.2 15 99.5 26 42 7 
4* L2.3 5 90.2 37 112 5 
5 L2.3 10 95.1 32 55 1 
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5 to 10 (669 vs. 48 h-1, Entry 1 vs. 2, Table 3.2). At a higher ligand concentration the 
formation of the unsaturated catalytically active species (such as complex A in Scheme 
3.3, Section 3.1.4) is inhibited, resulting in a decrease in activity.6   
On the other hand, when using the catalysts derived from L2.2 and L2.3 increasing the 
ligand concentration significantly increased the n-selectivity. Ligand concentration 
appeared to have a greater influence on selectivity for the 6-membered ligand L2.2, relative 
to L2.3. Increasing the L/Rh ratio from 5 to 15 for L2.2 greatly increased the n-selectivity 
from 91.3% to a remarkable 99.5% (Entry 1 vs. 3, Table 3.2). At higher ligand 
concentrations, the coordination equilibria lie towards the more sterically hindered 
fluorophosphite-rich intermediates, which favour the formation of the n-aldehyde.75 In 
addition, decreased amounts of isomerisation were observed at higher ligand 
concentrations for both L2.2 and L2.3 (Entry 1 vs. 3).   
As discussed, fluorophosphites L2.2 and L2.3 are very strong -acceptors (Chapter 2). The 
combination of their high -acceptor capacity, relatively small size and significant 
influence of ligand concentration on n-selectivity may suggest the formation of reactive 
and selective RhL3 species throughout the catalysis.
70 Such ligand-rich catalytic 
intermediates have been suggested when using PPyr3 (Section 3.1.4).
70 Relative to RhL2, 
these RhL3 species promote the formation of the n-alkyl Rh complex C (Scheme 3.3, 
Section 3.1.4).70 Since the 6-membered fluorophosphite L2.2 is smaller and a stronger -
acceptor than the 7-membered L2.3 (Chapter 2), the formation of RhL3 species would be 
more favoured, which may explain why ligand concentration has a greater influence on 
selectivity for L2.2 relative to L2.3.  
3.2.3 Effect of fluorophosphite aryl substitution  
To probe the effect of substitution on the aryl rings of the 5- and 6-membered 
fluorophosphites, ligands L2.6-2.8 were tested in the hydroformylation of 1-hexene (Scheme 
3.4). The same conditions as described in Section 3.2.1 (L/Rh = 5) were used and the 





Chapter 3: Fluorophosphites for alkene hydroformylation 
91 
 
Table 3.3 Catalytic hydroformylation of 1-hexene using the aryl substituted 
fluorophosphites L2.6-2.8.
a   
a Method: 4.83 mmol 1-hexene, 0.012 mmol [Rh(acac)(CO)2], ligand (L/Rh = 5 or 10), 2.5 
cm3 toluene, 20 bar of H2/CO (1/1), 90 °C. 
b Conversion = conversion to aldehydes, i.e. 
100% - (1-hexene and isomerisation). c TOF at the given conversion. d Isomerisation to 
2- and 3-hexene. Conversion and selectivity were determined by 1H NMR spectroscopy.  
The catalysts derived from the substituted 5-membered fluorophosphites L2.6-2.7 displayed 
zero catalytic activity (Entries 1-2, Table 3.3), similar to the unsubstituted analogue L2.1. 
The 31P{1H} NMR spectrum of the reaction mixture after catalysis when using the 3,5-
tBu substituted L2.6 showed complete degradation of the ligand to a P(V) 
spirophosphorane species, such as species 3.20. Despite the lack of catalytic activity 
observed when using the 3,6-tBu substituted fluorophosphite L2.7, the 
31P{1H} NMR 
spectrum of the reaction mixture at the end of the catalysis showed the ligand remained 
intact. The 5-membered fluorophosphites are stronger -acceptors than the larger ring 
analogues (Chapter 2). The high -accepting properties of the 5-membered 
fluorophosphites may lead to the displacement of CO from [HRhL3(CO)] to form the 
inactive [RhHL4] species.
12 Similar coordination behaviour was shown in Chapter 2, where 
upon the reaction of ligand L2.7 with [Rh2Cl2(CO)4] displacement of CO occurred. The 
formation of the [RhHL4] species may explain the lack of activity observed when using 
L2.7. Paired with their acute susceptibility to hydrolysis, it would appear that 5-membered 














/ h-1 c 
Isom. 
/ %d 
1 L2.6 5 0 0 - 0 
2 L2.7 5 0 0 - 0 
3 L2.8 5 92.0 48 1 656 16 
4 L2.8 10 99.0 33 72 10 
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By contrast, the 6-membered aryl substituted fluorophosphite L2.8 gave a highly active 
catalyst (Entry 3, Table 3.3), achieving a high TOF of 1 656 h-1 when using a L/Rh ratio 
of 5. The catalyst derived from L2.8 also displayed good selectivity towards the n-aldehyde 
(92.0%), slighter higher than that of the unsubstituted L2.2 (91.3%) (L/Rh = 5).  
Upon increasing the L/Rh ratio from 5 to 10 for L2.8 the catalytic activity dramatically 
decreased from a TOF of 1 656 to 72 h-1 (Entry 3 vs. 4, Table 3.3); the activity is highly 
sensitive to ligand concentration under these “concentrated-catalyst” conditions - at high 
concentrations the fluorophosphites inhibit catalysis. On the other hand, the n-selectivity 
significantly increased from 92.0 to 99.0% (Entry 3 vs. 4), for reasons explained above 
(Section 3.2.2). The amount of isomerisation was decreased upon increasing the ligand 
concentration of L2.8.      
The n-selectivity obtained when using a L/Rh ratio of 10 was also significantly higher than 
that of the catalyst derived from the unsubstituted analogue L2.2, under the same 
conditions (99.0 vs. 96.6%). This difference in reactivity may be explained by the increased 
steric bulk of the RhL3 catalytic intermediates when using L2.8, which would further 
promote the formation of the n-alkyl Rh complex. Nevertheless, there is a fine balance to 
be struck regarding steric hindrance: if the ligand is too bulky the dissociation of the RhL3 
intermediates to form less selective RhL2 species may be promoted.  
3.3 Catalytic hydroformylation of 1-hexene under "dilute-catalyst" conditions 
Catalytic hydroformylation was also performed at the Leibniz Institute for Catalysis 
(Rostock, Germany) by the author and Dr. Christoph Kubis, but at a lower Rh 
concentration of 1.14 mmol L-1 and a lower substrate concentration of 1 154 mmol L-1 
(conditions B). An aliquot of the reaction mixture was collected periodically and GC used 
to determine the ratio of products (see Chapter 7 for experimental details). Dr. Christoph 
Kubis (LIKAT, Rostock) performed kinetic modelling to calculate the turnover frequency 
(TOF). The results are presented and discussed below.  
3.3.1 Effect of fluorophosphite ligand  
The 6- and 7-membered fluorophosphites L2.2-2.3 were tested in the hydroformylation of 
1-hexene under conditions B using a L/Rh ratio of 5. The kinetic data is presented in 
Table 3.4 and the product distribution over time is shown in Figures 3.2 and 3.3.  
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Table 3.4 Catalytic hydroformylation of 1-hexene using ligands L2.2-2.3 under conditions 
B.  
Entry  Ligand n selectivity 
/ % 
TOF at 20% 
conversion / h-1 b 
Yield of aldehyde 
/ % c 
1 L2.2 85.4 1 438 72.4 
2 L2.3 86.9 2 970 88.1 
a Method: 40.3 mmol 1-hexene, 0.04 mmol [Rh(acac)(CO)2], ligand (L/Rh = 5), 35 cm
3 
toluene, 20 bar of H2/CO (1/1), 90 °C. 
b TOF at 0.8 mol L-1 1-hexene. c Remainder of 
products are alkenes (1-hexene or isomerisation). Conversion and selectivity were 
determined by GC.  
In general, compared to the “concentrated-catalyst” conditions above (conditions A), the 
TOFs obtained under these “dilute-catalyst” conditions (conditions B) were significantly 
higher (e.g. 2 438 vs. 669 h-1 for L2.2). The TOF is very sensitive to catalyst-concentration: 
at high concentrations the fluorophosphite ligands appear to inhibit catalysis.  
In contrast to the “concentrated-catalyst” conditions above, the 7-membered 
fluorophosphite L2.3 gave a significantly more active catalyst than the 6-membered 
analogue L2.2, with a slightly higher n-selectivity (Entry 1 vs. 2, Table 3.4). The catalyst 
derived from the 6-membered fluorophosphite L2.2 appeared to deactivate slightly over 
time, as seen in Figure 3.2. The dark orange/ brown colour of the reaction mixture after 
catalysis also suggested degradation of the catalyst. Deactivation of the catalyst under 
these “dilute-catalyst” conditions may have occurred because the ligand concentration is 
too low to stabilise the Rh catalytic intermediates. Contrary to this, IR and 31P{1H} / 
19F{1H} NMR spectroscopy of the reaction mixture after catalysis showed no signs of 
catalyst degradation; at present these observations cannot be reconciled.  
Compared to the results carried out under conditions A (Section 3.2), both ligands L2.2-2.3 
gave significantly less n-selective catalysts under conditions B. Under “dilute-catalyst” 
conditions (conditions B), the reaction equilibria (Scheme 3.3, Section 3.1.4) will lie 
towards the less sterically hindered intermediates (such as RhL and RhL2), which will 
favour the iso aldehyde relative to RhL3. Similar to the results given in Section 3.2, the 6-
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membered fluorophosphite L2.2 gave a more active isomerisation catalyst than the 7-
membered L2.3 (Figures 3.2 vs. 3.3).  
 
Figure 3.2 Product distribution over time using ligand L2.2, L/Rh = 5. X = unidentified 
products.   
 
 
Figure 3.3 Product distribution over time using ligand L2.3, L/Rh = 5. X = unidentified 
products.   








The commercially valuable ligand, Ethanox 398TM (3.6), was also tested in the catalytic 
hydroformylation of 1-hexene under conditions B. Results cannot be directly compared 
with the results above in Table 3.4, since a L/Rh ratio of 20 was used (instead of 5). 
Nonetheless, ligand 3.6 gave an extremely active catalyst, achieving ca. 100% conversion 
within 15 min. Even using a much higher ligand concentration, the catalyst derived from 
3.6 gave a TOF of 14 390 h-1, considerably higher than that of L2.2 and L2.3 (see Table 
3.4). A good n-selectivity of 89.5% was observed. The reaction mixture after catalysis was 
analysed by 1H NMR spectroscopy which showed a broad signal at -9.66 ppm which was 
assigned to a Rh-hydride species. All reaction mixtures were analysed by IR spectroscopy 
at the end of the catalysis. For the unsubstituted ligands L2.2-2.3 no (CO) bands were 
observed in the IR spectra suggesting only [RhHL4] was present after catalysis. Whereas, 
when using 3.6 one (CO) band was observed, which was tentatively assigned to the 
[RhHL3(CO)] species. This difference in chemistry may be attributed to the higher steric 
bulk of 3.6, which would promote the formation of the less sterically hindered RhL2 
intermediates in situ. 
3.3.2 Effect of ligand concentration  
The effect of ligand concentration for ligands L2.2-2.3 was investigated under conditions B 
and the results are presented in Table 3.5 and examples of the kinetic data are shown in 
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Table 3.5 Effect of ligand concentration for the catalytic hydroformylation of 1-hexene 
using ligands L2.2-2.3 under conditions B.  
Entry  L/Rh Ligand n selectivity / 
% 
TOF at 20% 
conversion / h-1 b 
Yield of 
aldehyde / % c 
1 5 L2.2 85.4 1 438 72.4 
2 10 L2.2 89.3 805 75.0 
3 15 L2.2 91.2 645 75.4 
4 5 L2.3 86.9 2 970 88.1 
5 10 L2.3 92.7 570 90.4 
a Method: 40.3 mmol 1-hexene, 0.04 mmol [Rh(acac)(CO)2], ligand (L/Rh = 5 or 10), 35 
cm3 toluene, 20 bar of H2/CO (1/1), 90 °C. 
b TOF at 0.8 mol L-1 1-hexene. c Remainder 
of products are alkenes (1-hexene or isomerisation). Conversion and selectivity were 
determined by GC.  
 
 
Figure 3.4 Product distribution over time using ligand L2.2, L/Rh = 10. X = unidentified 
products. 





Figure 3.5 Product distribution over time using ligand L2.2, L/Rh = 15. X = unidentified 
products.   
An increase in n-selectivity and a decrease in activity were observed upon increasing the 
ligand concentration of both ligands L2.2 and L2.3. Using the 6-membered L2.2 the n-
selectivity was increased from 85.4 to 91.2% upon increasing the L/Rh ratio from 5 to 15 
(Entry 1 vs. 3, Table 3.5). In contrast to conditions A, a greater effect of ligand 
concentration was observed using the 7-membered fluorophosphite L2.3. Upon increasing 
the L/Rh ratio from 5 to only 10 the selectivity increased from 86.9 to 92.7% and the 
TOF was decreased from 2 970 to 570 h-1 (Entry 4 vs. 5).  
3.3.3 Effect of temperature and pressure 
Preliminary studies to probe the effect of temperature on catalysis were carried out for 
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Table 3.6 Effect of temperature for the catalytic hydroformylation of 1-hexene using 
ligands L2.2 and 3.6 under conditions B. 




TOF at 20% 
conversion / h-1 b 
Yield of 
aldehyde / % c 
1 L2.2 90 89.3 805 75.0 
2 L2.2 80 90.7 742 80.3 
3 3.6 90 89.5 14,390 80.5 
4 3.6 80 87.0 6,538 89.9 
a Method: 40.3 mmol 1-hexene, 0.04 mmol [Rh(acac)(CO)2], ligand (L/Rh = 10 for L2.2 
and 20 for 3.6), 35 cm3 toluene, 20 bar of H2/CO (1/1), 90 °C or 80 °C. 
b  TOF at 0.8 mol 
L-1 1-hexene. c Remainder of products are alkenes (1-hexene or isomerisation). Conversion 
and selectivity were determined by GC.  
To control the catalyst activity for Ethanox 398TM (3.6) a L/Rh ratio of 20 was used, 
compared to 10 when using L2.2. Decreasing the temperature from 90 °C to 80 °C, the 
activity of the catalyst derived from 3.6 dropped dramatically (Entry 3 vs. 4, Table 3.6), 
but still surpassed those obtained for L2.2-2.3 (Table 3.5). However, little difference in n-
selectivity was observed. In contrast to 3.6, decreasing the temperature appeared to have 
minimal effect on the activity and selectivity of the catalyst derived from the 6-membered 
fluorophosphite L2.2; an explanation for this observation has eluded us. It would be of 
interest to perform the catalysis using L2.2 at a much lower temperature of 40 °C to 
confirm this result.  
Preliminary studies to probe the effect of CO pressure on catalysis were carried out for 
ligand L2.2 under conditions B (L/Rh = 10) and the results are given in Table 3.7. The H2 
pressure was kept constant, while the CO pressure was increased from 10 to 20 bar 
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Table 3.7 Effect of CO pressure for the catalytic hydroformylation of 1-hexene using 
ligand L2.2 under conditions B. 




TOF at 20% 
conversion / h-1 b 
Yield of 
aldehyde / % c 
1 L2.2 10:10 89.3 805 75.0 
2 L2.2 10:20 85.2 776 81.4 
a Method: 40.3 mmol 1-hexene, 0.04 mmol [Rh(acac)(CO)2], ligand (L/Rh = 10), 35 cm
3 
toluene, 20 bar of H2/CO (1/1) or 30 bar of H2/CO (1/2), 90 °C. 
b TOF at 0.8 mol L-1 1-
hexene. c Remainder of products are alkenes (1-hexene or isomerisation). Conversion and 
selectivity were determined by GC.  
Increasing the partial pressure of CO from 10 to 20 bar had a minimal effect on the 
activity of the catalyst derived from L2.2, but the n-selectivity of the catalyst was 
significantly decreased (Entry 1 vs. 2, Table 3.7). At a higher CO pressure there would be 
a decrease in the sterically hindered RhL3 intermediates due to ligand dissociation, which 
would lead to decreased amounts of n-aldehyde, as shown in Scheme 3.5.8,9,70 This is 
further supported by the sensitivity of the system to ligand concentration.       
 
Scheme 3.5 Initial equilibria forming the active catalyst species.70 
Due to high amounts of isomerisation observed when using the 6-membered L2.2, the 
catalytic hydroformylation of 2-hexene was investigated. A L2.2/Rh ratio of 10 was used 
under conditions B. Figure 3.6 shows the product distribution over time. A significant 
amount of the iso-aldehyde (2-heptanal) was observed, suggesting that the 2-hexene 
formed in the catalysis above contributes to the amount of iso-aldehyde formed. An 
insignificant amount of 1-hexene was observed (Figure 3.6); it is assumed that any 1-
hexene present immediately converts to the n-aldehyde due to the high reactivity of the 
n-alkyl Rh species. The majority of the 2-hexene consumed was isomerised to trans-2-
hexene, which increased steadily over time.   
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3.4 Conclusions and future work  
The 6- to 8-membered ring fluorophosphites L2.2-2.4 have been tested in the 
hydroformylation of 1-hexene and their Rh-catalysts have displayed high activities and n-
selectivities. In contrast, the catalysts derived from the 5-membered ring fluorophosphites 
L2.1 and L2.6-2.7 displayed zero hydroformylation activity. To probe the effect of the fluoro-
substituent on hydroformylation, the monophosphite L2.5 has also been tested, which 
gave a considerably less active and less n-selective catalyst than its fluorophosphite 
analogue L2.2. The effect of aryl fluorophosphite substitution has also been investigated: 
the n-selectivity of the Rh-catalyst was increased upon Me-substitution at the ortho position 
of the 6-membered fluorophosphite L2.2 (using a L/Rh ratio of 10, an excellent n-
selectivity of 99.0% was achieved using substituted L2.8).  
It has been shown that the product distribution was sensitive to the catalysis conditions: 
at a lower Rh concentration (conditions B) a lower n-selectivity was observed. Generally, 
it has been demonstrated that under both catalytic conditions tested, the ligand 
concentration has a large effect on the activity and n-selectivity of the Rh-catalyst. In 
general, increasing the L/Rh ratio led to a significant increase in the n-selectivity and 
decrease in activity. This may be associated with the involvement of the sterically hindered 
RhL3 species, a hypothesis which has previously only been suggested to explain similar 
observations with Rh-Pyr3 catalysts.
70 A remarkable n-selectivity of 99.5% was achieved 
using a L/Rh ratio of 15 for L2.2 (under conditions A); to verify this result the experiment 
should be repeated. Increasing the ligand concentration further to improve the n-
selectivity should also be considered in the future. However, there is a fine balance to be 
struck between the higher selectivity of the active RhL3 species and the formation of 
inactive RhL4 species. 
It would be of interest to further explore the involvement of reactive and selective RhL3 
species in the catalysis. Preliminary in situ high pressure IR studies have been performed 
by Dr. Christoph Kubis (LIKAT, Rostock) on the hydroformylation catalysis using L2.2. 
However, the Rh catalysts appeared to be insoluble in the solvent used (cyclohexane) and 
hence were undetectable by IR. Future work would focus on resolving this issue using 
alternative solvents. The application of in situ high pressure NMR spectroscopy should 
also be considered in the future to elucidate the mechanism. Finally, DFT calculations 
should also be carried out to investigate this hypothesis.  
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Five and six membered 
dioxaphosphacyclic diphosphites for 
alkene hydroformylation  
 
4.1 Introduction  
In this section, some highlights of the many applications of diphosphite ligands in Rh-
catalysed hydroformylation of alkenes will be discussed. The use of other phosphorus 
ligands in Rh-catalysed hydroformylation has been the subject of several reviews.1–8 The 
mechanism of hydroformylation has also been well documented and so will not be 
discussed here (see Chapter 3 also).1,3,7–11 
4.1.1 Diphosphites for Rh-catalysed hydroformylation  
Dioxaphosphacyclic diphosphites are the most extensively studied diphosphites.12 In the 
1980s, cyclic diphosphites emerged as excellent ligands for Rh-catalysed hydroformylation 
of alkenes, following the discovery of ligands such as 4.1a-c by Union Carbide Company 
(UCC) (Figure 4.1).13–15 Following this pioneering work by Bryant et al., cyclic diphosphites 
have received abundant attention as ligands for hydroformylation, as summarised in 
several reviews.1–3,12 In general, a dramatic increase in selectivity for the n-aldehyde was 













Figure 4.1 Bulky diphosphites developed by Bryant at UCC for hydroformylation. 
Many cyclic diphosphites contain a chiral element, either in the diol backbone or the 
phosphacycle, and optically pure ligands such as 4.1d have been applied in asymmetric 
hydroformylation, but this topic will also not be discussed herein.1,6,12,17,18  
To date, the most studied cyclic diphosphites contain 7- or 8-membered phosphacycles. 
There are only a few examples of diphosphites based on 6-membered phosphacycles 
derived from 1,8-dihydroxynaphthalenes. To the best of our knowledge, the only 
examples have been reported by Borner et al. (e.g. ligands 4.2a-b).19,20 The catalyst derived 
from the symmetrical diphosphite 4.2a displayed good n-selectivities in the 
hydroformylation of 1-octene (82-85%).19,20 Although not formally diphosphites, 6-
membered phosphacycles derived from hydroxybenzoates (e.g. 4.3) have been 
reported.12,21–24  





There are reports in patents of the use of 5-membered aromatic diphosphites derived 
from 1,2-dihydroxybenzene (catechols) with a biphenyl linker, such as 4.4a-c, for the 
hydroformylation of alkenes and hydroxy-alkenes.12,25–31 In general, the cyclic diphosphites 
reported for hydroformylation contain bulky ring substituents (e.g. tBu); not only are these 
bulky substituents apparently essential to catalyst performance, they have also been shown 








4.1.2 Synthesis of cyclic diphosphites 
Cyclic diphosphites are generally synthesised from one of the two-step procedures shown 
in Scheme 4.1.12,34 They are mainly derived from cheap and readily available diols and 
hence their highly modular synthesis makes them amenable to modification through 
substitution or ring size effects. In Scheme 4.1a, a cyclic chlorophosphite is formed upon 
the reaction of the corresponding dihydroxyarene and PCl3 in the presence of a base (e.g. 
NEt3). The reaction of the cyclic chlorophosphite with the diol linker affords the desired 
diphosphite.12 Cyclic chlorophosphites are versatile intermediates in the synthesis of 
numerous dioxaphosphacyclic ligands (see Chapter 2). Alternatively, in Scheme 4.1b a 
bis(dichlorophosphite) is formed upon the reaction of the appropriate diol and PCl3; this 




intermediate is then reacted with the corresponding dihydroxyarene to give the expected 
diphosphite.12  
 
Scheme 4.1 Conventional methods for the synthesis of cyclic diphosphites.12  
Symmetrical cyclic diphosphites, comprised of three identical dihydroxyarenes, can be 
synthesised in one-step from the dihydroxyarene and PCl3 in the presence of a base 
(Scheme 4.2). All the routes described so far result in salt formation (e.g. [Et3NH]Cl) and 
so an additional purification step is required in the work-up of a potentially hydrolytically 




Scheme 4.2 General synthesis of a symmetrical cyclic diphosphite.  
An alternative method to P-O bond formation is the silicon-phosphorus exchange 
reaction shown in Scheme 4.3. This route was first developed in 1957 when the stepwise 
replacement of the halogen in PCl3 by R’OSiMe3 gave the corresponding 





Scheme 4.3 Generalised Si-P exchange reaction between a chlorophosphine (where X 
= Cl, OR’, R) and silyl ether.  




In 2009, Majewski also reported the synthesis of such ligands in addition to mixed 
trialkylphosphites, P(OR1)(OR2)(OR3), from the HCl-catalysed reaction of the 
corresponding chlorophosphine and alkoxytrimethylsilane (Scheme 4.4).36  
 
Scheme 4.4 Synthesis of mixed trialkylphosphites via Si-P exchange reaction.   
In 2007, Musin et al. reported the synthesis of the unusual terephthalate derivative 4.5, 
where silylation of terephthalic acid was followed by the silicon-phosphorus exchange 
reaction shown in Scheme 4.5.37 To the best of our knowledge there are no other reports 
of silicon-phosphorus exchange reactions for the synthesis of P-O bonds. Silicon-
phosphorus exchange reactions have previously been used to access other P-Y bonds, 
such as in aminophosphines,38 C1-diphosphines,39 optically active C1-phosphine-
phosphonites40 and phosphophosphidites41 (where Y = N, C or P). In addition, 






Scheme 4.5 Example of a Si-P exchange reaction in the synthesis of P-O bonds.  
The silicon-phosphorus exchange reaction is an attractive alternative to traditional routes 
to cyclic chlorophosphites for the following reasons: (a) a simple purification is required 
due to the volatile by-products; (b) no acidic by-products are generated, which may 
catalyse the hydrolysis of the P-Cl bond; (c) the method is tolerant of acid-sensitive 
groups. To the best of our knowledge, this reaction has not yet been applied to the 
synthesis of cyclic chlorophosphites.   




Accordingly, in this project the aim was to investigate the potential of the silicon-
phosphorus exchange reaction as a general route to a range of cyclic chlorophosphites. 
We also aimed to synthesise the symmetrical 6-membered diphosphite, L4.2, and its 
stereoelectronic properties were to be investigated by preparing a range of its coordination 
complexes; ligand L4.2 has been claimed previously in patents by Borner et al. but was not 
synthesised.19,20 It was of interest to gauge the effect of ring size on Rh-catalysed 
hydroformylation of 1-hexene by comparing ligands L4.1-4.3, containing 5- to 7-membered 
phosphacycles.    
 
4.2 Silicon-phosphorus exchange reaction to chlorophosphites  
4.2.1 Factors affecting spirophosphorane formation  
Cyclic chlorophosphites (4.6) are useful intermediates to diphosphites and have been 
traditionally synthesised from the reaction of the appropriate dihydroxyarene and PCl3 
(Scheme 4.6).12 However, the formation of hydroxyphosphites (4.7) can lead to 
spirophosphorane side-products (4.8) during attempted syntheses of 5-membered 
chlorophosphites and diphosphites.45–48 Hydroxyphosphites 4.7 are known to be in 
equilibrium with their spirophosphorane tautomer 4.8 (Scheme 4.6).49–51  
 
 
Scheme 4.6 General formation of spirophosphorane (4.8) side-products during the 
synthesis of chlorophosphites 4.6.  
The formation of spirophosphorane side-products appeared to be more favoured with 5-
membered phosphacycles than with larger ring systems. The equilibria between the 
hydroxyphosphites 4.7a-c and spirophosphoranes 4.8a-c, have been evaluated 
computationally for a range of ring sizes (Table 4.1).52 Relative electronic and Gibbs free 




energies for 4.7a-c and 4.8a-c, containing 5- to 7-membered phosphacycles, have been 
calculated using the M1 method (by Tom Young at the University of Bristol). To be able 
to detect the equilibrium by 31P NMR spectroscopy, the minor species should be at least 
ca. 1% of the total concentration, i.e. the |Gexpt| < 3 kcal mol
-1.      
Table 4.1 Calculated energy differences between 4.7a-c and 4.8a-c.a  
 
 
a Computed at PBE0-D3BJ/6 311+G(d,p). 
The calculations agree with experimental observation: within error the 5-membered 
spirophosphorane 4.8a is sufficiently stable to be in an observable equilibrium with 4.7a. 
Whereas, no such observable equilibrium between the 6- or 7-membered analogues, 4.7b-
c and 4.8b-c, was predicted (K < 1 x 10-7, 298 K).  
To explain the favourable cyclisation for the 5-membered rings, DFT-optimised ground 
state geometries of 4.7a-c and 4.8a-c were evaluated (Figure 4.2). The high stability of 
the 5-membered spirophosphorane 4.8a can be explained on the basis of the following 
observations. Firstly, the intramolecular hydrogen bond in the hydroxyphosphite 4.7a 
deviates the most from linearity (110.8°) and hence is weaker than those in the larger ring 
systems, 4.7b-c.53 This is also reflected in the OH…H distance (2.42 Å) which only just 
falls within the distance required for a strong hydrogen bond (X…H < 2.5 Å).54 Secondly, 
deviation from the ideal O-P-O angle of 90° in the spirophosphorane 4.8a is minimal, 
relative to those in the larger ring systems, 4.8b-c (Figure 4.2). Finally, upon 
tautomerisation of the hydroxyphosphite 4.7a to spirophosphorane 4.8a, only a small 
Linker Compound 
no. 
Ring size  E / kcal 
mol-1 
G / kcal 
mol-1 
 
a 5 2.3 5.7 
 
b 6 6.8 12.2 
 
c 7 8.6 8.2 




change in the O-P-O angle of 2.0° is required. Whereas, for the larger ring systems a 
greater change is necessary: 3.4° for 4.7b/4.8b and 5.9° for 4.7c/4.8c.  
Figure 4.2 DFT-optimised geometries of hydroxyphosphites 4.7a-c and 
spirophosphoranes 4.8a-c. Significant bond angles (°) and bond lengths (Å) are 










To probe the effect of ring-substitution, the relative free energies for the equilibrium have 
been calculated (by Tom Young at the University of Bristol) for a range of 5-membered 
substituted analogues of 4.7a/4.8a (Table 4.2). As the steric bulk of the substituents 
increase, the stability of the spirophosphorane tautomer increases: E = -5.4 kcal mol-1 
for when R = tBu (4.7f/4.8f), cf. E = 2.3 kcal mol-1 for when R = H (4.7a/4.8a). 









a Computed at PBE0-D3BJ/6 311+G(d,p). 
To rationalise this, the geometry-optimised isomers of the tBu substituted 4.7f and 4.8f 
were evaluated using a space filling model (M1 method, Figure 4.3). The steric crowding 
imposed by the di-ortho substitution in hydroxyphosphite 4.7f is evident (Figure 4.3a). In 
the corresponding spirophosphorane 4.8f, a large degree of steric strain is relieved as 
shown by the 0.42 Å increase in the smallest (tBu)C-C(tBu) distance (Figure 4.3b). Adding 
to the stability of the spirophosphorane 4.8f is its close to ideal O-P-O angle of 90.6°. 
R =  Compound 
no. 
E / kcal 
mol-1 
H a 2.3 
Me d 1.3 
iPr e -3.3 
tBu f -5.4 





Figure 4.3 Space filling models of (a) the hydroxyphosphite 4.7f and (b) 
spirophosphorane 4.8f. Non-bonded carbon atoms encountering the most severe steric 
clashes are highlighted in green.    
4.2.2 Effect of solvent  
A novel silicon-phosphorus exchange route to chlorophosphites via silyl ether 
intermediates has been developed. As seen in Chapter 2, the 5-membered 
chlorophosphite 4.6a was synthesised successfully without the formation of 
spirophosphorane impurities via this route (Scheme 4.7). A range of solvents were tested 
for the silicon-phosphorus exchange reaction (Table 4.3) between the silyl ether 4.9a and 
an excess of PCl3 (2 equiv.) to give 4.6a. There is a correlation between the polarity of the 
solvent and rate of reaction: the rate of reaction is amplified when the polarity of the 
solvent is increased. Hence, acetonitrile was used as the solvent of choice for further 















Table 4.3 Range of solvents tested for the conversion of 4.9a to 4.6a (Scheme 4.7). 
Solvent εr




Acetonitrile 35.94 20 100 1 
Propionitrile 28.26 60 100 < 1 
Tetrahydrofuran 7.58 60 80 168 
1,1,2,2-tetrachloroethane 7.10 100 100 144 
Toluene 2.38 100 50 144 
1,4-dioxane 2.21 60 10 48 
a Dielectric constants from the literature.55,56 b Determined by integration of 31P{1H} NMR 
signals.   
4.2.3 Reaction scope 
The silicon-phosphorus exchange reaction has been applied to a range of 
chlorophosphites in Chapter 2, including the 6-membered chlorophosphite 4.6b (Scheme 
4.8). The chiral chlorophosphite 4.6c was synthesised from the silyl ether 4.9c in excellent 
yield and purity (Scheme 4.8). In contrast, the reaction of the corresponding diol with 
PCl3 gave large amounts (ca. 40%) of hydrolysis (P = 20.8 ppm) in our hands.








Scheme 4.8 Route to chlorophosphites 4.6b-c via the silyl ethers 4.9b-c. Compound 4.9c 
has been previously reported.58  




Majewski reported the synthesis of several alkyl-dichlorophosphites from their 
corresponding silyl ethers, but few aryl-dichlorophosphites.36 Attempts to synthesise 
dichlorophosphite 4.6d from the silyl ether 4.9d were unsuccessful, even in the presence 
of HCl (10 mol%) or at 60 °C. In contrast, the substituted dichlorophosphites 4.6e-g 
were successfully synthesised from the silyl ethers 4.9e-g (Scheme 4.9) in near quantitative 
yields and high purities. There is no consistent correlation between the electronic 
properties of the aryl substituents and conversion, since the reaction proceeded with silyl 
ethers containing electron-donating (X = OMe, 4.9e) or electron-withdrawing (X = CF3, 
4.9f) ortho-substituents, but does not proceed when using the unsubstituted analogue (X 
= H, 4.9d); an explanation for these observations has eluded us.     
 
Scheme 4.9 Route to dichlorophosphites 4.6d-g via the silyl ethers 4.9d-g.  
The simple work-up, the avoidance of spirophosphorane by-products, and the high yields 
and purities achieved using this silicon-phosphorus exchange route make it an attractive 
alternative to traditional routes to chlorophosphites and dichlorophosphites.   
4.3 Synthesis and coordination of 5- and 6-membered diphosphites  
4.3.1 Synthesis of diphosphite ligands  
The previously reported 5-membered diphosphite L4.1 has been prepared from the 
reaction of chlorophosphite 4.6a and silyl ether 4.9a (Scheme 4.10), involving the silicon-
phosphorus exchange reaction described in Section 4.2. Attempts to synthesise tBu 
substituted analogues of L4.1 via this method were unsuccessful; the presence of 
spirophosphorane by-products were persistent as predicted by calculations in Section 













Scheme 4.10 Synthesis of L4.1. 
From the computational studies above (Section 4.2.1), it can be suggested that the 
synthesis of the 6-membered diphosphite L4.2 should not be so blighted by 
spirophosphorane formation. Indeed, treatment of the dihydroxyarene with PCl3 in the 






Scheme 4.11 Synthesis of L4.2. 
Crystals suitable for X-ray crystallography of L4.2 were grown by slow diffusion of hexane 
into a saturated CH2Cl2 solution of the ligand (Figure 4.4). The P atoms are pyramidalised 
(Σ(angles at P) = 297°), consistent with sp3 hybridisation. Whereas, the angles within the 
6-membered phosphacycle are ca. 120°, in line with sp2 hybridisation. The P centre is out 
of the plane of the naphthalene ring (P1-O1-C1 121.05(12)°). Figure 4.4b shows the two 
phosphacycles adopt an anti-conformation in the solid state. The sum of the angles at P 
in the analogous 7-membered diphosphite59 is ca. 3° smaller than in L4.2; the more obtuse 
O-P-O angles in L4.2 may be as a result of the rigidity of the naphthalene ring. Generally, 
the more acute the O-P-O angle is, the lower the HOMO and LUMO energies of the 
ligand.60–62      
 
 





Figure 4.4 Crystal structure of L4.2. The hydrogen atoms are omitted for clarity. Thermal 
ellipsoids at 50% probability. Selected bond lengths (Å) and angles (°): P1-O1 1.6297(16), 
P1-O2 1.6450(15), P1-O3 1.6310(4), P2-O4 1.6292(13), P2-O5 1.6251(14), P2-O6 
1.6420(15), O1-P1-O2 99.20(8), O1-P1-O3 96.12(8), O2-P1-O3 101.82(7), O5-P2-O6 
99.59(7), O4-P2-O5 95.67(7), O4-P2-O6 101.67(7). See Appendix for experimental 
details.  
4.3.2 Synthesis of cis-[PtMe2L] complex 
The reaction of 1 equiv. of L4.2 with [PtMe2(cod)] (cod = 1,5-cyclooctadiene) in toluene 
gave the air-stable cis-[PtMe2(L4.2)] complex, 4.10 (Scheme 4.12). The 
31P{1H} NMR 
spectrum of 4.10 gave a singlet with a 1JP,Pt value of 2964 Hz, consistent with a cis-geometry 




Scheme 4.12 Synthesis of the cis-[PtMe2(L4.2)] complex 4.10.  
Crystals suitable for X-ray crystallography of 4.10 were grown by slow diffusion of hexane 
into a saturated CH2Cl2 solution of the complex (Figure 4.5). The crystal structure 
confirmed the cis geometry of the complex and showed the ligands are arranged in a 
slightly distorted square planar geometry around the Pt centre. Relative to the free ligand 
L4.2, a considerable increase in the sum of the angles at P (by ca. 6.8°) was observed. 
 
(a) (b) 





Figure 4.5 Crystal structure of 4.10. The hydrogen atoms are omitted for clarity. Thermal 
ellipsoids at 50% probability. Selected bond lengths (Å) and angles (°): P1-Pt1 2.2201(5), 
P2-Pt1 2.2219(6), P1-O1 1.6040(15), P1-O2 1.6057(15), P1-O3 1.6199(15), P2-O4 
1.6220(15), P2-O5 1.6081(16), P2-O6 1.6043(15), P1-Pt1-P2 92.451(19), C1-P1-C2 
83.53(9), O1-P1-O3 103.03(8), O1-P1-O3 96.58(8), O2-P1-O3 103.90(8), O5-P2-O6 
102.88(8), O4-P2-O5 103.67(8), O4-P2-O6 97.52(8). See Appendix for experimental 
details.   
4.3.3 Synthesis of cis-[Mo(CO)4L] complex 
The cis-[Mo(CO)4L] complex was targeted as a way to assess the electronic properties of 
the 6-membered diphosphite L4.2. The reaction of 1 equiv. of L4.2 with [Mo(CO)4(nbd)] 
(nbd = norbornadiene) in CH2Cl2 gave the partly insoluble cis-[Mo(CO)4(L4.2)] complex, 
4.11 (Scheme 4.13). The 31P{1H} NMR signal of complex 4.11 showed a singlet (P = 
147.8 ppm) with a coordination chemical shift  of +47 ppm relative to free L4.2; the 
analogous 7-membered diphosphite59,63 complex, cis-[Mo(CO)4(L4.3)], has a  of +36 




Scheme 4.13 Synthesis of cis-[Mo(CO)4(L4.2)], 4.11. 
The IR spectrum of complex 4.11 is consistent with a cis-geometry of the ligand. The 
(CO) (A1) value for 4.11 is 2057 cm
-1, showing that L4.2 is a stronger -acceptor than the 




analogous 6-membered monophosphite 4.12, where the (CO) of cis-[Mo(CO)4(4.12)2] is 




4.3.4 Rhodium(I) coordination chemistry  
The reaction of 2 equiv. of L4.2 with [Rh2Cl2(CO)4] in CH2Cl2 gave a single species which 
was tentatively assigned to the binuclear complex, trans-[Rh2Cl2(CO)2(µ-L4.2)2] 4.13 
(Scheme 4.14). Arbitrarily the syn isomer is depicted but it is not known whether the syn 





Scheme 4.14 Synthesis of trans-[Rh2Cl2(CO)2(L4.2)2], 4.13. 
The 31P{1H} NMR spectrum of complex 4.13 showed a doublet with 1JP,Rh = 180 Hz, 
typical of a trans-[RhCl(CO)(PR3)2] complex.
65 The chemical equivalence of the 
phosphorus nuclei excludes the assignment of the product to the mononuclear cis-
[RhCl(CO)(L4.2)] complex. Similar ligand-bridged binuclear structures of the type trans-
[RhCl2(CO)2{µ-R2P(CH2)3PR2}2] have been previously reported for several diphosphine 
ligands,62,66–68 but for only one diphosphite to the best of our knowledge.69        
4.4 Diphosphite ligands in alkene hydroformylation 
The 5- to 7-membered diphosphites, L4.1-4.3, were tested in the Rh-catalysed 
hydroformylation of 1-hexene (Scheme 4.15). The 7-membered diphosphite L4.3 was 
prepared according to the literature.59 The selectivity and conversion were determined by 
1H NMR spectroscopy (see Chapter 7 for experimental details). The reactions were run 
for 1 h and the results are shown in Table 4.4 and Figure 4.6.      





Scheme 4.15 Catalytic hydroformylation of 1-hexene using L4.1-4.3.  
Table 4.4 Catalytic hydroformylation of 1-hexene using L4.1-4.3 (see Chapter 7 for 
experimental details).a  
a Reaction conditions: 4.83 mmol 1-hexene, 0.012 mmol [Rh(acac)(CO)2], ligand, 1.5 cm
3 
toluene, 20 bar of CO/ H2  (1/1), 90 °C, 1 h. 
b Conversion = conversion to aldehydes, i.e. 
100% - (1-hexene and isomerisation). c Isomerisation to 2- and 3-hexene. Conversion and 
selectivity were determined by 1H NMR. Each run is an average of two runs. 




1 L4.1 1 - - 11 
2 L4.1 1.5 - - 11 
3 L4.2 1 77.2 39 49 
4 L4.2 1.5 82.5 32 46 
5 L4.2 2.5 - <1 <1 
6 L4.3 2.5 91.0 12 2 




Figure 4.6 Catalytic hydroformylation of 1-hexene using L4.1-4.3 at different L/Rh ratios. 
The lack of hydroformylation activity when using the catalyst derived from the 5-
membered L4.1 (Entries 1 and 2, Table 4.4) can be explained by the observation of 
complete degradation of the supporting ligand under catalytic conditions. The 31P{1H} 
NMR spectrum of the reaction mixture after catalysis showed two signals corresponding 
to spirophosphorane (4.8a) and hydrolysis (4.14) degradation products (Scheme 4.16).70 
Isomerisation to 2-hexene was observed in equal amounts when using a L/Rh ratio of 1 
and 1.5 (Entry 1 vs. 2), suggesting the same catalytic species may be responsible. Others 
have previously reported the use of ligand L4.1 in the hydroformylation of propene, but a 
disappointingly low n-selectivity of 60% was observed.31  
 























L/Rh           1                 1.5                 1                  1.5              2.5                 2.5 
Ligand    L4.1                    L4.1                     L4.2                    L4.2                   L4.2                      L4.3 




Relative to L4.1, the 6-membered L4.2 affords an active catalyst (Entry 1 vs. 3, Table 4.4). 
A moderate selectivity towards the n-aldehyde was observed when using a L4.2/Rh ratio 
of 1 (77.2%, Entry 3). Increasing the ligand concentration to a L/Rh ratio of 1.5 
considerably increased the n-selectivity to 82.5% (Entry 4). In both cases (Entries 3 and 
4), isomerisation to 2-hexene was significant; this might be reduced by modifying the 
catalysis procedure so that the addition of 1-hexene was made under a CO/H2 
atmosphere (see experimental details used for Chapter 3).71 When using higher 
concentrations of L4.2 (L/Rh = 2.5, Entry 5) catalytic activity was inhibited. The formation 
of inactive bis(chelate) species, such as [RhH(L)2], may be the reason for this. 
Furthermore, an insoluble yellow precipitate was observed at the end of the catalytic runs, 
indicating the choice of solvent may be a problem. The 7-membered L4.3 affords a 
relatively inactive catalyst when using a L/Rh ratio of 2.5, but a high n-selectivity was 
observed (91.0%, Entry 6). In general, the n-selectivities observed do not compete with 
those obtained when using industrially important diphosphites (Section 4.1.1); it is known 
that the large steric bulk incorporated in the backbone of these ligands is a crucial feature 
to obtaining high n-selectivity.3,16,72,73 The lack of steric bulk in the backbone of ligands 
















4.5 Conclusions and future work    
The formation of spirophosphorane side-products is a persistent issue in the synthesis of 
P-O bonds in 5-membered aryl dioxaphosphacycles. The equilibria between the 
spirophosphorane side-products (4.8a-c) and hydroxyphosphite tautomers (4.7a-c) have 
been evaluated computationally for a range of ring sizes and it has been shown that the 
5-membered systems are more susceptible to spirophosphorane formation than the larger 
ring systems, in agreement with the experimental observations. The stability of the 5-
membered spirophosphorane (4.8a) has been attributed to a combination of its strong 
intramolecular hydrogen bonds and ideal O-P-O angles.  
A silicon-phosphorus exchange reaction has been developed as a novel route to cyclic 
chlorophosphites 4.6a-c with varying phosphacycle ring sizes (see Chapter 2 also), and a 
range of aryl dichlorophosphites 4.6e-g. The desired product was obtained in high yield 
and purity under mild conditions; minimal work-up and purification are required because 
the only by-product is the volatile ClSiMe3.    
The novel 6-membered diphosphite L4.2 has been successfully synthesised and 
characterised by X-ray crystallography. The IR spectrum of the cis-[Mo(CO)4(L4.2)] 
complex (4.11) revealed the diphosphite L4.2 is a stronger -acceptor than the 6-membered 
monophosphite analogue, 4.12. The ligand-bridged binuclear species, trans-
[Rh2Cl2(CO)2(µ-L4.2)2] (4.13), was prepared upon the addition of the diphosphite to 
[Rh2Cl2(CO)4]. A comparative study of the coordination chemistry of diphosphites L4.1-4.3, 
containing the 5- to 7-membered phosphacycles, should be carried out in the future to 
probe the effect of ring size on their coordination properties.    
Diphosphites L4.1-4.3 with varying phosphacycle ring size have been tested in the Rh-
catalysed hydroformylation of 1-hexene. The catalyst derived from the 5-membered 
diphosphite L4.1 displayed no hydroformylation activity due to complete degradation 
under reaction conditions. By contrast, the catalyst derived from the 6-membered L4.2 
displayed good catalyst performance but increasing the ligand concentration to a L/Rh 
ratio of 2.5 inhibited the catalysis. Substitution of the aryl rings of L4.2 should be 
considered in the future to further increase the n-selectivity achieved during catalysis and 
hinder the formation of inactive [RhH(L)2] species at higher ligand concentrations. For 
example, the aryl substituted ligands 4.15a-b should be explored since the syntheses of 
the corresponding dihydroxyarene precursors have been previously reported.74 
Diphosphites containing 6-membered phosphacycles should be the focus of future 




studies due to their stability to the catalysis conditions (relative to their 5-membered 
analogues), their promising catalyst performance and the limited reports of such ligands 
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Chapter 5  
 
Pyridyl monophosphines for 
methoxycarbonylation  
 
5.1 Introduction  
5.1.1 Catalytic methoxycarbonylation of alkynes 
Alkynes are readily available building blocks, which can be used to produce both fine and 
bulk chemicals in large quantities and at low cost. Since the pioneering work of Reppe in 
the late 1930s,1 the one step, atom efficient Pd-catalysed alkoxycarbonylation of alkynes 
to produce either the branched or linear ,-unsaturated ester has been extensively 
studied (Scheme 5.1). The chemo- and regioselectivity of the reaction can be varied by 
tuning the reaction conditions and catalytic system used. Reppe reported the 
hydroxycarbonylation of acetylene (Scheme 5.1, R = R’ = H), which became an extremely 
important industrial process for the production of acetic acid, employed at BASF.1  Recent 
developments in Pd-catalysed carbonylation of alkynes using a range of nucleophiles have 
been well-reviewed.2–9 The methoxycarbonylation of propyne (Scheme 5.1, R = R’ = Me) 
and phenylacetylene (Scheme 5.1, R = Ph, R’ = Me) will be considered in detail herein. 
Although palladium catalysts dominate carbonylation research, other transition metal 




Scheme 5.1 Catalytic alkoxycarbonylation of alkynes.  
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5.1.1.1 Propyne methoxycarbonylation  
The Pd-catalysed methoxycarbonylation of propyne has been extensively studied because 
the branched product is the commercially valuable methyl methacrylate (MMA); this 
process was first developed by Shell (Scheme 5.2).12–15 MMA is an important precursor to 
the polymer, poly(methyl methacrylate) (PMMA), also known as Perspex, Plexiglass or 
Acrylic.16,17 PMMA has a wide range of applications including in the photonics, 
semiconductor and paint industries due to its desirable properties (e.g. it is shatterproof, 




Scheme 5.2 Catalytic methoxycarbonylation of propyne to produce MMA.  
MMA can be accessed via many different synthetic routes using a range of C2-C4 
hydrocarbon feedstocks, which have been summarised and compared by Nagai.16 One of 
these routes is Lucite’s “Alpha” Process, which is a two-step, high-yielding process that 
involves the Pd-catalysed methoxycarbonylation of ethene.18,19 The success of this process 
has resulted in its commercialisation on a multi-tonne scale. However, the synthesis of 
MMA via the Pd-catalysed methoxycarbonylation of propyne is an attractive alternative 
to the “Alpha” Process since only one step is required and it is 100% atom efficient.20 
Moreover, propyne is a readily available feedstock obtainable from naphtha crackers.20 
Despite attraction commercially, efforts to commercialise this route have failed partly due 
to catalyst poisoning by the propadiene (allene) impurities that contaminate the propyne 
feedstream.2,21 Propadiene is known to react with the catalyst to form inactive -allyl 
complexes.2,21   
5.1.1.2 Phenylacetylene methoxycarbonylation 
The Pd-catalysed methoxycarbonylation of other alkyl and aryl alkynes has been well 
studied.3,20 The methoxycarbonylation of phenylacetylene (Scheme 5.3) is of particular 
interest since the branched product, methyl atropate, is a valuable precursor for an 
important class of nonsteroidal anti-inflammatory agents, including the well-known 
compounds such as naproxen, ibuprofen and fenoprofen (Figure 5.1).3 Relative to the 
branched isomer, reports of the synthesis of linear esters from alkynes are limited to only 
a few catalyst systems.3,22,23 The linear product from the methoxycarbonylation of 
phenylacetylene, methyl cinnamate, is used in the perfume industry.24,25    










Figure 5.1 Anti-inflammatory agents which can be synthesised from methyl atropate.3  
5.1.2 Pyridyl phosphines in alkyne methoxycarbonylation  
Pyridyl phosphines display hemilabile coordination behaviour to transition metals since 
P-monodentate, N-monodentate and P,N-bidentate coordination modes are possible.26 
This hemilability can be exploited during catalysis (see Section 5.1.3). The coordination 
chemistry of pyridyl phosphine ligands and their application in homogeneous catalysis has 
been well documented.26,27  
5.1.2.1 Ph2P(2-Py) ligands in alkyne methoxycarbonylation  
The use of catalysts derived from pyridyl phosphine ligands, first reported by Drent et al. 
in the late 1980s, is still the benchmark for alkyne methoxycarbonylation (Scheme 5.4).12–
15,28,29 Upon replacement of one of the phenyl rings in ligand PPh3 with a 2-pyridyl (2-Py) 
ring (Ph2P(2-Py), L5.1), Drent observed a dramatic increase in catalyst performance in the 
methoxycarbonylation of propyne.12,13 Despite the use of mild conditions (45 °C and 
0.006 mol% catalyst loading), unprecedented activities and selectivities were achieved: > 
40,000 turnovers per hour and 98.9% branched selectivity (cf. 89% selectivity when using 
PPh3).
12,13 This rate enhancement was significantly diminished when using the 3-pyridyl 
(5.1a) and 4-pyridyl (5.1b) analogues, leading Drent to speculate that the spatial 















Scheme 5.4 Pd-catalysed methoxycarbonylation of propyne using pyridyl phosphines.12,13 
In addition, the catalyst activity was highly dependent on the type and amount of acid 
promoter used.12,13 By changing the acid from TsOH (p-toluenesulfonic acid) to MsOH 
(methanesulfonic acid), the rate doubled.12,13 In contrast, in the presence of strongly 
coordinating acids, HCl and acetic acid, the rate decreased dramatically to 10-100 
turnovers per hour.12,13 The high reactivity observed with TsOH and MsOH was 
attributed to the weakly coordinating nature of their conjugate base anions, resulting in 
increased availability of the coordination sites around the metal centre to the substrate 
molecules and/or phosphine ligand.12,13  
Drent observed that upon substitution of more than one phenyl group with a 2-pyridyl 
on the ligand, the catalytic activity decreased, but minimal effect on the selectivity was 
seen.12,13 The effect of substitution on the 2-pyridyl ring itself was also investigated. Me-
substitution at the 6-position of the 2-pyridyl ring (5.1c) gave a more active and selective 
catalyst than the unsubstituted analogue; the branched selectivity was increased from 
98.9% to 99.95%.12,13 However, when the Me-substituent was in the 4-position, no impact 
on the selectivity was observed.12,13 The electronic effect of the ligand on selectivity 
appeared to be minimal, which was confirmed as the catalysts derived from the 6-OMe 
ligand (5.1d) and 6-Br ligand (5.1e) gave essentially the same branched selectivity 
(99.65%).12,13 Importantly, both catalysts (5.1d-e) were considerably less active than the 6-
Me analogue (5.1c).12,13 Drent et al. observed similar effects when using other alkynes (e.g. 
acetylene and phenylacetylene) and using a variety of nucleophilic sources (e.g. water, 
alcohols, thiols, carboxylic acids and amines).12,13    








5.1.2.2 Other P, N-ligands in phenylacetylene methoxycarbonylation  
Inspired by the work of Drent, numerous monophosphine ligands which have the ability 
to form P,N (or other heteroatom) chelates have been designed, synthesised and tested 
in alkyne methoxycarbonylation. Diphosphines bearing the 2-pyridyl moiety have also 
been successfully applied to alkene methoxycarbonylation, but will not be discussed 
herein.30–33   
Exploratory research has been carried out into the effect of varying substitution of the 
phenyl rings of Ph2P(2-Py) (L5.1). In 2005, van Koten et al. reported the use of new Ar2P(2-
Py) ligands, 5.2a-b, in the methoxycarbonylation of phenylacetylene.34 The highest activity 
and selectivity towards the branched product was achieved using the catalyst derived from 
5.2b; using scCO2 as the solvent high branched selectivities were observed (>99%).
34 
Pringle et al. have recently tested a range of CgP(Py) ligands (such as 5.3), where CgP = 
6-phospha-2,4,8-trioxa-1.3.5.7-tetramethyladamant-6-yl, in the methoxycarbonylation of 
phenylacetylene.35 The catalyst derived from CgP(2-Py) was not as effective as Ph2P(2-Py) 
(L5.1), but most CgP(Py) ligands showed good activity and selectivity towards the branched 
product.35 The catalytic performance was enhanced upon Me-substitution at the 6-






Clarke et al. showed the catalyst derived from ligand 5.4 displayed low activity but good 
branched selectivity (90%) in the methoxycarbonylation of phenylacetylene.36 The 
coordination chemistry of the quinoline derived ligand was also investigated and it was 
shown that the ligand preferred to adopt a monodentate coordination mode but can also 
act as a bi- or tridentate ligand.36 Iminophosphine ligands 5.5 were reported by Scrivanti 
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et al. but the derived catalysts for the methoxycarbonylation of phenylacetylene displayed 
low yields despite employing relatively harsh conditions compared to when using L5.1.
37 
This was attributed to the formation of acetophenone side-products resulting from the 




Recently Li et al. tested ligands 5.6 in the methoxycarbonylation of a range of alkyl and 
aryl alkynes, including phenylacetylene.38 High catalytic activity and branched selectivity 
were observed and it was shown that P-substitution at the 1-position of the carbazole was 
critical to catalytic performance.38 The activity observed using the catalyst derived from 
5.6 (when R = Cy) was higher than the benchmark ligand L5.1; this was attributed to a 
stronger preference for P,N-chelation to Pd for 5.6.38 A series of bi-, tri- and 
tetraphosphines (e.g. 5.7a-c) has recently been tested in the methoxycarbonylation of 
phenylacetylene and shown that using water as an additive promotes catalytic activity.39 
The catalyst derived from the ionic tridentate ligand 5.7b displayed the highest activity 
and selectivity (up to 95%), which was attributed to its high -acceptor capacity.39 
Evidently, the pyrazole-nitrogen is not a determining factor in catalyst performance.       




A series of 2-pyrimidyl phosphines was reported by Reetz et al., and the catalyst derived 
from ligand 5.8 displayed comparable activity to Ph2P(2-Py) (L5.1) in the 
methoxycarbonylation of phenylacetylene and 1-hexyne.40 Evidence of P,N chelation to 
the Pd centre was observed upon the addition of AgBF4 to [PdCl2(5.8)2].
40 It was 
suggested that this hemilabile behaviour and the ability to protonate the pyrimidyl 
moieties were key to the catalytic activity,40 as originally proposed by Drent for Ph2P(2-
Py) ligands (Section 5.1.3).12,13 A decrease in activity was observed upon increasing the 
number of pyrimidyl substituents on the ligand, analogous to L5.1.
40  
 







Scrivanti et al. tested the (2-furyl)phosphines 5.9a-c in the methoxycarbonylation of 
phenylacetylene.41,42 Even when using harsher reaction conditions, ligands 5.9a-b gave 
very low activity catalysts compared to Ph2P(2-Py) (L5.1), but good branched selectivity 
was observed (up to 95%).41 The catalyst derived from the mixed 2-furyl/2-pyridyl ligand 
(5.9c) gave selectivities that rival L5.1 and higher catalytic activities at low acid 
concentrations.42 A Pd-catalyst of another OPN ligand, 5.10, was shown by Tooze et al. 
to give comparable activity to those of ligands 5.9a-b, but with improved catalyst 
stability.43 It can be suggested that the 2-pyridyl’s direct link to the P-atom was essential, 
since when a ligand with a CH2 linker between the P centre and 2-pyridyl moiety was 





Recently, Beller et al. reported a class of new diphosphine ligands bearing 2-pyridyl and 
tBu substituents (ligands 5.11a-b).44 The resulting catalysts are highly active and selective 
for the dialkoxycarbonylation of a range of alkyl and aromatic alkynes.44 It was 
demonstrated that the chemo- and regioselectivity of the methoxycarbonylation of 
phenylacetylene was controlled by varying the ligand.44 Using the catalyst derived from 
5.11a, the reaction gave the 1,4-dicarboxylic acid product, whereas using the catalyst 
derived from 5.11b the selectivity was switched to the branched ,-unsaturated ester 








Scheme 5.5 Ligand controlled chemoselectivity in the methoxycarbonylation of 
phenylacetylene.44  
5.1.3 Mechanism of alkyne methoxycarbonylation using P,N ligands 
The mechanism of alkyne methoxycarbonylation by Pd complexes of 2-pyridyl 
phosphines has been extensively investigated and the experimental evidence for the 
proposed mechanisms summarised by Drent and Cole-Hamilton.45  
5.1.3.1 Original carbomethoxy mechanism 
In 1993, Drent originally proposed a mechanism (cycle A, Scheme 5.6) termed the 
carbomethoxy mechanism, in an attempt to rationalise the remarkable performance of 
the Pd-Ph2P(2-Py) catalyst.
12,13 It was later termed the “non-classical” carbomethoxy 
mechanism by Cole-Hamilton et al.46 In 1999, Dervisi et al. reported a series of 
alkoxycarbonyl complexes which supported this mechanism.21 The dramatic rate 
enhancement observed when using L5.1 was attributed to its pyridyl-N acting as a “proton-
messenger” in the final protonolysis step of the catalytic cycle {step (f), Scheme 5.6}.12,13 
Another key feature to the success of L5.1 was its ability to coordinate to the Pd centre via 
either a ҡ1-(P) or ҡ2-(P,N) coordination mode.12,13 Acting as a transient P,N-chelate, it was 
suggested L5.1 can stabilise catalytic intermediates, yet the relative ease of dissociation of 
the pyridyl-N allowed for substrate binding. For the 3- and 4-pyridyl analogues (5.1a-b), 
the complexes are unable to adopt the conformations necessary to enable P,N-chelation, 
hence they cannot stabilise the catalytic intermediates. This accounts for their relative lack 
of catalytic activity.    




Scheme 5.6 Carbomethoxy mechanism proposed by Drent for alkyne 
methoxycarbonylation using ligand L5.1.
12,13  
Drent suggested that the turnover-limiting step of catalytic cycle A (Scheme 5.6) was the 
protonolysis step (step (f)) at low acid concentrations and propyne insertion (step (d)) at 
higher acid concentrations.12,13 As discussed in Section 5.1.2.1, steric effects play an 
important role in determining the selectivity. Drent proposed that the selectivity-
determining step was the migratory insertion of the propyne into the Pd-acyl bond (step 
(e)).12,13 It was suggested that the carbomethoxy group of this catalytic intermediate would 
be cis to the phosphine donor due to its higher trans influence (Figure 5.2).12,13 As a result, 
the pyridyl ring would be coordinated cis to the propyne. Me-substitution at the 6-position 
of the 2-pyridyl ring (ligand 5.1c) would then limit the available space for the coordinated 
propyne. Therefore, to reduce unfavourable steric interactions, shown in configuration 
5.12a, the methyl group of the propyne must be orientated away from the Pd-centre 
(configuration 5.12b); this pathway then leads to the branched product.12,13   







Figure 5.2 Spatial configurations in the selectivity determining step.13  
5.1.3.2         In situ base mechanism  
Scrivanti et al. proposed the “non-classical” hydride route as an alternative mechanism for 
alkyne methoxycarbonylation, which occurs via a Pd(0) complex.47,48 Labelling studies 
were performed which suggested a proton transfer from the 2-pyridyl ligand to the 
coordinated alkyne initiated the cycle.47,48  
In 2015, Bühl et al. probed four different catalytic pathways for alkyne 
alkoxycarbonylation using computational methods.46,49 The most viable pathway 
calculated was an in situ base mechanism (cycle B, Scheme 5.7), based on Scrivanti’s “non-
classical” Pd(0) mechanism.46 The other pathways were discounted based on either 
insurmountable calculated energy barriers or incorrect predictions of regioselectivities.46 
It was suggested that the selectivity-determining step in cycle B was the protonation of 
the coordinated propyne (step (a), cycle B, Scheme 5.7), which was governed by the steric 
effects of the ligand (similar to Drent’s original mechanism).46,49 Bühl et al. proposed that 
the turnover-limiting step was the final solvolysis step, which releases MMA and 
regenerates the catalyst (step (e), cycle B).46,49 Similar to Drent’s original mechanism, the 
dual role of the P,N ligand as a proton messenger (steps (a) and (e), cycle B) and a 








Scheme 5.7 In situ base mechanisms proposed by Bühl et al. for alkyne 
methoxycarbonylation.  
Based on pathway B, Bühl et al. predicted that upon replacement of Ph2P(2-Py) with the 
4-NMe2 substituted ligand 5.13, an increase in the overall catalytic activity would be 
observed due to the increase in basicity of the pyridyl-N.46,49 However, recently Pringle et 
al. have shown that the catalyst derived from 5.13 was considerably less active than its 
unsubstituted analogue, L5.1, for the methoxycarbonylation of phenylacetylene.
50,51 The 
choice of substrate (i.e. phenylacetylene or propyne) should not affect the computed 
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Given this experimental evidence, Bühl et al. proposed a modified in situ base mechanism, 
pathway C in Scheme 5.7, which was fully characterised by density functional theory.51 It 
was found that upon further examination of the acyl intermediate resulting from step (c) 
of the original pathway B, the isomeric acryloyl intermediate was also energetically 
accessible (step (g), pathway C).51 Key to this new proposed mechanism were the highly 
reactive acryloyl and ketene-type intermediates formed in steps (g)-(i) (pathway C), which 
until now had not been suggested as intermediates for alkoxycarbonylation. The proposed 
selectivity-determining step was the same as in the original pathway (step (a), Scheme 5.7). 
This re-calculated pathway (C) agreed with the experimental results discussed above for 
ligand 5.13: the overall energy barrier for ligand 5.13 was now 1.4 kcal mol-1 higher than 
that of L5.1. The reason proposed for this rectification was that the highest energy 
transition state (HETS) for pathway C is the product release rather than methanolysis 
step, and so the effect of basicity of the ligand is significantly reduced. This led the authors 
to predict that reducing the basicity of the ligand would have the opposite effect. It was 
shown that Cl-substitution at the 6-position of the 2-pyridyl ring (ligand L5.2) led to a small 
decrease in the overall energy barrier: 0.9 kcal mol-1 and 0.5 kcal mol-1 for the mono- and 
di-cationic calculated pathways respectively.51 Indeed, for the methoxycarbonylation of 
propyne, Drent has previously shown that the catalyst derived from ligand L5.2 was more 
active than that of L5.1.
14 However, slightly different conditions were used, so there 
remained a need to test ligands L5.2 and L5.1 under the same conditions.            
5.1.4 Aims of the project  
Inspired by Bühl’s prediction, we aimed to synthesise and test ligand L5.2 in the 
methoxycarbonylation of phenylacetylene under the same conditions to those used for 
Ph2P(2-Py) (L5.1) so their catalytic activity could be directly compared.  
As discussed in Section 5.1.2, there have been numerous reports of the application of aryl 
2-pyridyl phosphines in alkoxycarbonylation, but there are limited examples of alkyl 2-
pyridyl monophosphines. Furthermore, the effect of substitution on the 2-pyridyl ring 
has been well studied.12,13,35 Therefore, we aimed to synthesise and test a range of alkyl 2-
pyridyl phosphines, L5.3-5.5, in the Pd-catalysed methoxycarbonylation of various alkynes 
to probe the effect of the alkyl substituent in R2P(2-Py) on catalysis. The ability of the 
ligands to display P-monodentate (ҡ1) and/or P,N-chelate (ҡ2) coordination to Pd(II) and 
Pt(II) was also to be investigated and the stereoelectronic properties of the ligands 
assessed.    








5.2 Predicted pyridylphosphine for methoxycarbonylation  
5.2.1 Synthesis of 6-chloropyridyl phosphine L5.2  
Ligand L5.2 was synthesised in a good yield (74%) from the following modified literature 
procedure (see Chapter 7 for details).52 HPPh2 was treated with nBuLi in THF at -78 °C, 
followed by the reaction with 2,6-dichloropyridine at -78 °C (Scheme 5.8). Low 





Scheme 5.8 Synthesis of L5.2. 
 
 
Crystals of L5.2 suitable for X-ray crystallography were grown from a saturated MeOH 
solution of the ligand (Figure 5.3). The crystal structure of L5.2 shows the P atom is 
pyramidalised; the sum of angles at P is similar to that of L5.1 (305° vs. 306°).
53  The P1-
C13 bond length in L5.1 and L5.2 are the same (within 3 esd); the Cl-substituent on the 2-









Figure 5.3 Crystal structure of L5.2. The hydrogen atoms are omitted for clarity. Thermal 
ellipsoids at 50% probability. Selected bond lengths (Å) and angles (°): P1-C1 1.8294(17), 
P1-C7 1.8289(17), P1-C13 1.8422(17), C1-P1-C7 102.70(7), C7-P1-C13 101.99(7), C1-P1-
C13 100.60(7). See Appendix for experimental details.       
5.2.2 Catalytic methoxycarbonylation of phenylacetylene 
Ligands L5.1 and L5.2 were tested in the Pd-catalysed methoxycarbonylation of 
phenylacetylene (Scheme 5.9). Under standard conditions modified from the literature36 
(Method A, Chapter 7), catalysts derived from both L5.1 and L5.2 gave 100% conversion. 
However, in order to directly compare the activity of the catalysts, less than 100% 
conversion was required. To achieve this, the catalysis was then performed using half the 
concentration of acid, ligand and Pd (Method B); the reaction was run for 15 min or 1 h. 
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Table 5.1 Catalytic methoxycarbonylation of phenylacetylene using either Method A or 
Method B (Chapter 7).  
Entry Ligand Methoda Conv. at 15 
minb / % 
Conv. at 1 hb 
/ % 
Branched 
selectivityc / % 
1 L5.1 A - 100 > 99 
2 L5.2 A - 100 > 99 
3 L5.1 B 88 100 > 99 
4 L5.2 B 99 100 > 99 
a Method A: 5.5 mmol phenylacetylene, 5.5 x 10-3 mmol Pd(OAc)2, 0.22 mmol TsOH.H2O, 
0.11 mmol ligand, 1.5 cm3 MeOH, 45 bar of CO, 60 °C. Method B: 5.5 mmol 
phenylacetylene, 2.75 x 10-3 mmol Pd(OAc)2, 0.11 mmol TsOH.H2O, 0.055 mmol ligand, 
1.5 cm3 MeOH, 45 bar of CO, 60 °C. b Conversion and selectivity were determined by 1H 
NMR spectroscopy. Each result is an average of two runs. c The rest of the product was 
the linear isomer.  
Figure 5.4 Catalytic methoxycarbonylation of phenylacetylene using Method B. 
Conversion at 1 h or 15 min.   
Both ligands gave highly active and selective catalysts under standard conditions, Method 
A (Entries 1 and 2, Table 5.1). Under the modified conditions (Method B) and a reaction 
time of 1 h, the high activity and selectivity of both ligands was maintained (Entries 3 and 
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derived from L5.1 was significantly lower than for the catalyst derived from L5.2: 88% vs. 
99% (Entry 3 vs. Entry 4, 15 min). High selectivities for both ligands were retained under 
these conditions. As explained in Section 5.1.3, a slight decrease in the overall reaction 
barrier was predicted for the L5.2 system relative to L5.1. These catalytic results show that 
the L5.2 does indeed produce a more active catalyst.
51   
5.2.3 Platinum(II) coordination of L5.2  
The reaction of 1 or 2 equiv. of L5.2 with [PtCl2(cod)] (cod = 1,5-cyclooctadiene) in CH2Cl2 
gave the cis-[PtCl2(L5.2)2] complex 5.14 (Scheme 5.10). The 
31P{1H} NMR spectrum of 
5.14 gave a singlet with a 1JP,Pt value of 3695 Hz, indicative of a cis geometry. The analogous 
cis-[PtCl2(L5.1)2] complex has been previously synthesised and shows a 
1JP,Pt coupling 





Scheme 5.10 Synthesis of cis-[PtCl2(L5.2)2], 5.14.  
Crystals of 5.14 suitable for X-ray crystallography were grown by slow diffusion of hexane 
into a saturated CH2Cl2 solution of the complex (Figure 5.5). The crystal structure 
confirmed the cis geometry of phosphine ligands around the Pt centre, in a distorted 
square planar arrangement. Relative to free ligand, an increase in the sum of angles at P 
was observed (by ca. 7°), as expected from the Pt-P -bonding.55,56 The Pt-P bond lengths 
in 5.14 are similar to those of cis-[PtCl2(L5.1)2].













Figure 5.5 Crystal structure of 5.14. The hydrogen atoms are omitted for clarity. 
Disordered atoms in pyridyl and phenyl rings are omitted for clarity. Thermal ellipsoids 
at 50% probability. Selected bond lengths (Å) and angles (°): Pt1-P1 2.2553(14), Pt1-P2 
2.2548(13), Pt1-Cl1 2.3470(13), Pt1-Cl2 2.3674(13), P1-Pt1-P2 99.22(5), P1-Pt1-Cl1 
90.01(5), P2-Pt1-Cl2 82.74(5), Cl1-Pt1-Cl2 88.10(5). See Appendix for experimental 
details.  
It is widely reported that the ability of 2-pyridylphosphines to exhibit both P-
monodentate and P,N-bidentate behaviour is key to the successful application of such 
ligands in methoxycarbonylation catalysis.12,46 To investigate whether L5.2 would exhibit 
such hemilabile behaviour, complex 5.14 was treated with 1 equiv. of AgBF4 in CH2Cl2 to 
yield cis-[PtCl(к2-L5.2)(к






Scheme 5.11 Synthesis of complex 5.15. 
The 31P{1H} NMR spectrum of complex 5.15 gave two doublets at P = 4.3 ppm (
2JP,P = 
6 Hz, 1JP,Pt = 3940 Hz) and -41.9 ppm (
2JP,P = 6 Hz, 
1JP,Pt = 3141 Hz). The signal at -41.9 
ppm was assigned to the P,N-chelate due to its large upfield shift, which is characteristic 
of 4-membered Pt chelates.35,54,58–60 The small 2JP,P and large 
1JP,Pt values of 5.15 are 
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consistent with a cis geometry of phosphine ligands.61 Ligand L5.2 demonstrates both P-
monodentate and P,N-bidentate behaviour in complex 5.15.    
5.2.4 Palladium(II) coordination of L5.2 
The reaction of 1 equiv. of L5.2 with [PdCl2(NCPh)2] in CH2Cl2 gave cis-[PdCl2(L5.2)2] (cis-
5.16) (Scheme 5.12), resulting in a 1:1 mixture of [PdCl2(NCPh)2] and 5.16. In contrast, 
Iggo et al. have shown the analogous reaction with L5.1 gave the P,N-chelate complex 
[PdCl2(к
2-L5.1)], in addition to the cis- and trans-[PdCl2(L5.1)2] complexes.
59 Reaction of 2 
equiv. of L5.2 with [PdCl2(NCPh)2] gave a mixture of cis- and trans-[PdCl2(L5.2)2] (5.16) in 











Scheme 5.12 Reaction of [PdCl2(NCPh)2] with 1 or 2 equiv. L5.2.  
Crystals suitable for X-ray crystallography of cis-5.16 were grown by slow diffusion of 
hexane into a saturated CH2Cl2 solution of cis-/trans-5.16 (Figure 5.6). The crystal structure 
obtained showed a cis geometry of phosphine ligands around the Pd centre, in a distorted 
square planar arrangement. In comparison to free ligand, an increase of ca. 9° in the sum 









Figure 5.6 Crystal structure of cis-5.16. The hydrogen atoms are omitted for clarity. 
Disordered atoms in pyridyl and phenyl rings are omitted for clarity. Thermal ellipsoids 
at 50% probability. Selected bond lengths (Å) and angles (°): Pd1-P1 2.2691(16), Pd1-P2 
2.2638(16), Pd1-Cl1 2.3302(15), Pd1-Cl2 2.3568(14), P1-Pd1-P2 98.53(6), P1-Pd1-Cl1 
89.54(6), P2-Pd1-Cl2 82.30(5), Cl1-Pd1-Cl2 89.73(5). See Appendix for experimental 
details.  
Treatment of cis-/trans-5.16 with 1 equiv. of AgBF4 gave species that could not be 
identified by 31P{1H} NMR spectroscopy as a result of signal broadening, which could 
not be resolved at low temperature. The expected product from the addition of 2 equiv. 
of AgBF4 to cis-/trans-5.16 in CH2Cl2 was the bis-chelate complex [Pd(к
2-L5.2)2][BF4]2, 
where chloride abstraction by Ag+ from only the Pd centre has occurred. However, this 
product was not observed. Instead, the 31P{1H} NMR spectrum of the isolated mixture 
at ambient temperature showed four broadened signals at 34.1, 32.7, -5.3 (w1/2 ≈ 30 Hz) 
and -31.8 (w1/2 ≈ 180 Hz) ppm. The signal at -5.3 ppm was assigned to free ligand L5.2. 
Two isomers of complex 5.17 have been tentatively assigned as the other products, where 
chloride abstraction has occurred both at the Pd centre and on the pyridyl ring of the 
ligand (Scheme 5.13). The signals are broad at ambient temperature, possibly due to 
exchange between the P-monodentate and P,N-bidentate coordination modes occurring 
on the NMR timescale (5.17a/b, Scheme 5.14). Mass spectrometry showed a signal for 
the product complex 5.17 ([M-BF4]
+, see Chapter 7). However, there was also a signal 
which corresponded to a palladium complex containing three chlorine atoms, with the 
formula C34H26Cl3N2P2Pd.  










Scheme 5.14 Exchange occurring between isomers of complex 5.17.  
Upon cooling the solution to -90 °C, the signals at 34.1 and 32.7 ppm in the 31P{1H} 
NMR spectrum resolved into a sharp doublet at 37.8 ppm with a 2JP,P of 28 Hz and a 
broad singlet at 40.3 ppm (w1/2 ≈ 250 Hz) (Figure 5.7). The signal at -31.8 ppm resolved 
into two doublets at -30.1 and -35.5 ppm with 2JP,P couplings ca. 30 Hz, consistent with a 
cis geometry of P atoms. The four signals were observed in ca. a 1:1:1:1 ratio; hence a 1:1 
ratio of complexes 5.17a and 5.17b has been tentatively assigned (Scheme 5.14). 




Figure 5.7 Low temperature 31P{1H} NMR spectra of 5.17a/b in CD2Cl2. 
5.2.5 Rhodium(I) coordination of L5.2 
To assess the electronic properties of ligand L5.2, the trans-[RhCl(CO)(L5.2)2] complex 5.18 





Scheme 5.15 Synthesis of trans-[RhCl(CO)(L5.2)2], 5.18.  
At ambient temperature, the 31P{1H} NMR spectrum of 5.18 gave a broad signal at 30.4 
ppm (w1/2 ≈ 70 Hz). The fluxionality of complex 5.18 may be attributed to an equilibrium 
occurring on the NMR timescale between a mononuclear and binuclear Rh species, as 
shown in Scheme 5.16. Upon cooling the solution to -90 °C, the signal resolved into a 
doublet showing a 1JP,Rh value of 128 Hz, similar to that of L5.1 in the analogous trans-
[RhCl(CO)(L5.1)2] complex.
62 Cooling the solution shifted the equilibrium towards the 
mononuclear trans-[RhCl(CO)L2] complex, 5.18 (Scheme 5.16).    














Scheme 5.16 Equilibrium observed between mononuclear and binuclear Rh species.  
The IR spectrum of complex 5.18 showed a broad signal with a (CO) (A1) value of 1987 
cm-1. This value is significantly higher than the analogous trans-[RhCl(CO)(L5.1)2] complex, 
which has a (CO) (A1) value of 1975 cm
-1.63 The unexpectedly high value for complex 
5.18 may be attributed to the presence of the binuclear species, [Rh2Cl2(CO)2(L5.2)2], in 
solution, shown in the equilibrium above (Scheme 5.16). Subsequently, the electronic 
properties of L5.2 cannot be directly compared to L5.1.    
However, in the crystal structure obtained from the mixture there was no evidence of the 
binuclear species. Crystals of trans-[RhCl(CO)(L5.2)2] (5.18) suitable for X-ray 
crystallography were grown by slow diffusion of hexane into a saturated CH2Cl2 solution 
of the complex (Figure 5.8). The crystal structure confirmed the trans geometry of 
phosphine ligands. Relative to free ligand L5.2, an increase in the sum of angles at P was 
observed (by ca. 7°). The Rh-P bond length in complex 5.18 is shorter than in the 
analogous trans-[RhCl(CO)(L5.1)2] complex (2.3023(7) vs 2.3131(4) Å).
63 This subtle effect 
is consistent with Rh-P bond strength increasing as the -acceptor capacity of the ligand 
increases (L5.2 > L5.1). These effects are not detected in the corresponding Rh-C or C-O 














Figure 5.8 Crystal structure of 5.18. The hydrogen atoms are omitted for clarity. Thermal 
ellipsoids at 50% probability. Selected bond lengths (Å) and angles (°): Rh1-C35 1.824(3), 
O1-C35 1.145(3), Rh1-Cl1 2.3614(6), Rh1-P1 2.3049(7), Rh1-P2 2.2997(7), Cl1-Rh1-C35 
177.22(10), P1-Rh1-P2 172.98(3). See Appendix for experimental details.  
5.3 Synthesis of other R2P(2-Py) ligands 
Although there have been many developments into the effects of modifying the pyridyl 
substituent of Ar2P(2-Py) ligands on methoxycarbonylation catalysis, there are limited 
reports of the use of alkyl pyridyl monophosphines R2P(2-Py). In particular, bulky alkyl 
phosphines have not been explored. Herein, a range of alkyl pyridyl phosphines, R2P(2-
Py), will be investigated as ligands, including the bulky pyridyl phosphine, tBu2P(2-Py).  
Treatment of 2-bromopyridine with nBuLi at -78 °C, followed by the addition of the 
appropriate chlorophosphine gave the pyridylphosphines L5.3a and L5.4 in good yields (60-





Scheme 5.17 Synthesis of L5.3-5.4.  
Substitution at the 6-position of the pyridyl ring of L5.1 has shown to increase selectivity 
towards the desired branched product (see Section 5.1.2).12,13 Therefore, the 6-Me 
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analogue of the tBu2P derived L5.3a was synthesised (L5.3b). This novel ligand L5.3b was 
prepared from 2-bromo-6-methylpyridine via the lithium-halogen exchange reaction, 
followed by nucleophilic substitution, described in Scheme 5.17. 
The lithium-halogen exchange route was attempted for the PhobP analogue L5.5 (PhobP 
= 9-phosphabicyclo[3.3.1]nonan-9-yl), but led to dimeric R2P-PR2 side-products. Hence, 
ligand L5.5 was synthesised via the Pd-catalysed P-arylation of s-PhobPH, based on a 
previous literature procedure and the Weferling method (Scheme 5.18).66,67 Dimeric R2P-
PR2 side-products were a persistent issue, thus L5.5 could only be obtained in 90% purity 




Scheme 5.18 Synthesis of L5.5. 
5.4 Catalytic methoxycarbonylation of phenylacetylene using R2P(2-Py) ligands 
5.4.1 Catalysis under standard conditions 
Ligands L5.3-5.5 were tested in the Pd-catalysed methoxycarbonylation of phenylacetylene 
under standard conditions, modified from the literature (Method A, Chapter 7) (Scheme 
5.19).36 The reaction was run for 4.5 h and/or 1 h; the results are shown in Table 5.2 and 
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Table 5.2 Catalytic methoxycarbonylation of phenylacetylene using Method A (Chapter 
7).a   
Entry Ligand Conversion at 4.5 hb 
/ % 
Conversion at 1hb / 
% 
Branched 
selectivityc / % 
1 L5.1 100 100 99 
2 L5.3a 100 99 99 
3 L5.3b - 96 99 
4 L5.4 6 - 72 
5 L5.5 24 - 97 
6 tBu2PPh - 2 54 
a Method A: 5.5 mmol phenylacetylene, 5.5 x 10-3 mmol Pd(OAc)2, 0.22 mmol TsOH.H2O, 
0.11 mmol ligand, 1.5 cm3 MeOH, 45 bar of CO, 60 °C. b Conversion and selectivity were 
determined by 1H NMR spectroscopy. Each result is an average of two runs. c The rest of 
the product was the linear isomer.  
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Figure 5.10 Methoxycarbonylation of phenylacetylene. Conversion at 1 h.  
Comparing the pyridyl phosphines, L5.1, L5.3a, L5.4 and L5.5 (Figure 5.9), the catalyst derived 
from the Cy2P ligand L5.4 was the least active and selective (Entry 4, Table 5.2). The 
catalyst derived from the s-PhobP analogue L5.5 also displayed low activity, but in this case 
high branched selectivity was achieved (Entry 5). Pleasingly, the tBu2P ligand L5.3a gave a 
highly active catalyst, achieving 100% conversion within 4.5 h, while obtaining excellent 
branched selectivity (Entry 2, 4.5 h). This result rivals those observed when using the Ph2P 
analogue L5.1.  
To explore the catalytic activity of the tBu2P ligand L5.3a further, catalytic runs were carried 
out using analogous ligands (Figure 5.10). At a shorter reaction time of 1 h, using the 
catalyst derived from L5.3a, high branched selectivity and activity were retained (Entry 2, 
1 h, Table 5.2). To probe the effect of substitution at the 6-position of the 2-pyridyl ring, 
the Me-substituted ligand L5.3b was tested. When using the catalyst derived from L5.3b, a 
drop in branched selectivity was observed (to 96%) relative to when using the 
unsubstituted ligand L5.3a (Entry 3 vs. 2, 1 h). This contrasts with the Ph2P ligand L5.1, 
where substitution at the 6-position of the pyridyl ring led to increased branched 
selectivity.12,13 Ligand L5.3a gave a considerably more active catalyst than tBu2PPh (Entry 
2 vs. 6) and therefore the 2-pyridyl ring appears essential to high catalyst performance (as 
seen with L5.1).
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5.4.2 Catalysis on a larger scale 
The promising results obtained with the tBu2P based ligand L5.3a prompted its testing on 
a much larger scale. This is generally the next stage in commercial development and to 
achieve this ligand L5.3a was tested in collaboration with Lucite.
68 They tested ligands L5.1 
and L5.3a for the methoxycarbonylation of phenylacetylene (Scheme 5.20) under standard 
conditions but using 30 times the amount of substrate (0.1 mol% Pd, Method C). The 
reactions were also carried out at a lower catalyst loading of 0.01 mol% Pd (Method D) 
and the results are given in Table 5.3 and Figure 5.11. Due to chemical shift drifting of 
MeOH and starting material resonances in the 1H NMR spectra, a new method of 1H 
NMR spectroscopic analysis was developed to determine the conversion and selectivity 
(see Chapter 7 for details).68 A theoretical maximum turnover number (TON) was 










Equation 1 Calculation of maximum turnover number (TON).  
Table 5.3 Catalytic methoxycarbonylation of phenylacetylene using Method C (0.1 mol% 
Pd) or D (0.01 mol% Pd).a   
Entry Ligand Methoda Max TON Conversionb / % 
1 L5.1 C 990 100 
2 L5.1 D 8,890 34 
3 L5.3a C 1,000 100 
4 L5.3a D 9,180 37 
a Method C: (0.1 mol% Pd), 165 mmol phenylacetylene, 0.164 mmol Pd(OAc)2, 6.73 mmol 
TsOH.H2O, 3.35 mmol ligand, 300 cm
3 MeOH, 45 bar of CO, 60 °C, 4 h. Method D: 
(0.01 mol% Pd) 166 mmol phenylacetylene, 0.0209 mmol Pd(OAc)2, 0.736 mmol 
TsOH.H2O, 0.337 mmol ligand, 300 cm
3 MeOH, 45 bar of CO, 60 °C, 4 h. b Conversion 
was determined by 1H NMR spectroscopy (see Chapter 7).  
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Figure 5.11 Methoxycarbonylation of phenylacetylene using different catalyst loadings. 
Conversion at 4 h.  
Catalysts derived from both L5.1 and L5.3a displayed 100% selectivity towards the branched 
product in all catalytic runs. Pleasingly, the results obtained by Lucite show no loss in 
catalyst activity and selectivity when the reaction is performed on a scale more relevant to 
industry. 100% conversion was achieved when using both catalysts derived from L5.1 and 
L5.3a (Entry 1 and 3, Table 5.3) with similar TONs. Decreasing the catalyst loading to 0.01 
mol% Pd (Method D) saw a considerable decrease in activity to ca. 35% for both L5.1 and 
L5.3a (Entry 2 and 4). Under these modified conditions, the TON for the tBu2P ligand L5.3a 
was slightly higher than that obtained when using the Ph2P ligand L5.1.  
In an attempt to increase the TON at low catalyst loading (0.01 mol% Pd), the 
concentration of acid and ligand were increased to give a 1:60:120 ratio of Pd: ligand: acid 
(Method E). Ligands L5.1 and L5.3a were tested under these optimised conditions and the 
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Table 5.4 Catalytic methoxycarbonylation of phenylacetylene using a 1:60:120 ratio of 
Pd: ligand: acid at 0.01 mol% Pd (Method E).a  
Entry Ligand Max TON Conversionb / % 
1 L5.1 9,260 100 
2 L5.3a 10,000 100 
a Method E: (0.01 mol% Pd), 165 mmol phenylacetylene, 0.0165 mmol Pd(OAc)2, 2.01 
mmol TsOH.H2O, 1.00 mmol ligand, 300 cm
3 MeOH, 45 bar of CO, 60 °C, 4 h. b 
Conversion was determined by 1H NMR spectroscopy (see Chapter 7).  
Indeed, increasing the acid and ligand concentration increased the conversion to 100% 
for both ligands L5.1 and L5.3a, while retaining 100% branched selectivity (Table 5.4). In 
addition, high TONs of ca. 10,000 were calculated. To further increase the TON for the 
tBu2P ligand L5.3a at a 1:60:120 ratio of Pd: L: acid, the amount of substrate was increased 
to 829 mmol (Method F, Table 5.5). A longer reaction time of 22 h was required to achieve 
75% conversion. Under these conditions an excellent TON of 48,900 was achieved. 
Table 5.5 Catalytic methoxycarbonylation of phenylacetylene using an increased amount 
of substrate (Method F).a 
Entry Ligand Max TON Conversionb / % 
1 L5.3a 48,900 75 
a Method F: 829 mmol phenylacetylene, 0.0169 mmol Pd(OAc)2, 2.00 mmol TsOH.H2O, 
0.995 mmol ligand, 300 cm3 MeOH, 45 bar of CO, 60 °C, 22 h. b Conversion was 
determined by 1H NMR spectroscopy (see Chapter 7). 
5.5 Catalytic methoxycarbonylation of other substrates  
5.5.1 Catalytic methoxycarbonylation of propyne on a large scale 
As previously discussed, the valuable monomer, MMA, can be obtained in one step from 
the methoxycarbonylation of propyne (see Section 5.1.1). Ligands L5.1 and L5.3a were 
tested by Lucite on a relatively large scale in the Pd-catalysed methoxycarbonylation of 
propyne (Scheme 5.21). The reaction was run using 0.02 mol% Pd for 4 or 24 h, and the 
results are shown in Table 5.6. The reaction product mixture was analysed by gas 
chromatography (GC). Due to its volatility, the amount of propyne could not be 
accurately quantified and thus % conversion could not be calculated. Instead, gas uptake, 
TON and mass of MMA produced were used to indicate conversion (Table 5.6 and Figure 
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5.12). The TON calculated for these runs is the actual TON since an accurate value of 




Scheme 5.21 Catalytic methoxycarbonylation of propyne on a large scale.  
Table 5.6 Catalytic methoxycarbonylation of propyne using 0.02 mol% Pd (Method G).a  
Entry Ligand Reaction time 
/ h 
TON MMA 
producedb / g 
Branched 
selectivityc / % 
1 L5.1 4 3,373 55.8 99.7 
2 L5.3a 4 560 9.0 100 
3 L5.3a 24 2,400 39.0 99.4 
a Method G: 0.02 mol% Pd, 1:20:40 ratio of Pd: ligand: acid, 45 bar of CO, 60 °C. b 
Conversion and selectivity were determined by GC. Each result is an average of two or 
more runs. c The rest of the product was the linear isomer.  




Figure 5.12 Gas uptake monitored over time for the catalytic methoxycarbonylation of 
propyne using a) L5.1 and b) L5.3a.    
As expected,12–15 the Ph2P ligand L5.1 gave a highly active catalyst (Entry 1, Table 5.6). The 
gas uptake was monitored over time and appeared to plateau within 1 h (Figure 5.12a), 
suggesting full conversion had been achieved. In contrast, the tBu2P ligand L5.3a affords a 
much less active catalyst. Within 4 h, the gas uptake did not plateau (Figure 5.12b), 
suggesting the reaction did not reach full conversion. Moreover, to support this the TON 
and amount of MMA produced was significantly higher (ca. 6 x) when using the catalyst 
derived from the Ph2P ligand L5.1 (Entry 1 vs. 2). Nevertheless, the catalyst derived from 
L5.3a remained active over the 4 h and gave 100% branched selectivity under these 
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at a higher conversion, the reaction time was extended to 24 h; 100% conversion was 
achieved under these conditions (Entry 3). However, the selectivity dropped slightly to 
99.4%, marginally lower than that of L5.1. Increasing the catalyst loading from 0.02 to 0.2 
mol% Pd, 100% conversion could be achieved in less than 4 h, with retention of high 
branched selectivity (99.4%). Although the tBu2P ligand L5.3a gave a considerably less 
active catalyst than that of the Ph2P analogue L5.1, it displayed comparable branched 
selectivity.     
5.5.2 Catalytic methoxycarbonylation of 3,3-dimethylbutyne  
Ligands L5.1, L5.3a and the analogues of the tBu2P derived ligand L5.3a (L5.3b and tBu2PPh) 
were tested in the Pd-catalysed methoxycarbonylation of 3,3-dimethylbutyne under 
modified literature conditions (Scheme 5.22).36 3,3-dimethylbutyne is a more challenging 
substrate than phenylacetylene and propyne for this reaction; the branched product can 
also be used in mechanistic studies as a trapping agent.69 The reaction was run for 1 h and 





Scheme 5.22 Catalytic methoxycarbonylation of 3,3-dimethylbutyne.  
Table 5.7 Catalytic methoxycarbonylation of 3,3-dimethylbutyne.a 
  aMethod H: 5.5 mmol 3,3-dimethylbutyne, 5.5 x 10-3 mmol Pd(OAc)2, 0.22 mmol 
TsOH.H2O, 0.11 mmol ligand, 1.5 cm
3 MeOH, 45 bar of CO, 60 °C, 1 h. b Conversion 
and selectivity were determined by 1H NMR spectroscopy. Each result is an average of 
two runs. c The rest of the product was the linear isomer. 
Entry Ligand Conversionb / % Branched 
selectivityc / % 
1 L5.1 92 90 
2 L5.3a 99 99 
3 L5.3b 99 98 
4 tBu2PPh 0 0 




Figure 5.13 Methoxycarbonylation of 3,3-dimethylbutyne. Conversion at 1 h.  
The catalyst derived from the tBu2P ligand L5.3a displayed excellent conversion and 
branched selectivity within 1 h (Entry 2, Table 5.7). The substituted analogue L5.3b 
displayed similar results to L5.3a, suggesting Me-substitution of the pyridyl ring has little 
effect on the catalytic performance. Similar effects were observed when using 
phenylacetylene as the substrate (Section 5.4.1). Relative to L5.3a, the Ph2P analogue L5.1 
displayed low selectivity towards the branched product (90 vs. 99%, Entry 1 vs. 2). No 
conversion was observed when using tBu2PPh, suggesting once again that the 2-pyridyl 
ring in L5.3a is critical to its excellent catalytic performance.  
5.6 Platinum(II) coordination of R2P(2-Py) ligands 
To investigate the significant difference in catalytic activities observed between the tBu2P 
derived ligand L5.3a and the Cy2P analogue L5.4 (Section 5.4), their Pt(II) coordination 
chemistry was studied. The product of the reaction between [PtCl2(cod)] and ligand was 
dependent of the amount of ligand used; the reaction using 1 equiv. of ligand will be 
discussed first. The ability of the ligands to display P-monodentate and P,N-bidentate 
coordination will be discussed. The reactivity of ligands L5.3a and L5.4 will be compared to 
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The reaction of 1 equiv. of the tBu2P ligand L5.3a with [PtCl2(cod)] (cod = 1,5-
cyclooctadiene) in CH2Cl2 gave a 1:1 mixture of [PtCl2(к2-L5.3a)] (5.19a) and trans-[PtCl(к2-
L5.3a)(к1-L5.3a)][Cl] (trans-5.20a) (Scheme 5.23). The 
31P{1H} NMR spectrum of trans-5.20a 
gave two doublets at 39.5 ppm (2JP,P = 363 Hz, 
1JP,Pt = 2565 Hz) and -18.1 ppm (
2JP,P = 
363 Hz, 1JP,Pt = 1916 Hz). The upfield signal at -18.1 ppm, assigned to the P,N-chelate, is 
characteristic of a 4-membered chelate.35,54,58–60 The large 2JP,P and small 
1JP,Pt values of trans-
5.20a are consistent with a trans phosphine geometry.61,70 In contrast, the reaction of 1 
equiv. of the Cy2P ligand L5.4 with [PtCl2(cod)] in CH2Cl2 gave a 1:1 mixture of trans-
[PtCl2(L5.4)2] (trans-5.21b) and the remaining [PtCl2(cod)] (Scheme 5.23). The 
31P{1H} 
NMR spectrum of trans-5.21b gave a singlet with a 1JP,Pt value ca. 2500 Hz, indicative of a 
trans geometry.       
 
Scheme 5.23 Reaction of [PtCl2(cod)] with 1 equiv. L5.3a-5.4. 
This difference in coordination behaviour has been attributed to the steric bulk of L5.3a 
and L5.4. It has been shown that chelation of phosphines (including cyclometallation) can 
be promoted and stabilised by increasing the steric hindrance around the P-donor.71–74 In 
particular, significant effects were shown when using tBu geminal substituents, also 
known as the “gem-di-tert-butyl-effect”.73,74 Accordingly, P,N-chelation is favoured above 
when using the more sterically encumbered tBu2P ligand L5.3a, relative to when using the 
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Cy2P analogue L5.4. This may explain the low catalytic activity observed when using the 
Cy2P ligand L5.4 discussed earlier.    
Crystals of 5.19a suitable for X-ray crystallography were grown by slow diffusion of 
hexane into a saturated CH2Cl2 solution of 5.19a and trans-5.20a (Figure 5.14). The crystal 
structure of 5.19a confirmed the formation of the P,N-chelate and showed a distorted 
square planar geometry around the Pt centre. There is a significant degree of ring strain 
as shown by the acute P,N-chelate bite angle of 70.88(12)°, similar to that of L5.3a in the 
analogous [PtMe2(к2-L5.3a)] complex (70.0(2)°).
71   
 
Figure 5.14 Crystal structure of 5.19a. The hydrogen atoms are omitted for clarity. 
Thermal ellipsoids at 50% probability. Selected bond lengths (Å) and angles (°): Pt1-P1 
2.2325(13), Pt1-N1 2.019(4), Pt1-Cl1 2.2984(12), Pt1-Cl2 2.3524(12), P1-C1 1.864(5), P1-
C5 1.860(5), P1-Pt1-N1 70.88(12), Cl1-Pt1-Cl2 92.05(5). See Appendix for experimental 
details.    
However, when [PtCl2(cod)] was treated with 2 equiv. of ligand, different products were 
observed. The reaction of 2 equiv. of L5.3a and L5.4 with [PtCl2(cod)] (cod = 1,5-
cyclooctadiene) in CH2Cl2 gave predominantly complexes 5.20a-b (Scheme 5.24). The 
31P{1H} NMR spectrum of trans-5.20a was the same as above; free ligand L5.3a and trans-
5.21a were also present (ca. 25%) (see Chapter 7 for more details). The 31P{1H} NMR 
spectrum of cis-5.20b gave two doublets at 21.5 ppm (2JP,P = 7 Hz, 
1JP,Pt = 3601 Hz) and -
22.8 ppm (2JP,P = 7 Hz, 
1JP,Pt = 3110 Hz). The small 
2JP,P and large 
1JP,Pt values are consistent 
with a cis geometry.61,70 The difference in the geometry of the products from the tBu2P 
ligand L5.3a and Cy2P ligand L5.4 can be associated with the greater steric bulk of the tBu2P 
moiety, forcing isomerisation at the Pt centre, favouring a trans phosphine geometry. In 
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contrast to ligands L5.3a and L5.4, the reaction of 2 equiv. of the Ph2P ligand L5.1 with 
[PtCl2(cod)] gave the cis-[PtCl2(L5.1)2] complex.
50,54 P,N-chelation of L5.3a and L5.4 may be 










Scheme 5.24 Reaction of [PtCl2(cod)] with 2 equiv. L5.3a and L5.4.  





To further investigate the reactivity of ligands L5.3-5.5, their Pd(II) coordination was 
explored. Similar to their Pt(II) coordination chemistry above, the resulting product 
mixture was dependent of the amount of ligand used. The reaction of 1 equiv. of the 
tBu2P ligand L5.3a with [PdCl2(NCPh)2] in CH2Cl2 gave [PdCl2(к2-L5.3a)] (5.22a) as the sole 
product (Scheme 5.25). The upfield 31P{1H} NMR signal (δP = -11.3 ppm) for 5.22a is 
characteristic of a four-membered P,N-chelate ring.59  




Scheme 5.25 Reaction of [PdCl2(NCPh)2] with 1 equiv. L5.3-5.5. 
The analogous reaction using the Cy2P ligand L5.4 gave a 1:2 mixture of [PdCl2(к2-L5.4)] 
(5.22b) and [Pd2Cl4(L5.4)2] (5.23b) (Scheme 5.25). Mass spectrometry supported the 
presence of the binuclear species, 5.23b. As above, the 31P{1H} NMR signal of 5.22b 
showed a characteristic upfield shift (P = -30.2 ppm). The reaction of 1 equiv. of the 
Ph2P analogue L5.1 with [PdCl2(NCPh)2] gave a mixture of [PdCl2(к
2-L5.1)], cis-[PdCl2(L5.1)2] 
and trans-[PdCl2(L5.1)2] complexes.
59 Ligands L5.1, L5.3a and L5.4 all exhibit P,N-chelation in 
the above reactions. The strongest preference for P,N-chelation occurs upon reaction 
with the tBu2P ligand L5.3a, which is attributed to the high steric bulk of the tBu2P moiety 
and “gem-di-tert-butyl-effects”.71,74 There is no evidence of P,N-chelation upon reaction of 
[PdCl2(NCPh)2] with the s-PhobP analogue L5.5; the 
31P{1H} NMR spectrum showed only 
the presence of the binuclear species [Pd2Cl4(L5.5)2] (5.23c, ca. 80%) and cis- and trans-
[PdCl2(L5.5)2] (5.24c) (Scheme 5.25). Mass spectrometry confirmed the presence of these 
species (see Chapter 7). The reason for this observed difference in reactivity is unknown.  
Crystals of 5.22a suitable for X-ray crystallography were grown by slow diffusion of 
hexane into a saturated CH2Cl2 solution of the complex (Figure 5.15). The crystal structure 
confirmed the formation of the P,N-chelate. The acute P,N-chelate bite angle of 70.78(3)° 
indicates a considerable degree of ring strain is present, similar to that of its Pt analogue 
(Figure 5.14). The Ph2P ligand L5.1 also shows a similar degree of ring strain in the 
previously reported cis-[PdCl(к2-L5.1)(к1-L5.1)][BF4] complex.
59 




Figure 5.15 Crystal structure of 5.22a. The hydrogen atoms are omitted for clarity. 
Thermal ellipsoids at 50% probability. Selected bond lengths (Å) and angles (°): Pd1-P1 
2.2341(4), Pd1-N1 2.0186(12), Pd1-Cl1 2.3548(4), Pd1-Cl2 2.2904(4), P1-C6 1.8556(14), 
P1-C10 1.8568(15), P1-Pd1-N1 70.78(3), Cl1-Pd1-Cl2 95.847(14). See Appendix for 
experimental details.  
When [PdCl2(NCPh)2] was treated with 2 equiv. of ligand, different reactivity was 
observed. Upon the reaction of 2 equiv. of the tBu2P ligand L5.3a with [PdCl2(NCPh)2] in 
CH2Cl2, an equilibrium between trans-[PdCl2(L5.3a)2] (trans-5.24a), [PdCl2(к
2-L5.3a)] (5.22a) 
and free ligand L5.3a was observed (Scheme 5.26). This equilibrium was confirmed since 
the addition of L5.3a (1 equiv.) to the reaction mixture resulted in an increase of trans-5.24a 
as the equilibrium is shifted to the left. The reaction using the Cy2P analogue L5.4 gave a 
3:1 mixture of trans-[PdCl2(L5.4)2] (trans-5.24b) and [Pd2Cl4(L5.4)2] (5.23b) respectively 
(Scheme 5.26). The presence of the binuclear complex, 5.23b, was confirmed by mass 
spectrometry. Whereas, the reaction using the s-PhobP ligand L5.5 gave a 9:1 mixture of 
cis- and trans-[PdCl2(L5.5)2] (5.24c) (Scheme 5.26). Even though it has been shown that 
CgP and PhobP are sterically similar,75 the analogous reaction using CgP(2-Py) gave only 
the trans isomer, trans-[PdCl2(CgP(2-Py))2].
35 Similar behaviour to L5.5 has been reported 
when using the Ph2P ligand L5.1; the reaction of 2 equiv. of L5.1 with [PdCl2(cod)] gave a 
mixture of the cis- and trans-[PdCl2(L5.1)2] complexes.
59  




Scheme 5.26 Reaction of [PdCl2(NCPh)2] with 2 equiv. L5.3-5.5. 
In summary, it is clear that the tBu2P ligand L5.3a displays the strongest preference for 
P,N-chelation to Pt and Pd compared to the other ligands, and hence may readily form a 
P,N-chelate during catalysis.  
Crystals of trans-5.24a suitable for X-ray crystallography were grown by slow diffusion of 
hexane into a saturated CH2Cl2 solution of trans-5.24a, 5.22a and L5.3a (Figure 5.16). The 
crystal structure confirmed the trans geometry of the ligands around the Pd centre, in a 
square planar arrangement. The Pd-P bond length in the analogous trans-[PdCl2(L5.1)2] 
complex is shorter than that in trans-5.24a (2.3125(4) vs. 2.3784(4) Å).59 This may be 














Figure 5.16 Crystal structure of trans-5.24a. The hydrogen atoms are omitted for clarity. 
Thermal ellipsoids at 50% probability. Atoms suffixed with a dash (‘) are related by 
symmetry operation (-x, -y, -z). Selected bond lengths (Å) and angles (°): Pd-P1 2.3784(4), 
Pd1-Cl1 2.3082(4), Pd1-C1 1.9025(17), Pd1-C5 1.8816(16), P1-Pd1-P1 180.000, Cl1-Pd1-
Cl1 180.000, P1-Pd1-Cl1 91.194(14). See Appendix for experimental details.  
Crystals of cis-5.24c suitable for X-ray crystallography were grown by slow diffusion of 
hexane into a saturated CH2Cl2 solution of cis- and trans-5.24c (Figure 5.17). The crystal 
structure confirmed the cis geometry of ligands around the Pd centre, in a distorted square 
planar arrangement. Coordinated PhobPR ligands are known to have high rigidity,76 which 
may explain the tetrahedral distortion  of cis-5.24c (Cl-Pd-P ≈ 170°) (Figure 5.17). The 
phobane substituents of L5.5 adopt an anti-conformation in cis-5.24c. The pyridine rings 
of L5.5 are twisted towards the Pd centre, suggesting there may be some interaction 
between the pyridyl-N and the Pd; similar effects were observed in the previously reported 
crystal structure of trans-5.24c (synthesised by a similar method).67 The Pd-P bond length 
is ca. 0.04 Å longer in the previously synthesised trans-5.24c67 than in cis-5.24c, which can 
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Figure 5.17 Crystal structure of cis-5.24c. The hydrogen atoms and disordered solvent 
molecule are omitted for clarity. Thermal ellipsoids at 50% probability. Selected bond 
lengths (Å) and angles (°): Pd1-P1 2.2755(10), Pd1-P2 2.2719(9), Pd1-Cl1 2.3631(9), Pd1-
Cl2 2.3543(9), Cl1-Pd1-Cl2 88.316(3), P1-Pd1-P2 95.52(3), P1-Pd1-Cl1 169.96(4), P2-
Pd1-Cl2 169.15(4). See Appendix for experimental details.  
5.7.1 Formation of P,N-chelate  
In the above Pd(II) coordination studies, the s-PhobP derived ligand L5.5 did not display 
any к2-(P,N) coordination. To probe if such P,N-chelation was possible 1 equiv. of AgBF4 
was added to cis/trans-5.24c in CH2Cl2, and the chloride abstraction from 5.24c led to a 
solution of [PdCl(к2-L5.5)(к
1-L5.5)][BF4] (cis-5.25c[BF4]) and a white precipitate of AgCl 
(Scheme 5.27).   
Scheme 5.27 Synthesis of cis-5.25c[BF4]. 
The in situ 31P{1H} NMR spectrum of cis-5.25c[BF4] gave two doublets at 29.2 ppm (
2JP,P 
= 9 Hz) and -36.1 ppm (2JP,P = 9 Hz). The small 
2JP,P value is consistent with a cis 
geometry.61 The characteristic upfield shift at -36.1 ppm was assigned to the P,N-
chelate.35,54,58–60 This coordination behaviour demonstrates the ability of L5.5 to exhibit 
both P-monodentate and P,N-bidentate behaviour, even though it is not as readily 
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observed as with ligands L5.3-5.4. Analogous behaviour to L5.5 has been reported using the 
Ph2P analogue L5.1 and CgP(2-Py); however, both of these comparator complexes 
displayed fluxionality at ambient temperature.35,59  
5.8 Rhodium(I) coordination of R2P(2-Py) ligands  
Complexes of the type trans-[RhCl(CO)L2] were targeted as a way to compare the 
electronic properties of L5.3-5.5 from their IR spectra. Reaction of 4 equiv. of L5.3-5.5 with 
[Rh2Cl2(CO)4] in CH2Cl2 gave the trans-[RhCl(CO)L2] complexes (5.26a-c), where L = 





Scheme 5.28 Synthesis of trans-[RhCl(CO)L2] complexes 5.26a-c.  
The 31P{1H} NMR spectra of the Cy2P and PhobP complexes 5.26b-c showed a doublet 
with a 1JP,Rh value of ca. 120 Hz, consistent with a trans geometry, similar to that of the 
Ph2P ligand L5.1 in trans-[RhCl(CO)(L5.1)2].
62 The 31P{1H} NMR spectrum of the reaction 
with the tBu2P ligand L5.3a at ambient temperature showed a sharp signal at 39.5 ppm 
(assigned to free ligand, L5.3a) and two broad signals at 60.3 ppm (w1/2 ≈ 260 Hz) and 43.3 
ppm (w1/2 ≈ 310 Hz) in a 3:1 ratio (Scheme 5.29). Upon cooling the solution to -90 °C, 
the signal at 43.3 ppm resolved into a broad doublet of doublets at 66.5 ppm (2JP,P = 242 
Hz, 1JP,Rh = 128 Hz) and a broad doublet at 16.7 ppm (
2JP,P = 226 Hz) (Figure 5.18). Based 
on this, the mixture was tentatively assigned to complexes 5.26a and 5.26a’ (Scheme 5.29). 
The upfield signal at 16.7 ppm was assigned to the 4-membered P,N-chelate of 5.26a’ 
and the signal at 66.5 ppm to the monodentate-P of 5.26a’. The large 2JP,P values are 
consistent with a trans geometry.77 Both signals remain broad at low temperature (-90 °C) 
due to exchange between P-monodentate and P,N-bidentate coordination modes 
occurring on the NMR timescale. In addition, upon cooling the solution the signal for 
complex 5.26a (P = 60.3 ppm at 25 °C) diminished, as the equilibrium shown in Scheme 
5.29 shifted towards complex 5.26a’. Similar to the Pd(II) and Pt(II) coordination above, 
the steric bulk of the tBu2P ligand L5.3a promotes P,N-chelation.  







Scheme 5.29 Observed equilibrium between 5.26a and 5.26a’.  
Figure 5.18 Low temperature 31P{1H} NMR spectra of the equilibrium between 
complexes 5.26a and 5.26a’.  
The IR data for complexes 5.26a-c is given in Table 5.8. The data suggests that ligands 
L5.3-5.5 are weaker -acceptors/ stronger -donors than the Ph2P and CgP analogues.
50,63 
The trend in (CO) (A1) values suggests the -acceptor capacity increases in the order 
CgP(2-Py) > L5.1 > L5.5 > L5.4 > L5.3a, which is consistent with the electronegativity of the 
R2P moieties increasing in the order CgP > Ph2P > PhobP > Cy2P > tBu2P. The opposite 
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Table 5.8 IR data for trans-[RhCl(CO)L2] complexes 5.26a-c. 
Ligand Complex (CO) (A1)a / cm-1 
L5.3a 5.26a 1956 
L5.4 5.26b 1961 
L5.5 5.26c 1969 
L5.1
63 - 1975b 
CgP(2-Py)50 - 1988 
a Measured in CH2Cl2. 
bAs a KBr disc.   
5.9 Protonation studies of the tBu2P(2-Py) ligand   
An important factor contributing to the success of 2-pyridylphosphine ligands in 
methoxycarbonylation catalysis is their ability to act as a “proton messenger” (Section 
5.1.3).12,13,46,49,51 Since the catalytic performance of the tBu2P ligand L5.3a rivalled that of the 
Ph2P analogue L5.1 in the methoxycarbonylation of phenylacetylene (Section 5.4), its ability 
to be protonated was investigated. Accordingly, 1 equiv. of TsOH.H2O was added to the 
equilibrium mixture of trans-[PdCl2(L5.3a)2] (trans-5.24a), [PdCl2(к
2-L5.3a)] (5.22a) and free 
ligand L5.3a in CH2Cl2 (Scheme 5.30). 
The resulting 31P{1H} NMR spectrum gave a broad singlet at 32.0 ppm (40%, w1/2 ≈ 70 
Hz) and a relatively sharp singlet at -11.3 ppm (60%, w1/2 ≈ 7 Hz) which were assigned to 
protonated ligand (L5.3H
+) and [PdCl2(к
2-L5.3a)] (5.22a) respectively (Scheme 5.30). Upon 
the addition of acid, we postulate ligand L5.3a in trans-5.24a becomes protonated at the 
pyridyl nitrogen and dissociates from the Pd centre, leaving a vacant site available for P,N-
chelation, hence giving rise to an increase in 5.22a and the generation of L5.3H
+ (Scheme 
5.30).   
 











Scheme 5.30 Protonation studies of L5.3a in CH2Cl2. 
Upon cooling the solution to -80 °C the signal at 32.0 ppm sharpened slightly (w1/2 ≈ 40 
Hz) and a new signal was observed at 54.4 ppm which was assigned to trans-5.24a (Figure 
5.19). The signal for L5.3H
+ remained broad due to the pyridyl N-H exchanging. As the 
solution is cooled the equilibrium shown in Scheme 5.31, which is assumed to exist at 
ambient temperature, was shifted to the left. Due to the unreliably of 31P NMR 
integration,78 the shift to the trans-5.24a complex was not reflected in the corresponding 
integrals. This experiment shows that the tBu2P ligand L5.3a can be readily protonated.  
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Figure 5.19 Low temperature 31P{1H} NMR spectra of the protonation studies of L5.3a 
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5.10 Conclusions   
Bühl et al. recently proposed a revised mechanism for methoxycarbonylation catalysis, 
which involved highly reactive acryloyl and ketene type intermediates (Section 5.1.3).51 It 
was predicted that a rate enhancement would be observed when the 6-chloropyridyl 
phosphine L5.2 was used as the supporting ligand (cf. Ph2P(2-Py), L5.1). Herein, it has been 
demonstrated that ligand L5.2 did indeed produce a more active catalyst for the 
methoxycarbonylation of phenylacetylene, relative to L5.1.  
The Pt(II) and Pd(II) coordination chemistry of L5.2 has been investigated. The ability of 
L5.2 to form a P,N-chelate was only observed upon the addition of AgBF4 to the 
[MCl2(L5.2)2] complexes (where M = Pt or Pd); analogous behaviour has been observed 
when using Ph2P(2-Py) (L5.1).
59 Both к1- and к2-coordination modes of ligand L5.2 have 
been observed, which is widely reported  to be key to the success of 2-pyridyl phosphines 
in methoxycarbonylation catalysis.12,13  
The effect of the pyridyl group in Ph2P(Py) on catalytic methoxycarbonylation catalysis 
has been extensively studied,12,13,35 but there are limited reports using alkyl pyridyl 
phosphines (R2P(2-Py)).
35,44,79 Consequently, a series of alkyl pyridyl phosphines, L5.3a, L5.4 
and L5.5, has been synthesised and tested in the catalytic methoxycarbonylation of 
phenylacetylene. The alkyl substituent had a significant effect on catalysis: the catalysts 
derived from the Cy2P and PhobP ligands, L5.4 and L5.5 respectively, displayed poor 
catalyst performance. However, the tBu2P ligand L5.3a gave a highly active and selective 
catalyst, rivalling the performance of the catalyst derived from the Ph2P ligand L5.1.  
To probe the effect of substitution at the 6-position of the tBu2P ligand L5.3a, the 6-Me 
analogue L5.3b has been synthesised and tested in the catalytic methoxycarbonylation of 
phenylacetylene. Me-substitution at the 6-position of the pyridyl ring had little effect on 
catalyst performance (unlike the Ph2P analogue L5.1);
12,13 similar results were observed 
when using 3,3-dimethylbutyne as the substrate. The lack of activity observed when using 
the catalyst derived from tBu2PPh suggested the 2-pyridyl ring of tBu2P(2-Py) (L5.3a) is 
critical to its excellent catalyst performance. In the catalytic methoxycarbonylation of 
propyne, the catalyst derived from the tBu2P ligand L5.3a, although less active, displayed 
comparable selectivity towards MMA as the Ph2P ligand L5.1.  
Propadiene impurities in the propyne feed stream have been shown to lead to a loss in 
methoxycarbonylation activity when using the Ph2P ligand L5.1;
21 catalysts of the tBu2P 
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ligand L5.3a may tolerate higher levels of allene impurities in the propyne stream and this 
should be investigated in the future.  
The Pt(II) and Pd(II) coordination chemistry of ligands L5.3a, L5.4 and L5.5 has been 
investigated. The ability of the Cy2P and tBu2P ligands (L5.3a and L5.4) to demonstrate a ҡ2-
(P,N) coordination mode has been demonstrated in solution from the characteristic 
31P{1H} NMR spectra, and in the solid state for the tBu2P derived L5.3a from the crystal 
structures of the [MCl2(к
2-L5.3a)] complexes (where M = Pt or Pd). The PhobP ligand L5.5 
only displayed P,N-chelation upon the addition of AgBF4 to [PdCl2(L5.5)2] (5.24c). The IR 
spectra for the trans-[RhCl(CO)L2] complexes, where L = L5.3-5.5, showed that the -donor 
ability of the ligands increased in the order L5.3a > L5.4 > L5.5, consistent with the 
electronegativity of the alkyl substituents. The trans-[RhCl(CO)(L5.3a)2] complex (5.26a) 
displayed exchange between ҡ1-(P) and ҡ2-(P,N) coordination modes.  
In summary, all ligands L5.3-5.5 displayed both P-monodentate and P,N-bidentate 
coordination modes; the tBu2P ligand L5.3a exhibited the strongest preference for P,N-
chelation to Pt, Pd and Rh, which was attributed to its high steric bulk relative to the other 
ligands. The ability of the tBu2P ligand L5.3a to be protonated and its propensity for P,N-
chelation may explain its superior catalyst performance. DFT calculations should be 
carried out in the future to investigate the mechanism of catalytic methoxycarbonylation 
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Achiral monophosphines for 
enantioselective hydrogenation  
 
6.1 Introduction  
6.1.1 Rh-catalysed asymmetric hydrogenation  
The demand for a single enantiomer of a chiral compound is essential in the 
pharmaceutical industry, and increasingly important in the fragrance, agrochemical, 
flavour and food industries. Asymmetric catalysis can be used to access a single 
enantiomer. Asymmetric hydrogenation is the reduction of a prochiral olefin, ketone or 
imine using molecular hydrogen. In 1968, following the discovery of Wilkinson’s 
hydrogenation catalyst [RhCl(PPh3)3],
1 Knowles and Horner independently reported the 
first example of asymmetric hydrogenation.2,3 The use of optically active phosphorus 
ligands in asymmetric hydrogenation is ubiquitous and has been extensively reviewed.4–10 
Figure 6.1 displays the different elements of chirality in such ligands, for example P-
chirality (e.g. 6.1),11 backbone chirality (e.g. 6.2),12,13 axial chirality (e.g. 6.3)14–16 and 







Figure 6.1 Examples of phosphorus ligands used in asymmetric hydrogenation.  
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For many years, research into asymmetric hydrogenation has focussed on the use of chiral 
bidentate phosphorus ligands due to their inherent conformational rigidity resulting from 
their chelation to a metal centre. However, since the pioneering work of Pringle et al., 
DeVries et al. and Reetz et al. in 2000, monodentate phosphorus ligands (such as 6.5) have 
received increasing attention.7,19–23 The biaryl backbone in 6.5 leads to restricted rotation 
about the M-P bond favouring one rotamer, which in some cases increases the chiral 






The mechanism of asymmetric hydrogenation has been previously well documented, and 
so will not be considered in detail.4,24–26 As discussed, bidentate phosphorus ligands have 
inherent conformational rigidity leading to a highly defined chiral environment around 
the metal centre of the catalyst. It is well known that upon coordination of the classical 
bidentate ligand, dppe (1,2-bis(diphenylphosphino)ethane), a 5-membered chelate ring 
forms which will adopt two enantiomeric conformations,  and  (Scheme 6.1).27–29 In 
1983, Knowles developed a model called the “quadrant rule” to describe the chiral 
environment around the metal centre (Scheme 6.1), which was used to determine the 
configuration of the product.30 The quasi-axial P-substituents that are edge-on with 
respect to the MP2 plane have a greater steric hindrance (highlighted quadrants) relative 
to the quasi-equatorial P-substituents that are face on.31 Subsequently, the enantiofacial 
binding of the prochiral substrate and thus the absolute stereochemistry of the product 
will be influenced by the ligand conformation. Diphosphines which induce a -chirality 
of the chelate ring consistently give R-hydrogenation products.31,32 Hindering 
interconversion between the two conformers ( and ) may lead to chiral amplification, 
which can be achieved through the incorporation of a bulky substituent on the ligand 
backbone.31,33  








Scheme 6.1 Quadrant rule of metal complexes of diphosphines.  
6.1.2 Tropos ligands  
Many asymmetric catalysts are metal complexes of chiral and atropisomeric (atropos) 
ligands, such as BINAP (2,2’-bis(diphenylphosphino)-1,1’-binaphthyl, 6.3, Section 6.1.1). 
Atropos ligands are rigid molecules because rotation about their chiral axis is inhibited, 
whereas tropos ligands are flexible.34 Scheme 6.2 shows the atropisomerism of biphenyl 
compounds: rotation about the C-C single bond is inhibited when steric hindrance 
between the R/R’ substituents is large enough (e.g. when R = NO2 and R’ = CO2H).
35 
Racemic catalysts bearing tropos ligands have been broadly employed in asymmetric 
catalysis and well documented.34,36–39 Tropos ligands are versatile, highly modular and easy 





Scheme 6.2 Atropisomerism of biphenyl compounds.  
Racemic catalysts derived from tropos ligands can be resolved using either a “chiral 
controller” (Strategy A) or a “chiral activator” (Strategy B), as explained in Scheme 6.3.38 
In Strategy A, one enantiomer of the racemic catalyst is activated by a chiral activator 
(A*). Whereas, in Strategy B, a chiral controller (C*) is used to control the chirality of the 
racemic catalyst, which means it can be easily recovered and reused.38 Both strategies have 
been developed in asymmetric catalysis and reviewed by Mikami et al.38,40,41 




Scheme 6.3 Control of a racemic tropos catalyst using a chiral controller or activator.38  
Enantiomerically pure chiral dienes have been extensively applied as ligands in asymmetric 
catalysis,42 but their application as chiral activators in the resolution of tropos ligands is 
rare. In 2008, Brown et al. employed the enantiomerically pure diene, (S,S)-cod* ((S,S)-
bicyclo[3.3.1]nona-2,6-diene), to resolve BIPHEP and its derivatives (Scheme 6.4).43 
Upon the addition of [Rh(acac)((S,S)-cod*)] to BIPHEP, the two diastereomeric products 
resolved over time into a single diastereomer (an atropos precatalyst), as shown in the 
equilibrium in Scheme 6.4.43 When R = OR’ (R’ = Me, iPr or Bn) both diastereomeric 
products were observed at ambient temperature in a 1:1 ratio; resolution to the preferred 
diastereomer required gentle heating (50 °C).43 The resolved complexes were tested in 
asymmetric hydrogenation and moderate enantioselectivities were observed (up to 85% 
ee for the OiPr-BIPHEP derivative).43 The enantioselectivity was further increased to 95% 
using an excess of (S,S)-cod*; it was suggested that the catalyst configuration was further 
controlled by preventing free ligand racemisation.43 As anticipated, when using the non-
equilibrated diastereomeric mixture of complexes in catalysis no enantioselectivity was 
observed.43  
 









Scheme 6.4 In situ resolution of Rh-BIPHEP diastereomers using (S,S)-cod*.   
6.1.3  Restricted M-P rotation in tertiary phobane complexes 
Complexes of bidentate phosphorus ligands are generally more stable than their 
monodentate analogues owing to the chelate effect. However, monodentate phosphorus 
ligands are easier to synthesise due to their readily accessible and inexpensive precursors. 
Furthermore, they are suitable candidates for high throughput experiments and so it is 
easier to introduce structural diversity.44 Pseudo-chelates combine these advantages of 
mono- and bidentate ligands. Pseudo-chelates are the combination of two monodentate 
ligands that are functionalised with complementary binding motifs, which form a pseudo-
backbone via self-assembly.44  
Recently, Pringle et al. showed that the restricted M-P rotation in tertiary phobane metal 
complexes can be exploited to produce complexes with pseudo-chelate properties based 
on steric effects.45,46 Bicyclic tertiary PhobPR ligands (PhobP = 9-
phospha[3.3.1]bicyclononane) have been extensively applied in homogeneous catalysis47–
50 and exist in three isomeric forms, s-, a5- and a7-PhobPR (Figure 6.2). Despite the 
apparent low bulkiness of PhobPR ligands, unexpectedly high barriers to M-P rotation 
were observed for trans-[MCl2(PhobPBu)2] complexes (where M = Pt or Pd), which gave 
rise to anti and syn conformations (Scheme 6.5).45,46 Computational studies suggested that 
the restricted M-P rotation was attributed to the rigidity of the bicycle of PhobP.45 A 
combination of NMR spectroscopy and computational studies also demonstrated that the 
barrier to M-P rotation was dependent on the steric bulk of the R substituent of PhobPR: 
as the size of R increases the barrier increases.45 Restricted M-P rotation has been 
previously observed when using the inherently bulky tBu2PR ligands; the barriers to M-P 
rotation calculated by Shaw et al. for such complexes were of a similar magnitude to the 
“non-bulky” PhobPR complexes reported by Pringle et al.45,51,52   










Scheme 6.5 Fluxionality displayed by trans-[MCl2(PhobPR)2] complexes.  
Similarly, structural rigidity was observed for the analogous cis-[PtX2(PhobPR)2] 
complexes (where X = Cl or Me).46 However, three conformations were anticipated 
(Scheme 6.6) since the anti-form is a pair of enantiomers,  and , labelled by analogy to 
the conformations of dppe chelates (Scheme 6.1). For all the cis complexes considered, 
there was a thermodynamic preference for the anti-conformation over the syn-
conformation, and the epimerisation appeared to have an exceptionally high kinetic 
barrier.46 Using optically pure PhobPR ligands (when R = (R)-iso-pentyl or (R)-sec-pentyl) 
the two diastereomeric anti-conformers ( and ) were identifiable by 31P{1H} NMR 
spectroscopy.46  
 
Scheme 6.6 Fluxionality displayed by cis-[MCl2(PhobPR)2] complexes. 
The high rigidity of coordinated PhobPR ligands was exploited in asymmetric catalysis.46 
The cis-[Rh(nbd)(PhobPR*)2][BF4] complex (where R = (R)-iPn and nbd = 
norbornadiene) was synthesised and, as expected from the above discussion, two 
diastereomeric anti-conformers were observed ( and ).46 Resolution of the anti-
conformers was achieved through selective crystallisation, and the optically pure -
[Rh(nbd)(s-PhobP-(R)-iPn)2][BF4] complex was tested in the Rh-catalysed asymmetric 
hydrogenation of methyl-2-acetamidoacrylate (MAA).46 However, extremely low 
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temperatures of -50 °C were required to preserve the chirality of the catalyst, so 
conversion was low.46 Nonetheless, enantioselectivity was achieved (ee = 40%) using the 
single diastereomer.46 The enantioselectivity was attributed to the chirality of the anti-
conformer rather than the chirality of the R* substituent of PhobPR* since the 
diastereomeric mixture of complexes (-/ -[Rh]) gave essentially zero ee.46  
6.1.4 Aims of the project   
To advance these recent developments by Pringle et al., we aimed to design an optically 
active catalyst with achiral PhobPR ligands. Rather than using the chirality of the R* 
substituent in PhobPR*, resolution of the diastereomeric conformers of cis-[Rh((S,S)-
cod*)(PhobPR)2][OTf] complexes (where PhobPR = L6.1-6.5, Figure 6.3) was to be 
attempted by using the enantiomerically pure diene, (S,S)-cod*. We aimed to synthesise 
the chiral diene according to Scheme 6.7, as previously reported by Brown et al.53,54 The 
PhobPR ligands were synthesised by J. Lister (University of Bristol) according to literature 
methods.46  
 
Scheme 6.7 Synthesis of enantiomerically pure (S,S)-cod*, TMEDA = 
tetramethylethylenediamine.   
 






Figure 6.3 PhobPR ligands studied in this project. 
The fluxionality of the conformers of cis-[Rh((S,S)-cod*)(PhobPR)2][OTf] was also to be 
investigated. We attempted to demonstrate that rotamer-derived chirality alone can 
produce asymmetric induction by testing the resolved complex in Rh-catalysed 
asymmetric hydrogenation. 
6.2 cis-[Rh(cod*)(PhobPR)2][OTf] complexes 
In this section, the fluxionality of the cis-[Rh(cod*)(PhobPR)2][OTf] complexes was 
investigated; the chiral diene, cod*, was used either as a single enantiomer, (S,S)-cod*, or 
as a racemic mixture, rac-cod*. The racemic mixture, rac-cod*, was predominantly used 
for the following studies since its resolution required an additional two steps to its 
synthesis (Scheme 6.7, Section 6.1.4).  
6.2.1 Synthesis and resolution of the chiral rotamers 
The reaction of [Rh(C2H4)2(acac)] with 1.2 equiv. of rac-cod* or (S,S)-cod* in CDCl3 gave 
the starting complexes [Rh(acac)(rac-cod*)] (rac-6.6) and [Rh(acac)((S,S)-cod*)] {(S,S)-
6.6} respectively (Scheme 6.8).54 Moderate yields of ca. 65% were achieved.  
 
Scheme 6.8 Synthesis of the [Rh(acac)(cod*)] complexes (S,S)-6.6 and rac-6.6. 
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The reaction of 2 equiv. of ligands L6.1-6.5 with [Rh(acac)(rac-cod*)] (rac-6.6) in CH2Cl2 in 
the presence of Me3SiOTf gave the cis-[Rh(rac-cod*)L2][OTf] complexes 6.7a-e, where L 
= L6.1-6.5 (Scheme 6.9). The enantiomerically pure cis-[Rh((S,S)-cod*)L2][OTf] complexes 
6.7a-b*, where L = L6.1-6.2, were obtained from a similar procedure but using, 







Scheme 6.9 Synthesis of cis-[Rh(rac-cod*)L2][OTf] complexes 6.7a-e.  
The 31P{1H} NMR spectra for complexes 6.7a-e showed two doublets with 1JP,Rh values 
of ca. 140 Hz (Figure 6.4, Table 6.1). The signals correspond to the two diastereomeric 
anti-conformations of the complexes,  and  (Scheme 6.10). When using rac-cod* each 
doublet corresponds to a pair of enantiomers, -(S,S)/ -(R,R) (conformer A) and -
(R,R)/ -(S,S) (conformer B), as shown in Scheme 6.10. It has been previously reported 
for the cis-[PtX2(PhobPR)2] complexes, where X = Cl or Me, that an anti-conformation is 








Scheme 6.10 Fluxionality displayed by the anti-conformers of complex 6.7a, R = iBu. 




Figure 6.4 31P{1H} NMR spectrum of complex 6.7a, showing a thermodynamic 
preference for one anti-conformer (A).   
Table 6.1 31P{1H} NMR data for complexes 6.7a-e.a  
a Measured in CD2Cl2. 
b Determined by integration of 31P{1H} NMR signals.   
All complexes 6.7a-e were successfully resolved using the chiral diene cod*; there was a 
significant thermodynamic preference for one of the anti-conformers (ca. 90% major 
isomer), except for complex 6.7e where a 65:35 ratio of the anti-conformers was observed 
(Table 6.1). The ratio of the conformers was dependent on the ligand employed.  
Crystallisation of the racemic mixture of the four enantiomers of complex 6.7a was set 
up by slow diffusion of hexane into a saturated chlorobenzene solution of the complex. 
Fortuitously, crystals suitable for X-ray crystallography of a single enantiomer of the 
complex were grown, the -(S,S) conformer, -[Rh((S,S)-cod*)(L6.1)2][OTf] (Figure 6.5). 
The crystals were redissolved and the resulting 31P{1H} NMR spectrum confirmed they 
Ligand Complex P/ppm 
1JP,Rh / Hz % major conformer
b 
L6.1 6.7a 2.0, 1.7 147, 145 95 
L6.2 6.7b 4.2, 0.4 145, 146 96 
L6.3 6.7c 41.8, 40.3 142, 140 90 
L6.4 6.7d 40.7, 40.5 142, 141 93 
L6.5 6.7e 40.7, 38.8 142, 140 65 
A 
 / ppm 
A 
B B 
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were of the major conformer. Crystallisation of the racemic complex 6.7b was set up from 
slow diffusion of hexane into a saturated chlorobenzene solution of the complex. Crystals 
suitable for X-ray crystallography of two enantiomers of complex 6.7b, -(S,S) (Figure 
6.6) and -(R,R) (Figure 6.7), were grown. The two structures have been separated into 
two Figures for clarity (Figures 6.6 and 6.7).  
        
Figure 6.5 Crystal structure of -[Rh((S,S)-cod*)(L6.1)2][OTf] (6.7a). The hydrogen atoms 
and [OTf]- have been omitted for clarity. Thermal ellipsoids at 50% probability. Selected 
bond lengths (Å) and angles (°): Rh1-P1 2.3390(7), Rh1-P2 2.3462(7), Rh1-C13 2.301(2), 
Rh1-C14 2.230(2), Rh1-C17 2.287(3), Rh1-C18 2.226(3), P1-Rh1-P2 93.66(2), C14-Rh1-
C17 78.52(9), C13-Rh1-C18 78.47(10), C5-P1-C9 93.92(11), C26-P2-C30 94.19(11). See 






















Figure 6.6 Crystal structure of -[Rh((S,S)-cod*)(L6.2)2][OTf] (6.7b). The hydrogen 
atoms, [OTf]- counterions and -(R,R) conformer have been omitted for clarity. Thermal 
ellipsoids at 50% probability. Disorder from the nBu chain has been omitted for clarity. 
Selected bond lengths (Å) and angles (°): Rh1-P1 2.3225(7), Rh1-P2 2.3252(6), Rh1-C13 
2.236(2), Rh1-C14 2.256(2), Rh1-C17 2.239(3), Rh1-C18 2.269(3), P1-Rh1-P2 92.80(2), 
C14-Rh1-C17 79.37(9), C13-Rh1-C18 79.3(1), C1-P1-C5 94.75(12), C22-P2-C26 

























Figure 6.7 Crystal structure of -[Rh(R,R-cod*)(L6.2)2][OTf] (6.7b). The hydrogen atoms, 
[OTf]- counterions and -(S,S) conformer have been omitted for clarity. Thermal 
ellipsoids at 50% probability. Disorder from the phobane substituent has been omitted 
for clarity. Selected bond lengths (Å) and angles (°): Rh2-P3 2.3216(6), Rh2-P4 2.3193(7), 
Rh2-C46 2.275(2), Rh2-C47 2.241(3), Rh2-C50 2.260(3), Rh2-C51 2.222(3), P3-Rh1-P4 
93.24(2), C47-Rh2-C50 79.77(10), C46-Rh2-C51 79.39(10), C55-Rh2-C59 94.64(12), C34-
Rh2-C38 94.92(11). See Appendix for details.  
In each case, the crystal structures confirmed a cis geometry of the complex and showed 
a square planar geometry about the Rh(I) centre. The crystal structures of the -
conformers of complexes 6.7a (containing the s-PhobPiBu ligand) and 6.7b (containing 
the s-PhobPnBu ligand) are similar (Figures 6.5 and 6.6). The P1-Rh1-P2 angle of complex 
6.7a is slightly larger than that of 6.7b (by 0.86(2)°); although this effect is very subtle, it 
may reflect the greater steric bulk of the iBuP ligand L6.1, relative to the nBuP analogue 
L6.2. In accordance with this, the C-Rh-C diene bite angle of the iBu complex 6.7a is 
0.85(9)° smaller than that of the nBu analogue 6.7b. The bond lengths and angles of the 
two enantiomers ( ) of complex 6.7b are very similar (Figures 6.6 and 6.7).      
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The C-Rh-C diene bite angle in complex 6.7a (Figure 6.5) is ca. 12.5° larger than that of 
nbd in the analogous -[Rh(nbd)(L6.1)2][BF4] complex (nbd =  norbornadiene).46 
Accordingly, the P-Rh-P angle in 6.7a is ca. 11.5° smaller than that of -
[Rh(nbd)(L6.1)2][BF4].
46 These observations are consistent with the higher steric bulk of 
cod* relative to nbd. The P-Rh-P angle of complex 6.7b (average = 93.02(2)°, Figures 6.6 
and 6.7) is strikingly small compared to that of the achiral analogue -[Rh(cod)(L6.2)2][BF4] 
(by ca. 9°).46 This implies that cod* is more sterically encumbered than its achiral analogue, 
cod. The previously reported [Rh((S,S)-cod*)(BIPHEP)][OTf] complex also has a small 
P-Rh-P angle of 90.20(3)°.43 Since the diene bite angles (C-Rh-C) of 6.7b and -
[Rh(cod)(L6.2)2][BF4] are very similar, it is suggested that it is the rigidity of the cod* that 
induces the reduction in the P-Rh-P angle.46 As a result of this rigidity, cod* may be 
preorganised to be more strongly bound to the metal centre; this effect is not reflected in 
the corresponding C-Rh bond lengths. 
6.2.2 Kinetic study of the epimerisation of the Rh-complexes  
A kinetic study of the epimerisation of complexes 6.7a-e was carried out. The synthesis 
of complexes 6.7a-e (see Section 6.2.1) was monitored over time and the relative 
concentrations of each conformer were determined through integration of their 31P{1H} 
NMR signals. Since the rac-cod* was used for the purpose of these studies, each doublet 
in the 31P{1H} NMR spectrum corresponds to a pair of enantiomers (A and B, Section 
6.2.1).  
Figure 6.8 shows the series of 31P{1H} NMR spectra collected for the s-PhobPiBu 
complex 6.2a at ambient temperature. Initially, conformer A was the minor product, 
where a 1:8 ratio of A: B was detected. However, over time the amount of A increased 
relative to B and within 100 min the 20:1 thermodynamic ratio of A: B was established. 
When diastereomerically pure crystals of A were dissolved in CH2Cl2 at -80 °C, a similar 
equilibrium was established immediately, showing that the major diastereomer was the -
(S,S) conformer.  
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Figure 6.8 31P{1H} NMR spectra of the epimerisation between conformers A and B (for 
complex 6.7a). 
A plot of the relative concentrations of A and B against time is shown in Figure 6.9. The 
integrated first order rate law was then applied to the kinetic data to give the straight-line 
plot of ln[A]/[A]0 against time (Figure 6.10). The straight line indicates that the 
epimerisation of complex 6.7a is a first order process. The rate constant k was calculated 
from the gradient of the graph as 3.4 x10-4 s-1 and the half-life (t1/2) = 34 min. The 
racemisation of the previously reported cis-[Rh(nbd)(s-PhobPiPn)2][BF4] is also a first 
order process and the rate constants (k) at a range of temperatures (-15 to -35 °C) were 
of the same order of magnitude as that calculated for complex 6.7a.46  
 













Figure 6.9 Plot of the relative concentrations of conformers A and B (complex 6.7a) 
against time. 
 
Figure 6.10 First order kinetic plot of the epimerisation of complex 6.7a.  
Analogous kinetic data was collected for complexes 6.2b-e, but the ratio of conformers 
that was initially observed did not change over time. The thermodynamic ratio of 
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6.3 Catalytic asymmetric hydrogenation  
Since high resolution of the anti-conformers of the s-PhobPiBu complex 6.7a was 
achieved, complex 6.7a was tested in the Rh-catalysed asymmetric hydrogenation of 
standard substrates, methyl-2-acetamidoacrylate (MAA) and methyl-2-
acetamidocinnamate (MAC) under various conditions (Scheme 6.11). In the following 
studies the pre-prepared racemic complex cis-[Rh(rac-cod*)(L6.1)2][OTf] (6.7a) was used 
initially to optimise conversion. Once the conditions had been optimised, the catalysis 
was carried out using the enantiopure pre-prepared complex, cis-[Rh((S,S)-
cod*)(L6.1)2][OTf] (6.7a*), in an attempt to achieve enantioselective induction.  





Scheme 6.11 Catalytic asymmetric hydrogenation of MAA and MAC.  
Initial catalytic runs were carried out using MAA at 25 °C and 5 bar of H2 in CH2Cl2. 
Within 1 h, using a catalyst loading of 1 mol%, 100% conversion of the substrate was 
achieved using complex 6.7a. As previously demonstrated by Pringle et al., low 
temperatures are required to preserve the optical activity of the separate diastereomers.46 
The catalysis was thus carried out at 12 °C, but to offset the lower temperature an 
increased pressure of 10 bar of H2 was required. The reaction was run for 1 h using both 
MAA and MAC and the results are shown in Table 6.2.  
Table 6.2 Catalytic asymmetric hydrogenation at 12 °C.a  




a Method: 0.200 mmol substrate, 0.002 mmol 6.7a or 6.7a*, 5 cm3 CH2Cl2, 10 bar of H2, 
12 °C, 1 h. b Conversion and ee were determined by GC. Each result is an average of two 
runs.  
Entry Catalyst Substrate Conversionb / % ee / % 
1 6.7a MAA 100  1 (R)  
2 6.7a MAC 65  2 (S) 
3 6.7a* MAA 100 2 (S) 
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A higher conversion was achieved when using MAA relative to MAC (Entry 1 vs. 2, Table 
6.2) and so MAA was used as the substrate for the subsequent studies. Using the 
enantiopure catalyst (6.7a*) no enantioselectivity was observed under these conditions 
(Entry 3). In an attempt to slow epimerisation of the catalyst and encourage 
enantioselectivity, the temperature was further decreased to 0 °C. A higher catalyst loading 
(10 mol% Rh), higher pressure of H2 (20 bar) and more concentrated solutions (3 cm
3 of 
CH2Cl2) were used to compensate for the lower temperature (Table 6.3). 




a Method: 0.200 mmol MAA, 0.020 mmol 6.7a or 6.7a*, 3 cm3 CH2Cl2, 20 bar of H2, 0 
°C, 1 h. b Conversion and ee were determined by GC. Each result is an average of two 
runs.  
Using both complexes 6.7a and 6.7a* 100% conversion was observed. Unfortunately, 
essentially zero enantioselectivity was found using the enantiopure catalyst, 6.7a* (Entry 
2, Table 6.3). The temperature was further decreased to -50 °C and despite forcing 
conditions of a very high catalyst loading (50 mol%) and a high H2 pressure (20 bar), no 
conversion was observed.  
A preliminary experiment was carried out to determine the lowest temperature conversion 
could be observed (using 10 mol% Rh and 20 bar of H2). The temperature of the reaction 
mixture was gradually increased from -40 °C to -10 °C and after a reaction time of 1 h at 
a specific temperature a sample of the reaction mixture was analysed. This experiment 







Entry Catalyst Conversionb / % ee / % 
1 6.7a 100  2 (R)  
2 6.7a* 100 2 (R) 
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Table 6.4 Catalytic asymmetric hydrogenation at a range of temperatures and using a 
range of solvents.a 
a Method: 0.200 mmol MAA, 0.020 mmol 6.7a, 3 cm3 solvent, 20 bar of H2, 1 h. 
b 
Conversion and ee were determined by GC. Each result is an average of two runs.  
As expected, zero enantioselectivity was produced since the racemic catalyst 6.7a was 
used; this shows that an ee of up to 4% should be considered as within experimental error 
(Table 6.4). The lowest temperature at which any conversion was observed was -20 °C, 
and the highest conversions were attained when using CH2Cl2 and THF (Entries 5 and 
6). A high catalyst loading (50 mol%) and a high pressure of H2 (45 bar) were required to 
increase the conversion at -20 °C, THF was used as the solvent and the results are shown 
in Table 6.5. To aid solubility of the catalyst at this temperature less substrate was used 
(see Method, Table 6.5).  
Table 6.5 Catalytic asymmetric hydrogenation at -20 °C.a 
 
 
    
a Method: 0.052 mmol MAA, 0.026 mmol 6.7a or 6.7a*, 3 cm3 THF, 45 bar of H2, -20 
°C, 1 h. b Conversion and ee were determined by GC. Each result is an average of two 
runs.  
Entry Catalyst Temperature / °C Solvent Conversion / % ee / % 
1 6.7a -40 CH2Cl2 0 - 
2 6.7a -40 THF 0 - 
3 6.7a -40 Acetone 0 - 
4 6.7a -40 MeOH 0 - 
5 6.7a -20 CH2Cl2 2 0 
6 6.7a -20 THF 4 2 (S) 
7 6.7a -20 Acetone 0 - 
8 6.7a -20 MeOH 1 - 
9 6.7a -10 CH2Cl2 100 2 (R) 
10 6.7a -10 THF 100 2 (S) 
11 6.7a -10 Acetone 99 4 (S) 
12 6.7a -10 MeOH 100 2 (S) 
Entry Catalyst Conversionb / % ee / % 
1 6.7a 60  2 (R)  
2 6.7a* 66 2 (R) 
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Under these forcing conditions good conversions were achieved at -20 °C (ca. 60%, Table 
6.5). However, using the enantiopure catalyst 6.7a* enantioselective induction was not 
observed. A temperature of -50 °C was required for the previously reported -
[Rh(nbd)(a5-PhobPiPn)2][BF4] complex to preserve its chirality and allow for 
enantioselective induction.46 Unfortunately, the catalysis using 6.7a* at -50 °C was too 
slow to achieve any conversion, but the chirality of 6.7a* could not be preserved at -20 
°C.  
6.4 NMR studies of the hydrogenation catalysts  
6.4.1 Hydrogenation of cod* 
To gain further insight into the hydrogenation of the catalyst, the reaction mixtures were 
analysed by 31P{1H} NMR spectroscopy after catalysis and in situ. The reaction mixture at 
the end of the catalytic run at -20 °C was analysed (Entry 2, Table 6.5). Surprisingly, the 
resulting 31P{1H} NMR spectrum showed that the original complex (6.7a*) remained 
intact, despite conversion being observed. Brown et al. observed a similarly puzzling result 
when using the analogous [Rh((S,S)-cod*)(S-BIPHEP)]+ complex.43 Subsequently, they 
then showed that using an excess of diene (10 mol%) increased the enantioselectivity of 
the product.43 No increase in ee was observed when using an excess of (S,S)-cod* with our 
system. To encourage the hydrogenation of cod*, complex 6.7a was pressurised with 45 





Scheme 6.12 Hydrogenation of complex 6.7a with no substrate present.  
The resulting 31P{1H} NMR spectrum gave two doublets at 21.6 ppm (60%, 1JP,Rh = 115 
Hz) and 2.4 ppm (40%, 1JP,Rh = 147 Hz), which were assigned to complexes 6.8 and 6.7a 
respectively (Scheme 6.12). The cis-[RhH2S2(L6.1)2][OTf] complex (6.8) was assigned based 
on the following observations: (a) the small 1JP,Rh value of 115 Hz is indicative of a Rh(III) 
species; (b) a hydride signal was observed in the 1H NMR spectrum (H = -23.85 ppm, dt, 
1JH,Rh = 37 Hz, 
2JH,P = 15 Hz) consistent with the presence of equivalent P atoms such as 
in complex 6.8; (c) analogous species are common in previous NMR studies of Rh-diphos 
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hydrogenation catalysts.24,55 To observe near complete conversion to complex 6.8 (ca. 
90%), the reaction time had to be extended to 4 h. These studies show that cod* is 
considerably more stable to hydrogenation that its achiral analogue, cod. This can be 
attributed to the rigidity and pre-organisation of cod*, which leads to the cod* being 
bound more strongly to the metal centre (see Section 6.2.1).   
Upon addition of 1 equiv. of cod* to complex 6.8 (generated as above), 50% of 6.8 was 
converted to cis-[RhS2(L6.1)2][OTf] (6.9, Scheme 6.13). The 
31P{1H} NMR spectrum of 
complex 6.9 showed a broad doublet (w1/2 ≈ 40 Hz) at 31.4 ppm with a large 
1JP,Rh value 
of 206 Hz. This is consistent with a Rh(I) species containing ligands with a low trans 
influence (e.g. solvent molecules) trans to the P-donor.56 The reason for the broadness of 
the signal is unknown. The presence of only 50% of this complex also supported this 




Scheme 6.13 Synthesis of cis-[RhS2(L6.1)2][OTf] (6.9).  
Complex 6.9 readily formed (Scheme 6.13), suggesting that cod* can be easily 
hydrogenated under these conditions; this seems to be at odds with the studies described 
above.  Due to the sterically demanding coordinated cod*, it is possible that the 
conversion of complex 6.7a to 6.8 is very slow, but once complex 6.8 forms the cod* 
readily displaces the labile solvent molecules and hydrogenation of the diene ensues 
rapidly.  
6.4.2 Addition of substrate  
To investigate the species formed in situ upon the addition of substrate, 6 equiv. of MAA 
was added to complex 6.8 in MeOH and left to react for 1 h (Scheme 6.14). Complex 6.8 
was synthesised as above (Scheme 6.12), but the reaction was left for 6 h to allow for 




Scheme 6.14 Synthesis of complex 6.10.  
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The resulting 31P{1H} NMR spectrum gave predominantly (ca. 70%) two sets of doublets 
of doublets in a 2:1 ratio, consistent with the presence of two closely related products 
(Figure 6.11). The two anti-conformers of the cis-[Rh(к2-MAA)(L6.1)2][OTf] complex (6.10) 
were assigned as the products based on the following observations: (a) the small 2JP,P 
values of ca. 40 Hz are consistent with a cis geometry; (b) the large 1JP,Rh values of ca. 155 
Hz are typical of Rh(I) species; (c) two diastereomers of complex 6.10 would be expected 
since MAA is pro-chiral, -(R)/ -(S) and -(S)/ -(R) (C and D in Scheme 6.15).  
Figure 6.11 31P{1H} NMR of the reaction of MAA and complex 6.8 in MeOH. * = 






Scheme 6.15 Fluxionality displayed by the anti-conformers of complex 6.10. 
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6.4.3 Conclusions of NMR studies and relation to catalysis  
The following conclusions can be drawn from the NMR studies above. As discussed in 
Section 6.4.1, the hydrogenation of the catalyst precursor cis-[Rh(cod*)(L6.1)2]
+ (6.7a) to 
generate the catalytically active species, cis-[RhH2S2(L6.1)2]
+ (6.8) and cis-[RhS2(L6.1)2]
+ (6.9), 
is very slow; the conversion of 6.7a to 6.8 reached only 90% completion within 4 h, even 
under forcing conditions (45 bar of H2, 298 K). Hence, when catalysis was carried out at 
-20 °C full recovery of precursor 6.7a was observed (> 99% by 31P{1H} NMR 
spectroscopy). Coordinated cod* appears to be significantly more resistant to 
hydrogenation than its achiral analogue, cod. This may be as a consequence of the 
increased strength of the Rh-cod* binding resulting from the preorganised rigid structure 
of cod* and/or the effective large steric bulk of cod* inhibiting the approach of H2 for 
oxidative addition.       
Despite this, 66% conversion using complex 6.7a* was observed at -20 °C after 1 h. The 
question then arises of what the catalyst is in this instance, the following hypotheses have 
been suggested: 
a) Complex cis-[Rh((S,S)-cod*)(L6.1)2]+ (6.7a*) itself may be the catalyst, undergoing 
oxidative addition to give [RhH2((S,S)-cod*)(L6.1)2]
+. The cod* is then substituted 
by MAA and complex 6.7a* is reformed at the end of the catalysis by 
recoordination of the non-hydrogenated cod*. This is considered unlikely since it 
has been shown that cod* is rapidly hydrogenated by cis-[RhH2S2(L6.1)2]
+ (6.8) and 
an ee of greater than zero would be expected.   
b) A small amount of cis-[Rh((S,S)-cod*)(L6.1)2]+ (6.7a*) is hydrogenated to give cis-
[RhH2S2(L6.1)2]
+ (6.8) which is extremely active, so even at low levels the observed 
conversion is achieved. The amount of 6.8 present would have to be undetectable 
by 31P NMR spectroscopy (< 1%) and (as above) an ee of greater than zero would 
be expected.  
c) Another species ‘X’ is responsible for the catalysis, where ‘X’ does not have any 
coordinated P-ligands (e.g. colloidal Rh), gives a very broad 31P{1H} signal (e.g. a 
fluxional or paramagnetic complex) or is extremely active at low concentrations 
(e.g. a monophos complex, such as [RhH2S3(L6.1)]
+).  
The monophos complex is considered to be the most plausible hypothesis since it easily 
accounts for the zero ee observed, and further experimental studies also support this. The 
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formation of a monophos complex may be promoted by the increased steric hindrance 
of cod* relative to cod. 
At higher temperatures, conversion of cis-[Rh(cod*)(L6.1)2]
+ (6.7a) to catalytically active 
species 6.8 was observed. Scheme 6.16 shows the suggested pathway for the 
hydrogenation of cis-[Rh(cod*)(PhobPR)2]
+ complexes. Zero ee was observed at higher 
temperatures because of the lack of optical stability of either or both cis-[RhH2S2(L6.1)2]
+ 
(6.8) and cis-[RhS2(L6.1)2]
+ (6.9) intermediates (Scheme 6.16). If this epimerisation were 
slow relative to MAA hydrogenation, which should be possible at low temperatures, an ee 
would be expected. For the reasons above, this seems a forlorn hope for the cod* 
complexes discussed herein due to their resistance to hydrogenation at low temperatures.      
 
Scheme 6.16 Suggested pathway for the hydrogenation of complex 6.7a and the 
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6.5 Conclusions and future work  
A series of complexes of the type [Rh(cod*)L2][OTf] (6.7a-e), where L = L6.1-6.5, has been 
successfully synthesised. The 31P{1H} NMR spectra of the complexes confirmed the 
expectation that two diastereomeric anti-conformations ( and ) would exist and showed 
that a resolution of up to 96% was achieved using the chiral diene, cod*. The crystal 
structures of complexes 6.7a-b showed a surprisingly small P-Rh-P angle, relative to the 
values in the achiral cod analogues; this was attributed to the higher steric bulk of cod* 
resulting from its preorganised rigid structure. Kinetic data for the epimerisation of 
complex 6.7a showed the process was first order.  
The enantiopure complex, cis-[Rh((S,S)-cod*)(L6.1)2][OTf] (6.7a*), was tested in the 
asymmetric hydrogenation of MAA and MAC. Despite the use of low temperatures (-20 
°C) no enantioselectivity was observed. To prevent complex epimerisation the 
temperature was further decreased to -40 °C, but no conversion was detected. NMR 
studies of the hydrogenation catalysis showed that hydrogenation of the catalyst precursor 
cis-[Rh(cod*)(L6.1)2]
+ (6.7a) was sluggish, despite forcing conditions (45 bar H2, 4 h, 298 
K). This was attributed to the increased strength of the Rh-cod* binding. No 
enantioselectivity was observed at ambient temperature due to the lack of optical stability 
of either or both of the catalytically active intermediates, cis-[RhH2S2(L6.1)2]
+ (6.8) and cis-
[RhS2(L6.1)2]
+ (6.9) (Section 6.4.3), under the reaction conditions.   
In order to induce enantioselectivity, complex 6.7a* should be a more active 
hydrogenation catalyst. The catalysis should then proceed at low enough temperatures to 
prevent epimerisation of the anti-conformers and preserve optical activity. Therefore, the 
replacement of cod* with a less bulky chiral diene should be considered in the future, for 
example, chiral norbornadiene ((S,S)-nbd*, 6.11) reported by van der Eycken or (R,R)-
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7.1 General considerations 
Unless otherwise stated, all reactions were carried out using standard Schlenk line 
techniques or glove-box techniques under an atmosphere of dry N2 or Ar using oven-
dried glassware (200 °C). Toluene, THF, CH2Cl2, Et2O, hexane and MeCN were collected 
from a Grubbs type solvent system and deoxygenated by three successive freeze-pump-
thaw cycles and stored over 3 Å or 4 Å molecular sieves, which had been previously 
activated under reduced pressure (10-2 Torr) at 200 °C for 18 h. Chlorobenzene was dried 
over CaH2, distilled and deoxygenated by three successive freeze-pump-thaw cycles and 
stored over 4 Å molecular sieves. MeOH and pentane were purchased as anhydrous and 
degassed by bubbling with N2 for 30 min and stored over 3 Å and 4 Å molecular sieves 
respectively. Xylene, CD2Cl2, CDCl3, C6D6 and d8-THF were dried over activated 4 Å 
molecular sieves and deoxygenated by three successive freeze-pump-thaw cycles.   
The following reagents were distilled prior to use: SiMe3Cl, PCl3, o-phenylene 
chlorophosphite, tBu2PCl and Cy2PCl. NEt3 was dried over CaH2, distilled and 
deoxygenated by three successive freeze-pump-thaw cycles and stored over 4 Å molecular 
sieves. All dihydroxyarenes and diols were dissolved in toluene before use and the volatiles 
were then removed under reduced pressure; this was repeated twice to remove H2O. 
[Mo(CO)4(nbd)] was dissolved in CH2Cl2 and filtered through florisil. 1-hexene was 
purified by passing it through a short alumina column. The following reagents were 
prepared by the author according to literature methods: 3,6-di-tert-butylcatechol,1 2,7-di-
methyl-1,8-naphthalenediol2 and rac-/(S,S)-cod*.3 The following reagents were prepared 





PhobPH8 and ligands L6.1-6.5.
9 All other reagents were purchased from commercial sources 
and used without further purification.  
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All NMR spectra were recorded on a Jeol ECP (Eclipse) 300, Jeol ECS 300, Varian 400-
MR, or Jeol ECS 400 spectrometer at ambient temperature unless otherwise stated. 
Chemical shifts were referenced to residual solvent (1H and 13C), 85% H3PO4 (
31P) and 
CFCl3 (
19F). The external reference used for 195Pt was the absolute frequency 21.4 MHz 
(for TMS 1H = 100MHz). Mass spectra were carried out by the University of Bristol 
Spectrometry Service on a VG Analytical Autospec (EI) or VG Analytical Quattro (ESI) 
spectrometer. Crystal structures were determined by the University of Bristol 
Crystallography Service, using a Bruker APEX II or Bruker AXS Microstar diffractometer 
(see Appendix for more details). Infra-red spectroscopy was carried out on a Perkin Elmer 
Spectrum One FT-IR Spectrometer. 
7.2 Chapter 2  
7.2.1 Synthesis of 2.6a 
A solution of catechol (0.400 g, 3.63 mmol) in THF (20 mL) was cooled 
to -78 °C and nBuLi (5.00 mL, 7.99 mmol, 1.6 M in hexanes) was added 
dropwise over 10 min. The reaction mixture was then allowed to warm to ambient 
temperature and stirred for a further 2 h. SiMe3Cl (1.01 mL, 7.99 mmol) was then added 
dropwise over 10 min and the reaction mixture stirred for 20 h. The volatiles were 
removed under reduced pressure and the residue was dissolved in toluene (20 mL). The 
suspension was filtered, and the solid washed with toluene (3 x 10 mL). The volatiles were 
removed under reduced pressure to yield the crude product. Purification by distillation 
(70 °C, 0.5 Torr) gave the product as a colourless oil (0.786 g, 85%). 1H NMR (400 MHz, 
CDCl3): H (ppm) 6.86 (m, 4H, ArCH), 0.28 (s, 1JH,C = 119 Hz, 18H, Si(CH3)3). 13C{1H} 
NMR (101 MHz, CDCl3): C (ppm) 124.8 (s, ArCO), 122.0 (s, ArCH), 121.3 (s, ArCH), 
0.5 (s, 1JC,Si = 60 Hz, Si(CH3)3). 
1H and 13C{1H} NMR data agreed with the literature data.10 
7.2.2 Synthesis of 2.6b 
A solution of 1,8-dihydroxynaphthalene (2.00 g, 12.5 mmol) in THF (35 
mL) was cooled to -78 °C and nBuLi (17.2 mL, 27.5 mmol, 1.6 M in 
hexanes) was added dropwise over 10 min. The reaction mixture was then 
allowed to warm to ambient temperature and stirred for a further 2 h. SiMe3Cl (3.49 mL, 
27.5 mmol) was then added dropwise over 10 min and the reaction mixture stirred for 20 
h. The volatiles were removed under reduced pressure and the residue was dissolved in 
toluene (30 mL). The suspension was filtered, and the solid washed with toluene (3 x 15 
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mL). The volatiles were removed under reduced pressure to yield the crude product. 
Purification by Kugelruhr distillation (110 °C, 1 x10-6 Torr) gave the product as a 
colourless oil (2.72 g, 72%). 1H NMR (400 MHz, CDCl3): H (ppm) 7.41 (d, JH,H = 8.1 Hz, 
2H, ArCH), 7.27 (t, JH,H = 7.8 Hz, 2H, ArCH), 6.80 (d, JH,H = 7.4 Hz, 2H, ArCH), 0.27 (s, 
1JH,C = 118.9 Hz, 18H, Si(CH3)3). 
13C{1H} NMR (101 MHz, CDCl3): C (ppm) 152.0 (s, 
ArCO), 138.0 (s, ArC), 126.0 (s, ArCH), 122.6 (s, ArC), 121.9 (s, ArCH), 116.2 (s, ArCH), 
0.7 (s, 1JC,Si = 60 Hz, Si(CH3)3). HR-MS (EI): m/z calcd. for C16H24O2Si2 [M]
+ = 304.1315; 
obs. = 304.1309. 
7.2.3 Synthesis of 2.6c 
A solution of 2,2’-dihydroxybiphenyl (0.100 g, 0.536 mmol) in THF (10 
mL) was cooled to -78 °C and nBuLi (0.737 mL, 1.18 mmol, 1.6 M in 
hexanes) was added dropwise over 10 min. The reaction mixture was then 
allowed to warm to ambient temperature and stirred for a further 2 h. 
SiMe3Cl (1.50 mL, 1.18 mmol) was then added dropwise over 10 min and the reaction 
mixture stirred for 20 h. The volatiles were removed under reduced pressure and the 
residue was dissolved in toluene (10 mL). The suspension was filtered, and the solid 
washed with toluene (3 x 5 mL). The volatiles were removed under reduced pressure to 
yield the crude product. Purification by distillation (110 °C, 0.5 Torr) gave the product as 
a yellow oil (0.101 g, 57%). 1H NMR (400 MHz, CDCl3): H (ppm) 7.31-7.18 (m, 4H, 
ArCH), 7.00 (m, 2H, ArCH), 6.88 (dd, JH,H = 8.1, 1.2 Hz, 2H, ArCH), 0.08 (s, 18H, 
Si(CH3)3). 
13C{1H} NMR (101 MHz, CDCl3): C (ppm) 153.2 (s, ArCO), 132.0 (s, ArCH), 
131.0 (s, ArC), 128.3 (s, ArCH), 120.8 (s, ArCH), 119.7 (s, ArCH), 0.4 (s, Si(CH3)3). 
1H 
and 13C{1H} NMR data agreed with the literature data.11 
7.2.4 Synthesis of 2.6d  
A solution of bis(2-hydroxyphenyl)methane (1.50 g, 7.49 mmol) in THF 
(30 mL) was cooled to -78 °C and nBuLi (10.3 mL, 16.5 mmol, 1.6 M in 
hexanes) was added dropwise over 10 min. The reaction mixture was then 
allowed to warm to ambient temperature and stirred for a further 2 h. 
SiMe3Cl (2.09 mL, 16.5 mmol) was then added dropwise over 10 min and 
the reaction mixture stirred for 20 h. The volatiles were removed under reduced pressure 
and the residue was dissolved in toluene (25 mL). The suspension was filtered, and the 
solid washed with toluene (3 x 15 mL). The volatiles were removed under reduced 
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pressure to yield the crude product. Purification by Kugelruhr distillation (170 °C, 0.1 
Torr) gave the product as a colourless oil (1.82 g, 71%). 1H NMR (400 MHz, CDCl3): H 
(ppm) 7.10 (td, JH,H = 7.7, 1.9 Hz, 2H, ArCH), 7.01 (dd, JH,H = 7.6, 1.9 Hz, 2H, ArCH), 
6.88 (td, JH,H = 6.9, 1.3 Hz, 2H, ArCH), 6.82 (dd, JH,H = 8.0, 1.3 Hz, 2H, ArCH), 3.91 (s, 
2H, CH2), 0.25 (s, 18H, Si(CH3)3). 
13C{1H} NMR (101 MHz, CDCl3): C 153.7 (s, ArCO), 
131.7 (s, ArC), 130.9 (s, ArCH), 127.0 (s, ArCH), 121.3 (s, ArCH), 118.8 (s, ArCH), 30.7 
(s, CH2), 0.6 (s, 
1JC,Si = 60 Hz, Si(CH3)3). HR-MS (ESI): m/z calcd. for C19H28NaO2Si2 
[M+Na]+ = 367.1520; obs. = 367.1527. 
General procedure for the synthesis of the tBu substituted silyl ethers (2.6e-f) 
A solution of the dihydroxyarene (0.200 g, 0.900 mmol) in THF (8 mL) was cooled to -
78 °C and nBuLi (1.24 mL, 1.98 mmol, 1.6 M in hexanes) was added dropwise over 10 
min. The reaction mixture was then allowed to warm to ambient temperature and stirred 
for a further 2 h. SiMe3Cl (0.251 mL, 1.98 mmol) was then added dropwise over 10 min 
and the reaction mixture stirred for 20 h. The volatiles were removed under reduced 
pressure and the residue was dissolved in toluene (10 mL). The suspension was filtered, 
and the solid washed with toluene (3 x 10 mL). The volatiles were removed under reduced 
pressure to yield the crude product. For the synthesis of 2.6f, the 3,6-di-tert-butylcatechol 
was synthesised according to a modified literature.1   
7.2.5 Synthesis of 2.6e 
Purification by Kugelruhr distillation (100 °C, 0.1 Torr) gave the 
product as a white solid (0.249 g, 82%). 1H NMR (400 MHz, CDCl3): 
H (ppm) 6.93 (s, 1H, ArCH), 6.82 (s, 1H, ArCH), 1.39 (s, 9H, 
C(CH3)3) 1.30 (s, 9H, C(CH3)3), 0.38 (s, 9H, OSi(CH3)3), 0.32 (s, 9H, 
OSi(CH3)3). 
13C{1H} NMR (101 MHz, CDCl3): C (ppm) 145.1 (s, ArC), 142.5 (s, ArC), 
142.1 (s, ArC), 140.2 (s, ArC), 116.1 (s, ArCH), 114.2 (s, ArCH), 35.3 (s, C(CH3)3), 34.4 (s, 
C(CH3)3), 31.7 (s, C(CH3)3), 30.2 (s, C(CH3)3), 2.4 (s, 
1JC,Si = 61 Hz, Si(CH3)3), 1.2 (s, 
1JC,Si 
= 60 Hz, Si(CH3)3). HR-MS (EI): m/z calcd. for C20H38O2Si2 [M+H]
+ = 367.2410; obs. = 
367.2434. 1H NMR data agreed with the literature data.12 
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7.2.6 Synthesis of 2.6f 
Purification by Kugelruhr distillation (100 °C, 0.1 Torr) gave the product 
as a pale green oil (0.221 g, 83%). 1H NMR (400 MHz, CDCl3): H (ppm) 
6.80 (s, 2H, ArCH), 1.36 (s, 18H, C(CH3)3), 0.18 (s, 18H, Si(CH3)3). 
13C{1H} NMR (101 MHz, CDCl3): C (ppm) 146.6 (s, ArCO), 138.8 (s, 
ArC), 118.9 (s, ArCH), 34.7 (s, C(CH3)3), 31.1 (s, C(CH3)3), 1.6 (s, 
1JC,Si = 60 Hz, Si(CH3)3). 
HR-MS (EI): m/z calcd. for C20H38O2Si2 [M+H]
+ = 367.2410; obs. = 367.2427.  
7.2.7 Synthesis of 2.5b (from dihydroxyarene) 
A solution of 1,8-dihydroxynaphthalene (1.47 g, 9.20 mmol) in toluene 
(50 mL) was added dropwise to a mixture of PCl3 (4.01 mL, 46.0 mmol) 
and NEt3 (2.82 mL, 20.2 mmol) in toluene (15 mL) at -78 °C. The reaction 
mixture was gradually warmed to ambient temperature and stirred for 20 h. The reaction 
mixture was filtered, and the solid washed with toluene (3 x 15 mL). The volatiles were 
removed under reduced pressure to yield the product as a pale yellow solid (1.71 g, 83%). 
31P{1H} NMR (162 MHz, C6D6): P (ppm) 132.9 (s). 1H NMR (400 MHz, C6D6): H (ppm) 
7.13 (d, JH,H = 8.2 Hz, 2H, ArCH), 6.91 (t, JH,H = 8.0 Hz, 2H, ArCH), 6.71 (d, JH,H = 7.6 
Hz, 2H, ArCH). 31P{1H} and 1H NMR data agreed with the literature data.13   
7.2.8 Synthesis of 2.5c (from dihydroxyarene) 
A solution of 2,2’-dihydroxybiphenyl (2.00 g, 10.7 mmol) in toluene (60 
mL) was added dropwise to a mixture of PCl3 (4.69 mL, 53.7 mmol) and 
NEt3 (3.29 mL, 23.6 mmol) in toluene (15 mL) at -78 °C. The reaction 
mixture was gradually warmed to ambient temperature and stirred for 20 
h. The reaction mixture was filtered, and the solid washed with toluene (3 x 15 mL). The 
volatiles were removed under reduced pressure to yield the product as a pale yellow oil 
(2.36 g, 87%). 31P{1H} NMR (162 MHz, C6D6): P (ppm) 179.7 (s). 1H NMR (400 MHz, 
C6D6): H (ppm) 7.07 (dd, JH,H = 7.2, 1.8 Hz, 2H, ArCH), 6.94 (m, 4H, ArCH), 6.89 (m, 
2H, ArCH). 31P{1H} and 1H NMR data agreed with the literature data.14 
7.2.9 Synthesis of 2.5a (from silyl ether 2.6a) 
To a solution of 2.6a (0.125 g, 0.491 mmol) in MeCN (2 mL) was added 
PCl3 (0.428 mL, 4.91 mmol). The reaction mixture was stirred until 
completion (2 h), as identified by 31P{1H} NMR spectroscopy. The volatiles were 
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removed under reduced pressure to yield the product as a pale yellow solid (0.0860 g, 
99%). 31P{1H} NMR (162 MHz, C6D6): P (ppm) 174.4 (s). 1H NMR (400 MHz, C6D6): 
H (ppm) 6.73 (m, 2H, ArCH), 6.55 (m, 2H, ArCH). 31P{1H} and 1H NMR data agreed 
with the literature data.15 
7.2.10 Synthesis of 2.5b (from silyl ether 2.6b) 
To a solution of 2.6b (2.38 g, 7.80 mmol) in MeCN (40 mL) was added 
PCl3 (6.81 mL, 78.0 mmol). The reaction mixture was heated at 60 °C until 
completion (20 h), as identified by 31P{1H} NMR spectroscopy. The 
volatiles were removed under reduced pressure to yield the product as a white solid (1.68 
g, 96%). 31P{1H} NMR (162 MHz, C6D6): P (ppm) 133.0 (s). 1H NMR (400 MHz, C6D6): 
H (ppm) 7.14 (d, JH,H = 8.3 Hz, 2H, ArCH), 6.92 (t, JH,H = 8.0 Hz, 2H, ArCH), 6.71 (d, 
JH,H = 7.6 Hz, 2H, ArCH). 
31P{1H} and 1H NMR data agreed with the literature data.13 
7.2.11 Synthesis of 2.5c (from silyl ether 2.6c) 
To a solution of 2.6c (0.100 g, 0.303 mmol) in MeCN (2 mL) was added 
PCl3 (0.264 mL, 3.03 mmol). The reaction mixture was stirred until 
completion (3 h), as identified by 31P{1H} NMR spectroscopy. The 
volatiles were removed under reduced pressure to yield the product as a 
pale-yellow oil (0.0770 g, 99%). 31P{1H} NMR (162 MHz, C6D6): P (ppm) 179.5 (s). 1H 
NMR (400 MHz, C6D6): H (ppm) 7.48 (dd, JH,H = 7.6, 1.6 Hz, 2H, ArCH), 7.37 (m, 4H, 
ArCH), 7.38 (dd, JH,H = 8.0, 0.8 Hz, 2H, ArCH). 
31P{1H} and 1H NMR data agreed with 
the literature data.14 
7.2.12 Synthesis of 2.5d (from silyl ether 2.6d)  
To a solution of 2.6d (1.82 g, 5.28 mmol) in MeCN (25 mL) was added 
PCl3 (4.61 mL, 52.8 mmol). The reaction mixture was heated at 50 °C for 
48 h. The volatiles were then removed under reduced pressure. To ensure 
complete conversion of the dichlorophosphorus intermediate, the 
isolated crude product was redissolved in MeCN (20 mL) and heated at 60 °C for 20 h. 
Upon completion of the reaction as identified by 31P{1H} NMR spectroscopy, the 
volatiles were removed under reduced pressure to yield the product as a white solid (1.35 
g, 95%). 31P{1H} NMR (162 MHz, C6D6): P (ppm) 125.7 (s), -0.7 (s, 7% hydrolysis). 
31P{1H} NMR data agreed with the literature data.16 1H NMR (400 MHz, C6D6): H (ppm) 
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6.88 (d, JH,H = 7.4 Hz, 2H, ArCH), 6.75 (m, 6H, ArCH), 4.24 (d, 
2JH,H = 13.2 Hz, 1H, 
CH2), 3.01 (d, 
2JH,H = 13.0 Hz, 1H, CH2), contained signals for 7% hydrolysis product. 
13C{1H} NMR (101 MHz, C6D6): C (ppm) 150.3 (d, 2JC,P = 15 Hz, ArCO), 134.5 (s, ArC), 
130.1 (s, ArCH), 127.8 (s, ArCH), 125.9 (s, ArCH), 123.7 (s, ArCH), 33.8 (s, CH2). 
7.2.13 Synthesis of 2.5e (from silyl ether 2.6e)  
To a solution of 2.6e (1.30 g, 3.54 mmol) in MeCN (30 mL) was added 
PCl3 (1.55 mL, 17.7 mmol). The reaction mixture was stirred at 40 °C 
for 24 h. Upon completion, as identified by 31P{1H} NMR 
spectroscopy, the volatiles were removed under reduced pressure to 
yield the product as a clear oil (0.742 g, 75%). 31P{1H} NMR (162 MHz, C6D6): P (ppm) 
172.1 (s, >97%). 31P{1H} NMR data fitted with the literature data.17 1H NMR (400 MHz, 
C6D6): H (ppm) 7.08 (s, 1H, ArCH), 7.00 (s, 1H, ArCH), 1.31 (s, 9H, C(CH3)3), 1.07 (s, 
9H, C(CH3)3). 
13C{1H} NMR (101 MHz, C6D6): C (ppm) 147.8 (s, ArC), 145.0 (d, 2JC,P = 
7 Hz, ArCO), 144.9 (d, 2JC,P = 7 Hz, ArCO), 140.5 (s, ArC), 118.4 (s, ArCH), 109.7 (s, 
ArCH), 35.0 (s, C(CH3)3), 34.7 (s, C(CH3)3), 31.6 (s, C(CH3)3), 29.7 (s, C(CH3)3). HR-MS 
(EI): m/z calcd. for C14H20ClO2P [M]
+ = 286.0889; obs. = 286.0889. 
7.2.14 Synthesis of 2.5f (from silyl ether 2.6f)  
To a solution of 2.6f (0.927 g, 2.53 mmol) in MeCN (20 mL) was added 
PCl3 (1.10 mL, 12.6 mmol). The reaction mixture was stirred at 40 °C for 
24 h, which was gradually increased to 70 °C after 2 days. After 6 days, 
volatiles were removed under reduced pressure; MeCN (15 mL) and PCl3 
(1.10 mL, 12.6 mmol) were then added to the residue. 24 h later, the volatiles were 
removed under reduced pressure to yield the product as a yellow oil (contained 15% of 
2.6f’). 31P{1H} NMR (162 MHz, C6D6): P (ppm) 167.3 (s, 92%), 166.0 (s, 1%), -25.3 (s, 
7%, P(V) hydrolysis). 31P{1H} NMR data fitted with the literature data.1,18 1H NMR (400 
MHz, C6D6): H (ppm) 7.03 (s, 2H, ArCH), 1.41 (s, 18H, C(CH3)3). 13C{1H} NMR (101 
MHz, C6D6): C (ppm) 142.5 (d, 2JC,P = 8 Hz, ArCO), 135.5 (s, ArC), 120.9 (s, ArCH), 
118.5 (s), 29.7 (s, C(CH3)3), 29.5 (s, C(CH3)3). 
1H and 13C{1H} NMR spectra contained 
signals for 2.6f’.  
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7.2.15 Synthesis of 2.5g (from dihydroxyarene)  
A solution of 2,7-dimethylnapthalene-1,8-diol2 (0.388 g, 2.06 mmol) in 
toluene (15 mL) was added dropwise to a mixture of PCl3 (1.80 mL, 20.6 
mmol) and NEt3 (0.632 mL, 4.53 mmol) in toluene (10 mL) at -78 °C. The 
reaction mixture was gradually warmed to ambient temperature and 
stirred for 20 h. The reaction mixture was filtered, and the solid washed with toluene (3 x 
10 mL). The volatiles were removed under reduced pressure to yield the product as a pale 
yellow solid (0.420 g, 81%). 31P{1H} NMR (162 MHz, C6D6): P (ppm) 132.7 (s, 7%, 
mono-Me product), 132.3 (s, 93%). 1H NMR (400 MHz, C6D6): H (ppm) 7.09 (d, JH,H = 
8.3 Hz, 2H, ArCH), 6.81 (d, JH,H = 8.4 Hz, 2H, ArCH), 2.05 (s, 6H, CH3). 
13C{1H} NMR 
(101 MHz, C6D6): C (ppm) 140.2 (d, 2JC,P = 5 Hz, ArCO), 132.6 (d, 3JC,P = 2 Hz, ArC), 
129.5 (s, ArCH), 123.0 (s, ArCH), 122.5 (d, JC,P = 2 Hz, ArC), 116.9 (d, J = 15 Hz, ArC), 
15.0 (s, CH3). 
7.2.16 Synthesis of L2.1 
A solution of 2.5a (4.50 g, 25.2 mmol) in Et2O (10 mL) was added to a 
suspension of SbF3 (9.01 g, 50.4 mmol) in Et2O (10 mL). The reaction 
mixture was stirred at ambient temperature for 20 h. The resultant mixture was 
fractionated by vacuum distillation (0.1 Torr) using cooling baths at -20 °C, -40 °C and -
78 °C. The traps at -20 °C and -40 °C contained clear oils, which upon NMR analysis 
were found to be pure L2.1 (1.45 g, 73%).  
31P{1H} NMR (162 MHz, C6D6): P (ppm) 124.3 
(d, 1JP,F = 1306 Hz). 
19F{1H} NMR (377 MHz, C6D6): F (ppm) -37.2 (d, 1JF,P = 1306 Hz). 
1H NMR (400 Hz, C6D6): H (ppm) 7.21 (dd, JH,H = 6.0, 3.4 Hz, 2H, ArCH), 7.09 (dd, JH,H 
= 6.0, 3.4 Hz, 2H, ArCH). 31P{1H}, 19F{1H} and 1H NMR data agreed with the literature 
data.19 
7.2.17 Synthesis of L2.2 
A solution of 2.5b (1.10 g, 4.90 mmol) in toluene (15 mL) was added to a 
suspension of SbF3 (1.75 g, 9.80 mmol) in toluene (15 mL). The reaction 
mixture was stirred at ambient temperature until completion and then 
passed through a short silica column which was washed with toluene (3 x 10 mL). The 
solvent was removed under reduced pressure to yield the product as a colourless oil (0.560 
g, 55%). 31P{1H} NMR (162 MHz, C6D6): P (ppm) 100.6 (d, 1JP,F = 1241 Hz). 19F{1H} 
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NMR (377 MHz, C6D6): F (ppm) -52.7 (d, 1JF,P = 1241 Hz). 1H NMR (400 MHz, C6D6): 
H (ppm) 7.11 (d, JH,H = 8.4 Hz, 2H, ArCH), 6.91 (t, JH,H = 7.9 Hz, 2H, ArCH), 6.69 (d, 
JH,H = 7.6 Hz, 2H, ArCH). 
13C{1H} NMR (101 MHz, C6D6): C (ppm) 142.6 (s, ArCO), 
134.9 (s, ArC), 127.3 (s, ArCH), 122.9 (s, ArCH), 116.3 (d, 2JC,P = 16 Hz, ArC), 112.2 (s, 
ArCH). HR-MS (EI): m/z calcd. for C10H6FO2P [M]
+ = 208.0089; obs. = 208.0087. 
7.2.18 Synthesis of L2.3 
A solution of 2.5c (2.36 g, 10.0 mmol) in toluene (30 mL) was added to a 
suspension of SbF3 (3.58 g, 20.0 mmol) in toluene (20 mL). The reaction 
mixture was stirred at ambient temperature until completion and then 
passed through a short silica column which was washed with toluene (3 x 
15 mL). The solvent was removed under reduced pressure to yield the product as a white 
solid (1.54 g, 66%). 31P{1H} NMR (162 MHz, C6D6):  P (ppm) 135.8 (d, 1JP,F = 1309 Hz). 
31P{1H} data agreed with the literature data.20 19F{1H} NMR (377 MHz, C6D6): F (ppm) 
-52.4 (d, 1JF,P = 1309 Hz).  
1H NMR (400 MHz, C6D6): H (ppm) 7.39 (dd, JH,H = 7.6, 1.8 
Hz, 2H, ArCH), 7.30 (td, JH,H = 7.7, 1.8 Hz, 2H, ArCH), 7.27-7.22 (m, 2H, ArCH), 7.13 
(dt, JH,H = 7.9, 1.2 Hz, 2H, ArCH). 
13C{1H} NMR (101 MHz, C6D6): C (ppm) 148.5 (m, 
ArCO), 131.2 (d, 3JC,P = 3 Hz, ArC), 130.4 (s, ArCH), 129.6 (s, ArCH), 126.0 (s, ArCH), 
122.3 (s, ArCH). 
7.2.19 Synthesis of L2.4 
A solution of 2.5d (1.75 g, 6.61 mmol) in toluene (25 mL) was added to a 
suspension of SbF3 (2.36 g, 13.2 mmol) in toluene (15 mL). The reaction 
mixture was stirred at ambient temperature until completion and then 
passed through a short silica column which was washed with toluene (3 x 
15 mL). The solvent was removed under reduced pressure to yield the product as a 
colourless oil (1.20 g, 73%). 31P{1H} NMR (162 MHz, C6D6): P (ppm) 107.8 (d, 1JP,F = 
1254 Hz). 19F{1H} NMR (377 MHz, C6D6): F (ppm) -62.2 (d, 1JF,P = 1254 Hz, >96%). 1H 
NMR (400 MHz, C6D6): H (ppm) 6.88 (d, JH,H = 7.3 Hz, 2H, ArCH), 6.77 (m, 6H, ArCH), 
4.02 (d, 2JH,H = 13.6 Hz, 1H, CH2), 3.31 (d, 
2JH,H = 13.7 Hz, 1H, CH2). 
13C{1H} NMR (101 
MHz, C6D6): C (ppm) 148.5 (t, J = 7 Hz, ArCO), 133.7 (d, 3JC,P = 2 Hz, ArC), 130.2 (s, 
ArCH), 128.4 (s, ArCH), 125.7 (s, ArCH), 122.9 (d, JC,P = 2 Hz, ArCH), 34.4 (s, CH2). 
HR-MS (MALDI): m/z calcd. for C13H10FO2P [M+H]
+ = 249.0475; obs. = 249.0481. 
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7.2.20 Synthesis of L2.5 
NEt3 (0.31 mL, 2.2 mmol) was added to a solution of MeOH (90 L, 
2.2 mmol) in toluene (8 mL). This reaction mixture was then added 
dropwise over 10 min to a solution of 2.5b (0.250 g, 1.11 mmol) in 
toluene (10 mL) at -78 °C. After 30 min at -78 °C, the reaction mixture was passed through 
a short silica column and the silica was then washed with toluene (3 x 10 mL). The volatiles 
were removed under reduced pressure to yield the product as a white solid (0.201 g, 82%). 
31P{1H} NMR (162 MHz, C6D6): P (ppm) 113.9 (s). 31P{1H} data agreed with the 
literature data.21 31P NMR (162 MHz, C6D6): P (ppm) 113.9 (q, 3JP,H = 12 Hz). 1H NMR 
(400 MHz, C6D6): H (ppm) 7.13 (d, JH,H = 7.7 Hz, 2H, ArCH), 6.99 (t, JH,H = 8.0 Hz, 2H, 
ArCH), 6.79 (d, JH,H = 7.5 Hz, 2H, ArCH), 3.16 (d, 
3JH,P = 11.5 Hz, 3H, O(CH3)). 
13C{1H} 
NMR (101 MHz, C6D6): C (ppm) 145.2 (d, 2JC,P = 4 Hz, ArCO), 135.5 (d, 3JC,P = 2 Hz, 
ArC), 127.5 (s, ArCH), 122.3 (s, ArCH), 117.3 (m, ArC), 112.1 (s, ArCH), 50.1 (d, 2JC,P = 
13 Hz, 2JH,C = 146.1 Hz, O(CH3)). HR-MS (ESI): m/z calcd. for C11H10O3P [M+H]
+ = 
221.0368; obs. = 221.0360. 
7.2.21 Synthesis of L2.6 
A solution of 2.5e (0.742 g, 2.59 mmol) in toluene (20 mL) was added 
to a suspension of SbF3 (1.85 g, 10.4 mmol) in toluene (10 mL). The 
reaction mixture was stirred at ambient temperature until completion 
and then passed through a short silica column which was washed with 
toluene (3 x 10 mL). The solvent was removed under reduced pressure to yield the 
product as a cloudy white oil (0.559 g, 80%). 
31P{1H} NMR (162 MHz, C6D6): P (ppm) 
123.4 (d, 1JP,F = 1292 Hz, >97%). 
19F{1H} NMR (377 MHz, C6D6): F (ppm) -36.5 (d, 1JF,P 
= 1292 Hz). 1H NMR (400 Hz, C6D6): H (ppm) 7.11 (s, 1H, ArCH), 7.05 (s, 1H, ArCH), 
1.38 (s, 9H, C(CH3)3), 1.17 (s, 9H, C(CH3)3). 
13C{1H} NMR (101 MHz, C6D6): C (ppm) 
147.2 (s, ArC), 144.4 (d, 2JC,P = 7 Hz, ArCO), 139.9 (d, 
2JC,P = 7 Hz, ArCO), 136.0 (s, ArC), 
117.9 (s, ArCH), 109.0 (s, ArCH), 35.0 (s, C(CH3)3), 34.7 (s, C(CH3)3), 31.7 (s, C(CH3)3), 
29.7 (s, C(CH3)3). HR-MS (MALDI): m/z calcd. for C14H20O2P [M-F]
+ = 251.1195; obs. 
= 251.1199. 
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7.2.22 Synthesis of L2.7 
A solution of 2.5f (0.725 g, 2.53 mmol) in toluene (20 mL) was added to a 
suspension of SbF3 (1.81 g, 10.1 mmol) in toluene (10 mL). The reaction 
mixture was stirred at ambient temperature until completion and then 
passed through a short silica column which was washed with toluene (3 x 
10 mL). The solvent was removed under reduced pressure to yield the 
product as a colourless oil (0.512 g, 75%); the product contained 15% 2.6f’. 
31P{1H} NMR 
(162 MHz, C6D6): P (ppm) 119.3 (d, 1JP,F = 1286 Hz, 93%), -24.9 (s, 7%, P(V) hydrolysis). 
19F{1H} NMR (377 MHz, C6D6): F (ppm) -37.0 (d, 1JF,P = 1286 Hz, 97%). 1H NMR (400 
MHz, C6D6): H (ppm) 6.86 (s, 2H, ArCH), 1.35 (s, 18H, C(CH3)3). HR-MS (MALDI): 
m/z calcd. for C14H20O2P [M-F]
+ = 251.1195; obs. = 251.1201. 
7.2.23 Synthesis of L2.8 
A solution of 2.5g (0.420 g, 1.66 mmol) in toluene (10 mL) was added to 
a suspension of SbF3 (0.594 g, 3.33 mmol) in toluene (10 mL). The reaction 
mixture was stirred at ambient temperature until completion and then 
passed through a short silica column which was washed with toluene (3 x 
10 mL). Volatiles were removed under reduced pressure to yield the product as a white 
semi-solid (0.294 g, 75%). Crystals suitable for analysis by single crystal X-ray diffraction 
were grown by slow evaporation of a saturated toluene solution of L2.8. Contained 7% of 
the mono-Me product.  31P{1H} NMR (162 MHz, C6D6): P (ppm) 100.9 (d, 1JP,F = 1235 
Hz), 100.8 (d, 1JP,F = 1237 Hz, 7%, mono-Me product). 
19F{1H} NMR (376 MHz, C6D6): 
F (ppm) -51.8 (d, 1JF,P = 1235 Hz), -52.5 (d, 1JF,P = 1237 Hz, 7%). 1H NMR (400 MHz, 
C6D6): H (ppm) 7.14 (d, JH,H = 8.5 Hz, 2H, ArCH), 6.88 (d, JH,H = 8.4 Hz, 2H, ArCH), 
2.12 (s, 1JH,C = 12.8 Hz, 6H, CH3). 
13C{1H} NMR (101 MHz, C6D6): C (ppm) 139.7 (t, 
2JC,P = 4 Hz, ArCO), 132.6 (d, 
3JC,P = 2 Hz, ArC), 129.6 (s, ArCH), 122.5 (s, ArCH), 121.5 
(s, ArC), 117.0 (s, ArC), 15.1 (s, CH3). HR-MS (MALDI): m/z calcd. for C12H10FO2P 
[M+H]+ = 237.0475; obs. = 237.0469. 
Simulated NMR spectra of the fluorophosphite complexes  
For complexes 2.7, 2.8 and 2.12¸all J values were calculated from |K|, |L|, |M| and 
|N| (determined from Equations 1-4) and the corresponding 31P{1H} NMR spectrum 
(see Figure 7.1 for example of the labelled 31P{1H} NMR spectrum of complex 2.8b). 
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Using these values, the 31P{1H} and 19F{1H} NMR spectra were simulated in Mestrenova. 
The calculated J values are given in the experimental data below.  
|𝐾| =  |𝐽𝐴𝐴′ +  𝐽𝑋𝑋′|    (1) 
|𝐿| =  |𝐽𝐴𝑋 − 𝐽𝐴𝑋′|       (2) 
|𝑀| =  |𝐽𝐴𝐴′ −  𝐽𝑋𝑋′|     (3) 
|𝑁| =  |𝐽𝐴𝑋 +  𝐽𝐴𝑋′|       (4)  
 
 
Figure 7.1 Labelled 31P{1H} NMR spectrum of [PtCl2(L2.2)2] (2.8b).  
General procedure for the synthesis of cis-[Mo(CO)4L2] complexes (2.7a-h) 
To a solution of [Mo(CO)4(nbd)] (0.0200 g, 0.0670 mmol) in CH2Cl2 (0.5 mL) was added 
a solution of the ligand (0.133 mmol) in CH2Cl2 (0.5 mL) and stirred for 4 h.  
7.2.24 Synthesis of cis-[Mo(CO)4(L2.1)2] (2.7a) 
Upon completion of the reaction, the volatiles were removed under 
reduced pressure and the crude product was dissolved in toluene (2 
mL). The volatiles were then removed under reduced pressure to 
yield the product as a pale-yellow solid (0.0300 g, 86%). Crystals 
suitable for analysis by single crystal X-ray diffraction were grown by 
storing a saturated hexane solution of 2.7a at -20 °C for 48 h. 31P{1H} NMR (162 MHz, 
CD2Cl2): P (ppm) 170.2 (app. dt, N = 1270 Hz, 1JP,F = 1271 Hz, 2JP,P’ = 51 Hz, 4JF,F’ = 0 
Hz, 3JP,F’ = -1 Hz). 
19F{1H} NMR (377 MHz, CD2Cl2): F (ppm) -0.9 (app. dt, N = 1270 
Hz, 1JF,P = 1271 Hz, 
2JP,P’ = 51 Hz, 
4JF,F’ = 0 Hz, 
3JF’,P = -1 Hz). 
1H NMR (400 MHz, 
CD2Cl2): H (ppm) 7.17 (m, 2H, ArCH), 7.12 (m, 2H, ArCH). 13C{1H} NMR (101 MHz, 
CD2Cl2): C (ppm) 205.9 (m, Mo-CO), 202.9 (t, 2JC,P = 14 Hz, Mo-CO), 145.4 (d, 2JC,P = 6 
 / ppm 
|K| |M| 
|N| 
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Hz, ArCO), 124.6 (s, ArCH), 113.3 (m, ArCH). HR-MS (ESI): m/z calcd. for 
C16H8FMoO8P2 [M-F]
+ = 506.8731; obs. = 506.8749. IR (CH2Cl2): (CO) = 2072 cm
-1. 
7.2.25 Synthesis of cis-[Mo(CO)4(L2.2)2] (2.7b) 
Upon completion of the reaction, the volatiles were removed under 
reduced pressure. The product was precipitated with hexane (2 mL). 
The solid was allowed to settle, and supernatant was removed; 
residual solvent was then removed from the solid under reduced 
pressure to yield the product as a pale-yellow solid (0.0270 g, 65%). 
Crystals suitable for analysis by single crystal X-ray diffraction were 
grown by slow diffusion of hexane into a saturated CH2Cl2 solution of 2.7b. 
31P{1H} 
NMR (162 MHz, CD2Cl2): P (ppm) 144.3 (app. dt, N = 1194 Hz, 1JP,F = 1199 Hz, 2JP,P’ = 
51 Hz, 4JF,F’ = 0 Hz, 
3JP,F’ = -5 Hz). 
19F{1H} NMR (377 MHz, CD2Cl2): F (ppm) -23.2 
(app. dt, N = 1194 Hz, 1JF,P = 1199 Hz, 
2JP,P’ = 51 Hz, 
4JF,F’ = 0 Hz, 
3JF’,P = -5 Hz). 
1H 
NMR (400 MHz, CD2Cl2): H (ppm) 7.62 (d, JH,H = 8.4 Hz, 2H, ArCH), 7.45 (m, 2H, 
ArCH), 7.06 (d, JH,H = 7.6 Hz, 2H, ArCH). 
13C{1H} NMR (101 MHz, CD2Cl2): C (ppm) 
207.5 (m, Mo-CO), 204.0 (t, 2JC,P = 15 Hz, Mo-CO), 144.8 (m, ArC), 135.5 (s, ArC), 128.1 
(s, ArCH), 123.9 (s, ArCH), 115.7 (d, 2JC,P = 16 Hz, ArCO), 112.8 (s, ArCH). HR-MS 
(ESI): m/z calcd. for C24H12F2MoO8P2 [M]
+ = 625.9030; obs. = 625.9006. IR (CH2Cl2): 
(CO) = 2066 cm-1. 
7.2.26 Synthesis of cis-[Mo(CO)4(L2.3)2] (2.7c) 
Upon completion of the reaction, the volatiles were removed under 
reduced pressure. Hexane (5 mL) was added, and the mixture was 
kept at -20 °C for 20 h. Once the product had precipitated, the solid 
was allowed to settle, and the supernatant was removed; residual 
solvent was then removed under reduced pressure from the solid 
to yield the product as a pale-yellow solid (0.0320 g, 71%). Crystals 
suitable for analysis by single crystal X-ray diffraction were grown by slow diffusion of 
hexane into a saturated CH2Cl2 solution of 2.7c.
 31P{1H} NMR (162 MHz, CD2Cl2): P 
(ppm) 174.0 (app. dt, N = 1225 Hz, 1JP,F = 1227 Hz, 
2JP,P’ = 49 Hz, 
4JF,F’ = 0 Hz, 
3JP,F’ = -
2 Hz). 19F{1H} NMR (377 MHz, CD2Cl2): F (ppm) -21.4 (app. dt, N = 1225 Hz, 1JF,P = 
1227 Hz, 2JP,P’ = 49 Hz, 
4JF,F’ = 0 Hz, 
3JF’,P = -2 Hz). 
1H NMR (400 MHz, CD2Cl2): H 
(ppm) 7.54 (d, JH,H = 7.6 Hz, 2H, ArCH), 7.41 (m, 4H, ArCH), 7.26 (d, JH,H = 7.9 Hz, 2H, 
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ArCH). 13C{1H} NMR (101 MHz, CD2Cl2): C (ppm) 208.4 (m, Mo-CO), 204.9 (t, 2JC,P = 
14 Hz, Mo-CO), 148.7 (m, ArCO), 130.9 (s, ArCH), 130.4 (s, ArCH), 130.0 (s, ArC), 127.0 
(s, ArCH), 122.5 (s, ArCH). HR-MS (ESI): m/z calcd. for C28H16F2MoNaO8P2 [M+Na]
+ 
= 700.9241; obs. = 700.9240. IR (CH2Cl2): (CO) = 2059 cm
-1. 
7.2.27 Synthesis of cis-[Mo(CO)4(L2.4)2] (2.7d) 
Upon completion of the reaction, the volatiles were removed 
under reduced pressure. The product was precipitated with hexane 
(2 mL). The solid was allowed to settle, and the supernatant was 
removed; residual solvent was then removed from the solid under 
reduced pressure to yield the product as a pale-yellow solid (0.0270 
g, 48%). Crystals suitable for analysis by single crystal X-ray 
diffraction were grown by slow diffusion of hexane into a 
saturated CH2Cl2 solution of 2.7d. 
31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 148.2 
(app. dt, N = 1188 Hz, 1JP,F = 1189 Hz, 
2JP,P’ = 49 Hz, 
4JF,F’ = 0 Hz, 
3JP,F’ = -2 Hz). 
19F{1H} 
NMR (377 MHz, CD2Cl2): F (ppm) -29.3 (app. dt, N = 1188 Hz, 1JF,P = 1189 Hz, 2JP,P’ = 
49 Hz, 4JF,F’ = 0 Hz, 
3JF’,P = -2 Hz). 
1H NMR (400 MHz, CD2Cl2): H (ppm) 7.37 (d, JH,H = 
7.3 Hz, 2H, ArCH), 7.22 (m, 4H, ArCH), 7.11 (d, JH,H = 7.9 Hz, 2H, ArCH), 4.46 (d, 
2JH,H 
= 14.4 Hz, 1H, CH2), 3.70 (d, 
2JH,H = 14.5 Hz, 1H, CH2). 
13C{1H} NMR (101 MHz, 
CD2Cl2): C (ppm) 208.3 (m, Mo-CO), 204.8 (m, Mo-CO), 149.4 (m, ArCO), 132.4 (d, 3JC,P 
= 3 Hz, ArC), 131.2 (s, ArCH), 129.1 (s, ArCH), 126.9 (s, ArCH), 122.9 (d, JC,P = 3 Hz, 
ArCH), 35.0 (s, CH2). HR-MS (ESI): m/z calcd. for C30H20F2MoNaO8P2 [M+Na]
+ = 
728.9555; obs. = 728.9550. IR (CH2Cl2): (CO) = 2058 cm
-1. 
7.2.28 Synthesis of cis-[Mo(CO)4(L2.5)2] (2.7e) 
Upon completion of the reaction, the volatiles were removed under 
reduced pressure. The product was precipitated with hexane (2 
mL). The solid was allowed to settle, and the supernatant was 
removed; residual solvent was then removed from the solid under 
reduced pressure to yield the product as a white solid (0.0290 g, 
67%). Crystals suitable for analysis by single crystal X-ray 
diffraction were grown by storing a saturated pentane solution of 2.7e. 31P{1H} NMR 
(162 MHz, CD2Cl2): P (ppm) 151.1 (s). 31P NMR (162 MHz, CD2Cl2): P (ppm) 151.1 (m). 
1H NMR (400 MHz, CD2Cl2): H (ppm) 7.55 (d, JH,H = 8.3 Hz, 2H, ArCH), 7.39 (t, JH,H = 
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8.0 Hz, 2H, ArCH), 6.92 (d, JH,H = 7.5 Hz, 2H, ArCH), 3.68 (m, 3H, O(CH3)). 
13C{1H} 
NMR (101 MHz, CD2Cl2): C (ppm) 210.2 (m, Mo-CO), 206.1 (t, 2JC,P = 14 Hz, Mo-CO), 
146.0 (s, ArC), 135.5 (s, ArC), 128.0 (s, ArCH), 123.1 (s, ArCH), 116.0 (s, ArC), 112.5 (s, 
ArCH), 52.7 (s, O(CH3)). HR-MS (ESI): m/z calcd. for C24H19MoO8P2 [M-2(CO)+H]
+ = 
594.9615; obs. = 594.9614. IR (CH2Cl2): (CO) = 2051 cm
-1. 
7.2.29 Synthesis of cis-[Mo(CO)4(L2.6)2] (2.7f) 
Upon completion of the reaction, the volatiles were removed 
under reduced pressure and the crude product was dissolved in 
toluene (2 mL). The volatiles were then removed under reduced 
pressure (8 x10-6 Torr) to yield the product as an off-white solid. 
31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 168.0 (vir. dq, N = 
1266 Hz, ≈90%), 22.5 (s, 3%, hydrolysis), -21.7 (s, 3%, P(V) 
hydrolysis), -22.3 (s, 5%, P(V) hydrolysis). 19F{1H} NMR (377 MHz, CD2Cl2): F (ppm) -
1.8 (rac/meso, app. dt, N = 1267 Hz, 1JF,P = 1267 Hz, 
2JP,P’ = 51 Hz, 
4JF,F’ = 0 Hz, 
3JF’,P = -
0.4 Hz), -2.2 (rac/ meso, app. dt, N = 1263 Hz, 1JF,P = 1263 Hz, 
2JP,P’ = 51 Hz, 
4JF,F’ = 0 Hz, 
3JF’,P = -0.4 Hz). 
1H NMR (400 MHz, CD2Cl2): H (ppm) 7.11 (m, 1H, ArCH, rac/meso), 
7.07 (t, JH,H = 1.7 Hz, 1H, ArCH, rac/meso), 7.06 (t, JH,H = 1.7 Hz, 1H, ArCH, rac/meso), 
7.03 (d, JH,H = 1.7 Hz, 1H, ArCH, rac/meso), 1.37 (br. s, 9H, C(CH3)3, rac/meso), 1.32 (br. 
s, 9H, C(CH3)3, rac/meso), 1.31 (m, 18H, C(CH3)3, rac and meso). 
13C{1H} NMR (101 MHz, 
CD2Cl2): C (ppm) 203.2 (m, Mo-CO rac and meso), 147.8 (d, 2JC,P = 8 Hz, ArCO rac and 
meso), 145.4 (d, J = 4 Hz, ArC rac and meso), 141.1 (d, 2JC,P = 6 Hz, ArCO rac and meso), 
136.0 (m, ArC rac and meso), 118.7 (s, ArCH rac/meso) 118.6 (s, ArCH, rac/meso), 108.4 (m, 
ArCH rac and meso), 35.5 (s, C(CH3)3, rac and meso), 35.0 (d, J = 3 Hz, C(CH3)3, rac and 
meso), 31.9 (d, J = 2 Hz C(CH3)3, rac and meso), 29.8 (s, C(CH3)3, rac/meso), 29.7 (s, C(CH3)3, 
rac/meso). HR-MS (ESI): m/z calcd. for C32H40F2MoO8P2 [M]
+ = 750.1223; obs. = 
750.1232. IR (CH2Cl2): (CO) = 2069 cm
-1. 
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7.2.30 Synthesis of cis-[Mo(CO)4(L2.7)2] (2.7g) 
Upon completion of the reaction, the volatiles were removed 
under reduced pressure and the crude product was dissolved in 
toluene (2 mL). The volatiles were then removed under reduced 
pressure (8 x10-6 Torr) to yield the product as a light brown semi-
solid. Contained 15% 2.6f’ and 10% [Mo(CO)4(nbd)]. 
31P{1H} 
NMR (162 MHz, CD2Cl2): P (ppm) 165.9 (app. dt, N = 1262 Hz, 
1JP,F = 1263 Hz, 
2JP,P’ = 51 Hz, 
4JF,F’ = 0 Hz, 
3JP,F’ = -0.4 Hz, ≈90%), -25.1 (s, 10%, P(V) 
hydrolysis). 19F{1H} NMR (377 MHz, CD2Cl2): F (ppm) -1.9 (app. dt, N = 1263 Hz, 1JF,P 
= 1263 Hz, 2JP,P’ = 51 Hz, 
4JF,F’ = 0 Hz, 
3JF’,P = -0.4 Hz, 96%). 
1H NMR (400 MHz, CD2Cl2): 
H (ppm) 7.01 (s, 2H, ArCH), 1.38 (br. s, 18H, C(CH3)3). 13C{1H} NMR (101 MHz, 
CD2Cl2): C (ppm) 203.3 (t, 2JC,P = 15 Hz, Mo-CO), 143.6 (d, 2JC,P = 7 Hz, ArCO), 134.6 
(d, J = 5 Hz, ArC), 121.3 (s, ArCH), 31.5 (s, C(CH3)3), 29.8 (s, C(CH3)3). NMR spectra 
contain signals for 2.6f’. HR-MS (ESI): m/z calcd. for C32H40FMoO8P2 [M-F]
+ = 
731.1237; obs. = 731.1.  IR (CH2Cl2): (CO) = 2068 cm
-1. 
7.2.31 Synthesis of cis-[Mo(CO)4(L2.8)2] (2.7h) 
Upon completion of the reaction, the volatiles were removed under 
reduced pressure. The product was precipitated with hexane (2 mL). 
The solid was allowed to settle, and the supernatant was removed; 
residual solvent was then removed from the solid under reduced 
pressure to yield the product as a white solid (0.0328 g, 72%). 
Crystals suitable for analysis by single crystal X-ray diffraction were 
grown by slow diffusion of hexane into a saturated CH2Cl2 solution of 2.7h. 
31P{1H} 
NMR (162 MHz, CD2Cl2): P (ppm) 144.1 (app. dt, N = 1197 Hz, 1JP,F = 1200 Hz, 2JP,P’ = 
53 Hz, 4JF,F’ = 0 Hz, 
3JP,F’ = -1 Hz). 
19F{1H} NMR (377 MHz, CD2Cl2): F (ppm) -23.1 
(app. dt, N = 1199 Hz, 1JF,P = 1200 Hz, 
2JP,P’ = 53 Hz, 
4JF,F’ = 0 Hz, 
3JF’,P = -1 Hz). 
1H 
NMR (400 MHz, CD2Cl2): H (ppm) 7.46 (d, JH,H = 8.4 Hz, 2H, ArCH), 7.25 (d, JH,H = 8.4 
Hz, 2H, ArCH), 2.32 (s, 6H, CH3). 
13C{1H} NMR (101 MHz, CD2Cl2): C (ppm) 204.4 
(m, Mo-CO), 141.5 (s, ArC), 132.7 (s, ArC), 130.0 (s, ArCH), 123.2 (s, ArCH), 122.2 (s, 
ArC), 115.6 (s, ArC), 15.1 (s, CH3). HR-MS (MALDI): m/z calcd. for C28H20F2MoNaO8P2 
[M+Na]+ = 704.9554; obs. = 704.9548. IR (CH2Cl2): (CO) = 2064 cm
-1. 
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General procedure for the synthesis of cis-[PtCl2L2] complexes 2.8b-e 
To a solution of [PtCl2(cod)] (0.0200 g, 0.0535 mmol) in CH2Cl2 (0.5 mL) was added a 
solution of the ligand (0.112 mmol) in CH2Cl2 (0.5 mL) and stirred for 4 h. Upon 
completion of the reaction, the volatiles were removed under reduced pressure. The 
product was precipitated with hexane (2 mL). The solid was allowed to settle and the 
supernatant removed; the remaining residue was then washed with hexane (3 x 1 mL). 
Residual solvent was then removed from the solid under reduced pressure to yield the 
product. 
7.2.32 Synthesis of cis-[PtCl2(L2.2)2] (2.8b) 
White solid (0.0220 g, 61%). 31P{1H} NMR (162 MHz, 
CD2Cl2): P (ppm) 63.6 (AA’XX’, N = 1243 Hz, 1JP,Pt = 6172 
Hz, 1JP,F = 1248 Hz, 
2JP,P’ = 25 Hz, 
4JF,F’ = 5 Hz, 
3JP,F’ = -5 Hz). 
19F{1H} NMR (377 MHz, CD2Cl2): F (ppm) -39.6 (AA’XX’, N 
= 1242 Hz, 2JF,Pt = 632 Hz, 
1JF,P = 1248 Hz, 
2JP,P’ = 25 Hz, 
4JF,F’ = 5 Hz, 
3JF’,P = -5 Hz). 
1H 
NMR (400 MHz, CD2Cl2): H (ppm) 7.74 (d, JH,H = 8.4 Hz, 2H, ArCH), 7.51 (t, JH,H = 8.1 
Hz, 2H, ArCH), 7.13 (d, JH,H = 7.7 Hz, 2H, ArCH). 
13C{1H} NMR (101 MHz, CD2Cl2): 
C (ppm) 143.8 (m, ArCO), 135.6 (s, ArC), 128.4 (s, ArCH), 125.4 (s, ArCH), 114.4 (d, JC,P 
= 14 Hz, ArC), 113.7 (m, ArCH). HR-MS (ESI): m/z calcd. for C20H12F2O4P2ClPt [M-
Cl]+ = 646.9505; obs. = 646.9492. 
7.2.33 Synthesis of cis-[PtCl2(L2.3)2] (2.8c) 
White solid. Crystals suitable for analysis by single crystal X-
ray diffraction were grown by slow diffusion of hexane into 
a saturated CH2Cl2 solution of 2.8c. 
31P{1H} NMR (162 
MHz, CD2Cl2): P (ppm) 80.8 (AA’XX’, N = 1226 Hz, 1JP,Pt 
= 6056 Hz, 1JP,F = 1229 Hz, 
2JP,P’ = 22 Hz, 
4JF,F’ = 2 Hz, 
3JP,F’ 
= -3 Hz). 19F{1H} NMR (377 MHz, CD2Cl2): F (ppm) -44.6 (AA’XX’, N = 1227 Hz, 1JF,Pt 
= 649 Hz, 1JF,P = 1229 Hz, 
2JP,P’ = 22 Hz, 
4JF,F’ = 2 Hz, 
3JF’,P = -3 Hz). 
1H NMR (400 MHz, 
CD2Cl2): H (ppm) 7.50 (dd, JH,H = 6.8, 2.6 Hz, 2H, ArCH), 7.43 (m, 4H, ArCH), 7.64 (d, 
JH,H = 7.5 Hz, 2H, ArCH). 
13C{1H} NMR (101 MHz, CD2Cl2): C (ppm) 147.5 (d, 2JC,P = 
148 Hz, ArCO), 131.1 (s, 2 x ArCH), 128.8 (s, ArC), 128.2 (s, ArCH), 122.3 (s, ArCH). 
HR-MS (ESI): m/z calcd. for C24H16Cl2F2NaO4P2Pt [M-Na]
+ = 755.9412; obs. = 
755.9439. 
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7.2.34 Synthesis of cis-[PtCl2(L2.4)2] (2.8d) 
White solid (0.0340 g, 83%). 31P{1H} NMR (162 MHz, 
CD2Cl2): P (ppm) 58.2 (AA’XX’, N = 1200 Hz, 1JP,Pt = 6209 
Hz, 1JP,F = 1204 Hz, 
2JP,P’ = 24 Hz, 
4JF,F’ = 2 Hz, 
3JP,F’ = -4 
Hz). 19F{1H} NMR (377 MHz, CD2Cl2): F (ppm) -52.1 
(AA’XX’, N = 1197 Hz, 2JF,Pt = 574 Hz, 
1JF,P = 1204 Hz, 
2JP,P’ = 24 Hz, 
4JF,F’ = 2 Hz, 
3JF’,P = -4 Hz). 
1H NMR (400 MHz, CD2Cl2): H (ppm) 7.40 
(d, JH,H = 6.9 Hz, 2H, ArCH), 7.25 (m, 6H, ArCH), 4.52 (d, 
2JH,H = 14.3 Hz, 1H, CH2), 
3.71 (d, 2JH,H = 14.7 Hz, 1H, CH2). 
13C{1H} NMR (101 MHz, CD2Cl2): C (ppm) 148.6 (d, 
2JC,P = 13 Hz, ArCO), 132.0 (s, ArC), 131.4 (s, ArCH), 129.7 (s, ArCH), 129.1 (s, ArCH), 
122.4 (s, ArCH), 34.1 (s, CH2). HR-MS (ESI): m/z calcd. for C26H16Cl2FO4P2Pt [M-F-
2H2]
+ = 737.9533; obs. = 738.0. 
7.2.35 Synthesis of cis-[PtCl2(L2.5)2] (2.8e) 
White solid (0.0260 g, 69%). Crystals suitable for analysis by 
single crystal X-ray diffraction were grown by slow diffusion of 
pentane into a saturated CH2Cl2 solution of 2.8e. 
31P{1H} 
NMR (162 MHz, CD2Cl2): P (ppm) 62.7 (s, 1JP,Pt = 5869 Hz). 
31P NMR (162 MHz, CD2Cl2): P (ppm) 62.7 (m, 1JP,Pt = 5869 Hz). 1H NMR (400 MHz, 
CD2Cl2): H (ppm) 7.66 (d, JH,H = 8.4 Hz, 2H, ArCH), 7.43 (t, JH,H = 8.0 Hz, 2H, ArCH), 
6.95 (d, JH,H = 7.7 Hz, 2H, ArCH), 3.99 (m, 3H, O(CH3)). 
13C{1H} NMR (101 MHz, 
CD2Cl2): C (ppm) 144.9 (vir. t, 2JC,P = 4Hz, ArCO), 135.6 (s, ArC), 128.2 (s, ArCH), 124.4 
(s, ArCH), 114.9 (vir. t, J = 7 Hz, ArC), 113.3 (vir. t, J = 3 Hz, ArCH), 56.3 (vir. t, 3JC,P = 
2 Hz, O(CH3)). HR-MS (ESI): m/z calcd. for C22H18Cl2NaO6P2Pt [M+Na]
+ = 727.9498; 
obs. = 727.9496. 
General procedure for the synthesis of cis-[PtCl2L2] complexes 2.8f-g 
To a solution of [PtCl2(cod)] (0.0150 g, 0.0400 mmol) in CH2Cl2 (0.5 mL) was added a 
solution of the ligand (0.0220 g, 0.112 mmol) in CH2Cl2 (0.5 mL) and stirred for 4 h. Upon 
completion of the reaction, the volatiles were removed under reduced pressure and the 
crude product was dissolved in toluene (2 mL). The volatiles were then removed under 
reduced pressure (8 x10-6 Torr) to yield the product. 
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7.2.36 Synthesis of cis-[PtCl2(L2.6)2] (2.8f) 
Off-white solid (0.0120 g, 37%). 31P{1H} NMR (162 MHz, 
CD2Cl2): P (ppm) 89.9 (AA’XX’, N = 1306 Hz, 1JP,Pt = 6032 
Hz, rac/meso), 89.0 (AA’XX’, N = 1310 Hz, 1JP,Pt = 6038 Hz, 
rac/meso). 19F{1H} NMR (377 MHz, CD2Cl2): F (ppm) -21.3 
(AA’XX’). 
7.2.37 Synthesis of cis-[PtCl2(L2.7)2] (2.8g) 
White solid. Contaminated with ca. 10% 2.6f’. 31P{1H} 
NMR (162 MHz, C6D6): P (ppm) 90.0 (AA’XX’, N = 1296 
Hz, 1JP,Pt = 5947 Hz, 
1JP,F = 1296 Hz), -24.5 (s, 5%, 
hydrolysis P(V)). 19F{1H} NMR (377 MHz, C6D6): F (ppm) 
-18.3 (AA’XX’, N = 1296 Hz, 2JF,Pt = 777 Hz). 
1H NMR (400 MHz, C6D6): H (ppm) 6.77 
(s, 2H, ArCH), 1.25 (s, 18H, C(CH3)3), contains signals for 10% 2.6f’. 
7.2.38 Synthesis of cis-[PtCl2(L2.8)2] (2.8h) 
To a solution of [PtCl2(cod)] (0.0200 g, 0.0535 mmol) in CH2Cl2 
(0.5 mL) was added a solution of L2.8 (0.0260 g, 0.112 mmol) in 
CH2Cl2 (0.5 mL) and stirred for 4 h. Upon completion of the 
reaction, the volatiles were removed under reduced pressure. 
The product was precipitated with hexane (2 mL). The solid 
was allowed to settle and the supernatant removed; the remaining residue was then 
washed with hexane (3 x 1 mL). Residual solvent was then removed from the solid under 
reduced pressure to yield the product as a pale red solid. 31P{1H} NMR (162 MHz, 
CD2Cl2): P (ppm) 63.8 (AA’XX’, N = 1238 Hz, 1JP,Pt = 6159 Hz, 1JP,F = 1242 Hz, 2JP,P’ = 
28 Hz, 4JF,F’ = 3 Hz, 
3JP,F’ = -5 Hz, >93%), 54.9 (br. s). 
19F{1H} NMR (377 MHz, CD2Cl2): 
F (ppm) -39.5 (AA’XX’, N = 1237 Hz, 2JF,Pt = 633 Hz, 1JF,P = 1242 Hz, 2JP,P’ = 28 Hz, 
4JF,F’ = 3Hz, 
3JF’,P = -5 Hz). 
1H NMR (400 MHz, CD2Cl2): H (ppm) 7.57 (d, JH,H = 8.5 Hz, 
2H, ArCH), 7.29 (d, JH,H = 8.4 Hz, 2H, ArCH), 2.30 (s, 6H, CH3), contained signals for 
10% [PtCl2(cod)]. 
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7.2.39 Synthesis of cis-[PtMe2(L2.1)2] (2.9a) 
To a solution of [PtMe2(cod)] (0.0200 g, 0.0600 mmol) in d8-toluene 
(0.5 mL) was added a solution of L2.1 (0.0190 g, 0.120 mmol) in d8-
toluene (0.5 mL). Due to the high hydrolytic sensitivity of product, 
the by-product cod was not removed. 31P{1H} NMR (162 MHz, d8-
toluene): P (ppm) 143.4 (AA’XX’, N = 1341 Hz, 1JP,Pt = 3070 Hz, 1JP,F = 1347 Hz, 2JP,P’ = 
19 Hz, 4JF,F’ = 2 Hz, 
3JP,F’ = -6 Hz, 96%). 
19F{1H} NMR (377 MHz, d8-toluene): F (ppm) 
-27.9 (AA’XX’, N = 1341 Hz, 2JF,Pt = 344 Hz, 
1JF,P = 1347 Hz, 
2JP,P’ = 19 Hz, 
4JF,F’ = 2 Hz, 
3JF’,P = -6 Hz >92%). HR-MS (EI): m/z calcd. for C14H14F2O4P2Pt [M-H]
- = 540.9990; 
obs. = 540.9973. 
General procedure for the synthesis of [PtL4] complexes (2.10a,c-d) 
To a solution of [Pt(nbe)3] (0.0200 g, 0.0419 mmol) in THF (0.5 mL) was added a solution 
of the ligand (0.168 mmol) in THF (0.5 mL). Upon completion of the reaction, the 
volatiles were removed under reduced pressure. The product was precipitated with hexane 
(2 mL). The solid was allowed to settle, and the supernatant was removed and remaining 
solid washed with hexane (3 x 1 mL). Residual solvent was then removed from the solid 
under reduced pressure to yield the product.  
7.2.40 Synthesis of [Pt(L2.1)4] (2.10a) 
White solid (0.0290 g, 84%). 31P{1H} NMR (162 MHz, d8-
THF): P (ppm) 118.0 (>99%, AA’3XX’3, N = 1256 Hz, 1JP,Pt 
= 6102 Hz). 19F{1H} NMR (377 MHz, d8-THF): F (ppm) -
7.2 (AA’3XX’3). 
31P{1H} and 19F{1H} NMR data agreed with 
the literature data.22 
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7.2.41 Synthesis of [Pt(L2.3)4] (2.10c) 
Off-white solid (0.0420 g, 88%). 31P{1H} NMR (162 
MHz, d8-THF): P (ppm) 127.1 (AA’3XX’3, N = 1181 Hz, 
1JP,Pt = 6000 Hz). 
19F{1H} NMR (377 MHz, d8-THF): F 
(ppm) -23.9 (AA’3XX’3). 195Pt{1H} NMR (65 MHz, d8-
THF): Pt (ppm) -5638 (qq, 1JPt,P = 5999 Hz, 2JPt,F = 399 
Hz). 1H NMR (400 MHz, d8-THF): H (ppm) 7.47 (dd, 
JH,H = 7.1, 2.3 Hz, 2H, ArCH), 7.24 (tt, JH,H = 7.4, 5.4 Hz, 
4H, ArCH), 7.06 (m, 2H, ArCH). 13C{1H} NMR (101 MHz, d8-THF): C (ppm) 149.9 (s, 
ArCO), 131.5 (s, ArC), 130.7 (s, ArCH), 130.3 (s, ArCH), 126.7 (s, ArCH), 123.4 (s, 
ArCH). HR-MS (ESI): m/z calcd. for C48H32F4NaO8P4Pt [M+Na]
+ = 1154.0528; obs. = 
1154.0539. 
7.2.42 Synthesis of [Pt(L2.4)4] (2.10d) 
Off-white solid (0.0380 g, 85%). 31P{1H} NMR (162 
MHz, d8-THF): P (ppm) 155.6 (AA’XX’, 2.12d), 105.7 
(AA’3XX’3, N = 1132 Hz, 
1JP,Pt = 5981 Hz, 2.10d, 
>93%). 19F{1H} NMR (377 MHz, d8-THF): F (ppm) -
27.8 (AA’3XX’3, 2.10d, >93%) -43.9 (AA’XX’, 2.12d). 
195Pt{1H} NMR (65 MHz, d8-THF): Pt (ppm) -5282 (tt, 
1JPt,P = 6107 Hz, 
2JPt,F = 454 Hz, 2.12d), -5640 (qq, 
1JPt,P 
= 5983 Hz, 2JPt,F = 354, 2.10d). 
1H NMR (400 MHz, d8-THF): H (ppm) 7.29 (d, JH,H = 7.3 
Hz, 2H, ArCH), 7.15 (t, JH,H = 7.3 Hz, 2H, ArCH), 7.05 (t, JH,H = 7.3 Hz, 2H, ArCH), 6.91 
(d, JH,H = 7.9 Hz, 2H, ArCH), 4.27 (d, 
2JH,H = 14.2 Hz, 1H, CH2), 3.63 (d, 
2JH,H = 13.9 Hz, 
1H, CH2). 
13C{1H} NMR (101 MHz, d8-THF): C (ppm) 150.5 (s, ArCO), 133.4 (s, ArC), 
131.3 (s, ArCH), 128.8 (s, ArCH), 126.3 (s, ArCH), 123.8 (s, ArCH), 35.7 (s, CH2). HR-
MS (ESI): m/z calcd. for C52H40F4NaO8P4Pt [M+Na]
+ = 1210.1154; obs. = 1210.1160. 
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7.2.43 Synthesis of [Pt(L2.2)4] (2.10b) 
A chlorobenzene solution (1.5 mL) of [Pt(nbe)3] (0.0150 g, 
0.0314 mmol) was layered with a chlorobenzene solution 
(1.5 mL) of L2.2 (0.0226 g, 0.126 mmol). The mixture was 
left to stand and within 24 h crystals of 2.10b suitable for 
X-ray crystallography were obtained. The product was 
insoluble in all common organic solvents.  
 
7.2.44 Synthesis of [Pt(L2.5)4] (2.10e) 
To a solution of [Pt(nbe)3] (0.0200 g, 0.0419 mmol) in 
THF (0.5 mL) was added a solution of L2.5 (0.0369 g, 0.168 
mmol) in THF (0.5 mL). Upon completion of the reaction, 
the volatiles were removed under reduced pressure and the 
crude product was dissolved in toluene (1 mL). The 
volatiles were then removed under reduced pressure to 
yield the product as a white solid (0.0430 g, 96%). Crystals 
suitable for analysis by single crystal X-ray diffraction were grown by slow diffusion of 
hexane into a saturated THF solution of 2.10e. 31P{1H} NMR (162 MHz, d8-THF): P 
(ppm) 110.1 (s, 1JP,Pt = 5745 Hz). 
31P NMR (162 MHz, d8-THF): P (ppm) 110.1 (m, 1JP,Pt 
= 5745 Hz). 195Pt{1H} NMR (65 MHz, d8-THF): Pt (ppm) -5678.5 (q, 1JPt,P = 5746 Hz).  
1H NMR (400 MHz, d8-THF): H (ppm) 7.48 (d, JH,H = 8.3 Hz, 2H, ArCH), 7.35 (t, JH,H = 
7.9 Hz, 2H, ArCH), 6.93 (d, JH,H = 7.5 Hz, 2H, ArCH), 3.65 (m, 3H, O(CH3)). 
13C{1H} 
NMR (101 MHz, d8-THF): C (ppm) 147.6 (s, ArCO), 136.2 (s, ArC), 128.1 (s, ArCH), 
122.6 (s, ArCH), 177.4 (s, ArC), 112.6 (s, ArCH), 52.9 (s, O(CH3)). HR-MS (ESI): m/z 
calcd. for C44H36NaO12P4Pt [M+Na]
+ = 1098.0701; obs. = 1098.0690. 
7.2.45 Reaction between Ethanox 398TM (2.4) and [Pt(nbe)3] in a 4:1 stoichiometry 
To a solution of [Pt(nbe)3] (0.0100 g, 0.0209 mmol) in THF (0.5 
mL) was added a solution of 2.4 (0.0369 g, 0.168 mmol) in THF 
(0.5 mL). Upon completion of the reaction, a mixture of products 
was observed by in situ 31P{1H}, 19F{1H} and 195Pt{1H} NMR spectroscopy. 31P{1H} 
NMR (162 MHz, THF): P (ppm) 163.5 (AA’2XX’2, N = 1137 Hz, 1JP,Pt = 7600 Hz, 2.11f), 
146.0 (AA’XX’, N = 1246 Hz, 2.12f), 132.3 (d, 1JP,F = 1254 Hz, 2.4), 107.1 (br. d, 
1JP,F = 
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1238 Hz, 2.4). 19F{1H} NMR (377 MHz, THF): F (ppm) -21.7 (br. AA’XX’, N = 1286 
Hz, 1%, 2.12f), -33.4 (AA’XX’, N = 1247 Hz, 9%, 2.12f), -41.6 (AA’2XX’2, N = 1138 Hz, 
59%, 2.11f), -49.4 (AA’XX, N = 1161 Hz, 1%, 2.12f), -62.3 (d, 1JF,P = 1248 Hz, 23%, 2.4), 
-74.2 (d, 1JF,P = 1255 Hz, 7%, 2.4). 
195Pt{1H} NMR (65 MHz, THF): Pt (ppm) -5085.5 
(qq, 1JPt,P = 7607 Hz, 
2JPt,F = 591 Hz, 2.11f), 5317.8 (tt, 
1JPt,P = 6088 Hz, 
2JPt,F = 537 Hz, 
2.12f). 
General procedure for the NMR study of the reaction between ligand and 
[Pt(nbe)3] in a 2:1 stoichiometry  
To a solution of [Pt(nbe)3] (0.0200 g, 0.0419 mmol) in THF (0.5 mL) was added a solution 
of the ligand (0.0838 mmol) in THF (0.5 mL). The reaction mixture was analysed by in 
situ 31P{1H}, 19F{1H} and 195Pt{1H} NMR spectroscopy. 
7.2.46 Reaction with L2.1 
31P{1H} NMR (162 MHz, d8-THF): P (ppm) 167.2 (br. 
AA’XX’, N = 1281 Hz, 16%, 2.12a), 157.6 (d, 1JP,F = 
1337 Hz, 1JP,Pt = 6314 Hz, 7%, 2.13a), 118.0 (AA’3XX’3, 
N = 1256 Hz, 1JP,Pt = 6102 Hz, 77%, 2.10a). 
19F{1H} NMR (377 MHz, d8-THF): F (ppm) 
-7.3 (AA’3XX’3, 2.10a), -22.8 (br. AA’XX’, 2.12a), -23.2 (d, 
1JF,P = 1337 Hz, 
2JF,Pt = 714 
Hz, 2.13a). 195Pt{1H} NMR (65 MHz, d8-THF): Pt (ppm) -5571.9 (qq, 1JPt,P = 6098 Hz, 
2JPt,F = 445 Hz, 2.10a), -5688.8 (dd, 
1JPt,P = 6314 Hz, 
2JPt,F = 716 Hz, 2.13a). 
7.2.47 Reaction with L2.2 
Immediately an insoluble precipitate formed (assumed to be 
2.10b), the following species were observed in the filtrate: 31P{1H} 
NMR (162 MHz, d8-THF): P (ppm) 140.0 (AA’XX’, N = 1238 
Hz, 1JP,Pt = 6525 Hz, 
1JP,F = 1271 Hz, 
2JP,P’ = 182 Hz, 
4JF,F’ = 0 Hz, 
3JP,F’ = -34 Hz, 23%, 
2.12b), 129.2 (d, 1JP,F = 1268 Hz, 
1JP,Pt = 6423 Hz, 77%, 2.13b). 
19F{1H} NMR (377 MHz, 
d8-THF): F (ppm) -37.6 (AA’XX’, 1JF,P = 1271 Hz, 2JP,P’ = 182 Hz, 4JF,F’ = 0 Hz, 3JF’,P = -
34 Hz, 2JF,Pt = 593 Hz, 2.12b), -39.3 (d, 
1JF,P = 1268 Hz, 
2JF,Pt = 611 Hz, 2.13b). 
195Pt{1H} 
NMR (65 MHz, d8-THF): Pt (ppm) -5224.3 (tt, 1JPt,P = 6521 Hz, 1JPt,F = 597 Hz, 2.12b), -
5687.2 (dd, 1JPt,P = 6424 Hz, 
2JPt,F = 613 Hz, 2.13b). 
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7.2.48 Reaction with L2.3  
31P{1H} NMR (162 MHz, THF): P (ppm) 167.8 
(AA’XX’, N = 1267 Hz, 1JP,Pt = 6275 Hz, 
1JP,F = 1293 
Hz, 2JP,P’ = 167 Hz, 
4JF,F’ = 5 Hz, 
3JP,F’ = -26 Hz, 44%, 
2.12c), 156.4 (d, 1JP,F = 1291 Hz, 
1JP,Pt = 6215 Hz, 16%, 2.13c), 127.1 (AA’3XX’3, N = 1181 
Hz, 1JP,Pt = 6000 Hz, 40%, 2.10c). 
19F{1H} NMR (377 MHz, THF): F (ppm) -23.9 
(AA’3XX’3, 2.10c), -37.5 (AA’XX’, 
2JF,Pt = 596 Hz, 
1JF,P = 1293 Hz, 
2JP,P’ = 167 Hz, 
4JF,F’ = 
5 Hz, 3JF’,P = -26 Hz, 2.12c), -39.1 (d, 
1JF,P = 1291 Hz, 
2JF,Pt = 642 Hz, 2.13c). 
7.2.49 Reaction with L2.4 
31P{1H} NMR (162 MHz, d8-THF): P (ppm) 155.4 
(AA’XX’, N = 1212 Hz, 1JP,Pt = 6115 Hz, 
1JP,F = 1224 
Hz, 2JP,P’ = 147 Hz, 
4JF,F’ = 0 Hz, 
3JP,F’ = -12 Hz, 2.12d), 
141.6 (d, 1JP,F = 1224 Hz, 
1JP,Pt = 6253 Hz, 2.13d). 
19F{1H} NMR (377 MHz, d8-THF): F 
(ppm) -27.8 (AA’3XX’3, 6%, 2.10d), -43.8 (AA’XX’, 
2JF,Pt = 454 Hz, 
1JF,P = 1224 Hz, 
2JP,P’ 
= 147 Hz, 4JF,F’ = 0 Hz, 
3JF’,P = -12 Hz, 91%, 2.12d), -45.2 (d, 
1JF,P = 1223 Hz, 3%, 2.13d). 
195Pt{1H} NMR (65 MHz, d8-THF): Pt (ppm) -5282.0 (tt, 1JPt,P = 6110 Hz, 2JPt,F = 454 Hz, 
2.12d), -5751.2 (dd, 1JPt,P = 6252 Hz, 
2JPt,F = 567 Hz, 2.13d). HR-MS (ESI): m/z calcd. for 
C33H31O4PtF2P2 (2.12d) [M+H]
+ = 786.1320; obs. = 786.1313. 
7.2.50 Reaction with L2.5 
31P{1H} NMR (162 MHz, d8-THF): P (ppm) 147.5 (s, 
1JP,Pt = 5941 Hz, 53%, 2.12e), 136.0 (s, 
1JP,Pt = 5895 Hz, 
12%, 2.13e), 108.2 (s, 1JP,Pt = 5744 Hz, 35%, 2.10e). 
195Pt{1H} NMR (65 MHz, d8-THF): Pt (ppm) -5255.0 (t, 1JPt,P = 5942 Hz, 2.12e), -5685.7 
(q, 1JPt,P = 5744 Hz, 2.10e), -5707.5 (d, 
1JPt,P = 5902 Hz, 2.13e). 
7.2.51 Reaction with Ethanox 398TM (2.4) 
Three unassigned isomers of complex 2.12f were observed. 31P{1H} NMR 
(162 MHz, THF): P (ppm) 148.2 (AA’XX’, 2.12f), 147.5 (AA’XX’, 2.12f), 
146.1 (br. AA’XX’, N = 1252 Hz, 1JP,Pt = 6117 Hz, 2.12f). 
19F{1H} NMR (377 
MHz, THF): F (ppm) -21.7 (AA’XX’, N = 1275 Hz, 2JF,Pt = 493 Hz, 7%, 2.12f), -33.4 (br. 
AA’XX’, N = 1246 Hz, 2JF,Pt = 537 Hz, 82%, 2.12f), -49.4 (AA’XX’, N = 1161 Hz, 
2JF,Pt 
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= 318 Hz, 11%, 2.12f). 195Pt{1H} NMR (65 MHz, THF): Pt (ppm) -5303.8 (tt, 1JPt,P = 
6033 Hz, 2JPt,F = 492 Hz, 2.12f), -5313.7 (tt, 
1JPt,P = 6093 Hz, 
2JPt,F = 542 Hz, 2.12f), 5304.6 
(tt, 1JPt,P = 6032 Hz, 
2JPt,F = 495 Hz, 2.12f). 
7.2.52 Synthesis of [Rh2Cl2(L2.1)4] (2.14a) from [Rh2Cl2(CO)4] 
To a solution of [Rh2Cl2(CO)4] (0.0200 g, 0.0514 mmol) in 
C6D6 (0.5 mL) was added a solution of L2.1 (0.0160 g, 0.103 
mmol) in C6D6 (0.5 mL). After 2 h, the reaction mixture was 
saturated with N2 by three successive freeze-pump-thaw cycles 
to give an orange solution. 31P{1H} NMR (162 MHz, C6D6): P 
(ppm) 134.8 (br. d, 1JP,F = 1323 Hz). 
19F{1H} NMR (377 MHz, 
C6D6): F (ppm) -9.5 (br. d, 1JF,P = 1314 Hz). 31P{1H} and 19F{1H} NMR data fitted with 
literature data.23   
General procedure for the NMR study of the reaction between ligand and 
[Rh2Cl2(CO)4] in a 4:1 stoichiometry  
To a solution of [Rh2Cl2(CO)4] (0.0150 g, 0.0386 mmol) in CH2Cl2 (0.5 mL) was added a 
solution of the ligand (0.154 mmol) in CH2Cl2 (0.5 mL). After 2 h, the reaction mixture 
was saturated with N2 by three successive freeze-pump-thaw cycles. 
7.2.53 Synthesis of [Rh2Cl2(L2.2)4] (2.14b)/ [Rh(L2.2)5][Cl] (2.15b) 
31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 113.0 
(AA'4MM'4X, ≈ 20%, 2.15b), 112.6 (br. d, 
1JP,F = 1354 Hz, 
≈ 80%, 2.14b). 19F{1H} NMR (377 MHz, CD2Cl2): F 
(ppm) -19.5 (AA'4MM'4X, 2.15b), -30.1 (br. d, 2.14b). HR-MS (nanospray): m/z calcd. for 
C50H30F5O10P5Rh [2.15b-Cl]
+ = 1142.95; obs. =1143.03.  
7.2.54 Synthesis of [Rh2Cl2(L2.3)4] (2.14c)/ [Rh(L2.3)5][Cl] (2.15c)/ trans-
[RhCl(CO)(L2.3)2] (2.16c) 
31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 
144.4 (AA'4MM'4X, 2.15c), 129.1 (br. d, 
1JP,F = 
1260 Hz, 2.14c). 19F{1H} NMR (377 MHz, 
CD2Cl2): F (ppm) -19.1 (AA'4MM'4X, ≈ 18%, 2.15c), -31.1 (br. d, ≈ 15%, 1JF,P = 1152 Hz, 
2.16c), -44.1 (br. d, 1JF,P = 1152 Hz, ≈ 67%, 2.14c). HR-MS (ESI): m/z calcd. for 




+ = 1273.0279; obs. = 1273.0287. IR (CH2Cl2): (CO) of 2.16c 
= 2032 cm-1.    
7.2.55 Synthesis of [Rh2Cl2(L2.4)4] (2.14d)/ [Rh(L2.4)5][Cl] (2.15d)/ trans-
[RhCl(CO)(L2.4)2] (2.16d) 
31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 
115.6 (AA'4MM'4X, ≈ 30%, 2.15d) 108.8 (br. d, 
1JP,F = 1211 Hz, ≈ 70%, 2.14d). 
19F{1H} NMR 
(377 MHz, CD2Cl2): F (ppm) -36.5 (AA'4MM'4X, ≈ 23%, 2.15d), -38.3 (d, 1JF,P = 1223 
Hz, ≈ 4%, 2.16d), -52.3 (br. d, 1JF,P = 1205 Hz, ≈ 73%, 2.14d). HR-MS (ESI): m/z calcd. 
for C65H50F5O10P5Rh [2.15d-Cl]
+ = 1343.1062; obs. = 1343.1135. IR (CH2Cl2): (CO) of 
2.16d = 2028 cm-1.    
7.2.56 Synthesis of [Rh(L2.5)5][Cl] (2.15e)/ trans-[RhCl(CO)(L2.5)2] (2.16e) 
31P{1H} NMR (122 MHz, CH2Cl2): P (ppm) 122.6 (d, 1JP,Rh = 
127 Hz, 28%, 2.15e), 119.8 (d, 1JP,Rh = 181 Hz, 2%), 113.1 (d, 
1JP,Rh = 210 Hz, 70%, 2.16e). IR (CH2Cl2): (CO) of 2.16e = 
2023 cm-1. 
7.2.57 Synthesis of [Rh2Cl2(L2.6)4] (2.14f)/ [Rh(L2.6)5][Cl] (2.15f) 
31P{1H} NMR (162 MHz, CD2Cl2, -80 °C): P (ppm) 143.1 
(br. s, 2.15f), 130.4 (dd, 1JP,F = 1314 Hz, 
2JP,Rh = 321 Hz, 
2.14f), 130.0 (dd, 1JP,F = 1317 Hz, 
2JP,Rh = 320 Hz, 2.14f), 
116.8 (br. s, 2.15f). 19F{1H} NMR (377 MHz, CD2Cl2): F (ppm) -1.9 (AA'4MM'4X, 2.15f), 
-11.8 (br. d, 1JF,P = 1285 Hz, 2.14f). 
7.2.58 Synthesis of [Rh2Cl2(L2.7)4] (2.14g)/ [Rh(L2.7)5][Cl] (2.15g) 
31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 134.8 
(AA'4MM'4X, ≈ 38%, 2.15g), 128.2 (br. d, 
1JP,F = 1308 Hz, 
≈ 55%, 2.14g), -25.6 (s, 8%, hydrolysis P(V)).  
7.2.59 Synthesis of [Rh2Cl2(L2.8)4] (2.14h)/ [Rh(L2.8)5][Cl] (2.15h) 
31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 120.1 
(AA'4MM'4X, ≈ 60%, 2.15h), 107.3 (br. d, 
1JP,F = 1268 Hz, 
≈ 40%, 2.14h). 19F{1H} NMR (377 MHz, CD2Cl2): F 
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(ppm) -20.5 (AA'4MM'4X, 2.15h), -39.2 (br. d, 2.14h). HR-MS (ESI): m/z calcd. for 
C60H50F5O10P5Rh [2.15h-Cl]
+ = 1283.1; obs. = 1283.1. 
7.2.60 Synthesis of [Rh2Cl2(L2.2)4] (2.14b) from [Rh2Cl2(cod)2] 
To a solution of [Rh2Cl2(cod)2] (0.0200 g, 0.0406 mmol) 
in CH2Cl2 (0.5 mL) was added a solution of L2.2 (0.0337 
g, 0.162 mmol) in CH2Cl2 (0.5 mL). Upon completion 
of the reaction, the volatiles were removed under 
reduced pressure. The product was precipitated with 
hexane (ca. 2 mL). The solid was allowed to settle, and 
the supernatant was removed and remaining solid washed with hexane (3 x 1 mL). 
Residual solvent was then removed from the solid under reduced pressure to yield the 
product as an orange solid. 31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 108.2 (dd, 1JP,F 
= 1222 Hz, 1JP,Rh = 328 Hz). 
19F{1H} NMR (377 MHz, CD2Cl2): F (ppm) -30.8 (d, 1JF,P = 
1232 Hz). HR-MS (nanospray): m/z calcd. for C40H23ClF4O8P4Rh2 [M-Cl]
+ =1072.8157; 
obs. =1072.8163. 
7.2.61 NMR study of the reaction between L2.2 and [Rh2Cl2(CO)4] in a 10:1 
stoichiometry 
To a solution of [Rh2Cl2(CO)4] (0.0150 g, 0.0386 mmol) in 
CH2Cl2 (0.5 mL) was added a solution of L2.2 (0.0803 g, 
0.386 mmol) in CH2Cl2 (0.5 mL). After 2 h, the reaction 
mixture was saturated with N2 by three successive freeze-pump-thaw cycles. 
31P{1H} 
NMR (122 MHz, -50 °C, CH2Cl2): P (ppm) 118.8 (AA'4MM'4X, ≈ 36%, 2.15b), 112.6 (br. 
dm, ≈ 38%, 2.14b), 98.0 (d, 1JP,F = 1239 Hz, ≈ 26%, L2.2). 
19F{1H} NMR (377 MHz, 
CH2Cl2): F (ppm) -19.5 (AA'4MM'4X, 2.15b), -38.3 (br. d, 2.14b and L2.2). HR-MS (ESI): 
m/z calcd. for C50H30F5O10P5Rh [2.15b-Cl]
+ = 1142.9; obs. =1142.9. 
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7.2.62 Synthesis of [Rh(L2.3)5][Cl] (2.15c)  
To a solution of [Rh2Cl2(CO)4] (0.0150 g, 0.0386 
mmol) in CH2Cl2 (0.5 mL) was added a solution of 
L2.3 (0.0900 g, 0.386 mmol) in CH2Cl2 (0.5 mL). After 
2 h, the volatiles were removed under reduced 
pressure to yield the product as a yellow/ green solid. 
31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 143.8 
(AA’4MM’4X), 121.7 (dd, 
1JP,F = 1243 Hz, 
1JP,Rh = 240 
Hz, ≈ 3%, 2.16c). 19F{1H} NMR (377 MHz, 
CD2Cl2): F (ppm) -18.9 (AA’4MM’4X, > 93%), -23.5 (br. s, 3%), -34.0 (d, 1JF,P = 1245 Hz, 
5%). 1H NMR (400 MHz, CD2Cl2): H (ppm) 7.40 (m, 4H, ArCH), 7.30 (m, 2H, ArCH), 
7.06 (d, JH,H = 8.1 Hz, 2H, ArCH). 
13C{1H} NMR (101 MHz, CD2Cl2): C (ppm) 148.4 (s, 
ArCO), 131.2 (s, ArCH), 130.7 (s, ArCH), 128.9 (s, ArC), 128.0 (s, ArCH), 121.8 (s, 
ArCH). HR-MS (ESI): m/z calcd. for C60H40F5O10P5Rh [M-Cl]
+ = 1273.0279; obs. = 
1273.0276. 
General procedure for the synthesis of [RhL5][BF4] complexes 2.15b’, 2.15c’, 2.15e’ 
To a solution of [Rh(cod)2][BF4] (0.0150 g, 0.0369 mmol) in CH2Cl2 (0.5 mL) was added 
a solution of ligand (0.185 mmol) in CH2Cl2 (0.5 mL). Upon completion of the reaction, 
the volatiles were removed under reduced pressure. The product was precipitated with 
hexane (ca. 2 mL). The solid was allowed to settle, and the supernatant was removed; the 
remaining solid was then washed with hexane (3 x 1 mL). Residual solvent was removed 
from the solid under reduced pressure to yield the product. 
7.2.63 Synthesis of [Rh(L2.2)5][BF4] (2.15b’) 
Pale green solid (0.0390 g, 65%). 31P{1H} NMR 
(162 MHz, CD2Cl2): P (ppm) 118.5 (AA'4MM'4X, 
1JP,F = 1286 Hz). 
19F{1H} NMR (377 MHz, 
CD2Cl2): F (ppm) -19.4 (AA'4MM'4X, 1JF,P = 1290 
Hz, 5F, [Rh(PF)5][BF4]), -153.2 (2 s, 4F, 4:1 [
11BF4]: 
[10BF4]). 
1H NMR (400 MHz, CD2Cl2): H (ppm) 
7.74 (d, JH,H = 8.3 Hz, 2H, ArCH), 7.50 (t, JH,H = 
8.1 Hz, 2H, ArCH), 7.03 (d, JH,H = 7.7 Hz, 2H, ArCH). 
13C{1H} NMR (101 MHz, CD2Cl2): 
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C (ppm) 143.9 (s, ArCO), 135.6 (s, ArC), 128.4 (s, ArCH), 125.3 (s, ArCH), 114.8 (m, 
ArC), 113.4 (s, ArCH). HR-MS (ESI): m/z calcd. for C50H30F5O10P5Rh [M-BF4]
+ = 
1142.9497; obs. = 1142.9483. 
7.2.64 Synthesis of [Rh(L2.3)5][BF4] (2.15c’) 
Yellow/ green solid (0.0351 g, 70%) 31P{1H} 
NMR (162 MHz, CD2Cl2): P (ppm) 144.6 
(AA'4MM'4X, 
1JP,F = 1294 Hz). 
19F{1H} NMR (377 
MHz, CD2Cl2): F (ppm) -18.9 (AA'4MM'4X, 1JF,P = 
1192 Hz, 5F, [Rh(PF)5][BF4]), -149.5 (s, 4F, [BF4]). 
1H NMR (400 MHz, CD2Cl2): H (ppm) 7.38 (t, 
JH,H = 7.5 Hz, 4H, ArCH), 7.29 (t, JH,H = 8.2 Hz, 
2H, ArCH), 7.05 (d, JH,H = 8.2 Hz, 2H, ArCH), contains signals for residual cod. 
13C{1H} 
NMR (101 MHz, CD2Cl2): C (ppm) 148.5 (s, ArCO), 131.3 (s, ArC), 130.7 (s, ArCH), 
129.0 (s, ArCH), 128.0 (s, ArCH), 121.9 (s, ArCH). HR-MS (ESI): m/z calcd. for 
C60H40F5O10P5Rh [M-BF4]
+ = 1273.0279; obs. = 1273.0276. 
7.2.65 Synthesis of [Rh(L2.5)5][BF4] (2.15e’) 
Orange solid. Crystals suitable for analysis by single 
crystal X-ray diffraction were grown by slow 
diffusion of hexane into a saturated pentane 
solution of 2.15e’; the molecular structure obtained 
was heavily disordered (see Section 2.6). 31P{1H} 
NMR (162 MHz, CD2Cl2): P (ppm) 112.8 (d, 1JP,Rh 
= 187 Hz).  
1H NMR (400 MHz, CD2Cl2): H (ppm) 
7.57 (d, JH,H = 8.4 Hz, 2H, ArCH), 7.36 (t, JH,H = 8.0 Hz, 2H, ArCH), 6.67 (d, JH,H = 7.6 
Hz, 2H, ArCH), 3.72 (m, 3H, OCH3), contains signals for ca. 10% residual cod. HR-MS 
(ESI): m/z calcd. for C55H45O15P5Rh [M-BF4]
+ = 1203.0496; obs. = 1203.0455.  
7.3 Chapter 3  
General procedure for catalytic hydroformylation of 1-hexene (conditions A) 
Before use in catalysis the fluorophosphite ligands (L2.2-2.4) were passed through a florisil 
column with toluene and/ or stirred in suspension of florisil/ toluene. Solutions of 
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[Rh(acac)(CO)2] (0.012 mmol) in toluene (0.5 mL) and the ligand in toluene (1.0 mL) were 
added to a single cell autoclave (SS 316) under a nitrogen atmosphere. The autoclave was 
fitted with a pressure transducer and a separate reservoir. The autoclave was flushed with 
three cycles of CO/H2 (ca. 10 bar) and subsequently pressurised to 15 bar and heated at 
90 °C. After 1.5 h, a solution of 1-hexene (0.6 mL, 4.83 mmol) in toluene (1 mL) was 
added to the separate reservoir, which was flushed with three cycles of CO/H2 (ca. 20 
bar). Using overpressure, the substrate was injected into the autoclave and a total pressure 
of 20 bar CO/H2 was established. The reaction mixture was heated at 90 °C for the 
appropriate time (for active runs a pressure drop of ≈ 0.5 bar was observed before 
quenching with a solution of tBu3P (1 mL) in toluene (1 mL)). The autoclave was then 
transferred to an ice bath, and once cooled the system was vented. A small sample of the 
reaction mixture was dissolved in CDCl3 and analysed by 
1H NMR spectroscopy. 
Conversion and selectivity were determined by integration of the 2,3-hexene alkene 
proton (H = 5.48 ppm), 1-hexene alkene proton (H = 5.88 ppm), the 2-methyl-hexanal 
aldehyde proton (iso aldehyde, H = 9.65 ppm) and the heptanal aldehyde proton (n 
aldehyde, H = 9.79 ppm). 
The following equation was used to calculate the turnover frequency (TOF).  
TOF =  (
mol aldehyde product
mol Rh
) / time 
General procedure for catalytic hydroformylation of 1-hexene (conditions B) 
The following procedure was carried out by the author and Dr. C Kubis at the LIKAT 
(Rostock, Germany). Solutions of [Rh(acac)(CO)2] (0.04 mmol) in toluene (5 mL) and the 
ligand in toluene (10 mL) were added to a 200 mL stainless steel autoclave (premex reactor 
AG, Leimen, Germany) under an Ar atmosphere. This was then washed in with toluene 
(20 mL) and the autoclave was flushed with three cycles of CO/H2 (ca. 20 bar) and 
subsequently pressurised to 20 bar. The autoclave was then heated to 90 °C using an oil 
bath thermostat. After 1 h, 1-hexene (5 mL, 40.3 mmol) was added to the autoclave with 
an 8 mL stainless steel syringe using a syringe pump (PHD Ultra 4400, Harvard Apparatus 
GmbH, March-Hugstetten, Germany). An aliquot of the reaction mixture was collected 
periodically throughout the reaction by a connected automated sampling device (ASD) 
into GC vials under an Ar atmosphere. A pressure controller (Brooks Instrument, 
Hatfield, PA, USA) was used to maintain the pressure at 20 bar of CO/H2 during the 
reaction. The reaction mixture was heated at 90 °C for the appropriate time. After, the 
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system was cooled to ambient temperature and the system was vented. A small sample of 
the reaction mixture was analysed by 31P{1H} NMR and IR spectroscopy (keeping the 
sample under an atmosphere of Ar).  
The samples collected throughout the reaction were analysed by GC and the conversion 
and selectivity were determined.  
7.4 Chapter 4  
General procedure for the synthesis of silyl ethers 4.9c,e-g 
To a solution of the diol (0.100 g) in toluene (2 mL) NEt3 (2.2 eq.) was added. SiMe3Cl 
(2.2 or 1.1 eq.) was then added dropwise over 10 min and the reaction mixture stirred for 
20 h. The suspension was filtered, and the solid washed with toluene (3 x 5 mL). The 
volatiles were removed under reduced pressure to yield the product. 
7.4.1 Synthesis of 4.9c 
Colourless oil (0.168 g, 65%). 1H NMR (400 MHz, CDCl3): H (ppm) 3.61 
(m, 2H, CH), 1.05 (m, 6H, CH3), 0.09 (s, 18H, OSi(CH3)3). 
13C{1H} NMR 
(101 MHz, CDCl3): C (ppm) 77.1 (s, CH), 18.2 (s, CH3), 0.3 (s, OSi(CH3)3). 
1H and 13C{1H} NMR data agreed with the literature data.24 
7.4.2 Synthesis of 4.9e 
Yellow oil (0.0900 g, 57%). 1H NMR (400 MHz, CDCl3): H (ppm) 
6.73 (d, J = 0.7 Hz 4H, ArCH), 3.71 (s, 3H, OCH3), 0.20 (s, 9H, 
OSi(CH3)3). 
13C{1H} NMR (101 MHz, CDCl3): C (ppm) 154.4 (s, ArC). 149.0 (s, ArC), 
120.8 (s, ArCH), 114.6 (s, ArCH), 55.7 (s, OCH3), 0.2 (s, OSi(CH3)3). 
1H and 13C{1H} 
NMR data agreed with the literature data.25 
7.4.3 Synthesis of 4.9f 
Colourless oil (0.0400 g, 28%). 1H NMR: (400 MHz, CDCl3): H 
(ppm) 7.51 (d, J = 8.4 Hz, 2H, ArCH), 6.91 (d, J = 8.4 Hz, 2H, ArCH), 
0.30 (s, 9H, OSi(CH3)3). 
13C{1H} NMR (101 MHz, CDCl3): C (ppm) 158.3 (s, ArCF3), 
127.1 (q, 3JC,F = 4 Hz, ArCH), 123.8 (q, 
2JC,F = 34 Hz, ArC), 120.3 (s, ArCH), 0.3 (s, 
OSi(CH3)3), quat. C undetectable. 
1H NMR data agreed with the literature data.26 
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7.4.4 Synthesis of 4.9g  
Colourless oil (0.0840 g, 53%). 1H NMR (400 MHz, CDCl3): H (ppm) 
6.82-6.97 (m, 4H, ArCH), 3.83 (s, 3H, OCH3), 0.27 (s, 9H, OSi(CH3)3). 
13C{1H} NMR (101 MHz, CDCl3): C (ppm) 151.1 (s, ArC), 144.7 (s, ArC), 122.0 (s, 
ArCH), 121.1 (s, ArCH), 121.0 (s, ArCH), 112.2 (s, ArCH), 55.5 (s, OCH3), 0.4 (s, 
OSi(CH3)3). 
1H and 13C{1H} NMR data agreed with the literature data.27 
General procedure for the synthesis of chlorophosphites 4.6c,e-f 
To a solution of the appropriate silyl ether in MeCN (0.6 M) was added PCl3 (2 eq.). Upon 
completion, as identified by 31P{1H} NMR spectroscopy, the volatiles were removed 
under reduced pressure to yield the product. 
7.4.5 Synthesis of 4.6c   
Yellow oil (0.0520 g, 95%). 31P{1H} NMR (162 MHz, CDCl3): P (ppm) 171.3 
(s). 31P{1H} NMR data fitted with literature.28 1H NMR (400 MHz, CDCl3): 
H (ppm) 4.43 (m, 1H, CH), 3.39 (m, 1H, CH), 1.53 (d, JH,H = 6.2 Hz, 3H, CH3), 1.52 (d, 
JH,H = 6.2 Hz, 3H, CH3). 
13C{1H} NMR (101 MHz, CDCl3): C (ppm) 82.0 (s, 2x CH), 
19.2 (s, CH3), 17.5 (s, CH3). 
7.4.6 Synthesis of 4.6e  
Yellow oil (0.0820 g, 90%). 31P{1H} NMR (162 MHz, CDCl3): P 
(ppm) 178.6 (s). 31P{1H} NMR data fitted with the literature data.29 1H 
NMR (400 MHz, CDCl3): H (ppm) 7.11 (d, JH,H = 9.2 Hz, 2H, ArCH), 6.91 (d, JH,H = 9.2 
Hz, 2H, ArCH), 3.81 (s, 3H, OCH3). 
13C{1H} NMR (101 MHz, CDCl3): C (ppm) 157.6 
(s, ArC), 144.2 (d, 2JC,P = 12 Hz, ArC), 122.7 (d, J = 5 Hz, ArCH), 114.6 (s, ArCH), 55.7 
(s, OCH3).
   
7.4.7 Synthesis of 4.6f 
Yellow oil (0.0370 g, 94%). 31P{1H} NMR (162 MHz, CDCl3): P 
(ppm) 178.1 (s). 1H NMR (400 MHz, CDCl3): H (ppm) 7.68 (d, J = 8.7 
Hz, 2H, ArCH), 7.31 (d, J = 8.7 Hz, 2H, ArCH). 13C{1H} NMR (101 MHz, CDCl3): C 
(ppm) 152.8 (d, J = 12 Hz, ArC), 127.1 (q, 3JC,F = 4 Hz, ArCH), 122.4 (q, J = 5 Hz, ArCH), 
two quat. C’s undetectable. 
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7.4.8 Synthesis of L4.1 
Silyl ether 4.9a (0.329 g, 1.29 mmol) was added to the 
chlorophosphite 4.6a (0.452 g, 2.56 mmol) in MeCN (3 mL). 
The reaction mixture was stirred at ambient temperature for 4 
h. The volatiles were removed under reduced pressure to yield 
to crude product, which was redissolved in toluene (5 mL). The solution was then passed 
through a short silica column, which was then washed with toluene (3 x 2 mL). The 
solvent was removed under reduced pressure to yield the product as a white semi-solid 
(0.400 g, 80%). 31P{1H} NMR (162 MHz, CDCl3): P (ppm) 129.9 (s). 1H NMR (400 MHz, 
CDCl3): H (ppm) 7.10 (m, 4H, ArCH), 6.99 (m, 6H, ArCH), 6.90 (m, 2H, ArCH). 31P{1H} 
NMR data agreed with the literature.15    
7.4.9 Synthesis of L4.2 
1,8-dihydroxynapthalene (1.00 g, 6.24 mmol) in toluene (15 
mL) was cooled to 0 °C and NEt3 (1.74 mL, 12.5 mmol) and 
PCl3 (0.36 mL, 4.2 mmol) were then added dropwise. The 
reaction mixture was allowed to warm to ambient 
temperature and stirred for 2 h. The reaction mixture was 
filtered, and the solid washed with toluene (3 x 10 mL). Volatiles were removed under 
reduced pressure to yield the crude product as a light yellow solid. A toluene (20 mL) 
solution of the crude product was then passed through a short silica column, which was 
washed with toluene (3 x 10 mL). Volatiles were removed under reduced pressure to yield 
the product as an off-white solid (0.810 g, 73%). Crystals suitable for analysis by single 
crystal X-ray diffraction were grown by slow diffusion of hexane into a saturated CH2Cl2 
solution of L4.2. 
31P{1H} NMR (162 MHz, CDCl3): P (ppm) 100.9 (s). 1H NMR (400 
MHz, CDCl3): H (ppm) 7.49 (d, JH,H = 8.3 Hz, 4H, ArCH), 7.41 (m, 6H, ArCH), 7.18 (t, 
JH,H = 7.9 Hz, 2H, ArCH), 7.06 (d, JH,H = 7.5 Hz, 4H, ArCH), 6.93 (d, JH,H = 7.5 Hz, 2H, 
ArCH). 13C{1H} NMR (101 MHz, CDCl3): C (ppm) 146.3 (s, ArCO), 144.4 (m, ArCO), 
137.1 (s, ArC), 135.1 (s, ArC), 127.3 (s, ArCH), 126.1 (s, ArCH), 125.1 (s, ArCH), 122.3 
(s, ArCH), 121.3 (t, J = 2 Hz, ArC), 119.3 (t, J = 4 Hz, ArCH), 117.1 (m, ArC), 112.1 (s, 
ArCH). HR-MS (MALDI): m/z calcd. C30H18O6P2 [M+Na]
+ = 559.0471; obs. = 559.471. 
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7.4.10 Synthesis of cis-[PtMe2(L4.2)] (4.10)  
To a solution of [PtMe2(cod)] (0.0150 g, 0.0450 mmol) in 
toluene (0.5 mL) was added a solution of L4.2 (0.0480 g, 
0.0450 mmol) in toluene (0.5 mL). Precipitation of the 
product immediately occurred. The solid was allowed to 
settle and the supernatant removed. In air, the remaining 
residue was washed with toluene (3 x 1 mL). Residual solvent was then removed from the 
solid under reduced pressure to yield the product as a pale yellow solid (0.0240 g, 70%). 
Crystals suitable for analysis by single crystal X-ray diffraction were grown by slow 
diffusion of hexane into a saturated CH2Cl2 solution of 4.10. 
31P{1H} NMR (162 MHz, 
CD2Cl2): P (ppm) 112.6 (s, 1JP,Pt = 2964 Hz). 1H NMR (400 MHz, CD2Cl2): H (ppm) 7.74 
(d, JH,H = 8.3 Hz, 6H, ArCH), 7.62 (t, J = 8.0 Hz, 4H, ArCH), 7.35 (m, 6H, ArCH), 6.84 
(d, JH,H = 7.6 Hz, 2H, ArCH), 0.82 (s, 
2JH,Pt = 73.0 Hz, 6H, Pt-CH3). 
13C{1H} NMR (101 
MHz, CD2Cl2): C (ppm) 145.6 (s, ArCO), 144.3 (s, ArCO), 135.9 (s, ArC), 129.5 (s, ArC), 
128.7 (s, ArC), 128.3 (s, ArCH), 127.3 (s, ArCH), 126.9 (s, ArCH), 125.8 (s, ArC), 124.0 
(s, ArCH), 122.2 (s, ArCH), 113.2 (s, ArCH), 21.7 (s, Pt-CH3).  
7.4.11 Synthesis of cis-[Mo(CO)4(L4.2)] (4.11) 
To a solution of [Mo(CO)4(nbd)] (0.0150 g, 0.0499 mmol) 
in CH2Cl2 (0.5 mL) was added a solution of L4.2 (0.0300 g, 
0.0550 mmol) in CH2Cl2 (0.5 mL). Precipitation of the 
product occurred within 10 min. Upon completion, the 
volatiles were removed under reduced pressure. The 
product was precipitated with hexane (2 mL). The solid was allowed to settle, and the 
supernatant removed; the remaining residue was then washed with hexane (3 x 1 mL). 
Residual solvent was removed from the solid under reduced pressure to yield the product 
as a yellow solid. The product was partially soluble in all common organic solvents. 
31P{1H} NMR (162 MHz CD2Cl2): P (ppm) 147.8 (s). 1H NMR (400 MHz, CD2Cl2): H 
(ppm) 7.71 (d, JH,H = 8.4 Hz, 6H, ArCH), 7.60 (t, J = 8.0 Hz, 4H, ArCH), 7.38 (t, J = 8.0 
Hz, 2H, ArCH), 7.30 (d, JH,H = 7.5 Hz, 4H, ArCH), 6.84 (d, JH,H = 7.7 Hz, 2H, ArCH) 
HR-MS (EI): m/z calcd. for C34H18MoO10P2 [M+H]
+ = 746.9473; obs. = 746.9510; 
[M+Na]+ = 768.9320; obs. = 768.9330. IR (CH2Cl2): (CO) = 2057 cm
-1.  
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7.4.12 Synthesis of trans-[Rh2Cl2(CO)2(µ-L4.2)2] (4.13) 
To a solution of [Rh2Cl2(CO)4] (0.0200 g, 0.0514 mmol) in 
CH2Cl2 (1 mL) was added a solution of L4.2 (0.0550 g, 0.103 
mmol) in CH2Cl2 (1 mL). After 2 h, upon completion of 
the reaction, the volatiles were removed under reduced 
pressure. The product was precipitated with hexane (5 
mL). The solid was allowed to settle and the supernatant 
removed; the remaining residue was then washed with 
hexane (3 x 1 mL). Residual solvent was then removed from the solid under reduced 
pressure to yield the product as a yellow solid (0.0410 g, 57%). The product was partially 
soluble in all common organic solvents.  31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 
122.1 (d, 1JP,Rh = 180 Hz). 
1H NMR (400 MHz, CD2Cl2): H (ppm) 7.78 (d, J = 8.5 Hz, 4H, 
ArCH), 7.59 (t, J = 8.0 Hz, 4H, ArCH), 7.48 (m, 2H, ArCH), 7.29 (t, J = 8.0 Hz, 2H, 
ArCH), 7.06 (d, J = 7.7 Hz, 4H, ArCH), 6.89 (d, J = 7.7 Hz, 2H, ArCH). IR (solid phase): 
(CO) = 2059, 1980 cm-1.    
7.4.13 Catalytic hydroformylation of 1-hexene using L4.1-4.3  
Catalysis was performed using a Baskerville “Multi-Cell” autoclave. The appropriate 
ligand was added to the autoclave and the system was put under an atmosphere of N2. A 
solution of [Rh(acac)(CO)2] (0.012 mmol) in toluene (0.5 mL) was then added. This was 
then washed in using toluene (1 mL) and the autoclave was flushed with three cycles of 
CO/H2 (ca. 10 bar). The autoclave was then pressurised to 15 bar and heated at 90 °C. 
After 1 h, the autoclave was vented and 1-hexene (0.6 mL, 4.83 mmol) was added. The 
autoclave was then pressurised to 20 bar CO/H2 and heated at 90 °C for 1 h, unless 
otherwise stated. The autoclave was transferred to an ice bath and once cooled the system 
was vented. The reaction mixture was analysed by 1H and 31P{1H} NMR spectroscopy. 
The selectivity and conversion were determined as above (Section 7.3 – conditions A).   
7.5 Chapter 5  
7.5.1 Synthesis of L5.2 
Ph2PH (2.52 g, 13.5 mmol) in THF (15 mL) was cooled to -78 °C and 
nBuLi (8.45 mL, 13.5 mmol, 1.6 M in hexanes) was added dropwise. 
After stirring for 30 min at -78 °C the reaction mixture was allowed to warm to ambient 
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temperature and stirred for 1 h. The reaction mixture was then added dropwise to a 
solution of 2,6-dichloropyridine (2.00 g, 13.5 mmol) in THF (20 mL) at -78 °C. The 
reaction mixture was allowed to warm to ambient temperature and stirred for 18 h. 
Volatiles were removed under reduced pressure and the reaction mixture was dissolved 
in toluene (20 mL). Deoxygenated H2O (20 mL) was then added. The toluene layer was 
extracted, and the aqueous layer washed with toluene (3 x 10 mL). The organic portions 
were collected, dried over MgSO4, filtered and the volatiles were removed under reduced 
pressure to yield the crude product as a pale orange solid. Recrystallisation from MeOH 
gave the product as a white solid (2.44 g). The MeOH supernatant was then placed in a -
20 °C freezer where precipitation occurred. The supernatant was removed, and residual 
solvent removed from the solid under reduced pressure to yield additional product as a 
white solid (combined yield = 2.97 g, 74%). Crystals suitable for analysis by single crystal 
X-ray diffraction were grown from a saturated MeOH solution of L5.2. 
31P{1H} NMR 
(162 MHz, CDCl3): P (ppm) -2.7 (s). 1H NMR (400 MHz, CDCl3): H (ppm) 7.49 (td, JH,H 
= 7.8, 1.8 Hz, 1H, PyH), 7.38 (m, 10H, PhH), 7.20 (dd, JH,H = 8.0, 0.9 Hz, 1H, PyH), 6.95 
(dd, 1H, JH,H = 7.5, 0.7 Hz, 1H, PyH). 
31P{1H} and 1H NMR data agreed with the 
literature.30 
7.5.2 Synthesis of L5.3a 
The following procedure was modified from the literature.31,32 2-
bromopyridine (1.21 ml, 12.7 mmol) in Et2O (45 mL) was cooled to -78 °C 
and nBuLi (7.96 mL, 12.7 mmol, 1.6 M in hexanes) was added dropwise. 
After stirring for 1 h at -78 °C, tBu2PCl (2.20 mL, 11.6 mmol) was added dropwise and 
the reaction mixture was allowed to warm to ambient temperature. After stirring for 1 h, 
deoxygenated H2O (40 mL) was added. The Et2O layer was extracted, and the aqueous 
layer washed with Et2O (3 x 15 mL). The organic portions were combined, dried over 
MgSO4, filtered and the volatiles were removed under reduced pressure to yield the crude 
product. The crude product was then passed through silica with CH2Cl2 and the volatiles 
were removed. The residue was then purified by distillation (100°C, 0.2 Torr) to yield the 
product as a pale-yellow oil (1.92 g, 74%). 31P{1H} NMR (162 MHz, CDCl3): P (ppm) 
39.9 (s). 1H NMR (400 MHz, CDCl3): H (ppm) 8.70 (d, JH,H = 4.8 Hz, 1H, PyH), 7.57 (m, 
2H, PyH), 7.16 (m, 1H, PyH), 1.21 (d, 3JH,P = 12.0 Hz, 18H, C(CH3)3). 
31P{1H} and 1H 
NMR data agreed with the literature.31 
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7.5.3 Synthesis of L5.3b  
2-bromo-6-methylpyridine (0.30 mL, 2.6 mmol) in Et2O (10 mL) was 
cooled to -78 °C and nBuLi (1.69 mL, 2.70 mmol, 1.6 M in hexanes) was 
added dropwise. After stirring for 2 h at -78 °C, tBu2PCl (0.39 mL, 1.8 
mmol) was added and the reaction mixture allowed to warm to ambient temperature. 
After stirring for 16 h, deoxygenated H2O (10 mL) was added. The Et2O layer was 
extracted and the aqueous layer washed with Et2O (3 x 10 mL). The organic portions were 
combined, dried over MgSO4, filtered and the volatiles were removed under reduced 
pressure to yield the crude product as an orange oil. The crude product was then passed 
through silica with CH2Cl2, the volatiles removed under reduced pressure, to yield the 
product as a colourless oil (0.418 g, 67%). 31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 
36.8 (s). 1H NMR (400 MHz, CD2Cl2): H (ppm) 7.43 (td, JH,H = 7.7, 2.4 Hz, 1H, PyH), 
7.34 (d, JH,H = 7.7 Hz, 1H, PyH), 7.02 (d, JH,H = 7.2 Hz, 1H, PyH), 2.51 (s, 3H, CH3), 1.17 
(d, 3JH,P = 11.6 Hz, 18H, C(CH3)3). 
13C{1H} NMR (101 MHz, CD2Cl2): C (ppm) 149.2 (s, 
PyC), 134.2 (s, PyC), 133.5 (s, PyCH), 133.0 (s, PyCH), 122.5 (s, PyCH), 32.3 (s, C(CH3)3), 
32.1 (s, C(CH3)3), 29.9 (s, C(CH3)3), 29.8 (s, C(CH3)3), CH3 undetectable. HR-MS (EI): 
calc. for C14H24NP [M]
+ = 237.16; obs. = 237.19. 
7.5.4 Synthesis of L5.4 
The following procedure was modified from the literature.33 2-
bromopyridine (0.75 mL, 7.9 mmol) in Et2O (30 mL) was cooled to -78 
°C and nBuLi (4.94 mL, 7.91 mmol, 1.6 M in hexanes) was added 
dropwise. After stirring for 1 h at -78 °C, Cy2PCl (1.23 mL, 5.54 mmol) 
was added dropwise and the reaction mixture was allowed to warm to ambient 
temperature. After stirring for 1 h, deoxygenated H2O (40 mL) was added. The Et2O layer 
was extracted, and the aqueous layer washed with Et2O (3 x 15 mL). The organic portions 
were combined, dried over MgSO4, filtered and the volatiles were removed under reduced 
pressure to yield the crude product. The crude product was then passed through silica 
with CH2Cl2, the volatiles removed under reduced pressure, to yield the product as an 
orange oil (0.894 g, 59%). 31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 6.9 (s). 1H NMR 
(400 MHz, CD2Cl2): H (ppm) 8.66 (d, JH,H = 4.9 Hz, 1H, PyH), 7.58 (vir. t, JH,H = 7.5 Hz, 
1H, PyH), 7.47 (m, 1H, PyH), 7.17 (m, 1H, PyH), 2.08 (vir. td, J = 11.7, 3.1 Hz, 2H, CyH), 
1.89-1.55 (m, 10H, CyH), 1.40-1.09 (m, 8H, CyH), 0.98 (m, 2H, CyH). 31P{1H} and 1H 
NMR data fitted with literature.33 
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7.5.5 Synthesis of L5.5 
2-bromopyridine (1.10 mL, 11.5 mmol) in xylene (25 mL) was treated with 
s-PhobPH (1.62 g, 11.5 mmol), 1,4-diazabicyclo[2.2.2]octane (DABCO) 
(3.29 g, 29.5 mmol) and [Pd(PPh3)4] (0.322 g, 0.295 mmol). The reaction 
mixture was refluxed at 180 °C for 18 h and then cooled to 100 °C. Xylene 
(20 mL) was then added to precipitate the product. The solid was allowed to settle and 
the supernatant removed; the precipitate was then washed with xylene (2 x 10 mL). 
Volatiles were removed under reduced pressure and the residue triturated with toluene (2 
x 10 mL). The volatiles were removed to yield the product as an orange oil (0.420 g, 21%). 
31P{1H} NMR (162 MHz, C6D6): P (ppm) 15.3 (s, P-P species, 9%), -19.6 (s, >85%), 
contains signals for other unidentified minor impurities. 1H NMR (400 MHz, C6D6): H 
(ppm) 8.54 (d, JH,H = 4.8 Hz, 1H, PyH), 7.08 (m, 1H, PyH), 6.97 (d, JH,H = 7.6 Hz, 1H, 
PyH), 6.59 (dd, JH,H = 7.5, 4.9 Hz, 1H, PyH), 2.46-1.17 (m, 14H, PhobH). 
13C{1H} NMR 
(101 MHz, C6D6): C (ppm) 167.0 (d, 1JC,P = 15 Hz, PyC), 150.4 (d, 3JC,P = 5 Hz, PyCH), 
134.6 (d, 3JC,P = 2 Hz, PyCH), 126.1 (d, 
2JC,P = 19 Hz, PyCH), 120.5 (d, 
4JC,P = 2 Hz, PyCH), 
32.0 (d, 1JC,P = 13 Hz, PhobC), 26.2 (d, JC,P = 5 Hz, PhobC), 25.4 (d, JC,P = 11 Hz, PhobC), 
23.5 (d, JC,P = 7 Hz, PhobC), 22.4 (d, JC,P = 1 Hz, PhobC). HR-MS (ESI): m/z calcd. for 
C13H18NP [M]
+ = 219.1, obs. = 220.1. 
7.5.6 Synthesis of cis-[PtCl2(L5.2)2] (5.14) 
To a solution of [PtCl2(cod)] (0.0200 g, 0.0535 mmol) in CH2Cl2 (1 
mL) was added a solution of L5.2 (0.0318 g, 0.107 mmol) in CH2Cl2 
(1 mL). Upon completion, the product was precipitated with hexane 
(5 mL). The solid was allowed to settle, and supernatant was 
removed; residual solvent was then removed from the solid to yield 
the product as a white solid (0.0302 g, 70%). Crystals suitable for analysis by single crystal 
X-ray diffraction were grown by slow diffusion of hexane into a saturated CH2Cl2 solution 
of 5.14. 31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 11.0 (s, 1JP,Pt = 3695 Hz). 1H NMR 
(400 MHz, CD2Cl2): H (ppm) 7.92 (dd, JH,H = 7.6, 4.7 Hz, 1H, PyH), 7.64 (dd, J = 11.0, 
8.3 Hz, 4H, PhH), 7.59 (td, JH,H = 7.8, 3.4 Hz, 1 Hz, PyH), 7.41 (t, JH,H = 7.5 Hz, 2H, 
PyH), 7.25 (m, 6H, PhH). 13C{1H} NMR (126 MHz, CD2Cl2): C (ppm) 156.3 (d, J = 1 
Hz, ArC), 155.6 (d, J = 1 Hz, ArC), 151.6 (q, J = 9 Hz, ArC), 138.8 (vir. t, J = 5 Hz, 
PyCH), 135.9 (vir. t, J = 5 Hz, PhCH), 131.8 (s, PyCH), 130.1 (m, PyCH), 128.5 (vir. t, J 
= 6 Hz, PhCH), 126.1 (s, PhCH). HR-MS (ESI): m/z calcd. for C34H26Cl3N2P2Pt [M-Cl]
+ 
Chapter 7: Experimental  
252 
 
= 824.0282, obs. = 824.0278. 
7.5.7 Synthesis of cis-[PtCl(к2-L5.2)(к1-L5.2)][BF4] (5.15)  
A solution of complex 5.14 (0.0320 g, 0.0368 mmol) in 
CH2Cl2 (2 mL) was added to AgBF4 (0.0720 g, 0.0368 
mmol). Immediately a white precipitate formed. Upon 
completion, the supernatant was removed and the 
precipitate washed with CH2Cl2 (3 x 1 mL). The washings 
and supernatant were combined, and the volatiles removed under reduced pressure to 
yield the product as a white solid (0.0210 g, 63%). 31P{1H} NMR (162 MHz, CD2Cl2): P 
(ppm) 4.3 (d, 2JP,P = 6 Hz, 
1JP,Pt = 3940 Hz, к
1-Ph2P), -41.9 (s, 
2JP,P = 6 Hz, 
1JP,Pt = 3141 
Hz, к2-Ph2P). 
1H NMR (400 MHz, CD2Cl2): H (ppm) 8.13 (td, JH,H = 8.0, 2.9 Hz, 1H, 
PyH), 7.83-7.78 (m, 4H, ArCH), 7.73-7.70 (m, 5H, ArCH), 7.62 (td, JH,H = 7.4, 2.0 Hz, 
4H, ArCH), 7.54 (dd, JH,H = 7.7, 5.2 Hz, 1H, ArCH), 7.49-7.45 (m, 9H, ArCH), 7.15 (dd, 
JH,H = 8.1, 2.5 Hz, 1H, PyH), 7.05 (dd, JH,H = 7.6, 4.8 Hz, 1H, PyH). 
13C{1H} NMR (101 
MHz, CD2Cl2): C (ppm) 143.0 (d, JC,P = 5 Hz, ArC), 140.1 (d, JC,P = 9 Hz, ArC), 135.3 (d, 
JC,P = 11 Hz, ArC), 134.9 (d, JC,P = 13 Hz, ArC), 134.4 (s, ArCH), 133.4 (s, ArCH), 131.8 
(s, ArCH), 130.3 (d, JC,P = 13 Hz, ArCH), 129.6 (d, JC,P = 12 Hz, ArCH), 129.4 (m, ArCH), 
128.8 (s, ArCH), 128.6 (s, ArCH), 127.8 (s, ArCH), 126.3 (s, ArCH), 125.6 (s, ArCH), 
119.0 (s, ArCH), two quat. C’s undetectable. HR-MS (ESI): m/z calcd. for 
C34H26Cl3N2P2Pt [M-BF4]
+ = 824.0282, obs. = 824.0305. 
7.5.8 Synthesis of cis-[PdCl2(L5.2)2] (cis-5.16) 
To a solution of [PdCl2(NCPh)2] (0.0200 g, 0.0521 mmol) in CH2Cl2 
(1 mL) was added a solution of L5.2 (0.0156 g, 0.0521 mmol) in 
CH2Cl2 (1 mL). The product was identified as the cis isomer from the 
subsequent reaction and crystal structure obtained (Section 7.5.9). In 
situ 31P{1H} NMR (162 MHz, CH2Cl2): P (ppm) 28.5 (s). 
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7.5.9 Synthesis of cis- and trans-[PdCl2(L5.2)2] (5.16) 
To a solution of [PdCl2(NCPh)2] (0.0200 g, 
0.0521 mmol) in CH2Cl2 (1 mL) was added a 
solution of L5.2 (0.0310 g, 0.104 mmol) in 
CH2Cl2 (1 mL). Upon completion of the 
reaction, the volatiles were removed under 
reduced pressure. The product was precipitated 
with hexane (ca. 5 mL) and the solid was allowed to settle. The supernatant was removed, 
and remaining residue washed with hexane (3 x 3 mL). Residual solvent was then removed 
from the solid under reduced pressure to yield the product as a pale-yellow solid (0.0230 
g, 58%). Crystals of cis-5.16 suitable for analysis by single crystal X-ray diffraction were 
grown by slow diffusion of hexane into a saturated CH2Cl2 solution of the mixture of cis- 
and trans-5.16.  31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 29.2 (s, cis-5.16, 68%), 23.7 
(s, trans-5.16, 32%). 1H NMR (400 MHz, CD2Cl2): H (ppm) 7.86 (m, 1H, PyH), 7.69 (dd, 
JH,H = 11.8, 7.5 Hz, 4H, ArCH), 7.57-7.43 (m, 4H, PhH), 7.36-7.26 (m, 4H, PhH). 
13C{1H} 
NMR (101 MHz, CD2Cl2): C (ppm) 157.6 (d, JC,P = 2 Hz, ArC), 157.0 (d, JC,P = 2 Hz, 
ArC), 156.7 (s, ArC), 156.4 (s, ArC), 151.9 (m, ArC), 151.7 (m, ArC), 139.0 (m, PyCH), 
138.6 (vir. t, J = 4 Hz, PyCH), 136.1 (vir. t, J = 6 Hz, PhCH), 135.9 (vir. t, J = 5 Hz, 
PhCH), 131.9 (s, PyCH), 131.7 (s, PyCH), 130.6 (vir. t, J = 12 Hz, ArCH), 129.0 (m, 
ArCH), 128.7 (m, ArCH), 128.6 (m, ArCH), 125.9 (s, PhCH), 125.6 (s, PhCH). HR-MS 
(ESI): m/z calcd. for C34H26Cl3N2P2Pd [M-Cl]
+ = 734.9670, obs. = 734.9663.   
7.5.10 Synthesis of cis-[PdCl(к2-L5.1)(к1-L5.2)][BF4] (5.17)  
A solution of cis- and trans-5.16 (0.0200 g, 0.0259 mmol) in 
CH2Cl2 (2 mL) was added to AgBF4 (0.0100 g, 0.0518 
mmol). Immediately precipitate formed. Upon 
completion, the supernatant was removed, and the 
precipitate washed with CH2Cl2 (3 x 1 mL). The washings 
and supernatant were combined, and the volatiles were removed under reduced pressure 
to yield the product as an orange solid. A 1:1 mixture of complexes 5.17a and 5.17b was 
observed. 31P{1H} NMR (122 MHz, CD2Cl2, -90 °C): P (ppm) 40.3 (br. s), 37.8 (d, 2JP,P = 
28 Hz, к1-Ph2P), 24.3 (br. s, к
1-Ph2P), -4.7 (s, L5.2), -30.1 (d, 
2JP,P = 33 Hz, к
2-Ph2P), -35.5 
(d, 2JP,P = 29 Hz, к
2-Ph2P). 
1H NMR (400 MHz, CD2Cl2): H (ppm) 8.03-7.96 (br. m, 2H, 
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ArCH), 7.72 (br. dt, J = 9.2, 4.1 Hz, 7H, ArCH), 7.59 (br. m, 5H, ArCH), 7.49-7.41 (br. 
m, 12H, ArCH).  
7.5.11 Synthesis of trans-[RhCl(CO)(L5.2)2] (5.18) 
To a solution of [Rh2Cl2(CO)4] (0.0200 g, 0.0515 mmol) in 
CH2Cl2 (1 mL) was added a solution of L5.2 (0.0613 g, 0.206 
mmol) in CH2Cl2 (1 mL). Upon completion, the volatiles 
were removed under reduced pressure to yield the product 
as a yellow solid (0.0640 g, 82%). Crystals suitable for analysis by single crystal X-ray 
diffraction were grown by slow diffusion of hexane into a saturated CH2Cl2 solution of 
5.18. 31P{1H} NMR (122 MHz, CD2Cl2, -90°C): P (ppm) 30.8 (d, 1JP,Rh = 128 Hz). 1H 
NMR (400 MHz, CD2Cl2): H (ppm) 7.86 (d, JH,H = 6.9 Hz, 4H, PhH), 7.69 (d, JH,H = 7.0 
Hz, 1H, PyH), 7.63 (t, JH,H = 7.7 Hz, 1H, PyH), 7.51-7.43 (m, 6H, PhH), 7.31 (dd, JH,H = 
7.8, 1.1 Hz, 1H, PyH). 13C{1H} NMR (101 MHz, CD2Cl2): C (ppm) 186.9 (d, 1JC,Rh = 74 
Hz, Rh-CO), 159.8 (br. s, ArC), 152.0 (s, ArC), 138.9 (s, PyCH), 135.7 (s, PhCH), 132.4 
(s, ArC), 131.2 (s, PhCH), 129.9 (s, PyCH), 128.8 (s, PhCH), 125.4 (s, PyCH). HR-MS 
(ESI): m/z calcd. for C35H26Cl2N2OP2Rh [M-Cl]
+ = 724.9947, obs. = 724.9939. IR 
(CH2Cl2): (CO) = 1987 cm
-1. 
General procedure for the reaction between ligand and [PtCl2(cod)] in a 1:1 ratio 
To a solution of [PtCl2(cod)] (0.0200 g, 0.0535 mmol) in CH2Cl2 (1 mL) was added a 
solution of ligand (0.0535 mmol) in CH2Cl2 (1 mL). Upon completion, the product was 
precipitated with hexane (ca. 15 mL). The solid was allowed to settle, and the supernatant 
was removed; the precipitate was then washed with hexane (3 x 3 mL). Residual solvent 
was removed from the solid under reduced pressure to yield the product(s).  
7.5.12 Synthesis of [PtCl2(к2-L5.3a)] (5.19a)/ trans-[PtCl(к2-L5.3a)(к1-L5.3a)][Cl] 
(trans-5.20a) 
White solid. Crystals of 5.19a suitable for 
analysis by single crystal X-ray diffraction 
were grown by slow diffusion of hexane 
into a saturated CH2Cl2 solution of the 
mixture of 5.19a and trans-5.20a.31P{1H} 
NMR (162 MHz, CD2Cl2): P (ppm) 39.5 (d, 2JP,P = 363 Hz, 1JP,Pt = 2565 Hz, 25%, к1-
PtBu2 trans-5.20a), -15.1 (s, 
1JP,Pt = 3136 Hz, 50%, 5.19a), -18.1 (d, 
2JP,P = 363 Hz, 
1JP,Pt = 
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1916 Hz, 25%, к2-PtBu2 trans-5.20a). HR-MS (ESI): m/z calcd. for trans-5.20a 
C26H44ClN2P2Pt [M-Cl]
+ = 676.2316; obs = 676.2329. 
7.5.13 Synthesis of trans-[PtCl2(L5.4)2] (trans-5.21b)          
Cream solid. Contains trans-5.21b and [PtCl2(cod)] in ca. a 1:1 ratio 
(as expected). 31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 27.5 (s, 
1JP,Pt = 2481 Hz). 
1H NMR (400 MHz, CD2Cl2): H (ppm) 8.68 (d, JH,H 
= 4.4 Hz, 1H, PyH), 7.90 (d, JH,H = 7.6 Hz, 1H, PyH), 7.72 (dt, JH,H 
= 7.6, 4.0 Hz, 1H, PyH), 7.30 (m, 1H, PyH), 1.83-1.66 (m, 8H, CyH), 1.48-1.25 (m, 8H, 
CyH), 1.13 (m, 4H, CyH), 0.86 (m, 2H, CyH), contains signals for [PtCl2(cod)]. HR-MS 
(ESI): m/z calcd. for C34H52ClN2P2Pt [M-Cl]
+ = 781.3, obs. = 781.3. 
General procedure for the reaction between ligand and [PtCl2(cod)] in a 2:1 ratio 
To a solution of [PtCl2(cod)] (0.0200 g, 0.0535 mmol) in CH2Cl2 (1 mL) was added a 
solution of ligand (0.107 mmol) in CH2Cl2 (1 mL). Upon completion, the product was 
precipitated with hexane (ca. 15 mL). The solid was allowed to settle and the supernatant 
removed; the precipitate was then washed with hexane (3 x 3 mL). Residual solvent was 
then removed from the solid under reduced pressure to yield the product.  
7.5.14 Synthesis of trans-[PtCl(к2-L5.3a)(к1-L5.3a)][Cl] (trans-5.20a) 
White solid. 31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 
42.2 (s, 1JP,Pt = 2482 Hz, 10%, trans-5.21a), 40.0 (d, 
2JP,P = 363 
Hz, 1JP,Pt = 2571 Hz, к
1-tBu2P trans-5.20a), 39.4 (br. s, 15%, 
L5.3a), -17.8 (d, 
2JP,P = 363 Hz, 
1JP,Pt = 1916 Hz, к
2-tBu2P trans-
5.20a). 1H NMR (400 MHz, CD2Cl2): H (ppm) 8.85 (d, JH,H = 4.8 Hz, 1H, PyH), 8.70-
8.58 (m, 2H, PyH), 7.99 (m, 1H, PyH), 7.91 (t, JH,H = 6.7 Hz, 1H, PyH), 7.69 (m, 1H, 
PyH), 7.47 (m, 1H, PyH), 7.40 (t, JH,H = 6.9 Hz, 1H, PyH), 1.66-1.24 (m, 74H, tBu-C(CH3)3 
(all species)), also contained signals for trans-5.21a and L5.3a. HR-MS (ESI): calc. for trans-
5.20a C26H44ClN2P2Pt [M-Cl]
+ = 676.2313; obs = 676.2316.    
7.5.15 Synthesis of cis-[PtCl(к2-L5.4)(к1-L5.4)][Cl] (cis-5.20b) 
Cream solid. 31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 21.5 
(d, 2JP,P = 7 Hz, 
1JP,Pt = 3601 Hz, к
1-Cy2P), -22.8 (d, 
2JP,P = 7 Hz, 
1JP,Pt = 3110 Hz, к
2-Cy2P). 
1H NMR (400 MHz, CD2Cl2): H 
(ppm) 9.04 (t, JH,H = 4.2 Hz, 1H, PyH), 8.89 (d, JH,H = 4.7 Hz, 
Chapter 7: Experimental  
256 
 
1H, PyH), 8.49 (m, PyH), 8.14 (br. s, 1H, PyH), 7.94 (m, 1H, PyH), 7.87 (t, JH,H = 6.6 Hz, 
1H, PyH), 7.74 (d, JH,H = 7.9 Hz, 1H, PyH), 7.60 (m, 1H, PyH), 1.96-1.67 (m, 22H, CyH), 
1.55-1.28 (m, 14H, CyH), 1.22-0.96 (m, 6H, CyH), 0.86 (m, 2H, CyH), 0.59 (m), contains 
signals for ca. 10% [PtCl2(cod)]. HR-MS (ESI): m/z calcd. for C34H52ClN2P2Pt [M-Cl]
+ = 
781.3, obs. = 781.3. 
General procedure for the reaction between ligand and [PdCl2(NCPh)2)] in a 1:1 
ratio  
To a solution of [PdCl2(NCPh)2] (0.0200 g, 0.0521 mmol) in CH2Cl2 (1 mL) was added a 
solution of ligand (0.0521 mmol) in CH2Cl2 (1 mL). Upon completion, the solvent was 
removed under reduced pressure and the crude product was dissolved in toluene (5 mL). 
Volatiles were then removed under reduced pressure to yield the product(s).  
7.5.16 Synthesis of [PdCl2(к2-L5.3a)] (5.22a) 
Yellow solid (0.0100 g, 48%). Crystals suitable for analysis by single 
crystal X-ray diffraction were grown by slow diffusion of hexane into a 
saturated CH2Cl2 solution of 5.22a. 
31P{1H} NMR (162 MHz, CD2Cl2): 
P (ppm) -11.3 (s). 1H NMR (400 MHz, CD2Cl2): H (ppm) 8.88 (m, 1H, PyH), 8.08 (tt, 
JH,H = 7.9, 1.8 Hz, 1H, PyH), 7.64 (m, 1H, PyH), 7.55 (dd, JH,H = 7.9, 4.1 Hz, 1H, PyH), 
1.60 (d, 3JH,P = 17.1 Hz, 18H, C(CH3)3). 
13C{1H} NMR (101 MHz, CD2Cl2): C (ppm) 
149.4 (d, 1JC,P = 9 Hz, PyC), 139.9 (d, 
2JC,P = 4 Hz, PyCH), 130.8 (d, 
3JC,P = 3 Hz, PyCH), 
128.5 (d, 3JC,P = 1 Hz, PyCH), 116.9 (s, PyCH), 37.8 (d, 
1JC,P = 12 Hz, C(CH3)3), 29.7 (d, 
2JC,P = 3 Hz, C(CH3)3). HR-MS (ESI): m/z calcd. for C13H22ClNPPd [M-Cl]
+ = 364.02, 
obs. = 364.02. 
7.5.17 Synthesis of [PdCl2(к2-L5.4)] (5.22b) and [Pd2Cl4(L5.4)2] (5.23b) 
Yellow solid. 31P{1H} NMR (162 MHz, 
CD2Cl2): P (ppm) 42.8 (s, 67%, 5.23b), -30.2 
(s, 33%, 5.22b). 1H NMR (400 MHz, 
CD2Cl2): H (ppm) 9.12 (s, 1H, PyH), 8.30 
(m, 1H, PyH) 8.06 (m, 1H, PyH), 7.94 (m, 1H, PyH), 7.78 (s, 1H, PyH), 7.69-7.58 (m, 2H, 
PyH), 7.53-7.42 (m, 2H, PyH), 3.14 (br. s, 1H, CyH), 2.97 (br. s, 1H, CyH), 2.50-2.30 (m, 
5H, CyH), 2.18 (m, 2H, CyH), 2.06 (m, 2H, CyH), 2.00-1.69 (m, 14H, CyH), 1.44-1.20 
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(m, 12H, CyH), 1.14 (m, 2H, CyH). HR-MS (ESI): m/z calcd. for 5.23b C34H56Cl3N2P2Pd2 
[M-Cl+2H2]
+ = 871.4, obs. = 871.1. 
7.5.18 Synthesis of [Pd2Cl4(L5.5)2] (5.23c), cis- and trans-[PdCl2(L5.4)2] (5.24c) 




Light orange solid. 31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 34.2 (br. s, 80%, 5.23c), 
15.8 (s, 10%, trans-5.24c), 13.7 (s, 10%, cis-5.24c). HR-MS (ESI): m/z calcd. for 5.24 
C26H38ClN2P2Pd [M-Cl+H2]
+ = 581.1, obs. = 581.1; for 5.23c C26H38Cl3N2P2Pd2 [M-
Cl+H2]
+ = 757.0, obs. = 756.9. 
General procedure for the reaction between ligand and [PdCl2(NCPh)2)] in a 2:1 
ratio  
To a solution of [PdCl2(NCPh)2] (0.0200 g, 0.0521 mmol) in CH2Cl2 (1 mL) was added a 
solution of ligand (0.104 mmol) in CH2Cl2 (1 mL). Upon completion, the solvent was 
removed under reduced pressure and the crude product was dissolved in toluene (5 mL). 
Volatiles were then removed under reduced pressure to yield the product(s).  
7.5.19 Synthesis of [PdCl2(к2-L5.3a)] (5.22a), trans-[PdCl2(L5.3a)2] (trans-5.24a) and 
L5.3a 
Yellow solid. Crystals of trans-5.24a suitable for 
analysis by single crystal X-ray diffraction were 
grown by slow diffusion of hexane into a saturated 
CH2Cl2 solution of the mixture of 5.22a, trans-5.24a 
and L5.3a. 
31P{1H} NMR (162 MHz, CD2Cl2): P 
(ppm) 52.8 (s, 50%, trans-5.24a), 39.3 (s, 25%, L5.3a), -11.7 (s, 25%, 5.22a). 
1H NMR (400 
MHz, CD2Cl2): H (ppm) 8.89 (br. s, 1H, PyH), 8.68 (br s, 1H, PyH), 8.60 (d, JH,H = 3.4 
Hz, 1H, PyH), 8.07 (tt, JH,H = 8.0, 1.9 Hz, 1H, PyH), 7.95 (d, JH,H = 8.1 Hz, 1H, PyH), 
7.69-7.61 (m, 2H, PyH), 7.61-7.52 (m, 3H, PyH), 7.26-7.10 (m, 4H, PyH), 1.60 (d, 3JH,P = 
17.1 Hz, 36H, C(CH3)3), 1.20 (d, 
3JH,P = 11.6 Hz, 18H, C(CH3)3). 
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7.5.20 Synthesis of [Pd2Cl4(L5.4)2] (5.23b) and trans-[PdCl2(L5.4)2] (trans-5.24b) 
Yellow solid. 31P{1H} NMR (162 MHz, 
CD2Cl2): P (ppm) 42.8 (s, 25%, 5.23b), 
33.1 (s, 75%, trans-5.24b). 1H NMR (400 
MHz, CD2Cl2): H (ppm) 8.65 (m, 2H, 
PyH), 7.82 (m, 2H, PyH), 7.67 (m, 3H, PyH), 7.46 (m, 1H, PyH), 7.30-7.25 (m, 2H, PyH), 
7.23-7.18 (m, 1H, PyH), 7.17-7.08 (m, 1H, PyH), 2.31 (s, 2H, CyH), 2.11 (br. s, 4H, CyH), 
1.90-1.61 (m, 24H, CyH), 1.55-1.17 (m, 28H, CyH), 1.12 (m, 7H, CyH). HR-MS (ESI): 
m/z calcd. for trans-5.24b C34H52ClN2P2Pd [M-Cl]
+ = 691.2333, obs. = 691.2333; for 
5.23b C34H54Cl3N2P2Pd2 [M-Cl+H2]
+ = 869.0897, obs. = 869.0771.        
7.5.21 Synthesis of cis- and trans-[PdCl2(L5.5)2] (5.24c) 
Orange solid. Crystals of cis-5.24c suitable 
for analysis by single crystal X-ray 
diffraction were grown by slow diffusion 
of hexane into a saturated CH2Cl2 
solution of the mixture of cis- and trans-
5.24c. 31P{1H} NMR (162 MHz, CD2Cl2): 
P (ppm) 15.8 (s, 90%, cis-5.24c), 10.3 (s, 10%, trans-5.24c). 1H NMR (400 MHz, CD2Cl2): 
H (ppm) 8.66 (d, JH,H = 4.9 Hz, 1H, PyH), 8.28 (t, JH,H = 6.8 Hz, 1H, PyH), 7.83 (m, 1H, 
PyH), 7.36 (t, JH,H = 5.2 Hz, 1H, PyH), 2.10-0.78 (m, 36H, PhobH). HR-MS (ESI): m/z 
calcd. for C26H38ClN2P2Pd [M-Cl+H2]
+ = 581.1, obs. = 581.1. 
7.5.22 In situ synthesis of cis-[PdCl(к2-L5.5)(к1-L5.5)][BF4] (cis-5.25c[BF4]) 
A solution of cis- and trans-5.24c (0.0120 g, 0.0194 mmol) 
in CH2Cl2 (1 mL) was added to AgBF4 (0.004 g, 0.0194 
mmol). Immediately a white precipitate formed. The 
reaction was monitored by 31P{1H} NMR spectroscopy. In 
situ 31P{1H} NMR (162 MHz, CH2Cl2): P (ppm) 29.2 (d, 
2JP,P = 8 Hz, к
1-PhobP), -36.1 (d, 2JP,P = 9 Hz, к
2-PhobP).   
General procedure for the synthesis of trans-[RhCl(CO)L2] complexes (5.26a-c) 
To a solution of [Rh2Cl2(CO)4] (0.0200 g, 0.0515 mmol) in CH2Cl2 (1 mL) was added a 
solution of ligand (0.206 mmol) in CH2Cl2 (1 mL). Upon completion, the product was 
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precipitated with hexane (ca. 10 mL). The solid was allowed to settle and the supernatant 
was removed; the precipitate was then washed with hexane (3 x 2 mL). Residual solvent 
was then removed from the solid under reduced pressure to yield the product.  
7.5.23 Synthesis of trans-[RhCl(CO)(L5.3a)2] (5.26a) 
An equilibrium between complexes 
5.26a and 5.26a’ was established. Dark 
orange solid. 31P{1H} NMR (162 MHz, 
CD2Cl2): P (ppm) 60.3 (br. d, 1JP,Rh = 
124 Hz, 5.26a), 43.3 (br. s, 5.26a’), 39.5 
(s, L5.3a), 35.5 (d, 
1JP,Rh = 136 Hz, <5%, unidentified species). 
31P{1H} NMR (162 MHz, 
CD2Cl2, -90 °C): P (ppm) 66.5 (br. dd, 2JP,P = 242 Hz, 1JP,Rh = 128Hz, к1-tBu2P  5.26a’), 
16.7 (br. d, 2JP,P = 226 Hz, к
2-tBu2P 5.26a’). HR-MS (ESI): m/z calcd. for C27H44N2OP2Rh 
[M-Cl]+ = 577.2, obs. = 577.2. IR (CH2Cl2): (CO) = 1956 cm
-1. 
7.5.24 Synthesis of trans-[RhCl(CO)(L5.4)2] (5.26b)  
Light brown solid (0.0281 g, 76%). 31P{1H} NMR (162 MHz, 
CD2Cl2): P (ppm) 41.2 (d, 1JP,Rh = 122 Hz). 1H NMR (400 MHz, 
CD2Cl2): H (ppm) 8.71 (d, JH,H = 4.7 Hz, 1H, PyH), 8.00 (d, JH,H = 
7.3 Hz, 1H, PyH), 7.73 (t, JH,H = 7.8 Hz, 1H, PyH), 7.29 (dd, JH,H = 
7.6, 4.9 Hz, 1H, PyH), 2.88 (m, 2H, CyH), 2.15 (br. s, 2H, CyH), 1.83-1.67 (m, 8H, CyH), 
1.35 (m, 8H, CyH), 1.11 (m, 2H, CyH). 13C{1H} NMR (101 MHz, CD2Cl2): C (ppm) 
221.8 (m, Rh-CO), 126.1 (vir. t, JC,P = 26 Hz, PyC), 149.6 (vir. t, JC,P = 5 Hz, PyCH), 135.1 
(vir. t, JC,P = 5 Hz, PyCH), 133.7 (vir. t, J C,P = 14 Hz, PyCH), 124.3 (s, PyCH), 32.3 (vir. t, 
JC,P = 12 Hz, CyCH2), 29.3 (s, CyCH2), 29.2 (s, CyCH2), 27.7 (vir. t, JC,P = 7 Hz, CyCH2), 
27.5 (vir. t, JC,P = 5 Hz, CyCH2), 27.1 (s, CyCH2). HR-MS (ESI): m/z calcd. for 
C35H52N2OP2Rh [M-Cl]
+ = 681.2604, obs. = 681.2597. IR (CH2Cl2): (CO) = 1961 cm
-1. 
7.5.25 Synthesis of trans-[RhCl(CO)(L5.5)2] (5.26c)  
Only ca. 80% pure by 31P{1H} NMR; other unidentifiable Rh 
species present. 31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 
17.9 (d, 1JP,Rh = 120 Hz). HR-MS (ESI): m/z calcd. for 
C27H36ClKN2OP2Rh [M+K]
+ = 643.1, obs. = 643.1. IR 
(CH2Cl2): (CO) = 1969 cm
-1. 
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7.5.26 Catalytic methoxycarbonylation of phenylacetylene and 3,3’-
dimethylbutyne (Method A)    
Adapted from a previously reported procedure.34,35 Catalysis was performed using a 
Baskerville “Multi-Cell” autoclave. The ligand (0.11 mmol) was added to the autoclave 
and the system put under an atmosphere of N2. Solutions of Pd(OAc)2 (5.5 x 10
-3 mmol) 
in MeOH (0.5 mL) and TsOH.H2O (0.22 mmol) in MeOH (0.5 mL) were added, followed 
by the substrate (5.5 mmol). This was then washed in using MeOH (0.5 mL) and the 
autoclave flushed with three cycles of CO (ca. 10 bar). The autoclave was then pressurised 
to 45 bar and heated to 60 °C. After either 1 h or 4.5 h, the autoclave was transferred to 
an ice bath and once cooled, the system was vented. 
When using 3,3’-dimethylbutyne as the substrate, a small sample of the reaction mixture 
was dissolved in CDCl3 and analysed by 
1H NMR spectroscopy. Conversion and 
selectivity were determined by integration of the 3,3’-dimethylbutyne alkynyl proton (H 
2.05 ppm) and the 4,4’-dimethyl-methylester (H 7.10 and 6.02 ppm) and 3,3’-dimethyl-2-
methylene-methylester (H 5.87 and 5.48 ppm) alkenyl protons. For phenylacetylene, see 
below (Section 7.5.27).  
7.5.27 Catalytic methoxycarbonylation of phenylacetylene (Method B)  
Adapted from a previously reported procedure.34,35 Catalysis was performed using a 
Baskerville “Multi-Cell” autoclave. The ligand (5.5 x 10-2 mmol) was added to the 
autoclave and the system was put under an atmosphere of N2. Solutions of Pd(OAc)2 (2.8 
x 10-3 mmol) in MeOH (0.5 mL) and TsOH.H2O (0.11 mmol) in MeOH (0.5 mL) were 
added, followed by phenylacetylene (5.5 mmol). This was then washed in using MeOH 
(0.5 mL) and the autoclave was flushed with three cycle of CO (ca. 10 bar). The autoclave 
was then pressurised to 45 bar and heated to 60 °C. After 15 min or 1 h, the autoclave 
was transferred to an ice bath and once cooled, the system was vented. 
When using phenylacetylene, for both methods A and B, a small sample of the reaction 
mixture was dissolved in CDCl3 and analysed by 
1H NMR spectroscopy. Conversion and 
selectivity were determined by integration of the phenylacetylene alkynyl proton (H 3.10 
ppm) and the methyl atropate (H 6.38 and 5.90 ppm) and methyl cinnamate (H 7.71 and 
6.42 ppm) alkenyl protons. 
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7.5.28 Catalytic methoxycarbonylation of phenylacetylene on a larger scale  
The following procedure was performed and supplied by Dr M. Waugh and M. Nixon (at 
Lucite).36 In a N2 glove-box, [Pd(OAc)2] (0.0370 g, 0.164 mmol) and the appropriate ligand 
(3.30 mmol for 0.1 mol% cat loading) were added to a schlenk flask. The schlenk flask 
was removed from the glove-box and put under an atmosphere of N2. MeOH (200 mL) 
was then added, followed by TsOH.H2O (1.26 g, 6.60 mmol) in MeOH, and 
phenylacetylene (17.1 g, 167 mmol). The autoclave was put under vacuum for 30 min and 
the catalyst solution was then added. The autoclave was then pressurised to 45 bar of CO 
and heated to 60 °C. After 4 h, unless otherwise stated, the autoclave was cooled to 
ambient temperature and the system was vented.  
A sample of the reaction mixture was dissolved in CDCl3 and analysed by 
1H NMR 
spectroscopy: conversion and selectivity were determined by setting the integral area for 
the phenyl protons to 903 in this case (H 7.38-7.30 ppm), because 903 mmol of phenyl 
protons were present in the reaction mixture at the start of the reaction, and integrating 
the relative methyl atropate alkenyl signal (H 6.34 ppm) (which if 100% conversion was 
achieved would be equal to 165).36 
7.5.29 Catalytic methoxycarbonylation of propyne  
The following procedure was performed and supplied by Dr M. Waugh and M. Nixon (at 
Lucite).36 In a N2 glove-box, [Pd(OAc)2] and the appropriate ligand were added to a 
schlenk flask. The schlenk flask was removed from the glove-box and put under an 
atmosphere of N2. MeOH (200 mL) was then added, followed by TsOH.H2O in MeOH 
(100 mL). The autoclave was put under vacuum for 30 min and then the catalyst solution 
was added. Propyne was condensed into a pre-evacuated cooled pressure bomb and then 
added to the autoclave, which was then pressurised to 45 bar of CO and heated at 60 °C. 
The gas pressure of the autoclave was monitored throughout the reaction. After 4 h, 
unless otherwise stated, the autoclave was cooled to ambient temperature and the system 
was vented.  
The reaction mixture was distilled under vacuum and the volatiles were collected in a 
liquid N2 cooled flask. The volatiles were allowed to warm to ambient temperature and 
then weighed and analysed by Agilent GC. The % weight of methyl methacrylate (MMA) 
and methyl crotonate in the reaction volatiles were calculated from the GC analysis, and 
in combination with the mass of the reaction volatiles the mass of the products were 
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determined and therefore the selectivity and turnover number calculated (TON = mol of 
product produced per mol of Pd catalyst used).  
7.6 Chapter 6  
7.6.1 Synthesis of [Rh(acac)(cod*)] complexes ((S,S)-/rac-6.6) 
The following procedure was modified from the literature.3 The 
following reaction was carried out in a N2 glove-box. To a solution of 
[Rh(acac)(C2H4)2] (0.200 g, 0.774 mmol) in CDCl3 (5 mL) was added 
rac-cod* (0.153 g, 0.929 mmol, 73% wt% soln in pentane).3,37 The reaction vessel was open 
to the N2 atmosphere in order to release the C2H4 that was generated. The reaction was 
monitored by 1H NMR spectroscopy and stirred for 30 h. Upon completion the volatiles 
were removed under reduced pressure (1 x10-6 Torr) to yield the product as a yellow solid 
(0.161 g, 64%). 1H NMR (400 MHz, CDCl3): H (ppm) 5.32 (s, 1H, acac CH), 4.45 (m, 
2H, cod* CH), 3.82 (m, 2H, cod* CH), 2.81 (dt, JH,H = 15.2, 4.2 Hz, 2H, cod* CH), 2.12 
(m, 4H, cod* CH2), 1.92 (d, JH,H = 0.6, 6H, acac CH3), 1.16 (m, 2H, cod* CH2). 
1H NMR 
data agreed with the literature data.3 The same procedure was used to prepare the 
enantiomerically pure complex (S,S)-6.6, but (S,S)-cod* was used instead of rac-cod*.    
General procedure for the synthesis of cis-[Rh(cod*)L2][OTf] complexes (6.7a-e) 
To a solution of rac-6.6 (0.0220 g, 0.0681 mmol) and the ligand (0.0280 g, 0.136 mmol) in 
CH2Cl2 (1 mL) was added Me3SiOTf (1.00 mL, 0.0681 mmol, 1.26 M in CH2Cl2). Upon 
completion of the reaction, the volatiles were removed under reduced pressure. The 
product was precipitated with hexane (ca. 10 mL). The solid was allowed to settle and the 
supernatant was removed; residual solvent was then removed from the solid under 
reduced pressure to yield the product. The same procedure was used to prepare the 
enantiomerically pure complexes 6.7a* and 6.7b*, but (S,S)-6.6 was used instead of rac-
6.6. 
7.6.2 Synthesis of cis-[Rh(rac-cod*)(L6.1)2][OTf] (6.7a) 
Orange solid (0.0370 g, 70%). Crystals of -(S,S)-6.7a suitable 
for analysis by single crystal X-ray diffraction were grown by 
slow diffusion of hexane into a saturated chlorobenzene 
solution of 6.7a. 31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 
9.5 (s, 2%), 2.0 (d, 1JP,Rh = 147 Hz, 95%), 1.7 (d, 
1JP,Rh = 145 Hz, 5%, minor diastereomer). 
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1H NMR (400 MHz, CD2Cl2): H (ppm) 5.76 (d, JH,H = 7.5 Hz, 2H, cod* CH), 5.68 (m, 
0.1H, cod* CH (minor diastereomer)), 4.47 (m, 2H, cod* CH), 4.28 (m, 0.1H, cod* CH 
(minor diastereomer)), 2.53 (s, 4H, cod* CH2), 2.36-1.72 (m, 38H, CH2, CH), 1.52 (m, 
2H, CH2), 1.16 (vir. t, JH,H = 5.8 Hz, 12H, iBu-CH3). 
13C{1H} NMR (101 MHz, CD2Cl2): 
C (ppm) 94.7 (s, cod* CH), 94.0 (s, cod* CH), 40.6 (s, CH2), 34.9 (m, CH2), 32.5 (s, CH2), 
31.2 (s, CH2), 31.1 (s, CH2), 28.8 (s, CH), 28.0 (s, CH), 27.2 (m, CH2), 27.0 (s, CH), 26.6 
(s, CH), 26.4 (s, iBu-(CH3)2), 24.4 (s, iBu-(CH3)2), 22.3 (s, CH2), 19.4 (s, CH2). HR-MS 
(ESI): m/z calc. for C33H58P2Rh [M-OTf]
+ = 619.3069; obs = 619.3060.  
7.6.3 Synthesis of cis-[Rh(rac-cod*)(L6.2)2][OTf] (6.7b) 
Orange solid (0.0320 g, 60%). Crystals of -(S,S)- and -(R,R)-
6.7b suitable for analysis by single crystal X-ray diffraction 
were grown by slow diffusion of hexane into a saturated 
chlorobenzene solution of 6.7b. 31P{1H} NMR (162 MHz, 
CD2Cl2): P (ppm) 4.2 (d, 1JP,Rh = 145 Hz, 4%, minor diastereomer), 0.4 (d, 1JP,Rh = 146 Hz, 
96%). 1H NMR (400 MHz, CD2Cl2): H (ppm) 5.56 (d, JH,H = 7.5 Hz, 2H, cod* CH), 5.29 
(s, 0.1H, cod* CH (minor diastereomer)), 4.51 (t, JH,H = 6.6 Hz, 2H, cod* CH), 4.10 (br. 
s, 0.1H, cod* CH (minor diastereomer)), 2.51 (s, 4H, cod* CH2), 2.36 (m, 4H), 2.19-1.41 
(m, 48H, CH2, CH), 1.01 (t, 
3JH,H = 7.3 Hz, 6H, nBu-CH3). 
13C{1H} NMR (101 MHz, 
CD2Cl2): C (ppm) 95.3 (s, cod* CH), 94.5 (s, cod* CH), 39.4 (s, CH2), 30.5 (m, CH2), 30.2 
(s, CH2), 28.5 (s, CH2), 27.5 (m, CH), 26.7 (s, CH), 26.5 (s, CH2), 25.3 (m, CH2), 24.9 (m, 
CH2), 21.6 (m, CH2, CH), 18.2 (s, CH2), 13.6 (s, nBu-CH3). HR-MS (ESI): m/z calc. for 
C33H58P2Rh [M-OTf]
+ = 619.3069; obs = 619.3058.  
7.6.4 Synthesis of cis-[Rh(rac-cod*)(L6.3)2][OTf] (6.7c) 
Orange solid (0.0240 g, 46%). 31P{1H} NMR (162 MHz, 
CD2Cl2): P (ppm) 41.8 (d, 1JP,Rh = 142 Hz, 90%), 40.3 (d, 1JP,Rh 
= 140 Hz, 10%). 1H NMR (400 MHz, CD2Cl2): H (ppm) 6.05 
(m, 0.2H, cod* CH (minor diastereomer)), 5.79 (m, 2H, cod* 
CH), 4.57 (m, 0.2H cod* CH (minor diastereomer)), 4.40 (m, 
2H, cod* CH), 2.71 (m, 2H, cod* CH), 2.55-1.39 (m, 48H, CH, CH2), 1.09 (d, 
3JH,H = 6.6 
Hz, 6H, iBu-CH3), 1.03 (d, 
3JH,H = 6.5 Hz, 6H, iBu-CH3). HR-MS (ESI): m/z calc. for 
C33H58P2Rh [M-OTf]
+ = 619.3069; obs = 619.3049. 
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7.6.5 Synthesis of cis-[Rh(rac-cod*)(L6.4)2][OTf] (6.7d) 
Orange solid (0.0280 g, 52%). 31P{1H} NMR (162 MHz, 
CD2Cl2): P (ppm) 50.3 (d, 1JP,Rh = 145 Hz, 10%, unidentified 
species), 40.5 (d, 1JP,Rh = 141 Hz, 84%), 40.7 (d, 
1JP,Rh = 142 
Hz, 6%, minor diastereomer). 1H NMR (400 MHz, CD2Cl2): 
H (ppm) 6.05 (m, 0.2H, cod* CH (minor diastereomer)), 5.72 
(d, JH,H = 7.4 Hz, 2H, cod* CH), 4.54 (t, 
3JH,H = 5.9 Hz, 2H, cod* CH), 4.07 (br. s, 0.2H, 
cod* CH (minor diastereomer)), 2.44-1.40 (m, 90H, CH2, CH), 1.25 (m, 10H, CH, CH2), 
0.94 (m, 10H, nBu-CH3), 0.85 (m, 14H, CH3), mixture contained impurities. HR-MS 
(ESI): m/z calc. for C33H58P2Rh [M-OTf]
+ = 619.3069; obs = 619.3043.  
7.6.6 Synthesis of cis-[Rh(rac-cod*)(L6.5)2][OTf] (6.7e) 
The workup described above yielded an oily residue, so the 
product was triturated with Et2O (10 mL). The solid was 
allowed to settle, and supernatant was removed; residual 
solvent was then removed from the solid under reduced 
pressure to yield the product as an orange solid (0.0150 g, 
28%). 31P{1H} NMR (162 MHz, CD2Cl2): P (ppm) 40.7 (d, 1JP,Rh = 142 Hz, 35%, minor 
diastereomer), 38.8 (d, 1JP,Rh = 140 Hz, 65%). 
1H NMR (400 MHz, CD2Cl2): H (ppm) 5.36 
(br. m, 1H, cod* CH (minor diastereomer)), 5.24 (br. m, 2H, cod* CH),  4.27 (br. s, 3H, 
cod* CH), 2.52-2.29 (m, 14H, CH2, CH), 2.21-1.51 (m, 58H, CH2, CH), 1.01 (vir. t, JH,H = 
7.3 Hz, 9H, nBu-CH3). HR-MS (ESI): m/z calc. for C33H58P2Rh [M-OTf]
+ = 619.3069; 
obs = 619.3067. 
7.6.7 Procedure for the kinetic study on the epimerisation of complexes 6.7a-e 
At 0 °C, to a solution of rac-6.6 (0.0110 g, 0.0341 mmol) and the ligand (0.0140 g, 0.069 
mmol) in CH2Cl2 (0.5 mL) was added Me3SiOTf (0.5 mL, 0.0341 mmol, 1.26 M in CH2Cl2). 
The NMR sample was kept at 0 °C until the 31P{1H} NMR spectroscopic kinetic data was 
collected, at ambient temperature.   
7.6.8 Catalytic asymmetric hydrogenation procedure  
Catalysis was performed using a Baskerville “Multi-Cell” autoclave. Pre-prepared 
complexes 6.7a or 6.7a* and the appropriate substrate (0.200 mmol) were added to the 
autoclave and the system was put under a N2 atmosphere. The appropriate solvent (3 or 
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5 mL) was then added and the reaction mixture stirred for 5 min to ensure the solutions 
were homogenised. For the runs conducted at lower temperatures, the autoclave was 
placed in the appropriate cooling bath and stirred for a further 10 min to reach the 
required temperature. The autoclave was then flushed with three cycles of H2 (ca. 10 bar) 
and pressurised with H2. After stirring the reaction mixture for the required time, the 
system was vented. A small sample (0.2 mL) of the reaction mixture was dissolved in 
CH2Cl2 and analysed by GC.  
GC conditions for enantiomer resolution: 
MAA: Varian CP-Chirasil-DEX CD (25 m) column. 90 °C for 1 min, then 5 °C/min to 
140 °C for 11 min. Retention times: 7.71 (S), 7.89 (R). 
MAC: Varian CP-Chirasil-DEX CD (25 m) column. 120 °C for 1 min, then 3 °C/ min to 
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8.1 X-ray crystallography  
All X-ray diffraction experiments were carried out at 100 K, with the exception of 2.10b 
and L4.2 which were carried out at 200 K. All data were collected on a Bruker APEX II 
diffractometer using Mo-K radiation ( = 0.71073 Å). Intensities were integrated in 
SAINT1 and absorption corrections based on equivalent reflections were applied using 
SADABS.2 All structures were solved using ShelXT,3 ShelXS4 and Superflip,5,6 and refined 
by full matrix least squares against F2 in ShelXL4,7 using Olex2.8 All of the non-hydrogen 
atoms were refined anisotropically. While all of the hydrogen atoms were located 
geometrically and refined using a riding model. Crystal structure and refinement data are 
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Table 8.1 Crystal data.  
 
 
Identification code 2.7a 2.7b 2.7c 
Empirical formula C16H8F2MoO8P2 C24H12F2MoO8P2 C28H16F2MoO8P2 
Formula weight 524.10 624.22 676.29 
Temperature/K 100(2) 100(2) 100(2) 
Crystal system orthorhombic orthorhombic monoclinic 
Space group Pnma Fdd2 P21/c 
a/Å 13.9152(3) 43.6028(6) 17.5271(6) 
b/Å 20.6660(4) 9.9809(2) 7.6758(3) 
c/Å 6.43140(10) 10.58170(10) 21.0653(7) 
α/° 90 90 90 
β/° 90 90 111.373(2) 
γ/° 90 90 90 
Volume/Å3 1849.49(6) 4605.10(12) 2639.11(17) 
Z 4 8 4 
ρcalcg/cm3 1.882 1.801 1.702 
μ/mm-1 0.946 0.776 0.684 
F(000) 1032.0 2480.0 1352.0 
Crystal size/mm3 0.344 × 0.325 × 0.199 0.294 × 0.288 × 0.126 0.402 × 0.258 × 0.252 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) MoKα (λ = 0.71073) 
2θ range for data collection/° 3.942 to 55.988 5.688 to 55.826 3.99 to 55.946 
Index ranges 
-18 ≤ h ≤ 18, 
-26 ≤ k ≤ 27, 
-8 ≤ l ≤ 8 
-57 ≤ h ≤ 57, 
-13 ≤ k ≤ 13, 
-13 ≤ l ≤ 11 
-23 ≤ h ≤ 22, 
-9 ≤ k ≤ 10, 
-27 ≤ l ≤ 27 
Reflections collected 15356 10131 23439 
Rint / Rsigma 0.0247 / 0.0151 0.0193 / 0.0170 0.0216 /0.0207 
Data/restraints/parameters 2297/0/139 2624/1/168 6334/0/370 
Goodness-of-fit on F2 1.109 1.112 1.028 
Final R indexes [I>=2σ (I)] 
R1 = 0.0205, 
wR2 = 0.0466 
R1 = 0.0145, 
wR2 = 0.0375 
R1 = 0.0211, 
wR2 = 0.0529 
Final R indexes [all data] 
R1 = 0.0232, 
wR2 = 0.0478 
R1 = 0.0148, 
wR2 = 0.0376 
R1 = 0.0249, 
wR2 = 0.0546 
Largest diff. peak/hole / e Å-3 0.56/-0.39 0.25/-0.24 0.38/-0.39 
Flack parameter - -0.035(11) - 
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Identification code 2.7d 2.7e 2.8c  
Empirical formula C30H20F2MoO8P2 C26H18MoO10P2 C24H16Cl2F2O4P2Pt  
Formula weight 704.34 648.28 734.30  
Temperature/K 100(2) 100(2) 100(2)  
Crystal system triclinic triclinic triclinic  
Space group P-1 P-1 P-1  
a/Å 9.0915(3) 8.2570(2) 8.9338(2)  
b/Å 12.3578(5) 11.6685(3) 9.8824(2)  
c/Å 13.8479(5) 14.7840(4) 15.4858(4)  
α/° 104.240(2) 69.9560(10) 99.689(2)  
β/° 98.951(3) 76.9430(10) 94.617(2)  
γ/° 100.618(3) 83.4250(10) 115.7300(10)  
Volume/Å3 1448.86(9) 1302.45(6) 1195.78(5)  
Z 2 2 2  
ρcalcg/cm3 1.614 1.653 2.039  
μ/mm-1 0.627 0.684 6.271  
F(000) 708.0 652.0 704.0  
Crystal size/mm3 0.256 × 0.231 × 0.15 0.297 × 0.279 × 0.216 0.259 × 0.145 × 0.08  
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) MoKα (λ = 0.71073)  
2θ range for data collection/° 4.664 to 55.98 2.992 to 55.934 4.698 to 55.9  
Index ranges 
-11 ≤ h ≤ 11, 
-16 ≤ k ≤ 16, 
-18 ≤ l ≤ 18 
-10 ≤ h ≤ 10, 
-15 ≤ k ≤ 15, 
-19 ≤ l ≤ 19 
-11 ≤ h ≤ 11, -13 ≤ k ≤ 
13, -19 ≤ l ≤ 20  
Reflections collected 26861 24212 21890  
Rint / Rsigma 0.0525 / 0.0495 0.0265 / 0.0245 
5733 [Rint = 0.0438, Rsigma 
= 0.0416]  
Data/restraints/parameters 6977/0/388 6269/0/354 5733/0/316  
Goodness-of-fit on F2 1.014 1.022 1.065  
Final R indexes [I>=2σ (I)] 
R1 = 0.0342, 
wR2 = 0.0668 
R1 = 0.0238, 
wR2 = 0.0558 
R1 = 0.0261, wR2 = 
0.0498  
Final R indexes [all data] 
R1 = 0.0484, 
wR2 = 0.0719 
R1 = 0.0278, 
wR2 = 0.0577 
R1 = 0.0336, wR2 = 
0.0516  
Largest diff. peak/hole / e Å-3 0.47/-0.51 0.49/-0.36 1.16/-0.99  
Flack parameter - - - 
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Table 8.1 Crystal data (continued).  
Identification code 2.8e 2.10b·C6H5Cl 2.10e 
Empirical formula C22H18Cl2O6P2Pt C46H29ClF4O8P4Pt C44H36O12P4Pt 
Formula weight 706.29 1140.11 1075.70 
Temperature/K 100.0 200(2) 99.98 
Crystal system triclinic tetragonal triclinic 
Space group P-1 P4/n P-1 
a/Å 8.2014(2) 15.2985(4) 11.8627(2) 
b/Å 9.8489(2) 15.2985(4) 12.1538(2) 
c/Å 14.7353(3) 8.8050(3) 15.4498(3) 
α/° 77.3976(10) 90 83.6712(10) 
β/° 83.9807(9) 90 77.7952(10) 
γ/° 75.1287(10) 90 73.4378(10) 
Volume/Å3 1121.15(4) 2060.76(13) 2083.86(7) 
Z 2 2 2 
ρcalcg/cm3 2.092 1.837 1.714 
μ/mm-1 6.678 3.701 3.586 
F(000) 680.0 1120.0 1068.0 
Crystal size/mm3 0.376 × 0.292 × 0.058 0.379 × 0.117 × 0.102 0.449 × 0.293 × 0.084 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) MoKα (λ = 0.71073) 
2Θ range for data collection/° 2.836 to 60.43 3.766 to 55.762 3.502 to 59.148 
Index ranges 
-11 ≤ h ≤ 11, -13 ≤ k ≤ 
13, -20 ≤ l ≤ 20 
-20 ≤ h ≤ 19, 
-18 ≤ k ≤ 20, 
-11 ≤ l ≤ 11 
-16 ≤ h ≤ 16, 
-16 ≤ k ≤ 16, 
-21 ≤ l ≤ 21 
Reflections collected 25381 18431 45772 
Independent reflections 
6657 [Rint = 0.0332, 
Rsigma = 0.0304] 
0.0734 / 0.0435 0.0322 / 0.0286 
Data/restraints/parameters 6657/360/391 2476/85/180 11692/0/554 
Goodness-of-fit on F2 1.042 1.176 1.033 
Final R indexes [I>=2σ (I)] 
R1 = 0.0198, wR2 = 
0.0424 
R1 = 0.0390, 
wR2 = 0.0679 
R1 = 0.0195, 
wR2 = 0.0437 
Final R indexes [all data] 
R1 = 0.0230, wR2 = 
0.0433 
R1 = 0.0587, 
wR2 = 0.0724 
R1 = 0.0219, 
wR2 = 0.0445 
Largest diff. peak/hole / e Å-3 1.25/-0.65 0.64/-0.78 0.95/-0.81 
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Identification code L2.8 2.7h  L4.2 
Empirical formula C12H10FO2P C28H20F2MoO8P2  C30H18O6P2  
Formula weight 236.17 680.32  536.38  
Temperature/K 100(2) 100(2)  200(2)  
Crystal system triclinic monoclinic  triclinic  
Space group P-1 P21/c  P-1  
a/Å 8.3229(2) 7.8434(2)  7.2434(2)  
b/Å 8.5875(2) 18.9214(4)  11.7049(3)  
c/Å 8.7858(3) 18.5143(4)  14.2729(4)  
α/° 68.494(2) 90  84.8305(14)  
β/° 84.637(2) 90.6770(10)  88.0629(15)  
γ/° 65.826(2) 90  81.1711(14)  
Volume/Å3 531.81(3) 2747.48(11)  1190.66(6)  
Z 2 4  2  
ρcalcg/cm3 1.475 1.645  1.496  
μ/mm-1 0.252 0.658  0.230  
F(000) 244.0 1368.0  552.0  
Crystal size/mm3 0.301 × 0.25 × 0.16 0.474 × 0.371 × 0.206  0.509 × 0.349 × 0.25  
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073)  MoKα (λ = 0.71073)  
2Θ range for data collection/° 4.994 to 55.702 3.078 to 55.906  3.534 to 55.7  
Index ranges 
-10 ≤ h ≤ 10, -11 ≤ k ≤ 
11, -11 ≤ l ≤ 11 
-10 ≤ h ≤ 10, -24 ≤ k ≤ 
24, -24 ≤ l ≤ 24  
-9 ≤ h ≤ 9, -15 ≤ k 
≤ 15, -18 ≤ l ≤ 18  
Reflections collected 8986 25012  21422  
Independent reflections 
2531 [Rint = 0.0277, 
Rsigma = 0.0266] 
6604 [Rint = 0.0305, 
Rsigma = 0.0283]  
5652 [Rint = 0.0229, 
Rsigma = 0.0209]  
Data/restraints/parameters 2531/0/147 6604/0/374  5652/0/343  
Goodness-of-fit on F2 1.049 1.037  1.051  
Final R indexes [I>=2σ (I)] 
R1 = 0.0408, wR2 = 
0.1073 
R1 = 0.0264, wR2 = 
0.0599  
R1 = 0.0420, wR2 = 
0.1105  
Final R indexes [all data] 
R1 = 0.0543, wR2 = 
0.1160 
R1 = 0.0346, wR2 = 
0.0632  
R1 = 0.0500, wR2 = 
0.1153  
Largest diff. peak/hole / e Å-3 0.56/-0.37 0.40/-0.33  0.29/-0.36  
Flack parameter - -  
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Identification code 4.10 L5.2 5.14 
Empirical formula C32H24O6P2Pt C17H13ClNP  C34H26Cl4N2P2Pt  
Formula weight 761.54 297.70  861.40  
Temperature/K 100(2) 100(2)  100(2)  
Crystal system monoclinic monoclinic  monoclinic  
Space group P21/c P21/c  P21/n  
a/Å 12.9862(3) 12.6658(3)  10.9748(15)  
b/Å 14.8874(3) 9.3254(3)  18.760(2)  
c/Å 18.1010(3) 12.6606(3)  16.123(2)  
α/° 90 90  90  
β/° 93.6582(11) 97.254(2)  98.839(9)  
γ/° 90 90  90  
Volume/Å3 3492.35(12) 1483.42(7)  3280.2(7)  
Z 4 4  4  
ρcalcg/cm3 1.448 1.333  1.744  
μ/mm-1 4.146 0.354  4.729  
F(000) 1488.0 616.0  1680.0  
Crystal size/mm3 0.49 × 0.34 × 0.06 0.536 × 0.391 × 0.174  0.207 × 0.179 × 0.101  
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073)  MoKα (λ = 0.71073)  
2Θ range for data collection/° 3.142 to 60.264 3.242 to 55.862  4.206 to 55.89  
Index ranges 
-18 ≤ h ≤ 18, -21 ≤ k ≤ 
20, -25 ≤ l ≤ 25 
-16 ≤ h ≤ 16, -12 ≤ k ≤ 
10, -16 ≤ l ≤ 16  
-14 ≤ h ≤ 14, -24 ≤ k 
≤ 24, -19 ≤ l ≤ 21  
Reflections collected 68905 12766  29519  
Independent reflections 
10292 [Rint = 0.0472, 
Rsigma = 0.0301] 
3556 [Rint = 0.0374, 
Rsigma = 0.0367]  
7788 [Rint = 0.0765, 
Rsigma = 0.0741]  
Data/restraints/parameters 10292/0/372 3556/0/181  7788/547/487  
Goodness-of-fit on F2 1.041 1.026  1.017  
Final R indexes [I>=2σ (I)] 
R1 = 0.0213, wR2 = 
0.0490 
R1 = 0.0361, wR2 = 
0.0791  
R1 = 0.0407, wR2 = 
0.0730  
Final R indexes [all data] 
R1 = 0.0296, wR2 = 
0.0512 
R1 = 0.0512, wR2 = 
0.0859  
R1 = 0.0589, wR2 = 
0.0787  
Largest diff. peak/hole / e Å-3 1.04/-0.98 0.45/-0.24  0.78/-1.11  
Flack parameter - - - 
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Identification code cis-5.16 5.18 5.19a  
Empirical formula C34H26Cl4N2P2Pd  C35H26Cl3N2OP2Rh  C26H44Cl4N2P2Pt2  
Formula weight 772.71  761.78  978.55  
Temperature/K 100(2)  100(2)  100(2)  
Crystal system monoclinic  orthorhombic  orthorhombic  
Space group P21/n  Iba2  P212121  
a/Å 10.9124(6)  16.5553(4)  9.6258(3)  
b/Å 18.6581(10)  30.6526(7)  11.4622(3)  
c/Å 16.1039(8)  12.9723(3)  14.8141(4)  
α/° 90  90  90  
β/° 99.292(4)  90  90  
γ/° 90  90  90  
Volume/Å3 3235.8(3)  6583.0(3)  1634.48(8)  
Z 4  8  2  
ρcalcg/cm3 1.586  1.537  1.988  
μ/mm-1 1.031  0.891  8.993  
F(000) 1552.0  3072.0  936.0  
Crystal size/mm3 0.188 × 0.182 × 0.122  0.496 × 0.327 × 0.304  0.385 × 0.319 × 0.148  
Radiation MoKα (λ = 0.71073)  MoKα (λ = 0.71073)  MoKα (λ = 0.71073)  
2Θ range for data collection/° 3.366 to 52.742  2.796 to 56.012  4.494 to 55.848  
Index ranges 
-13 ≤ h ≤ 13, -22 ≤ k 
≤ 23, -20 ≤ l ≤ 19  
-21 ≤ h ≤ 21, -40 ≤ k ≤ 
40, -16 ≤ l ≤ 17  
-12 ≤ h ≤ 12, -15 ≤ k 
≤ 15, -19 ≤ l ≤ 19  
Reflections collected 23407  30238  14684  
Independent reflections 
6616 [Rint = 0.0965, 
Rsigma = 0.1000]  
7668 [Rint = 0.0378, 
Rsigma = 0.0364]  
3905 [Rint = 0.0313, 
Rsigma = 0.0294]  
Data/restraints/parameters 6616/1193/521  7668/1/397  3905/0/169  
Goodness-of-fit on F2 1.068  1.021  1.045  
Final R indexes [I>=2σ (I)] 
R1 = 0.0585, wR2 = 
0.1026  
R1 = 0.0231, wR2 = 
0.0456  
R1 = 0.0178, wR2 = 
0.0334  
Final R indexes [all data] 
R1 = 0.1034, wR2 = 
0.1154  
R1 = 0.0260, wR2 = 
0.0466  
R1 = 0.0189, wR2 = 
0.0336  
Largest diff. peak/hole / e Å-3 0.73/-0.82  0.43/-0.23  0.49/-0.60  
Flack parameter - -0.003(12) -0.020(4) 
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Table 8.1 Crystal data (continued).  
 
 
Identification code 5.22a trans-5.24a  cis-5.24c·CH2Cl2 
Empirical formula C13H22Cl2NPPd C26H44Cl2N2P2Pd  C26.7H37.4Cl3.4N2P2Pd  
Formula weight 400.58 623.87  675.25  
Temperature/K 100(2) 100(2)  100(2)  
Crystal system orthorhombic monoclinic  monoclinic  
Space group Pbca P21/c  P21/c  
a/Å 15.0320(3) 10.9700(3)  10.8894(3)  
b/Å 13.2243(3) 8.2389(2)  9.7232(3)  
c/Å 16.4720(3) 16.4000(4)  28.5291(8)  
α/° 90 90  90  
β/° 90 106.542(2)  90.719(2)  
γ/° 90 90  90  
Volume/Å3 3274.43(12) 1420.90(6)  3020.42(15)  
Z 8 2  4  
ρcalcg/cm3 1.625 1.458  1.485  
μ/mm-1 1.541 0.971  1.040  
F(000) 1616.0 648.0  1382.0  
Crystal size/mm3 0.527 × 0.287 × 0.215 0.366 × 0.313 × 0.136  
0.368 × 0.184 × 
0.111  
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073)  MoKα (λ = 0.71073)  
2Θ range for data collection/° 4.79 to 55.89 5.182 to 55.924  4.426 to 55.936  
Index ranges 
-19 ≤ h ≤ 19, -15 ≤ k ≤ 
17, -21 ≤ l ≤ 19 
-14 ≤ h ≤ 14, -10 ≤ k 
≤ 10, -16 ≤ l ≤ 21  
-12 ≤ h ≤ 14, -12 ≤ 
k ≤ 12, -37 ≤ l ≤ 34  
Reflections collected 28457 11970  27015  
Independent reflections 
3929 [Rint = 0.0254, Rsigma 
= 0.0148] 
3411 [Rint = 0.0348, 
Rsigma = 0.0330]  
7254 [Rint = 0.0617, 
Rsigma = 0.0618]  
Data/restraints/parameters 3929/0/169 3411/0/157  7254/144/379  
Goodness-of-fit on F2 1.049 1.056  1.045  
Final R indexes [I>=2σ (I)] R1 = 0.0163, wR2 = 0.0390 
R1 = 0.0234, wR2 = 
0.0562  
R1 = 0.0460, wR2 = 
0.1022  
Final R indexes [all data] R1 = 0.0185, wR2 = 0.0397 
R1 = 0.0286, wR2 = 
0.0586  
R1 = 0.0698, wR2 = 
0.1111  
Largest diff. peak/hole / e Å-3 0.38/-0.38 0.76/-0.55  1.32/-0.82  
Flack parameter - - - 
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Table 8.1 Crystal data (continued).  
Identification code -(S,S)6.7a rac-6.7b 
Empirical formula C34H58F3O3P2RhS C34H58F3O3P2RhS  
Formula weight 768.71 768.71  
Temperature/K 100(2) 100(2)  
Crystal system orthorhombic monoclinic  
Space group Pna21 P21/c  
a/Å 19.8075(16) 21.5264(4)  
b/Å 10.4794(8) 16.5233(3)  
c/Å 16.7222(13) 21.8522(4)  
α/° 90 90  
β/° 90 114.6529(8)  
γ/° 90 90  
Volume/Å3 3471.0(5) 7064.1(2)  
Z 4 8  
ρcalcg/cm3 1.471 1.446  
μ/mm-1 0.694 0.682  
F(000) 1616.0 3232.0  
Crystal size/mm3 0.524 × 0.342 × 0.228 0.48 × 0.36 × 0.23  
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073)  
2Θ range for data collection/° 4.112 to 55.948 3.206 to 55.91  
Index ranges 
-25 ≤ h ≤ 26, -13 ≤ k ≤ 
13, -22 ≤ l ≤ 21 
-28 ≤ h ≤ 28, -21 ≤ k ≤ 
21, -28 ≤ l ≤ 28  
Reflections collected 30650 64116  
Independent reflections 
8233 [Rint = 0.0230, Rsigma 
= 0.0237] 
16956 [Rint = 0.0395, Rsigma 
= 0.0385]  
Data/restraints/parameters 8233/1/401 16956/97/814  
Goodness-of-fit on F2 1.032 1.021  
Final R indexes [I>=2σ (I)] R1 = 0.0190, wR2 = 0.0449 R1 = 0.0383, wR2 = 0.0850  
Final R indexes [all data] R1 = 0.0203, wR2 = 0.0455 R1 = 0.0540, wR2 = 0.0932  
Largest diff. peak/hole / e Å-3 0.51/-0.24 1.24/-0.55  
Flack parameter 0.044(7) - 
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